data_2n70_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n70 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.538 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -74.88 -41.97 58.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.557 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.7 mt -51.85 -42.93 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.66 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.0 109.002 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.53 96.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.3 mt -66.6 -57.29 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.242 -1.152 . . . . 0.0 109.091 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.39 -36.89 23.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 108.73 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.564 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.26 -57.28 13.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.564 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 18.3 mt -51.75 -50.35 60.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.833 . . . . 0.0 109.745 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mt -53.05 -31.95 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.3 -59.15 2.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -49.81 -42.85 47.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 2.2 tt -72.72 -42.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.2 tt -59.78 -28.5 67.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.048 . . . . 0.0 109.064 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -45.43 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.51 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 61.5 ttt180 -55.76 -34.95 65.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.38 -51.07 6.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 -179.894 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 CA-C-O 121.178 0.407 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.64 -47.64 85.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.586 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.544 ' CG1' HD22 ' C' ' 331' ' ' ASN . 11.4 t -62.63 -33.58 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.31 -59.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.68 -39.53 17.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.933 . . . . 0.0 108.957 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.26 -32.0 68.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.387 -0.821 . . . . 0.0 109.247 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -63.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.6 tp -50.94 -38.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.031 -1.043 . . . . 0.0 108.366 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.92 -44.18 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -55.5 -48.41 70.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -55.91 -38.29 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -1.148 . . . . 0.0 108.705 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.15 -35.91 76.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.247 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.2 OUTLIER -55.68 -47.98 75.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.046 -1.034 . . . . 0.0 109.025 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.6 tp -67.79 -36.96 81.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.629 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.827 -1.171 . . . . 0.0 108.145 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.7 -35.13 65.12 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . 0.526 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -60.7 -56.12 25.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 109.419 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.32 -41.11 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.375 -0.828 . . . . 0.0 109.575 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -36.86 79.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.4 -50.58 58.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.73 -28.69 68.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.553 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.544 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -74.9 -42.1 58.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.9 mt -51.81 -43.01 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.5 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -59.23 -44.5 96.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 83.4 mt -66.63 -57.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -1.111 . . . . 0.0 109.082 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.4 mt -49.31 -36.83 22.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 108.802 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.573 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.36 -57.26 13.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.043 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 18.5 mt -51.7 -50.34 60.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -0.784 . . . . 0.0 109.772 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 19.2 mt -53.09 -32.07 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.626 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.21 -58.81 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.16 -0.962 . . . . 0.0 109.682 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -50.22 -42.59 51.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.869 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 2.2 tt -73.03 -41.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 109.6 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.2 tt -59.8 -28.54 67.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 -45.36 30.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 109.421 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . 0.526 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 61.6 ttt180 -55.73 -34.99 65.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.35 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.4 -51.23 6.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.391 -0.818 . . . . 0.0 109.554 -179.817 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 121.216 0.423 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.61 -47.56 85.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.538 ' CG1' HD22 ' A' ' 131' ' ' ASN . 11.5 t -62.69 -33.48 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.553 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.41 -59.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.72 -39.52 17.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 108.972 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.32 -31.84 67.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.522 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.7 tp -50.92 -38.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.112 -0.993 . . . . 0.0 108.394 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.92 -44.25 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -55.33 -48.53 68.79 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' D' ' 435' ' ' ILE . 1.8 mp -55.88 -38.33 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -1.128 . . . . 0.0 108.644 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.06 -36.05 77.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.2 OUTLIER -55.58 -48.04 75.46 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.923 -1.11 . . . . 0.0 108.976 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.614 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.7 tp -67.77 -36.96 81.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.821 -1.151 . . . . 0.0 109.665 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.13 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.873 -1.142 . . . . 0.0 108.089 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.74 -35.12 65.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . 0.51 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.2 t90 -60.5 -56.09 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.517 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 16.2 tt -65.56 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.624 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.57 -36.89 79.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.437 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.46 -50.52 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.82 -28.72 69.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 121.508 0.671 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -37.5 71.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 109.525 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.85 -46.11 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.518 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.5 tt -75.57 -31.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 108.864 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.03 85.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 63.0 mt -68.32 -52.97 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -1.048 . . . . 0.0 108.936 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -50.02 -35.01 23.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 108.904 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.547 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.94 -58.07 7.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.547 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 12.7 mt -55.35 -46.8 76.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.602 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.2 mt -55.27 -34.89 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.53 -57.4 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -50.38 -54.51 21.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.317 -0.864 . . . . 0.0 109.576 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 3.8 tt -58.93 -42.7 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.479 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 6.3 mt -54.41 -31.06 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 0.0 109.043 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.2 -34.92 56.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 109.486 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -29.87 67.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.576 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.04 -15.73 20.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.645 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.686 -179.728 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.489 1.209 0 CA-C-O 121.235 0.431 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.0 mp -50.42 -41.45 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.23 -58.87 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.07 -39.61 13.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.101 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.69 -33.68 66.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.865 . . . . 0.0 109.163 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.44 -62.02 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.977 . . . . 0.0 109.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.2 tp -51.28 -38.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.718 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 7.3 mt -54.03 -46.45 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 108.549 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.67 88.73 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.64 -52.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -1.148 . . . . 0.0 108.715 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.7 -38.32 72.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 109.551 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -53.49 -47.44 69.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.036 -1.04 . . . . 0.0 109.352 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.627 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.8 tp -67.16 -36.74 82.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.13 -40.11 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.99 -34.43 66.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.72 -55.19 36.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.6 tt -63.51 -35.5 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.778 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.5 -62.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -46.76 -50.85 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.605 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.606 HH11 ' CG ' ' B' ' 245' ' ' ARG . 0.1 OUTLIER -57.12 -35.41 69.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -37.58 71.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.526 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.81 -46.28 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 tt -75.35 -31.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.115 -0.991 . . . . 0.0 108.978 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.11 -45.92 86.39 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 63.0 mt -68.32 -53.11 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.374 -1.074 . . . . 0.0 108.911 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.4 tp -49.78 -35.22 21.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.553 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.7 -58.2 7.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.553 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 12.7 mt -55.33 -46.68 76.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -0.819 . . . . 0.0 109.704 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.28 -35.06 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.56 -56.83 4.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -50.79 -54.3 24.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 3.9 tt -59.18 -42.53 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.09 -1.006 . . . . 0.0 109.436 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.477 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 6.3 mt -54.49 -31.04 55.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.39 -34.75 54.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -29.87 67.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.58 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.05 -15.69 20.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.702 -179.754 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 121.19 0.412 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mp -50.4 -41.39 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.07 -35.98 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.629 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.22 -58.91 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.23 -39.55 14.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.61 -33.72 66.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.184 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.49 -61.98 1.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.417 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.2 tp -51.32 -38.57 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 108.688 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 7.4 mt -53.95 -46.43 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.67 -46.73 88.71 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.58 -52.97 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -1.136 . . . . 0.0 108.744 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.65 -38.45 72.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.629 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -53.35 -47.54 69.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.054 -1.029 . . . . 0.0 109.334 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.629 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 8.0 tp -67.05 -36.91 83.09 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.11 -39.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.855 -1.153 . . . . 0.0 107.925 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.13 -34.35 66.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -60.46 -55.32 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.638 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.62 -35.38 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.5 -62.48 1.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.533 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -46.77 -50.86 17.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.584 HH11 ' CG ' ' D' ' 445' ' ' ARG . 0.1 OUTLIER -57.13 -35.29 69.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.469 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.391 0.615 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.595 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.4 OUTLIER -74.91 -38.03 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.623 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.1 mt -50.42 -44.95 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.414 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.0 tt -77.91 -35.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 109.025 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.86 -46.65 90.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 79.2 mt -67.23 -56.4 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -1.072 . . . . 0.0 109.177 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mt -49.93 -33.58 17.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.007 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.12 -52.71 61.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 109.122 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.455 ' CD2' ' CE1' ' D' ' 437' ' ' HIS . 5.9 mt -55.37 -38.06 68.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.736 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.5 mt -68.77 -29.7 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.65 -55.25 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 109.826 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.12 -43.39 61.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 4.0 tp -72.79 -44.39 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.033 -1.042 . . . . 0.0 109.697 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.2 mt -48.52 -35.5 13.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 109.218 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -47.22 23.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -28.16 6.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -16.39 15.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.029 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.872 -179.525 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.49 1.316 0 CA-C-O 121.159 0.4 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.84 -37.81 32.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.597 ' CG1' HD22 ' C' ' 331' ' ' ASN . 6.6 t -64.64 -35.89 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.57 -58.11 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 109.339 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.33 -37.27 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.946 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.11 -35.28 66.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.021 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -62.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 tp -51.02 -40.22 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.05 -1.031 . . . . 0.0 108.585 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.1 mt -53.73 -42.31 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.12 -46.7 92.37 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -57.28 -39.12 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 0.0 108.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.31 -35.27 73.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.422 -0.799 . . . . 0.0 109.371 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.513 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -55.07 -49.81 70.72 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.934 -1.104 . . . . 0.0 109.014 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.513 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 12.0 tp -67.68 -36.6 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.66 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.74 -37.56 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.859 -1.151 . . . . 0.0 108.293 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.29 -40.62 62.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -53.74 -53.19 55.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.502 -0.749 . . . . 0.0 109.415 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 14.9 tt -67.39 -33.57 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.18 -59.51 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -52.54 -43.14 64.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.601 HH11 ' CG ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -62.85 -30.96 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.597 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.4 OUTLIER -75.09 -38.07 61.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.529 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 4.4 mt -50.43 -45.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 tt -77.7 -35.49 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.104 -0.998 . . . . 0.0 108.932 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.79 88.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.06 -56.54 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.276 -1.132 . . . . 0.0 109.198 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 mt -49.84 -33.67 17.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 108.981 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.469 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.15 -52.6 61.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.135 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.469 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 5.9 mt -55.43 -37.98 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.773 . . . . 0.0 109.753 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 7.7 mt -68.88 -29.63 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.83 -54.66 5.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.819 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -51.55 -43.45 62.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.055 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 4.1 tp -72.62 -44.39 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 mt -48.46 -35.65 13.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.014 -1.054 . . . . 0.0 109.21 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -47.16 23.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -28.23 6.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.99 . . . . 0.0 109.565 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.94 -16.34 15.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.528 -0.733 . . . . 0.0 110.017 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 109.853 -179.607 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.489 1.242 0 CA-C-O 121.298 0.458 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.87 -37.79 32.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.595 ' CG1' HD22 ' A' ' 131' ' ' ASN . 7.0 t -64.69 -35.87 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.69 -58.08 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.274 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.37 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.136 -0.978 . . . . 0.0 108.933 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -73.09 -35.21 66.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.058 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -62.74 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.0 tp -51.01 -40.26 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.21 -0.932 . . . . 0.0 108.573 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.3 mt -53.6 -42.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.171 -0.955 . . . . 0.0 108.475 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.09 -46.82 92.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.13 -39.23 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.34 -35.19 73.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.459 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.3 OUTLIER -55.06 -49.8 70.7 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.014 -1.054 . . . . 0.0 109.082 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.512 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 12.4 tp -67.62 -36.72 81.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.78 -1.168 . . . . 0.0 109.663 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.7 -37.62 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 108.211 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.2 -40.59 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -53.77 -53.03 57.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 109.481 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.6 -33.4 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.14 -59.65 4.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -52.47 -43.16 64.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.605 HH11 ' CG ' ' D' ' 445' ' ' ARG . 0.0 OUTLIER -62.91 -30.86 71.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.53 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -40.11 28.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 109.585 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.52 -45.21 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.347 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tt -76.73 -44.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.173 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -48.11 -45.19 26.86 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.1 -55.66 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.01 -33.16 17.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.94 . . . . 0.0 108.929 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.538 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.33 -55.12 31.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 12.1 mt -55.06 -45.85 75.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.24 -35.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.39 -57.06 3.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.4 t-105 -48.9 -51.76 28.19 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.205 -0.935 . . . . 0.0 109.682 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 1.6 tt -65.26 -41.85 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 0.0 110.077 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.473 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 tt -59.42 -30.69 68.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.04 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -37.77 59.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.18 73.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.32 -47.38 8.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.662 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 121.203 0.418 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -59.0 5.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.595 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.38 -35.08 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.62 -59.59 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.371 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.27 -37.48 10.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.45 -32.43 66.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.861 . . . . 0.0 109.233 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -58.51 4.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.71 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.82 -35.41 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.037 -1.039 . . . . 0.0 108.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.12 -44.17 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.75 -45.14 95.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.56 -53.81 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.224 -1.163 . . . . 0.0 108.961 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.53 -35.41 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.299 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.62 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -56.06 -48.74 75.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.62 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.8 tp -64.48 -37.71 88.5 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.638 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.36 -38.98 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.85 -32.7 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.31 -57.77 8.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.501 -0.75 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.11 -38.12 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.63 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.3 -26.84 64.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.53 -43.15 23.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.605 HH11 ' CG ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -64.42 -55.75 18.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.596 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 -40.24 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 mt -51.47 -45.29 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.327 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 11.2 tt -76.54 -44.6 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.249 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -48.32 -44.98 28.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.25 -55.58 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -1.115 . . . . 0.0 109.211 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.07 -33.07 17.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.548 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -62.4 -55.07 31.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 108.893 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.548 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 12.0 mt -55.14 -45.84 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.394 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.28 -35.5 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.41 -56.36 4.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.4 t-105 -49.44 -51.6 34.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -0.863 . . . . 0.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 1.5 tt -65.49 -41.85 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.847 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.475 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.4 tt -59.22 -30.9 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.036 -1.04 . . . . 0.0 109.2 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -37.66 59.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -32.14 73.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.35 -47.38 8.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.643 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.571 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 121.235 0.431 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -58.95 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.602 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.32 -35.15 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.7 -59.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.417 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -37.35 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.214 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.53 -32.4 66.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -58.38 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.732 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.7 tp -56.97 -35.34 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 108.89 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.3 mt -57.04 -44.24 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 108.568 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.63 -45.26 94.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.48 -53.75 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -1.146 . . . . 0.0 108.978 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.624 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -55.98 -48.85 75.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.624 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 8.0 tp -64.41 -37.8 88.8 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.637 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.3 -39.01 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.91 -32.6 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.26 -57.77 8.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.418 -0.801 . . . . 0.0 109.59 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.22 -38.0 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.23 -26.96 65.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -79.43 -43.26 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' D' ' 445' ' ' ARG . 0.0 OUTLIER -64.41 -55.72 19.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.535 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.578 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.49 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER -80.22 -44.7 19.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 109.989 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.49 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mm -51.77 -42.55 32.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.533 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 13.2 tt -76.12 -42.08 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.226 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -51.31 -45.92 52.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 76.0 mt -66.31 -57.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -1.11 . . . . 0.0 109.277 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.52 -34.33 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.154 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.2 -60.62 3.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.225 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.586 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 12.3 mt -50.9 -44.55 59.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -57.66 -32.9 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.59 -56.74 3.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.602 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.3 t-105 -48.44 -48.35 37.54 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.333 -0.854 . . . . 0.0 109.619 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 2.9 tt -68.69 -42.07 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.479 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 tt -57.85 -31.88 67.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.107 . . . . 0.0 109.183 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -46.07 50.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.12 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.09 -23.26 65.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.109 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.04 -16.54 20.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.568 -179.804 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.223 0.426 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -47.5 73.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.82 -42.67 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.9 t -58.26 -56.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.316 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.23 21.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 108.947 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.81 66.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.01 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.5 t-20 -68.48 -63.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.54 -36.49 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.116 -0.99 . . . . 0.0 108.425 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 22.5 mt -58.4 -42.55 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.58 84.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -56.1 -52.11 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.105 -1.232 . . . . 0.0 108.672 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.35 74.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.449 -0.782 . . . . 0.0 109.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.619 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -52.73 -46.78 67.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.075 -1.016 . . . . 0.0 109.449 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.619 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.7 tp -67.5 -37.63 83.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.764 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.8 mm -49.37 -39.86 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.817 -1.177 . . . . 0.0 108.028 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.97 -35.67 66.96 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.92 -57.28 13.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.573 -0.704 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 11.3 tt -60.05 -37.86 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.583 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.19 -58.96 5.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.488 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' B' ' 244' ' ' ASP . 4.5 m-20 -55.55 -51.06 68.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -49.73 -28.1 5.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.334 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.18 0.514 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.484 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -80.18 -44.84 19.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 0.0 110.033 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.6 mm -51.72 -42.62 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.504 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 13.2 tt -75.99 -42.14 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -51.32 -45.8 52.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.33 -57.34 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -1.111 . . . . 0.0 109.227 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.42 -34.3 16.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.165 -0.96 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.595 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.18 -60.71 3.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.329 -0.857 . . . . 0.0 109.143 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.595 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 12.2 mt -50.84 -44.58 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.484 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.72 -32.85 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.66 -56.24 4.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.574 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.3 t-105 -49.02 -47.98 44.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.606 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 2.8 tt -69.05 -41.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -57.73 -32.04 67.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.57 -45.92 50.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.183 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.06 -23.26 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.889 . . . . 0.0 109.15 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.01 -16.48 20.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.648 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 109.56 -179.763 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 CA-C-O 121.257 0.44 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.77 -47.41 73.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.78 -42.7 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.611 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.9 t -58.25 -56.61 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.87 -40.4 21.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 108.936 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.7 66.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 109.029 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.5 t-20 -68.52 -63.81 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.5 -36.54 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.4 -42.48 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.72 -47.54 84.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' D' ' 435' ' ' ILE . 1.8 mp -56.18 -52.06 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.138 -1.213 . . . . 0.0 108.629 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.36 74.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.547 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.623 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -52.69 -46.81 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.095 -1.003 . . . . 0.0 109.402 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.623 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.8 tp -67.55 -37.53 82.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.78 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.2 mm -49.38 -39.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.857 -1.152 . . . . 0.0 108.045 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.99 -35.66 66.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.69 -57.39 13.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.679 . . . . 0.0 109.629 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.25 -37.73 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.12 -58.95 5.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 0.0 109.414 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' D' ' 444' ' ' ASP . 4.5 m-20 -55.71 -50.94 68.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -49.86 -27.98 5.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.296 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.503 179.857 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -80.76 -42.68 21.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 109.641 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 131' ' ' ASN . 4.4 mt -50.12 -44.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.42 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.1 tt -76.16 -47.24 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.227 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -47.75 -43.27 22.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.18 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -1.186 . . . . 0.0 109.254 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.7 -31.96 5.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.588 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.17 -58.81 5.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.364 -0.835 . . . . 0.0 109.0 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.588 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 13.0 mt -48.98 -50.99 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.18 -33.47 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.59 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.63 -58.42 3.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.975 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -53.09 -46.03 68.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.29 -0.882 . . . . 0.0 109.996 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -67.59 -42.44 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.816 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.465 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 tt -55.63 -34.64 65.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.082 -1.012 . . . . 0.0 108.811 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.3 -35.12 63.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.512 -0.743 . . . . 0.0 109.222 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -32.61 72.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.2 -14.72 23.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.65 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.496 1.825 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.798 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.244 0 CA-C-O 121.234 0.431 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.02 -61.25 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.968 . . . . 0.0 109.575 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 11.0 t -51.39 -40.52 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.25 -58.0 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.217 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.19 -36.26 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 108.977 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.5 -30.93 64.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.379 -0.826 . . . . 0.0 109.187 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -59.61 3.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 tp -55.44 -36.94 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 0.0 108.689 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 12.7 mt -56.64 -42.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.255 -0.903 . . . . 0.0 108.679 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.35 95.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 81.3 mt -59.71 -53.27 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 0.0 108.76 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.63 -37.0 70.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.373 -0.829 . . . . 0.0 109.22 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -54.2 -47.43 72.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.295 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 8.0 tp -67.11 -37.56 84.11 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.683 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 41.0 mm -49.36 -39.4 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.848 -1.157 . . . . 0.0 107.994 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -35.32 65.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -60.12 -57.93 10.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.514 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 9.5 tt -61.27 -35.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.2 -32.72 73.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.3 -36.76 69.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.586 HH11 ' CG ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -72.55 -47.1 50.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' C' ' 332' ' ' ILE . 0.2 OUTLIER -80.61 -42.85 21.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.578 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' C' ' 331' ' ' ASN . 4.4 mt -50.02 -44.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.437 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 11.2 tt -76.04 -47.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 109.286 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -47.95 -43.36 23.91 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 98.2 mt -68.19 -59.1 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -1.129 . . . . 0.0 109.27 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.84 -31.89 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 108.867 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.6 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.21 -58.62 6.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 13.1 mt -49.02 -51.06 33.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -0.877 . . . . 0.0 109.73 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.11 -33.64 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -57.87 3.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 109.916 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -53.71 -45.82 70.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 110.01 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 1.0 OUTLIER -67.71 -42.25 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 109.665 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -55.8 -34.55 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.999 -1.063 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.54 -34.95 63.09 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.402 -0.811 . . . . 0.0 109.139 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -32.59 71.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.118 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.31 -14.57 23.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.877 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.413 -0.804 . . . . 0.0 109.647 -179.817 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.49 1.286 0 CA-C-O 121.188 0.412 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.04 -61.09 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.638 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 11.3 t -51.55 -40.42 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.6 t -57.31 -57.99 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.26 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.1 -36.35 13.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 108.958 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.46 -30.96 65.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.1 OUTLIER -68.13 -59.6 3.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.656 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.0 tp -55.43 -36.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.973 -1.08 . . . . 0.0 108.667 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 12.7 mt -56.68 -42.6 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.579 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.07 -45.35 95.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 81.8 mt -59.68 -53.19 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -1.116 . . . . 0.0 108.823 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.73 -36.93 70.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.228 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.628 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -54.21 -47.41 72.18 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.229 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 8.0 tp -67.1 -37.69 84.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.62 -1.232 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.8 mm -49.23 -39.59 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -35.19 65.69 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -59.97 -58.0 10.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.512 -0.743 . . . . 0.0 109.493 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 9.7 tt -61.41 -35.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 0.0 109.615 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.24 -32.65 73.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.31 -36.76 68.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.584 HH11 ' CG ' ' D' ' 445' ' ' ARG . 0.0 OUTLIER -72.55 -47.14 50.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.468 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.336 0.589 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -39.48 61.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.6 mt -52.86 -45.17 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.273 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.46 -26.87 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 0.0 109.018 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.85 -55.75 29.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.32 -48.17 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -1.085 . . . . 0.0 108.702 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 tp -50.03 -40.04 43.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 108.59 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.556 ' HE2' ' HE2' ' C' ' 337' ' ' HIS . 0.0 OUTLIER -60.11 -52.89 63.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.409 -0.807 . . . . 0.0 108.882 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.508 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 12.4 mt -56.84 -49.76 74.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.401 -0.812 . . . . 0.0 109.568 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.62 -33.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.336 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.64 -59.7 2.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -48.57 -53.3 18.86 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 3.4 tt -60.15 -43.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.488 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 7.0 mt -54.8 -31.68 59.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.134 . . . . 0.0 108.952 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.19 -33.49 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mp -93.48 -16.51 24.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.888 . . . . 0.0 109.707 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.63 -179.87 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 121.303 0.46 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' B' ' 226' ' ' LEU . 10.8 mp -63.44 -57.58 9.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -36.34 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.2 -0.937 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -57.38 -59.31 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.218 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.28 16.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.92 -29.75 66.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -0.823 . . . . 0.0 109.098 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' B' ' 228' ' ' VAL . 33.8 m-20 -67.74 -63.62 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 7.2 tp -50.34 -36.46 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 108.534 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 17.9 mt -57.85 -43.44 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.212 -0.93 . . . . 0.0 108.579 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.81 88.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.94 -50.85 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 108.707 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.35 -38.44 77.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -53.2 -46.69 69.14 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.957 -1.089 . . . . 0.0 109.278 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.8 tp -67.82 -36.87 81.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.746 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -49.62 -39.83 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.29 -38.08 68.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -57.21 -56.09 26.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.507 -0.746 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.47 -47.23 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.18 -15.4 63.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.955 . . . . 0.0 109.495 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -58.18 3.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.524 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.56 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -61.17 -31.78 71.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.631 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 109.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -39.4 61.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.89 -45.2 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.225 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 12.6 tt -78.3 -27.16 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.79 -55.73 29.2 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.32 -48.02 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -1.106 . . . . 0.0 108.78 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 2.1 tp -50.11 -39.99 44.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.556 ' HE2' ' HE2' ' A' ' 137' ' ' HIS . 0.0 OUTLIER -60.11 -52.83 63.69 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.519 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 12.3 mt -56.88 -49.92 74.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.795 . . . . 0.0 109.488 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 36.0 mt -52.49 -33.16 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -79.7 -59.01 2.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -49.13 -52.93 23.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.697 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 3.4 tt -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.486 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 7.1 mt -54.81 -31.64 59.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.953 -1.092 . . . . 0.0 109.101 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -77.36 -32.63 55.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -72.24 -33.59 67.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.542 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.35 -16.68 24.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.659 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.581 -179.791 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.243 0 CA-C-O 121.238 0.432 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' D' ' 426' ' ' LEU . 10.8 mp -63.42 -57.59 9.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.93 -36.36 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.429 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -57.44 -59.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.942 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.35 16.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 108.59 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -69.85 -29.82 67.15 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.451 -0.78 . . . . 0.0 109.123 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' D' ' 428' ' ' VAL . 33.5 m-20 -67.65 -63.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 7.3 tp -50.47 -36.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.125 -0.985 . . . . 0.0 108.569 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 17.7 mt -57.8 -43.52 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.523 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.77 87.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.98 -50.77 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -1.175 . . . . 0.0 108.741 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.42 -38.43 77.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.392 -0.817 . . . . 0.0 109.499 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -53.2 -46.64 69.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.9 tp -67.78 -36.97 81.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.759 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 37.0 mm -49.61 -39.74 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.81 -1.181 . . . . 0.0 107.836 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.38 -37.9 68.62 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.4 t90 -57.31 -55.89 28.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.507 -0.746 . . . . 0.0 109.091 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.71 -47.25 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.93 -15.6 63.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -58.09 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.558 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -61.23 -31.78 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -74.67 -43.07 57.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -50.74 -45.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 tt -73.0 -34.97 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.223 -0.923 . . . . 0.0 108.894 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -41.86 81.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.59 -58.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.342 -1.093 . . . . 0.0 108.999 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.91 -33.62 11.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.925 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.421 ' ND1' ' C ' ' A' ' 137' ' ' HIS . 0.0 OUTLIER -64.12 -51.02 65.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.031 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.454 ' CD2' ' CE1' ' D' ' 437' ' ' HIS . 5.6 mt -59.45 -40.77 87.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.85 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.6 tt -82.81 -54.1 5.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 109.541 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -50.77 -43.7 58.49 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.281 -0.887 . . . . 0.0 109.737 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 10.0 tp -72.21 -46.68 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.2 mt -48.88 -32.51 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 109.062 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.04 -54.27 7.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -50.56 -23.27 2.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.34 -17.57 16.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.812 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 121.324 0.468 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.63 -47.99 28.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.89 -38.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.96 -58.83 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.49 15.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.45 67.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.297 -0.877 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.438 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.6 tp -50.12 -37.69 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.123 -0.986 . . . . 0.0 108.519 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.0 mt -55.92 -43.81 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.182 -0.949 . . . . 0.0 108.497 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.11 -44.29 93.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.9 -41.39 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -1.204 . . . . 0.0 108.561 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -68.04 -33.79 75.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.275 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.476 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -57.37 -48.06 80.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.019 -1.051 . . . . 0.0 109.163 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.476 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 9.4 tp -68.23 -35.55 78.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.65 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.42 -41.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.643 -1.286 . . . . 0.0 108.227 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.36 -38.66 71.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -55.45 -54.51 42.87 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.27 -52.45 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.0 109.225 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.03 -41.62 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -62.66 -47.19 84.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.494 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.605 HH11 ' CG ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.54 -37.97 82.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.3 OUTLIER -74.75 -43.07 56.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.3 mt -50.65 -46.02 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.9 tt -72.74 -35.09 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.196 -0.94 . . . . 0.0 108.951 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.88 81.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.59 -58.37 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 109.062 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.89 -33.63 11.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.94 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' C' ' 337' ' ' HIS . 0.0 OUTLIER -64.12 -50.97 66.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.433 -0.792 . . . . 0.0 109.034 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' B' ' 237' ' ' HIS . 5.5 mt -59.58 -40.69 88.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.523 -0.736 . . . . 0.0 109.609 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.582 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.79 -53.44 5.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 109.581 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -51.34 -43.43 61.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.917 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 9.9 tp -72.43 -46.52 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 mt -48.74 -32.7 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.139 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -76.19 -54.17 7.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.378 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -50.48 -23.18 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.398 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.48 -17.53 16.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 109.719 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.294 0.456 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.57 -48.04 28.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.85 -38.65 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.9 -58.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -39.44 15.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.09 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.77 -32.38 67.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.229 -0.919 . . . . 0.0 109.175 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -63.45 1.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.7 tp -50.13 -37.63 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.132 -0.98 . . . . 0.0 108.525 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 9.9 mt -56.1 -43.66 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.14 -0.975 . . . . 0.0 108.467 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.33 93.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.87 -41.49 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.111 -1.229 . . . . 0.0 108.54 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.95 -33.81 75.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.426 -0.796 . . . . 0.0 109.261 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.48 ' ND1' ' C ' ' D' ' 437' ' ' HIS . 0.3 OUTLIER -57.4 -48.15 79.85 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.027 -1.045 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.477 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 9.7 tp -68.05 -35.8 78.82 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.618 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 17.0 mt -50.45 -41.69 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.725 -1.234 . . . . 0.0 108.21 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.41 -38.55 71.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -55.35 -54.59 41.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.43 -0.794 . . . . 0.0 109.073 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.32 -52.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.328 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -41.73 17.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -62.68 -47.2 84.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.605 HH11 ' CG ' ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.55 -37.98 83.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.626 ' ND2' ' N ' ' A' ' 132' ' ' ILE . 0.0 OUTLIER -76.03 -39.79 54.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.457 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.626 ' N ' ' ND2' ' A' ' 131' ' ' ASN . 7.2 mt -53.55 -44.3 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 109.378 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.1 tt -74.64 -36.41 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.127 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.59 91.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.05 -60.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.344 -1.092 . . . . 0.0 109.136 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.98 -24.96 7.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.267 -0.896 . . . . 0.0 108.899 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.468 ' HE2' ' HE2' ' C' ' 337' ' ' HIS . 0.0 OUTLIER -67.86 -55.51 12.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.159 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.464 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 2.4 mt -55.33 -48.27 74.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mt -58.41 -30.96 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 tt -75.96 -46.28 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.377 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CZ3' ' C' ' 341' ' ' TRP . 1.0 OUTLIER -50.65 -47.09 58.66 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 110.032 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.635 ' CG2' ' HE2' ' D' ' 437' ' ' HIS . 9.5 tt -71.16 -42.91 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.04 -1.037 . . . . 0.0 109.908 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.83 -36.74 17.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -75.63 -53.05 9.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.83 . . . . 0.0 109.592 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 66.9 ttt180 -50.48 -23.14 2.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.57 -17.42 15.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.724 . . . . 0.0 109.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 109.996 -179.63 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.207 0 CA-C-O 121.336 0.473 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.38 -41.62 39.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.595 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.611 ' CG1' HD22 ' C' ' 331' ' ' ASN . 13.8 t -61.05 -42.97 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.564 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.6 t -57.91 -58.63 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.431 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.74 -37.43 13.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.22 -31.2 67.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.137 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.0 t-20 -67.71 -64.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.41 -36.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.127 -0.983 . . . . 0.0 108.565 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.78 -45.12 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.28 -46.53 86.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.4 ' CD1' ' N ' ' B' ' 235' ' ' ILE . 1.8 mp -56.44 -40.43 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.313 . . . . 0.0 108.533 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -35.44 75.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.461 -0.774 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.621 ' HE2' ' CG2' ' C' ' 342' ' ' ILE . 3.1 t-80 -54.07 -52.07 62.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.064 -1.022 . . . . 0.0 109.164 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.85 -32.37 70.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.888 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.09 -38.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.516 -1.365 . . . . 0.0 107.864 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.85 62.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -50.5 -52.63 36.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.425 -0.797 . . . . 0.0 109.433 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.8 tt -68.0 -33.7 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.4 -58.3 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -58.9 -42.08 88.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -20.77 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.947 . . . . 0.0 109.607 -179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.612 ' ND2' ' N ' ' C' ' 332' ' ' ILE . 0.0 OUTLIER -76.16 -39.83 54.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.612 ' N ' ' ND2' ' C' ' 331' ' ' ASN . 7.3 mt -53.56 -44.37 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -74.61 -36.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.42 91.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.07 -60.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.119 . . . . 0.0 109.103 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.0 -24.84 7.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 108.844 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.468 ' HE2' ' HE2' ' A' ' 137' ' ' HIS . 0.0 OUTLIER -68.07 -55.33 12.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.358 -0.839 . . . . 0.0 109.149 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.448 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 2.4 mt -55.35 -48.37 74.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.38 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 24.2 mt -58.44 -31.0 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -76.16 -45.45 33.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CZ3' ' CH2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -51.42 -46.72 63.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.436 -0.79 . . . . 0.0 110.063 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.621 ' CG2' ' HE2' ' B' ' 237' ' ' HIS . 9.8 tt -71.42 -42.77 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 0.0 109.946 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.81 -36.7 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.192 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' C' ' 345' ' ' ARG . 0.0 OUTLIER -75.92 -52.89 9.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' C' ' 344' ' ' ASP . 67.0 ttt180 -50.4 -23.13 2.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 109.494 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.66 -17.36 15.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 109.858 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.625 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.245 0.436 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -41.6 39.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.596 ' CG1' HD22 ' A' ' 131' ' ' ASN . 14.3 t -61.16 -42.82 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.569 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.6 t -58.09 -58.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.89 -37.32 13.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.21 67.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 109.059 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.0 t-20 -67.71 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.42 -36.79 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 108.552 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 8.6 mt -55.85 -44.99 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 108.325 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.48 86.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -56.41 -40.41 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.058 -1.26 . . . . 0.0 108.577 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -35.49 75.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.353 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.635 ' HE2' ' CG2' ' A' ' 142' ' ' ILE . 3.0 t-80 -53.96 -52.07 61.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.099 -1.0 . . . . 0.0 109.185 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . . . . . . . . . 11.3 tp -69.77 -32.43 70.92 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.976 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.14 -38.21 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.514 -1.366 . . . . 0.0 107.858 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.83 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.5 t90 -50.4 -52.57 36.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 109.487 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.9 tt -68.3 -33.43 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.46 -58.28 9.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -58.84 -42.19 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.558 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -63.19 -20.75 65.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.528 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.484 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -72.92 -42.19 63.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.597 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.463 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -51.06 -46.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.504 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 tt -72.17 -34.15 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 108.768 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.69 -41.93 83.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.37 -57.1 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.45 -1.029 . . . . 0.0 109.054 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -39.52 43.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 108.694 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.532 ' NE2' ' CD2' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -55.65 -55.37 32.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.518 ' CD2' ' NE2' ' C' ' 337' ' ' HIS . 4.3 mt -58.24 -53.54 57.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 81.8 mt -52.92 -29.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.47 -57.6 3.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.589 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.4 OUTLIER -50.01 -54.69 18.45 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -58.39 -44.93 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.466 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 mt -48.64 -36.27 15.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.0 -1.062 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -37.04 60.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -0.872 . . . . 0.0 109.604 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -64.37 -28.67 69.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.22 -14.18 18.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.799 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 0.0 109.779 -179.749 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.244 0.435 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.81 -53.91 28.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.501 ' CG1' HD22 ' C' ' 331' ' ' ASN . 21.3 t -56.9 -43.64 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' B' ' 231' ' ' ASN . 9.0 t -57.3 -55.36 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.82 23.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.228 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -67.69 -26.26 66.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.208 -0.932 . . . . 0.0 109.16 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' B' ' 228' ' ' VAL . 0.2 OUTLIER -69.97 -65.73 0.68 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.0 tp -50.31 -36.17 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.736 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 28.6 mt -57.95 -44.04 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.95 -43.17 95.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.8 -44.03 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -1.221 . . . . 0.0 108.739 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.06 -36.03 82.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.297 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -55.87 -48.27 75.85 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.93 -36.06 79.49 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.767 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 10.6 mt -50.11 -40.48 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.183 . . . . 0.0 108.006 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.06 -39.21 69.19 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -55.51 -55.75 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.469 -0.77 . . . . 0.0 109.047 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.9 mt -55.49 -48.7 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.75 -50.42 66.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.452 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -48.99 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -53.55 -44.15 69.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 0.0 109.438 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.501 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.09 -42.37 63.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.1 mt -50.77 -46.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.8 tt -71.97 -34.24 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.092 -1.005 . . . . 0.0 108.815 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.9 83.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.41 -57.13 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.343 -1.092 . . . . 0.0 109.071 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.02 -39.72 42.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 108.691 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.518 ' NE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -55.41 -55.5 30.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 109.044 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.532 ' CD2' ' NE2' ' A' ' 137' ' ' HIS . 4.3 mt -58.24 -53.57 56.74 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.537 -0.727 . . . . 0.0 109.735 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 82.3 mt -52.92 -29.93 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.57 -56.92 4.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -50.66 -54.67 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 109.738 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 0.8 OUTLIER -58.33 -44.87 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.245 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.465 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 mt -48.49 -36.5 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 0.0 109.197 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -36.85 60.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -64.39 -28.62 69.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.26 -14.24 18.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.786 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.73 -179.779 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.263 0.443 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.67 -54.01 26.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.484 ' CG1' HD22 ' A' ' 131' ' ' ASN . 21.4 t -56.89 -43.75 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.616 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' D' ' 431' ' ' ASN . 9.5 t -57.27 -55.34 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.78 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -67.92 -25.97 65.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.238 -0.914 . . . . 0.0 109.157 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.2 OUTLIER -70.06 -65.79 0.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.0 tp -50.22 -36.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 28.4 mt -58.04 -43.91 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 108.468 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.06 -43.08 95.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.82 -44.1 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -1.234 . . . . 0.0 108.626 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.14 -35.88 81.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.217 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.06 -48.18 76.53 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.98 -1.075 . . . . 0.0 109.439 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.83 -36.25 80.03 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.81 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 10.5 mt -50.02 -40.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 108.059 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.01 -39.14 69.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -55.52 -55.66 29.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.086 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.8 mt -55.79 -48.52 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.43 -0.794 . . . . 0.0 109.146 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.69 -50.54 65.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -48.91 69.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -53.62 -44.15 69.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.564 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.3 OUTLIER -69.07 -38.81 79.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.481 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.46 -47.89 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.8 tt -77.75 -27.08 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -0.922 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.09 -55.12 32.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 mm -65.24 -48.67 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.023 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.5 -38.69 60.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.982 . . . . 0.0 108.735 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.55 ' NE2' ' CD2' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -59.59 -52.35 65.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.025 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.539 ' CD2' ' NE2' ' C' ' 337' ' ' HIS . 3.5 mt -57.34 -49.43 76.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.78 . . . . 0.0 109.674 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.34 -34.69 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 109.86 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -77.93 -45.14 24.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.06 -1.025 . . . . 0.0 109.918 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 2.1 t-105 -48.7 -51.45 28.56 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 109.948 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -71.33 -39.9 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.53 -40.27 18.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.094 -1.004 . . . . 0.0 109.252 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.31 -43.64 32.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.428 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.25 -34.41 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.74 -49.37 5.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.753 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.715 -179.814 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.294 0.456 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -59.89 3.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.581 ' CG1' HD22 ' C' ' 331' ' ' ASN . 12.7 t -53.5 -39.5 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.32 -54.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.7 -42.37 24.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.15 -32.62 70.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -65.13 -65.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.706 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.3 tp -50.01 -39.22 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.143 -0.973 . . . . 0.0 108.777 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 12.9 mt -53.77 -43.3 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.83 -43.33 98.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -60.83 -43.55 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -1.143 . . . . 0.0 108.979 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -33.08 73.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.523 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.5 OUTLIER -57.12 -51.42 69.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.018 -1.051 . . . . 0.0 109.281 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.523 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 11.7 tp -68.19 -33.62 74.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.73 -39.94 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.741 -1.224 . . . . 0.0 108.06 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.5 tt -73.28 -39.52 65.29 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -52.97 -52.17 59.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.48 -33.78 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.571 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.11 -62.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.94 . . . . 0.0 109.406 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -53.06 -47.84 68.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -48.23 -50.43 29.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.598 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 109.475 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.581 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.3 OUTLIER -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.841 . . . . 0.0 109.516 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.28 -48.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.404 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.9 tt -77.63 -27.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 108.782 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.12 -55.09 32.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.7 mm -65.38 -48.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 108.995 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.45 -38.75 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 108.757 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.539 ' NE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.56 -52.24 66.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 109.093 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.55 ' CD2' ' NE2' ' A' ' 137' ' ' HIS . 3.5 mt -57.33 -49.56 75.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 14.4 mt -52.35 -34.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 0.0 109.912 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.21 -44.22 26.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.81 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 2.1 t-105 -49.56 -51.07 39.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 110.06 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -71.65 -39.79 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.49 -40.23 17.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 0.0 109.299 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.48 -43.56 31.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.27 -34.37 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.76 -49.61 5.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.64 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.855 . . . . 0.0 109.733 -179.755 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.267 0.445 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -59.9 3.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.564 ' CG1' HD22 ' A' ' 131' ' ' ASN . 12.3 t -53.52 -39.4 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.373 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 9.3 t -60.34 -54.65 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 109.427 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.81 -42.26 25.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.139 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -70.35 -32.44 70.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.252 -0.905 . . . . 0.0 109.188 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -65.23 -65.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.726 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.3 tp -49.88 -39.36 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 0.0 108.774 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 12.9 mt -53.77 -43.18 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.251 -0.906 . . . . 0.0 108.691 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.3 98.19 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -60.98 -43.4 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -1.188 . . . . 0.0 108.914 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -33.08 73.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.339 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.523 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.5 OUTLIER -57.12 -51.36 69.61 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.049 -1.032 . . . . 0.0 109.314 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.523 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 12.0 tp -68.15 -33.65 74.88 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.643 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.71 -39.95 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.658 -1.277 . . . . 0.0 108.125 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.36 -39.43 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -52.86 -52.29 57.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.58 -33.64 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.01 -62.83 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.08 -47.95 68.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -48.09 -50.45 28.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.618 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.386 -179.89 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -73.53 -40.99 63.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.3 mt -50.85 -42.86 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.45 -29.1 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.977 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.46 -53.53 44.71 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -65.26 -50.21 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -1.154 . . . . 0.0 108.892 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 tp -50.24 -40.12 46.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 108.585 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.593 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.93 -58.95 6.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.427 -0.795 . . . . 0.0 108.939 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.593 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 17.1 mt -49.23 -48.74 45.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.693 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.81 -32.37 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.52 -58.44 3.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.042 . . . . 0.0 109.705 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -50.45 -44.04 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.763 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 1.6 tt -71.41 -41.46 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.989 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.469 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 tt -58.29 -29.32 65.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 0.0 109.02 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.77 -44.03 28.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.882 . . . . 0.0 109.367 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.516 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 22.3 ttt180 -54.62 -36.3 64.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 -50.53 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.697 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.462 -0.774 . . . . 0.0 109.524 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.489 1.236 0 CA-C-O 121.182 0.409 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.45 -59.26 5.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.432 ' CG1' HD22 ' C' ' 331' ' ' ASN . 25.5 t -50.66 -47.58 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -48.79 -58.63 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.123 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.73 -36.44 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.28 -32.53 68.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 109.067 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.3 m120 -66.63 -62.64 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 7.9 tp -50.94 -37.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.074 -1.016 . . . . 0.0 108.494 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.05 -42.22 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.16 -47.72 85.42 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.28 -39.15 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.237 -1.155 . . . . 0.0 108.6 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.5 mp -68.46 -36.83 79.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.421 -0.799 . . . . 0.0 109.276 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -54.28 -46.93 72.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.019 -1.05 . . . . 0.0 108.982 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.6 tp -68.74 -37.74 79.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.31 -37.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.973 -1.079 . . . . 0.0 108.095 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.54 -37.37 63.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . 0.56 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -58.52 -57.0 14.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.688 . . . . 0.0 109.436 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 16.4 tt -63.72 -40.17 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.544 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.29 -48.03 81.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.593 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -41.1 90.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -68.67 -25.36 64.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.432 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.57 -41.09 63.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.419 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.4 mt -50.84 -42.93 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.313 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.33 -29.17 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.034 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.52 -53.39 45.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 3.7 tp -65.3 -50.21 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -1.136 . . . . 0.0 108.89 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.3 tp -50.3 -40.17 47.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 108.57 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.603 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.92 -58.81 6.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.603 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 17.1 mt -49.26 -48.86 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.76 -32.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.514 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.68 -58.13 3.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.607 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -50.74 -43.63 58.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 109.905 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 1.6 tt -71.88 -41.11 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.077 -1.014 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -58.36 -29.34 65.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.85 -44.0 28.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 22.5 ttt180 -54.58 -36.2 64.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -50.67 6.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.408 -0.807 . . . . 0.0 109.554 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.488 1.156 0 CA-C-O 121.247 0.436 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.42 -59.22 5.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.405 ' CG1' HD22 ' A' ' 131' ' ' ASN . 26.9 t -50.63 -47.53 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -48.8 -58.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.148 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.5 11.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.31 -32.4 68.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 109.085 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.4 m120 -66.7 -62.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 7.8 tp -50.89 -37.37 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 108.584 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.0 -42.29 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.88 83.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.18 -39.12 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -1.155 . . . . 0.0 108.548 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.59 -36.79 79.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.356 -0.84 . . . . 0.0 109.184 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -54.3 -46.91 72.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.975 -1.078 . . . . 0.0 108.878 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.614 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.8 tp -68.77 -37.76 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.574 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.36 -37.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.66 -37.3 62.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . 0.516 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.1 t90 -58.37 -56.96 15.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.594 -0.691 . . . . 0.0 109.528 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 16.5 tt -63.92 -39.98 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.33 -48.0 81.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.86 -41.01 90.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -68.77 -25.34 64.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.377 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.466 179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.39 0.614 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -37.32 65.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.97 -44.77 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 tt -78.12 -32.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.255 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.85 97.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 82.3 mt -68.22 -57.0 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.314 -1.11 . . . . 0.0 109.058 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.21 -33.67 13.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.142 -0.974 . . . . 0.0 108.7 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.551 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.4 -55.76 27.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.85 . . . . 0.0 108.99 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.551 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 18.0 mt -54.16 -48.07 71.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.675 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.23 -33.67 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -82.31 -57.6 3.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.7 OUTLIER -50.58 -43.69 56.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.849 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 3.0 tt -68.94 -44.73 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.861 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 0.7 OUTLIER -52.88 -34.68 55.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.74 -1.225 . . . . 0.0 108.741 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -78.21 -31.2 49.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.446 -0.784 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.1 -42.98 95.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.641 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -50.11 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.522 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 CA-C-O 121.2 0.417 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.12 -45.36 52.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 0.0 109.74 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.87 -35.85 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 109.557 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.57 -56.91 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.09 -39.08 19.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.009 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.85 68.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.212 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -63.41 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.443 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.5 tp -49.93 -39.5 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.054 -1.028 . . . . 0.0 108.613 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 8.6 mt -53.98 -45.02 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.169 -0.957 . . . . 0.0 108.444 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.1 -49.34 68.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -53.38 -38.02 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.069 -1.254 . . . . 0.0 108.487 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.31 -37.36 80.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.279 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.604 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.2 OUTLIER -55.32 -48.28 74.39 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.094 -1.004 . . . . 0.0 109.314 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 8.3 tp -67.16 -39.49 86.48 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.697 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . 0.405 ' C ' ' O ' ' B' ' 238' ' ' LEU . 11.4 mt -47.46 -40.01 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.321 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.73 -34.42 64.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . 0.42 ' N ' ' O ' ' B' ' 238' ' ' LEU . 84.9 t90 -60.1 -54.88 40.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.403 -0.81 . . . . 0.0 109.636 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -51.79 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.257 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.89 -53.57 31.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.609 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -54.85 18.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.598 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -58.02 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.489 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.83 -37.44 64.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.82 -44.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.492 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.8 tt -78.03 -33.04 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.7 97.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 82.2 mt -68.39 -56.96 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.316 -1.108 . . . . 0.0 109.006 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mt -49.26 -33.49 12.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.557 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.59 -55.67 28.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.87 . . . . 0.0 108.976 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.557 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 18.0 mt -54.14 -48.11 71.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 55.3 mt -54.38 -33.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -82.35 -57.33 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.044 -1.035 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -50.75 -43.63 58.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.867 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 2.9 tt -69.13 -44.56 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 0.8 OUTLIER -52.88 -34.77 56.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.7 -1.25 . . . . 0.0 108.835 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.37 -30.97 48.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.11 -43.04 95.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.06 -50.09 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.842 . . . . 0.0 109.426 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.2 0.417 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -45.32 54.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.91 -35.86 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.52 -56.89 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.16 -39.11 19.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.019 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.08 -33.79 68.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.205 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.29 -63.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.5 tp -49.97 -39.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.087 -1.008 . . . . 0.0 108.577 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 8.6 mt -54.06 -44.99 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.478 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.07 -49.34 67.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.47 -37.94 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -1.228 . . . . 0.0 108.476 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.41 -37.24 80.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.547 -0.72 . . . . 0.0 109.244 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.616 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.2 OUTLIER -55.42 -48.09 74.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.039 -1.038 . . . . 0.0 109.346 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 8.4 tp -67.14 -39.62 86.58 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.716 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' D' ' 438' ' ' LEU . 11.4 mt -47.47 -39.97 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 0.0 108.353 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.7 -34.41 64.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' D' ' 438' ' ' LEU . 85.4 t90 -60.03 -54.87 40.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.518 -0.739 . . . . 0.0 109.62 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -51.66 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.121 -0.987 . . . . 0.0 109.368 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.92 -53.57 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -54.79 19.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.553 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.586 HH11 ' CG ' ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.09 -20.09 37.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.321 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.461 0.648 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.478 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -72.7 -43.75 62.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 5.0 mt -48.49 -47.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.1 tt -71.35 -33.44 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 108.776 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.2 64.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.3 mm -70.2 -55.28 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.8 mt -48.89 -34.49 12.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 108.66 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.568 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.18 -57.61 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.568 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 3.5 mt -56.35 -51.48 68.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.707 -0.62 . . . . 0.0 110.031 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.07 -28.72 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.5 tt -78.92 -58.72 3.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.73 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -50.19 -52.49 35.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.448 ' N ' ' CG ' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.054 . . . . 0.0 109.249 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 2.6 mt -49.46 -35.83 20.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.927 -1.108 . . . . 0.0 109.174 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -36.11 60.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.494 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -67.1 -28.15 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.97 -16.33 19.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 109.699 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.583 -179.686 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 121.273 0.447 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.73 -60.34 2.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 t -52.35 -34.56 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.99 -58.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.01 -41.16 15.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.259 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.13 68.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 109.147 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -59.5 4.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.811 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.16 -33.93 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.066 -1.022 . . . . 0.0 109.14 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.99 -49.11 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.126 -0.984 . . . . 0.0 108.815 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.12 -45.13 96.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -49.13 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -1.203 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.6 -36.55 84.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.68 -49.04 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 109.236 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' B' ' 239' ' ' ILE . 11.0 tp -67.65 -35.53 79.06 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.821 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' B' ' 238' ' ' LEU . 3.1 mm -50.05 -37.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.35 -38.3 60.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -54.52 -50.53 67.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.81 -38.74 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.719 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -44.0 97.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.524 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.59 35.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.2 OUTLIER -53.99 -42.51 69.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.477 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.1 OUTLIER -72.63 -43.93 62.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.477 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 5.1 mt -48.39 -48.11 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 6.3 tt -71.17 -33.5 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.866 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -53.34 -46.04 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.29 -55.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.81 -34.49 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.668 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.571 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.1 OUTLIER -62.15 -57.58 10.98 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.571 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 3.4 mt -56.5 -51.35 68.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.638 -0.664 . . . . 0.0 110.041 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.02 -28.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.06 -58.23 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -50.55 -52.61 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.447 ' N ' ' CG ' ' C' ' 341' ' ' TRP . 0.9 OUTLIER -59.88 -43.85 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.126 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.446 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 2.6 mt -49.48 -35.75 20.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 109.211 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -36.03 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.887 . . . . 0.0 109.491 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -67.18 -28.15 67.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.93 -16.4 19.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.634 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 109.531 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 CA-C-O 121.276 0.448 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.83 -60.34 2.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 9.1 t -52.24 -34.63 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.94 -58.09 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.11 15.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.99 68.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.122 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -59.35 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.843 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.12 -34.07 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.146 -0.971 . . . . 0.0 109.104 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.9 -49.11 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.03 96.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.68 -49.06 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.273 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.65 -36.52 84.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.219 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.69 -49.1 68.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 109.244 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' D' ' 439' ' ' ILE . 11.1 tp -67.69 -35.47 78.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.633 -1.227 . . . . 0.0 109.832 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' D' ' 438' ' ' LEU . 3.1 mm -50.03 -37.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.793 -1.192 . . . . 0.0 107.877 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.32 -38.33 60.28 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -54.41 -50.59 67.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.483 -0.76 . . . . 0.0 109.605 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.92 -38.57 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.73 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -43.94 97.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.045 -1.034 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.69 34.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.2 OUTLIER -54.0 -42.46 69.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.508 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.467 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.439 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.2 OUTLIER -70.4 -36.22 73.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.368 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.6 mt -53.91 -48.12 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.402 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 tt -72.24 -30.77 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 108.76 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.38 -44.64 84.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.6 mt -69.68 -55.04 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -1.102 . . . . 0.0 109.126 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.83 -36.7 27.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 108.963 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.518 ' NE2' ' CD2' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -64.83 -43.5 92.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.504 ' CD2' ' HE2' ' C' ' 337' ' ' HIS . 3.6 mt -69.42 -47.27 64.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.775 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.5 mt -54.88 -34.41 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.626 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.69 -47.55 18.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.728 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.6 t-105 -46.42 -48.88 18.69 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.5 tt -72.48 -41.92 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.948 . . . . 0.0 109.96 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 tp -47.83 -40.46 21.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 109.345 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.95 -43.83 33.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.92 -33.52 17.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.54 -49.52 5.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.483 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 121.247 0.436 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.09 -49.7 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.435 ' CG1' HD22 ' C' ' 331' ' ' ASN . 61.3 t -59.82 -37.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.37 -57.25 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -33.77 8.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.59 67.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.897 . . . . 0.0 109.241 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . 0.486 ' CG ' ' N ' ' B' ' 232' ' ' ILE . 0.1 OUTLIER -66.56 -61.05 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.486 ' N ' ' CG ' ' B' ' 231' ' ' ASN . 8.6 tp -52.43 -38.39 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 0.0 108.687 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.14 -44.22 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.9 -43.79 96.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.02 -41.75 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -1.221 . . . . 0.0 108.679 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -35.16 78.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.83 . . . . 0.0 109.106 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.532 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.4 OUTLIER -56.5 -50.78 70.77 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.088 -1.007 . . . . 0.0 109.416 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.532 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 11.1 tp -68.16 -33.83 75.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.521 -1.272 . . . . 0.0 109.79 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' B' ' 238' ' ' LEU . 16.9 mt -50.58 -40.1 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.68 -1.263 . . . . 0.0 107.831 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.15 -42.15 66.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -50.25 -48.04 54.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 108.927 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.12 -52.11 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.279 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.33 -31.94 46.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.88 -33.48 64.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.388 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -77.57 -25.95 50.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.439 179.849 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.435 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.2 OUTLIER -70.45 -36.26 73.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.8 mt -53.79 -48.33 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.2 tt -72.05 -30.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 108.742 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.66 84.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 6.6 mt -69.66 -55.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -1.122 . . . . 0.0 109.054 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.79 -36.56 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.989 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.504 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -64.86 -43.63 92.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.518 ' CD2' ' NE2' ' A' ' 137' ' ' HIS . 3.6 mt -69.3 -47.4 64.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.766 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.7 mt -54.83 -34.53 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.74 -46.97 20.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.6 t-105 -46.95 -48.71 21.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . . . . . . . . . 11.0 tt -72.71 -41.76 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 3.3 tp -47.75 -40.59 20.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.357 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.97 -43.9 33.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.88 -33.49 17.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.626 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.5 -49.63 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 121.256 0.44 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.19 -49.64 51.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.439 ' CG1' HD22 ' A' ' 131' ' ' ASN . 60.9 t -59.82 -37.77 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 0.0 109.545 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.7 t -64.25 -57.36 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.098 -1.001 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.96 -33.93 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.888 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.54 -33.54 66.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.487 ' CG ' ' N ' ' D' ' 432' ' ' ILE . 0.1 OUTLIER -66.51 -61.11 2.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' D' ' 431' ' ' ASN . 8.6 tp -52.36 -38.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 108.654 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.13 -44.2 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.213 -0.929 . . . . 0.0 108.525 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.99 -43.67 96.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.14 -41.61 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.11 -1.229 . . . . 0.0 108.761 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -35.24 78.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.099 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.4 OUTLIER -56.44 -50.71 70.9 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.192 -0.942 . . . . 0.0 109.501 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.531 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 11.6 tp -68.22 -33.85 75.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.738 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.64 -40.12 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.637 -1.29 . . . . 0.0 107.81 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.06 -42.12 66.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -50.13 -48.04 53.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.004 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.29 -52.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.18 -32.07 45.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.91 -33.38 63.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -77.56 -26.03 50.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.463 ' OD1' ' CG1' ' D' ' 427' ' ' VAL . 0.5 OUTLIER -72.01 -38.34 69.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 0.0 109.54 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.55 -44.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.308 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tt -78.43 -28.71 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 108.763 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.1 27.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 136' ' ' LEU . 6.2 tp -63.34 -50.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -1.227 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 135' ' ' ILE . 3.7 mt -52.1 -37.75 55.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.085 -1.009 . . . . 0.0 108.74 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.57 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -60.03 -56.03 26.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 108.981 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.57 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 6.3 mt -50.16 -38.62 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.768 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.39 -30.06 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.604 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.63 -53.27 6.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -52.77 -41.46 64.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 10.1 tp -74.36 -47.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.039 -1.038 . . . . 0.0 110.007 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.477 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 2.3 tp -50.2 -30.49 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.006 -1.059 . . . . 0.0 109.032 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.505 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 6.0 t0 -78.35 -46.6 19.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 109.539 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.37 -33.8 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.42 -51.54 4.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.784 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 147' ' ' PHE . 34.7 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 109.616 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.256 0.44 . . . . 0.0 112.394 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.79 -62.29 1.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.42 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.472 ' CG1' ' OD1' ' C' ' 331' ' ' ASN . 39.3 t -50.22 -45.97 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.0 t -48.89 -56.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.042 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.65 18.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.85 -34.64 73.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.431 -0.793 . . . . 0.0 109.145 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -60.8 3.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.067 -1.021 . . . . 0.0 109.254 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.21 -42.0 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.114 -0.991 . . . . 0.0 109.054 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 18.3 mt -50.49 -37.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -63.63 -44.67 96.12 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.65 -39.69 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -1.208 . . . . 0.0 108.533 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.04 -36.23 77.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.381 -0.824 . . . . 0.0 109.138 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.505 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -54.59 -48.79 71.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.972 -1.08 . . . . 0.0 108.954 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.505 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 8.3 tp -66.7 -38.53 86.93 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.695 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.91 -38.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.916 -1.115 . . . . 0.0 108.205 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -36.46 64.34 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -59.77 -56.53 20.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.0 109.566 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.6 tt -61.12 -39.05 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.666 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.3 -54.87 41.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.003 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.83 -50.81 55.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.13 -41.19 87.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.445 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.472 ' OD1' ' CG1' ' B' ' 227' ' ' VAL . 0.5 OUTLIER -71.95 -38.61 69.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.48 -44.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.963 . . . . 0.0 109.286 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . 0.42 HG22 HD12 ' C' ' 333' ' ' ILE . 9.0 tt -78.42 -28.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 108.743 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -63.59 -54.97 27.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' C' ' 336' ' ' LEU . 6.3 tp -63.28 -50.2 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -1.227 . . . . 0.0 108.823 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . 0.43 ' N ' ' CG2' ' C' ' 335' ' ' ILE . 3.7 mt -52.07 -37.85 55.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.103 -0.998 . . . . 0.0 108.756 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.558 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -60.0 -55.89 28.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.027 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.558 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 6.3 mt -50.27 -38.7 42.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.415 -0.803 . . . . 0.0 109.676 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.37 -30.05 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -81.91 -52.64 6.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -53.14 -41.44 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.148 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 10.1 tp -74.39 -47.87 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.97 -1.081 . . . . 0.0 109.872 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.478 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 2.3 tp -50.12 -30.5 11.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.046 -1.034 . . . . 0.0 109.141 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' D' ' 445' ' ' ARG . 6.0 t0 -78.6 -46.41 19.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.36 -33.88 22.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.461 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.3 -51.73 4.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' C' ' 347' ' ' PHE . 34.5 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 121.242 0.434 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.88 -62.19 1.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.463 ' CG1' ' OD1' ' A' ' 131' ' ' ASN . 39.4 t -50.26 -45.94 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.912 . . . . 0.0 109.208 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.84 -56.88 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.005 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.7 -37.56 18.96 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -69.87 -34.64 73.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.112 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -60.8 3.25 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.079 -1.013 . . . . 0.0 109.27 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.12 -41.96 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.177 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 18.7 mt -50.58 -37.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -63.62 -44.7 96.09 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.59 -39.71 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -1.206 . . . . 0.0 108.483 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.02 -36.33 77.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.387 -0.82 . . . . 0.0 109.175 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.499 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.3 OUTLIER -54.49 -48.76 71.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.041 -1.037 . . . . 0.0 108.998 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.499 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 8.4 tp -66.69 -38.55 87.0 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.687 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.93 -38.1 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 108.163 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -36.5 64.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.7 -56.39 22.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.684 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.8 tt -61.33 -38.99 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.22 -54.89 41.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.81 -50.87 55.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -59.06 -41.31 87.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.427 0.632 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 -38.01 45.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.14 -44.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 tt -79.53 -38.98 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 0.0 109.179 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.24 -44.46 75.09 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.8 mt -69.82 -54.98 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -1.07 . . . . 0.0 109.164 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.3 -33.48 13.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.09 -1.006 . . . . 0.0 108.67 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.77 -59.01 5.1 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.569 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 5.6 mt -49.73 -37.72 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.483 -0.76 . . . . 0.0 109.697 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.9 mt -68.99 -30.71 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.08 -54.95 4.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.697 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.2 OUTLIER -50.25 -44.06 53.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.256 -0.903 . . . . 0.0 109.89 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 4.2 tp -72.17 -45.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.617 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.476 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 2.7 mt -49.46 -31.77 10.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.95 -1.094 . . . . 0.0 108.961 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.62 -45.62 24.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -50.33 -34.46 23.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.86 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.637 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 121.24 0.433 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.03 -41.37 25.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -39.75 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.43 -57.82 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.942 . . . . 0.0 109.481 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -46.92 -40.21 13.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.202 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.47 68.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.6 tp -49.55 -38.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.166 -0.959 . . . . 0.0 108.681 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.44 -41.38 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 108.486 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.96 95.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -58.97 -51.53 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.293 . . . . 0.0 108.503 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.8 -37.95 77.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.757 . . . . 0.0 109.545 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.2 OUTLIER -52.61 -48.58 66.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.991 -1.068 . . . . 0.0 109.094 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.521 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 8.1 tp -65.84 -38.26 88.41 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.713 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 38.5 mm -49.44 -38.34 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.764 -1.21 . . . . 0.0 108.094 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.98 -34.87 64.39 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -60.99 -56.56 19.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.485 -0.76 . . . . 0.0 109.346 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.94 -38.57 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.5 -0.75 . . . . 0.0 109.619 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.18 -38.37 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.539 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.42 -48.13 71.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.349 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.43 -40.74 83.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.413 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -38.08 44.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 3.2 mt -51.08 -44.41 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 12.5 tt -79.46 -39.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.168 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -54.18 -44.45 74.43 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 86.5 mt -69.8 -55.02 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.333 -1.098 . . . . 0.0 109.115 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.31 -33.52 13.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.665 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.615 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.67 -58.98 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.428 -0.795 . . . . 0.0 108.92 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.615 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 5.6 mt -49.78 -37.68 30.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 50.7 mt -69.13 -30.68 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.07 -54.64 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 109.666 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -50.38 -44.18 54.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.97 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 4.2 tp -72.18 -45.42 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 109.6 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.478 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 2.7 mt -49.48 -31.82 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 108.891 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.78 -45.47 24.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.785 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -50.23 -34.55 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.654 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.572 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.277 0.449 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.02 -41.25 25.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.55 -39.65 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.138 -0.976 . . . . 0.0 109.597 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.56 -57.77 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -46.89 -40.22 13.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 109.219 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.31 -35.57 68.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -63.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.6 tp -49.55 -38.24 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.166 -0.959 . . . . 0.0 108.632 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.42 -41.41 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.151 -0.968 . . . . 0.0 108.469 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.94 95.92 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . 0.422 ' N ' ' CD1' ' D' ' 435' ' ' ILE . 1.8 mp -58.92 -51.49 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.062 -1.258 . . . . 0.0 108.523 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.84 -37.85 77.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.594 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.519 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.2 OUTLIER -52.67 -48.58 66.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 109.046 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.519 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 8.3 tp -65.76 -38.38 88.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.751 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 38.1 mm -49.38 -38.41 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.762 -1.211 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.0 -34.74 64.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -61.05 -56.38 21.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.26 -38.4 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.03 -38.62 89.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -66.32 -48.12 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -40.76 83.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.299 179.9 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' D' ' 431' ' ' ASN . 0.1 OUTLIER -74.72 -42.88 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.933 . . . . 0.0 109.39 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.424 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mt -51.16 -43.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.604 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.3 tt -74.06 -36.26 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.005 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -50.89 -42.79 47.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.2 mt -71.46 -53.06 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.4 -1.059 . . . . 0.0 109.17 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.17 -37.9 23.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.188 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 137' ' ' HIS . 0.0 OUTLIER -67.54 -44.17 78.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.27 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.464 ' CD2' ' CE1' ' D' ' 437' ' ' HIS . 4.5 mt -60.61 -49.69 76.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.485 -0.759 . . . . 0.0 109.983 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.91 -24.05 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 tt -80.96 -59.95 2.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -0.94 . . . . 0.0 109.894 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.0 OUTLIER -50.59 -42.49 55.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.261 -0.9 . . . . 0.0 109.962 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 3.7 tp -72.77 -42.38 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.85 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 4.9 mt -48.69 -40.69 29.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 0.0 109.096 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -39.1 61.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 145' ' ' ARG . 0.2 OUTLIER -51.03 -37.6 46.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.473 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.9 -48.49 6.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.461 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.276 0 CA-C-O 121.185 0.41 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.15 -51.5 53.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.422 ' CG1' HD22 ' C' ' 331' ' ' ASN . 23.6 t -57.31 -41.55 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.4 -56.29 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.25 -38.43 12.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.248 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.28 66.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 109.375 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . 0.437 ' OD1' ' ND2' ' C' ' 331' ' ' ASN . 0.1 OUTLIER -67.3 -58.46 4.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.444 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.3 tp -54.01 -36.48 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.067 . . . . 0.0 108.565 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 8.4 mt -58.54 -44.44 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 108.728 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.84 -41.56 91.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.18 -36.31 71.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.113 -1.227 . . . . 0.0 108.702 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.72 -35.47 78.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.868 . . . . 0.0 108.858 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -58.53 -51.85 68.15 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.58 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 14.0 tp -63.27 -38.99 93.33 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.619 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 13.9 mt -48.68 -43.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.901 -1.125 . . . . 0.0 108.464 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.88 -42.5 90.22 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -57.9 -43.89 86.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.32 -56.08 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 108.969 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.76 -21.17 62.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 109.532 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.33 -60.67 2.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.375 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.03 -34.5 71.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' B' ' 231' ' ' ASN . 0.1 OUTLIER -74.65 -43.01 57.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.7 mt -51.02 -43.84 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -0.831 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 6.6 tt -73.9 -36.3 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -50.93 -42.73 47.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 6.1 mt -71.46 -53.17 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.374 -1.074 . . . . 0.0 109.181 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.09 -37.91 22.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.173 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.475 ' ND1' ' C ' ' C' ' 337' ' ' HIS . 0.0 OUTLIER -67.54 -44.2 78.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.443 ' CD2' ' CE1' ' B' ' 237' ' ' HIS . 4.4 mt -60.6 -49.84 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.71 -24.25 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.965 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 2.7 tt -81.06 -59.47 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.854 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -50.97 -42.59 60.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 110.006 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 3.8 tp -72.57 -42.57 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 109.611 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.477 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 4.9 mt -48.62 -40.64 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 109.192 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.96 60.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 109.369 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' C' ' 345' ' ' ARG . 0.3 OUTLIER -51.11 -37.47 46.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.429 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.03 -48.48 6.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.489 1.221 0 CA-C-O 121.187 0.411 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -51.56 52.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 24.3 t -57.3 -41.52 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.41 -56.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.49 13.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.176 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.97 -35.31 66.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 109.383 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.448 ' OD1' ' ND2' ' A' ' 131' ' ' ASN . 0.1 OUTLIER -67.22 -58.46 4.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.3 tp -53.95 -36.54 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 108.602 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 8.4 mt -58.45 -44.45 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.152 -0.968 . . . . 0.0 108.762 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.77 -41.65 90.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 23.1 mm -61.24 -36.26 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -1.187 . . . . 0.0 108.645 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.7 -35.44 78.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.341 -0.849 . . . . 0.0 108.913 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.582 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.2 OUTLIER -58.56 -51.89 67.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.107 -0.995 . . . . 0.0 108.977 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.582 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 14.4 tp -63.09 -39.23 94.1 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.562 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 14.0 mt -48.62 -43.35 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.814 -1.179 . . . . 0.0 108.453 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -42.55 89.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.94 -43.67 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.758 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.57 -55.88 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 108.994 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.81 -21.13 62.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.39 -60.66 2.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.98 -34.53 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 0.0 109.343 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.412 0.625 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.484 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.0 OUTLIER -77.84 -50.4 12.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.8 mm -47.61 -44.54 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.469 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.1 tt -72.41 -37.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.012 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -52.17 -49.8 48.59 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.0 mm -65.23 -55.05 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -1.217 . . . . 0.0 109.289 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.4 -33.83 14.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.581 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.97 -60.25 3.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 109.401 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.581 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 4.7 mt -49.05 -39.68 28.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.712 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.7 mt -69.18 -27.72 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.78 -54.11 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.12 -0.988 . . . . 0.0 109.627 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.89 -42.49 62.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 10.3 tp -72.82 -45.26 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.476 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.0 mt -49.12 -33.73 12.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.276 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.78 -43.57 25.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.855 . . . . 0.0 109.655 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.565 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 25.5 ttt180 -50.1 -39.51 42.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.877 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.13 -53.52 3.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 109.854 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.446 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.49 1.288 0 CA-C-O 121.208 0.42 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . 0.419 ' CG1' ' OD1' ' C' ' 331' ' ' ASN . 16.7 t -52.48 -44.63 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.361 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' B' ' 231' ' ' ASN . 4.8 t -53.86 -56.67 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -38.42 17.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 108.806 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.52 -28.83 65.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.327 -0.858 . . . . 0.0 109.076 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.2 m-20 -69.04 -63.79 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.215 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.7 tp -49.05 -36.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 20.2 mt -58.96 -41.07 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 231' ' ' ASN . . . -56.87 -42.86 92.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' B' ' 235' ' ' ILE . 1.7 mp -61.22 -41.03 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -1.23 . . . . 0.0 108.662 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -35.28 78.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 0.0 109.089 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.486 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -56.87 -48.96 76.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.167 -0.958 . . . . 0.0 109.414 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.486 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 9.5 tp -68.1 -35.13 77.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.701 -1.2 . . . . 0.0 109.761 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.56 -41.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.726 -1.233 . . . . 0.0 108.104 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tt -69.96 -40.59 75.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . 0.553 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 88.3 t90 -54.45 -55.93 23.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.05 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.1 mt -53.12 -54.48 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.04 -53.98 23.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.564 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -52.88 -28.13 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -74.64 -48.37 26.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.888 . . . . 0.0 109.516 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.311 0.577 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.479 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.0 OUTLIER -77.92 -50.57 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.998 -179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.479 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.9 mm -47.31 -44.84 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 11.2 tt -72.19 -38.01 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.083 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -52.19 -49.75 48.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 11.5 mm -65.36 -55.01 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -1.22 . . . . 0.0 109.279 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.36 -33.91 14.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.587 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.89 -60.4 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.84 . . . . 0.0 109.297 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.587 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 4.8 mt -48.91 -39.64 26.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 11.0 mt -69.33 -27.73 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.0 tt -82.98 -53.53 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.637 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -52.28 -42.51 63.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 10.3 tp -72.72 -45.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.475 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.0 mt -49.14 -33.69 12.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 109.313 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.94 -43.41 24.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . 0.553 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 25.4 ttt180 -50.2 -39.51 44.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.04 -53.75 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.227 0.428 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' D' ' 431' ' ' ASN . 16.9 t -52.46 -44.59 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.352 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' D' ' 431' ' ' ASN . 4.8 t -53.9 -56.72 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.345 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.0 -38.57 17.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 108.859 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -70.5 -28.81 65.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.2 m-20 -68.98 -63.88 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.194 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.7 tp -48.93 -36.39 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 20.2 mt -59.01 -41.03 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' D' ' 431' ' ' ASN . . . -56.99 -42.8 93.06 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' D' ' 435' ' ' ILE . 1.7 mp -61.22 -40.97 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.14 -1.212 . . . . 0.0 108.631 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -35.16 78.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.062 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.3 OUTLIER -56.77 -49.21 75.99 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.362 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.487 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 9.9 tp -67.92 -35.27 78.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.712 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.52 -41.9 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.708 -1.245 . . . . 0.0 108.104 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.0 tt -70.0 -40.56 75.2 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . 0.565 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 89.0 t90 -54.31 -55.98 22.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.102 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 65.8 mt -53.18 -54.46 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.01 -53.99 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -52.82 -28.27 21.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.341 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -74.56 -48.31 27.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.598 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.553 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.311 0.577 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.464 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -74.75 -43.66 53.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.482 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 8.7 mt -51.06 -45.8 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.489 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.74 -36.36 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 108.891 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -40.66 78.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.0 mt -67.96 -56.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.419 -1.048 . . . . 0.0 109.071 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.56 -35.87 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 108.792 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.573 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -58.5 -59.25 5.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.12 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 11.2 mt -53.25 -51.42 62.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 75.4 mt -54.01 -31.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.15 -58.63 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.552 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.5 OUTLIER -50.95 -50.94 56.96 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 2.0 tt -61.72 -41.99 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.469 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 4.8 mt -54.2 -35.9 62.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.075 . . . . 0.0 108.978 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -29.36 57.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.416 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.32 -35.28 79.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.27 -15.33 20.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.714 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 109.649 -179.708 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.489 1.254 0 CA-C-O 121.323 0.468 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.92 -60.59 2.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.957 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 t -55.51 -39.02 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.481 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.39 -56.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.45 -43.28 23.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.239 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.35 68.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.337 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.31 -65.16 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 tp -49.92 -37.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.177 -0.952 . . . . 0.0 108.675 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 13.2 mt -54.75 -45.89 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.47 -46.2 88.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.0 -53.93 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -1.167 . . . . 0.0 108.93 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.35 -38.18 71.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 0.0 109.424 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -53.51 -47.21 70.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.088 -1.008 . . . . 0.0 109.375 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.4 tp -67.81 -36.36 80.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.04 -39.89 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.764 -1.21 . . . . 0.0 107.894 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -37.47 69.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.4 -57.61 12.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.63 -54.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.258 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.65 -52.17 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.77 -33.8 57.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -65.29 -52.98 50.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 331' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -74.8 -43.66 53.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 8.8 mt -50.96 -46.0 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.52 -36.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 108.986 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.56 -40.64 79.06 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 82.0 mt -67.93 -56.29 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.343 -1.093 . . . . 0.0 109.057 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.51 -35.93 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.928 . . . . 0.0 108.766 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 337' ' ' HIS . . . . . 0.578 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -58.41 -59.18 5.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.184 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 338' ' ' LEU . . . . . 0.578 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 11.1 mt -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 75.6 mt -54.24 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.38 -58.1 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.494 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -51.37 -50.76 58.9 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 342' ' ' ILE . . . . . 0.47 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 2.0 tt -61.94 -41.94 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 343' ' ' LEU . . . . . 0.47 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 4.9 mt -53.95 -36.14 62.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.968 -1.083 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -29.33 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.36 -35.3 79.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.21 -15.28 20.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.0 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.672 -179.765 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 CA-C-O 121.308 0.462 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.8 -60.66 2.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 4.9 t -55.48 -39.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.499 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.32 -56.82 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.37 23.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -69.54 -30.3 68.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.3 -65.09 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.4 tp -49.89 -37.97 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 108.612 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 13.3 mt -54.67 -45.86 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 108.572 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.51 -46.22 88.37 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.05 -53.9 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 108.885 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.37 -38.16 71.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.44 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 437' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -53.54 -47.16 70.25 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.101 -0.999 . . . . 0.0 109.272 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 438' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.7 tp -67.87 -36.44 80.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.713 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.1 mm -50.03 -39.88 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 107.862 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -37.33 68.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.31 -57.69 11.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.738 . . . . 0.0 109.168 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 67.0 mt -54.77 -53.9 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.64 -52.21 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.79 -33.73 56.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 445' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -65.36 -52.97 50.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -86.69 111.91 21.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.498 ' N ' HD21 ' A' ' 120' ' ' ASN . 1.4 m120 -73.22 -16.68 61.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.06 168.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.9 p -81.09 150.74 28.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -87.64 -7.43 57.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.31 70.67 5.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.08 -27.29 57.43 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.409 1.406 . . . . 0.0 112.521 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 10.5 mp -73.04 -44.6 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.737 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.31 -56.01 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.486 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 35.0 m -59.86 -54.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.681 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.486 ' H ' ' CG2' ' A' ' 128' ' ' VAL . . . -54.01 -24.31 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.195 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.05 -20.73 24.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.538 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -74.88 -41.97 58.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.557 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.7 mt -51.85 -42.93 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.66 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.0 109.002 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.53 96.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.3 mt -66.6 -57.29 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.242 -1.152 . . . . 0.0 109.091 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.39 -36.89 23.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 108.73 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.564 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.26 -57.28 13.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.564 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 18.3 mt -51.75 -50.35 60.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.833 . . . . 0.0 109.745 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mt -53.05 -31.95 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.3 -59.15 2.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -49.81 -42.85 47.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 2.2 tt -72.72 -42.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.2 tt -59.78 -28.5 67.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.048 . . . . 0.0 109.064 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.2 OUTLIER -76.55 -45.43 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.51 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 61.5 ttt180 -55.76 -34.95 65.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.38 -51.07 6.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -96.2 35.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' ASP . 30.1 t80 -47.35 -30.15 3.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -67.76 -48.83 65.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 m -55.75 -48.76 74.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.9 mm -53.86 -49.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -54.43 -39.97 67.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.05 -41.89 77.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.574 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -49.19 -54.78 14.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -43.98 96.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.36 100.87 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 157' ' ' HIS . 2.1 m-70 54.77 -135.07 1.46 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.13 -28.04 2.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 157' ' ' HIS . 11.5 mt -89.34 120.34 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -1.182 . . . . 0.0 109.359 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.8 tttm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.465 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.414 ' H ' ' HG ' ' B' ' 219' ' ' SER . 3.3 p -63.52 -27.87 69.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.445 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.0 129.46 35.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -162.37 63.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 21.7 p -164.04 129.35 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 70.5 m -86.0 -122.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -146.69 71.06 12.63 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.42 -36.42 27.03 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.447 1.431 . . . . 0.0 112.513 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.64 -47.64 85.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.586 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.544 ' CG1' HD22 ' C' ' 331' ' ' ASN . 11.4 t -62.63 -33.58 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.31 -59.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.68 -39.53 17.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.933 . . . . 0.0 108.957 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.26 -32.0 68.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.387 -0.821 . . . . 0.0 109.247 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -63.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.6 tp -50.94 -38.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.031 -1.043 . . . . 0.0 108.366 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.92 -44.18 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -55.5 -48.41 70.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -55.91 -38.29 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -1.148 . . . . 0.0 108.705 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.15 -35.91 76.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.247 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.2 OUTLIER -55.68 -47.98 75.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.046 -1.034 . . . . 0.0 109.025 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.6 tp -67.79 -36.96 81.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.629 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.827 -1.171 . . . . 0.0 108.145 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.7 -35.13 65.12 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . 0.526 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -60.7 -56.12 25.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 109.419 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.32 -41.11 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.375 -0.828 . . . . 0.0 109.575 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -36.86 79.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.4 -50.58 58.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.73 -28.69 68.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -57.22 7.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.45 108.41 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.47 -86.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -144.55 -82.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 7.7 m -87.7 -142.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.378 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 62.1 mt 48.73 89.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.363 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -158.55 94.56 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.546 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -82.89 146.99 28.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -152.67 136.36 16.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.2 OUTLIER -91.64 116.3 28.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -62.2 108.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -168.75 96.93 0.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -164.3 -136.48 2.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 42.7 mt -83.34 -11.13 58.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.487 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.278 0.561 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 86.2 p -86.76 111.95 21.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.354 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . 0.496 HD21 ' N ' ' C' ' 320' ' ' ASN . 1.4 m120 -73.21 -16.71 61.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.14 168.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.418 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 86.7 p -81.16 150.83 28.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.922 . . . . 0.0 109.356 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 44.3 t -87.68 -7.48 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.877 . . . . 0.0 109.538 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.26 70.77 5.61 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.16 -27.35 56.77 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.426 1.418 . . . . 0.0 112.479 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' C' ' 326' ' ' LEU . 10.5 mp -72.96 -44.6 60.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.3 -56.02 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.682 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.479 ' CG2' ' H ' ' C' ' 329' ' ' ALA . 35.0 m -59.88 -54.4 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.669 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.479 ' H ' ' CG2' ' C' ' 328' ' ' VAL . . . -53.85 -24.49 15.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.264 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.04 -20.53 24.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.337 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.544 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -74.9 -42.1 58.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.9 mt -51.81 -43.01 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.5 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -59.23 -44.5 96.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 83.4 mt -66.63 -57.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -1.111 . . . . 0.0 109.082 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.4 mt -49.31 -36.83 22.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 108.802 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.573 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.36 -57.26 13.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.043 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 18.5 mt -51.7 -50.34 60.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -0.784 . . . . 0.0 109.772 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 19.2 mt -53.09 -32.07 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.626 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.21 -58.81 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.16 -0.962 . . . . 0.0 109.682 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -50.22 -42.59 51.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.869 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 2.2 tt -73.03 -41.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 109.6 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.2 tt -59.8 -28.54 67.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.2 OUTLIER -76.64 -45.36 30.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 109.421 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . 0.526 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 61.6 ttt180 -55.73 -34.99 65.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.35 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.4 -51.23 6.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -96.03 35.27 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.391 -0.818 . . . . 0.0 109.554 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' C' ' 344' ' ' ASP . 30.2 t80 -47.37 -30.03 2.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.388 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -67.8 -48.84 65.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.522 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 5.2 m -55.65 -48.72 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.8 -49.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.41 -40.04 67.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.06 -41.79 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.575 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -49.38 -54.55 16.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.98 96.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.503 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.41 100.99 4.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' C' ' 357' ' ' HIS . 2.1 m-70 54.65 -135.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.2 -28.09 2.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' C' ' 357' ' ' HIS . 11.7 mt -89.27 120.28 30.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 38.9 tttm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.506 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.289 0.566 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.3 p -63.44 -27.84 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -82.98 129.46 35.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.432 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -162.38 63.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 21.1 p -164.01 129.31 2.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 70.3 m -85.95 -122.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -146.71 71.09 12.61 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.41 -36.47 26.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.429 1.419 . . . . 0.0 112.526 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.61 -47.56 85.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.538 ' CG1' HD22 ' A' ' 131' ' ' ASN . 11.5 t -62.69 -33.48 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.553 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.41 -59.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.72 -39.52 17.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 108.972 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.32 -31.84 67.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.522 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.7 tp -50.92 -38.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.112 -0.993 . . . . 0.0 108.394 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.92 -44.25 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -55.33 -48.53 68.79 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' D' ' 435' ' ' ILE . 1.8 mp -55.88 -38.33 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -1.128 . . . . 0.0 108.644 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.06 -36.05 77.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.2 OUTLIER -55.58 -48.04 75.46 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.923 -1.11 . . . . 0.0 108.976 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.614 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.7 tp -67.77 -36.96 81.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.821 -1.151 . . . . 0.0 109.665 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.13 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.873 -1.142 . . . . 0.0 108.089 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.74 -35.12 65.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . 0.51 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.2 t90 -60.5 -56.09 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.517 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 16.2 tt -65.56 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.624 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.57 -36.89 79.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.437 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.46 -50.52 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.82 -28.72 69.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.28 -57.21 7.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -82.49 108.32 15.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.46 -86.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -144.47 -82.39 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.818 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 7.9 m -87.58 -142.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 61.2 mt 48.69 89.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -158.49 94.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -82.86 147.04 28.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.327 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -152.67 136.32 16.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' D' ' 455' ' ' PHE . 0.2 OUTLIER -91.54 116.26 28.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -62.21 108.99 1.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -168.78 96.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.342 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -164.34 -136.48 2.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 42.9 mt -83.41 -11.05 58.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -1.145 . . . . 0.0 109.427 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.477 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.4 33.36 6.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 m120 49.05 53.7 12.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.53 153.11 20.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.1 t -173.73 10.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.5 p -56.14 -17.21 6.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.901 . . . . 0.0 109.426 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 51.32 70.03 2.2 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.57 -26.53 54.14 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.273 1.315 . . . . 0.0 112.292 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.47 -54.64 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 109.642 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.01 -35.52 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.489 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 131' ' ' ASN . 5.8 t -70.35 -66.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.585 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.87 -17.78 0.22 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.461 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -89.88 -28.45 19.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.578 -0.701 . . . . 0.0 109.31 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -71.46 -37.5 71.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 109.525 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.85 -46.11 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.518 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.5 tt -75.57 -31.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 108.864 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.03 85.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 63.0 mt -68.32 -52.97 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -1.048 . . . . 0.0 108.936 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -50.02 -35.01 23.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 108.904 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.547 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.94 -58.07 7.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.547 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 12.7 mt -55.35 -46.8 76.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.602 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.2 mt -55.27 -34.89 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.53 -57.4 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -50.38 -54.51 21.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.317 -0.864 . . . . 0.0 109.576 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 3.8 tt -58.93 -42.7 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.479 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 6.3 mt -54.41 -31.06 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 0.0 109.043 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 148' ' ' PHE . 11.8 t70 -77.2 -34.92 56.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -29.87 67.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.576 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.04 -15.73 20.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.645 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.37 39.06 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.686 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.93 -24.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.44 -38.64 68.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.902 . . . . 0.0 109.368 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 p -69.46 -45.77 68.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.81 -47.66 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.457 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.29 -40.83 95.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -75.0 -30.18 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -57.65 -39.9 78.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.502 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -31.32 46.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.544 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -59.27 111.72 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.491 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -65.91 -63.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.35 136.1 1.93 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.92 115.68 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.2 mttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.438 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 37.1 m -74.57 2.59 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.412 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -155.78 68.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.392 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -55.57 161.75 1.91 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.849 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.21 -16.75 58.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.63 -21.16 48.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.403 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' B' ' 224' ' ' ASP . 1.3 m-20 56.47 70.74 1.35 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 109.569 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -64.96 -28.27 58.03 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.453 1.435 . . . . 0.0 112.359 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.0 mp -50.42 -41.45 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 2.7 t -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.23 -58.87 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.07 -39.61 13.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.101 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.69 -33.68 66.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.865 . . . . 0.0 109.163 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.44 -62.02 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.977 . . . . 0.0 109.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.2 tp -51.28 -38.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.718 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 7.3 mt -54.03 -46.45 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 108.549 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.67 88.73 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.64 -52.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -1.148 . . . . 0.0 108.715 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.7 -38.32 72.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 109.551 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -53.49 -47.44 69.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.036 -1.04 . . . . 0.0 109.352 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.627 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.8 tp -67.16 -36.74 82.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.13 -40.11 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.99 -34.43 66.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.72 -55.19 36.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.6 tt -63.51 -35.5 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.778 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.5 -62.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -46.76 -50.85 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.605 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.1 OUTLIER -57.12 -35.41 69.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -48.41 66.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.64 127.99 3.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -84.72 -39.17 18.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -64.49 152.57 41.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.877 . . . . 0.0 109.481 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 41.5 m -161.23 -53.63 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.85 116.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.619 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' B' ' 253' ' ' ARG . 31.3 m-85 -84.94 -33.95 22.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' B' ' 252' ' ' TYR . 99.2 mtt180 -56.5 -166.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.93 164.69 33.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.415 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.407 ' O ' ' O ' ' B' ' 256' ' ' GLU . 88.2 m-85 -86.92 54.64 3.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.456 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 255' ' ' PHE . 34.9 mt-10 48.56 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.418 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 151.71 30.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -172.58 126.37 1.26 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.29 119.67 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -1.173 . . . . 0.0 109.433 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 15.7 pttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.506 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.44 ' H1 ' ' CD ' ' C' ' 318' ' ' ARG . 10.5 mpt_? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.46 33.36 6.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.359 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 5.7 m120 49.0 53.68 12.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.32 153.19 19.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 5.0 t -173.86 10.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 2.5 p -56.24 -17.13 6.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 26.5 t0 51.36 70.03 2.2 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.736 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.64 -26.48 53.71 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.307 1.338 . . . . 0.0 112.246 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.58 -54.55 39.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 88.9 t -52.11 -35.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' C' ' 331' ' ' ASN . 6.3 t -70.08 -66.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.457 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.87 -17.84 0.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.45 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.18 -27.85 19.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 109.214 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.0 OUTLIER -71.45 -37.58 71.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.526 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.81 -46.28 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 tt -75.35 -31.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.115 -0.991 . . . . 0.0 108.978 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.11 -45.92 86.39 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 63.0 mt -68.32 -53.11 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.374 -1.074 . . . . 0.0 108.911 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.4 tp -49.78 -35.22 21.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.553 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.7 -58.2 7.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.553 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 12.7 mt -55.33 -46.68 76.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -0.819 . . . . 0.0 109.704 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.28 -35.06 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.56 -56.83 4.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -50.79 -54.3 24.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 3.9 tt -59.18 -42.53 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.09 -1.006 . . . . 0.0 109.436 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.477 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 6.3 mt -54.49 -31.04 55.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' C' ' 348' ' ' PHE . 11.9 t70 -77.39 -34.75 54.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -29.87 67.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.58 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.05 -15.69 20.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -147.38 39.03 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.702 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.89 -24.75 1.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.393 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.4 -38.55 68.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.424 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 57.9 p -69.47 -45.79 68.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.539 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' C' ' 351' ' ' ILE . 1.7 mp -58.81 -47.76 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.2 -40.87 95.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -74.98 -30.14 61.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.71 -39.89 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -31.31 46.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -59.24 111.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -66.05 -63.6 1.05 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.501 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.98 1.91 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 115.73 28.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -1.169 . . . . 0.0 109.504 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 18.3 mttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.422 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 37.2 m -74.59 2.65 9.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -155.85 68.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.54 161.88 1.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -16.62 58.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.6 -21.16 48.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' D' ' 424' ' ' ASP . 1.4 m-20 56.36 70.78 1.35 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.595 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -65.07 -28.13 57.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.402 1.401 . . . . 0.0 112.352 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mp -50.4 -41.39 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.07 -35.98 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.629 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.22 -58.91 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.23 -39.55 14.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.61 -33.72 66.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.184 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.49 -61.98 1.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.417 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.2 tp -51.32 -38.57 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 108.688 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 7.4 mt -53.95 -46.43 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.67 -46.73 88.71 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.58 -52.97 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -1.136 . . . . 0.0 108.744 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.65 -38.45 72.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.629 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -53.35 -47.54 69.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.054 -1.029 . . . . 0.0 109.334 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.629 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 8.0 tp -67.05 -36.91 83.09 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.11 -39.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.855 -1.153 . . . . 0.0 107.925 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.13 -34.35 66.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -60.46 -55.32 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.638 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.62 -35.38 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.5 -62.48 1.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.533 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -46.77 -50.86 17.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.1 OUTLIER -57.13 -35.29 69.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.469 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -48.48 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.49 128.03 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.65 -39.24 18.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.504 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -64.41 152.62 40.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 40.9 m -161.33 -53.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 60.5 mt -49.76 116.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . 0.412 ' O ' ' O ' ' D' ' 453' ' ' ARG . 31.3 m-85 -84.92 -34.02 22.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' D' ' 452' ' ' TYR . 99.2 mtt180 -56.45 -166.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.84 164.7 33.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.409 ' O ' ' O ' ' D' ' 456' ' ' GLU . 88.3 m-85 -86.88 54.69 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' D' ' 455' ' ' PHE . 35.0 mt-10 48.48 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 151.66 30.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -172.48 126.34 1.26 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.26 119.66 22.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -1.204 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 15.8 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.479 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.452 ' H ' ' HG ' ' A' ' 119' ' ' SER . 0.7 OUTLIER -52.06 160.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.499 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.59 21.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.46 164.14 38.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.137 -0.977 . . . . 0.0 109.578 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -74.67 81.69 2.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.4 p -150.24 163.62 37.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.0 70.21 8.5 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.568 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.43 -27.67 54.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.322 1.348 . . . . 0.0 112.321 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.25 -51.99 67.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.0 t -52.52 -35.2 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.366 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' A' ' 130' ' ' ALA . 10.8 t -65.23 -65.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.49 -17.99 0.36 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 108.611 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -88.22 -27.4 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.361 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.595 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.4 OUTLIER -74.91 -38.03 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.623 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.1 mt -50.42 -44.95 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.414 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.0 tt -77.91 -35.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 109.025 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.86 -46.65 90.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 79.2 mt -67.23 -56.4 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -1.072 . . . . 0.0 109.177 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mt -49.93 -33.58 17.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.007 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.12 -52.71 61.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 109.122 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.455 ' CD2' ' CE1' ' D' ' 437' ' ' HIS . 5.9 mt -55.37 -38.06 68.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.736 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.5 mt -68.77 -29.7 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.65 -55.25 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 109.826 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.12 -43.39 61.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 4.0 tp -72.79 -44.39 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.033 -1.042 . . . . 0.0 109.697 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.2 mt -48.52 -35.5 13.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 109.218 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -76.56 -47.22 23.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -28.16 6.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -16.39 15.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.029 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -146.4 42.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.872 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' ASP . 20.2 p90 -50.46 -37.31 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -59.94 -30.37 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.561 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.1 m -77.28 -51.97 9.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.42 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.55 -39.53 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -64.12 -52.47 59.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -57.89 -39.87 78.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.448 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.82 -55.63 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.65 -22.48 65.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.329 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.445 ' C ' ' CD2' ' A' ' 157' ' ' HIS . 2.4 tt0 59.49 -163.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.346 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.445 ' CD2' ' C ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -152.86 -22.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 0.0 109.547 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.07 167.27 36.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.32 128.8 37.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -1.114 . . . . 0.0 109.503 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 pttm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.501 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.455 ' H2 ' ' H ' ' B' ' 219' ' ' SER . 84.8 mtm180 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.455 ' H ' ' H2 ' ' B' ' 218' ' ' ARG . 0.5 OUTLIER 54.76 -177.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.563 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.16 144.18 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.448 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.59 107.68 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 109.415 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' SER . . . . . 0.554 ' HG ' ' H ' ' B' ' 223' ' ' SER . 77.8 p -75.01 -46.38 35.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' SER . . . . . 0.554 ' H ' ' HG ' ' B' ' 222' ' ' SER . 0.8 OUTLIER 51.47 21.94 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.52 161.56 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.237 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -54.34 -27.48 48.59 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.091 1.194 . . . . 0.0 112.369 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.84 -37.81 32.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.597 ' CG1' HD22 ' C' ' 331' ' ' ASN . 6.6 t -64.64 -35.89 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.57 -58.11 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 109.339 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.33 -37.27 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.946 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.11 -35.28 66.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.021 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -62.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 tp -51.02 -40.22 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.05 -1.031 . . . . 0.0 108.585 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.1 mt -53.73 -42.31 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.12 -46.7 92.37 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -57.28 -39.12 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 0.0 108.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.31 -35.27 73.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.422 -0.799 . . . . 0.0 109.371 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.513 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -55.07 -49.81 70.72 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.934 -1.104 . . . . 0.0 109.014 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.513 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 12.0 tp -67.68 -36.6 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.66 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.74 -37.56 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.859 -1.151 . . . . 0.0 108.293 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.29 -40.62 62.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -53.74 -53.19 55.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.502 -0.749 . . . . 0.0 109.415 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 14.9 tt -67.39 -33.57 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.18 -59.51 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -52.54 -43.14 64.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -62.85 -30.96 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -61.0 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 3.3 t80 54.01 -174.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' B' ' 248' ' ' PHE . 0.1 OUTLIER -88.07 179.61 6.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.452 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -56.55 149.23 17.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.94 . . . . 0.0 109.438 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 48.2 t -56.61 -34.57 67.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.406 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.4 HD11 HG21 ' B' ' 251' ' ' ILE . 9.1 mm -81.33 114.93 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' B' ' 252' ' ' TYR . 0.3 OUTLIER -63.43 141.17 58.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.543 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.02 114.66 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -82.91 -102.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' B' ' 255' ' ' PHE . 48.1 t80 -148.94 -14.82 0.31 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.362 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.14 153.12 21.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.512 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.23 -43.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 157.84 98.46 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 7.9 mt -63.42 -37.76 88.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -1.142 . . . . 0.0 109.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 79.0 mttt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.482 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.23 160.9 0.71 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.363 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.57 21.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -153.43 164.12 38.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 2.5 p -74.61 81.68 2.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 58.2 p -150.19 163.71 37.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.11 70.17 8.41 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.42 -27.51 54.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.345 1.363 . . . . 0.0 112.302 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.41 -51.99 67.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.51 -35.4 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.3 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' C' ' 331' ' ' ASN . 11.5 t -65.02 -65.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.873 . . . . 0.0 109.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.42 -18.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 108.718 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -88.48 -26.8 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.532 -0.73 . . . . 0.0 109.275 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.597 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.4 OUTLIER -75.09 -38.07 61.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.529 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 4.4 mt -50.43 -45.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 tt -77.7 -35.49 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.104 -0.998 . . . . 0.0 108.932 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.79 88.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.06 -56.54 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.276 -1.132 . . . . 0.0 109.198 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 mt -49.84 -33.67 17.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 108.981 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.469 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.15 -52.6 61.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.135 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.469 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 5.9 mt -55.43 -37.98 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.773 . . . . 0.0 109.753 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 7.7 mt -68.88 -29.63 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.83 -54.66 5.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.819 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -51.55 -43.45 62.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.055 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 4.1 tp -72.62 -44.39 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 mt -48.46 -35.65 13.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.014 -1.054 . . . . 0.0 109.21 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -76.57 -47.16 23.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -28.23 6.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.99 . . . . 0.0 109.565 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.94 -16.34 15.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.528 -0.733 . . . . 0.0 110.017 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -146.43 43.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 109.853 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' C' ' 344' ' ' ASP . 20.3 p90 -50.64 -37.24 39.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.431 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -60.0 -30.35 69.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.498 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 18.9 m -77.25 -52.0 9.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.55 -39.5 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 0.0 109.421 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -64.17 -52.5 58.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.379 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -57.85 -39.85 78.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.492 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -55.52 11.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.61 -22.57 65.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.373 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . 0.447 ' C ' ' CD2' ' C' ' 357' ' ' HIS . 2.4 tt0 59.58 -163.82 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . 0.447 ' CD2' ' C ' ' C' ' 356' ' ' GLU . 0.0 OUTLIER -152.9 -22.16 0.16 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.03 167.34 36.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.43 128.83 37.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 pttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.492 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 54.72 -177.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.27 144.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.49 107.73 10.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.485 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 77.8 p -75.06 -46.29 35.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.47 21.87 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.49 161.56 1.07 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.29 -27.47 48.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.042 1.161 . . . . 0.0 112.49 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.87 -37.79 32.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.595 ' CG1' HD22 ' A' ' 131' ' ' ASN . 7.0 t -64.69 -35.87 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.69 -58.08 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.274 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.37 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.136 -0.978 . . . . 0.0 108.933 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -73.09 -35.21 66.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.058 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.99 -62.74 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.0 tp -51.01 -40.26 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.21 -0.932 . . . . 0.0 108.573 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.3 mt -53.6 -42.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.171 -0.955 . . . . 0.0 108.475 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.09 -46.82 92.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.13 -39.23 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.34 -35.19 73.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.459 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.3 OUTLIER -55.06 -49.8 70.7 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.014 -1.054 . . . . 0.0 109.082 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.512 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 12.4 tp -67.62 -36.72 81.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.78 -1.168 . . . . 0.0 109.663 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.7 -37.62 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 108.211 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.2 -40.59 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -53.77 -53.03 57.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 109.481 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.6 -33.4 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.14 -59.65 4.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -52.47 -43.16 64.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -62.91 -30.86 71.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.53 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -60.95 2.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 3.3 t80 53.91 -174.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' D' ' 448' ' ' PHE . 0.1 OUTLIER -88.07 179.52 6.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -56.46 149.18 17.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 109.39 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 48.1 t -56.59 -34.46 67.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . 0.409 HG23 HD11 ' D' ' 451' ' ' ILE . 8.9 mm -81.38 114.9 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' D' ' 452' ' ' TYR . 0.3 OUTLIER -63.48 141.26 58.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.451 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -162.05 114.77 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -83.09 -102.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' D' ' 455' ' ' PHE . 47.9 t80 -148.95 -14.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.32 153.08 21.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.15 -43.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.361 -0.837 . . . . 0.0 109.458 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 157.81 98.42 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 7.9 mt -63.43 -37.81 88.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.542 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.35 12.86 2.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -56.67 -38.28 72.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -148.12 140.39 24.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.11 157.35 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.3 t -148.92 -98.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 1.8 p30 -157.24 69.52 4.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.58 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.54 -27.23 53.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.396 1.397 . . . . 0.0 112.435 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.8 mt -72.74 -43.45 62.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.695 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.3 -56.04 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.148 -0.97 . . . . 0.0 109.547 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 34.5 m -58.91 -53.29 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.121 -0.987 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 128' ' ' VAL . . . -55.63 -26.32 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.15 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.15 -17.45 34.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.356 -0.84 . . . . 0.0 109.376 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -40.11 28.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 109.585 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.52 -45.21 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.347 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.0 tt -76.73 -44.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.173 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -48.11 -45.19 26.86 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.1 -55.66 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.01 -33.16 17.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.94 . . . . 0.0 108.929 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.538 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.33 -55.12 31.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 12.1 mt -55.06 -45.85 75.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.24 -35.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.39 -57.06 3.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.4 t-105 -48.9 -51.76 28.19 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.205 -0.935 . . . . 0.0 109.682 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 1.6 tt -65.26 -41.85 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 0.0 110.077 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.473 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 tt -59.42 -30.69 68.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.04 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -37.77 59.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.18 73.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.32 -47.38 8.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.662 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -93.03 35.47 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.42 ' CE2' ' NH2' ' B' ' 245' ' ' ARG . 32.8 t80 -47.21 -26.73 1.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -69.19 -46.55 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.325 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -60.37 -44.77 95.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.0 -47.74 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -55.23 -43.71 74.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -64.86 -45.02 87.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.01 -46.68 78.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -30.86 70.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -69.14 135.64 51.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -160.84 93.07 0.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.16 101.41 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 159' ' ' LEU . 10.4 mp -67.12 -50.44 61.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -1.178 . . . . 0.0 109.367 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.353 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.7 t -160.65 -63.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.43 133.29 7.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -62.46 -52.63 62.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 59.5 p -84.17 152.27 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.438 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 22.4 t -60.6 -94.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -149.66 70.25 9.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.24 -33.61 38.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.402 1.401 . . . . 0.0 112.534 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -59.0 5.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.595 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.38 -35.08 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.62 -59.59 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.371 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.27 -37.48 10.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.45 -32.43 66.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.861 . . . . 0.0 109.233 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -58.51 4.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.71 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.82 -35.41 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.037 -1.039 . . . . 0.0 108.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.12 -44.17 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.75 -45.14 95.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.56 -53.81 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.224 -1.163 . . . . 0.0 108.961 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.53 -35.41 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.299 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.62 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -56.06 -48.74 75.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.62 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.8 tp -64.48 -37.71 88.5 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.638 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.36 -38.98 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.85 -32.7 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.31 -57.77 8.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.501 -0.75 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.11 -38.12 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.63 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.3 -26.84 64.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.53 -43.15 23.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -64.42 -55.75 18.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.11 -43.43 98.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.596 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 3.2 t80 64.86 173.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -172.4 152.35 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.868 . . . . 0.0 109.469 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -173.55 8.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' B' ' 250' ' ' SER . 46.3 p 49.32 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 4.3 tt -62.02 -24.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -51.41 130.95 28.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -74.8 -29.51 61.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' B' ' 255' ' ' PHE . 0.3 OUTLIER -67.45 163.54 20.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' B' ' 254' ' ' PHE . 2.1 t80 71.46 30.1 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.424 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -163.53 163.56 24.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -59.86 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.482 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.18 167.8 14.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 13.9 mt -78.59 161.49 26.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -1.104 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 43.3 tttt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.432 -179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.328 0.585 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.31 12.88 2.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -56.72 -38.29 72.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.06 140.25 24.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.91 157.29 26.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 -98.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' C' ' 324' ' ' ASP . 1.8 p30 -157.21 69.39 4.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.47 -27.17 54.53 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.363 1.375 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 35.8 mt -72.83 -43.38 62.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.31 -56.1 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' C' ' 329' ' ' ALA . 34.3 m -58.8 -53.3 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.394 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' C' ' 328' ' ' VAL . . . -55.6 -26.39 43.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.28 -17.16 35.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.284 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 -40.24 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 mt -51.47 -45.29 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.327 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 11.2 tt -76.54 -44.6 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.249 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -48.32 -44.98 28.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.25 -55.58 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -1.115 . . . . 0.0 109.211 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.07 -33.07 17.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.548 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -62.4 -55.07 31.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 108.893 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.548 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 12.0 mt -55.14 -45.84 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.394 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.28 -35.5 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.41 -56.36 4.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.4 t-105 -49.44 -51.6 34.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -0.863 . . . . 0.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 1.5 tt -65.49 -41.85 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.847 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.475 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.4 tt -59.22 -30.9 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.036 -1.04 . . . . 0.0 109.2 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -37.66 59.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -32.14 73.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.35 -47.38 8.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.643 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -93.03 35.44 1.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.571 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.418 ' CE2' ' NH2' ' D' ' 445' ' ' ARG . 32.7 t80 -47.11 -26.71 1.17 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -69.4 -46.37 67.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 7.7 t -60.4 -44.72 95.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.37 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.01 -47.62 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 0.9 OUTLIER -55.39 -43.65 75.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.419 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -64.92 -44.99 87.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.0 -46.79 78.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -30.77 70.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -69.17 135.75 51.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.584 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -160.93 92.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -177.13 101.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' C' ' 359' ' ' LEU . 10.4 mp -67.07 -50.49 61.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -1.106 . . . . 0.0 109.433 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.401 179.872 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 31.1 t -160.61 -63.63 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.516 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.5 133.32 7.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -62.64 -52.4 63.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 59.3 p -84.26 152.14 24.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.498 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 21.7 t -60.54 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -149.7 70.07 9.49 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.22 -33.5 39.43 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.319 1.346 . . . . 0.0 112.608 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -58.95 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.602 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.32 -35.15 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.7 -59.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.417 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -37.35 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.214 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.53 -32.4 66.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -58.38 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.732 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.7 tp -56.97 -35.34 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 108.89 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.3 mt -57.04 -44.24 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 108.568 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.63 -45.26 94.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.48 -53.75 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -1.146 . . . . 0.0 108.978 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.624 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -55.98 -48.85 75.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.624 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 8.0 tp -64.41 -37.8 88.8 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.637 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.3 -39.01 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.91 -32.6 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.26 -57.77 8.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.418 -0.801 . . . . 0.0 109.59 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.22 -38.0 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.23 -26.96 65.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -79.43 -43.26 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -64.41 -55.72 19.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.13 -43.52 98.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 3.3 t80 64.95 173.69 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.376 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -172.44 152.3 2.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 109.483 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -173.46 8.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 450' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' D' ' 450' ' ' SER . 45.7 p 49.35 92.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.92 -24.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.674 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -51.36 130.95 28.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -74.72 -29.65 61.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . 0.422 ' O ' ' CB ' ' D' ' 455' ' ' PHE . 0.3 OUTLIER -67.44 163.6 20.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' D' ' 454' ' ' PHE . 2.0 t80 71.5 29.93 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -163.34 163.64 25.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -59.96 2.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 149.15 167.77 14.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 14.0 mt -78.58 161.47 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.14 . . . . 0.0 109.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 43.4 tttt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.452 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -167.96 95.76 0.42 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -58.37 -55.8 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -157.94 -9.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t 48.37 31.49 2.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.3 t -74.96 -173.03 1.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -148.58 69.76 10.38 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.21 -29.61 55.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.289 1.326 . . . . 0.0 112.376 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.57 -44.96 48.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.42 -56.95 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.088 -1.008 . . . . 0.0 109.739 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 33.2 m -57.83 -50.94 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 128' ' ' VAL . . . -63.83 -14.05 49.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.806 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.93 -48.75 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.49 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER -80.22 -44.7 19.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 109.989 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.49 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mm -51.77 -42.55 32.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.533 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 13.2 tt -76.12 -42.08 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.226 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -51.31 -45.92 52.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 76.0 mt -66.31 -57.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -1.11 . . . . 0.0 109.277 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.52 -34.33 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.154 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.2 -60.62 3.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.225 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.586 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 12.3 mt -50.9 -44.55 59.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -57.66 -32.9 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.59 -56.74 3.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.602 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.3 t-105 -48.44 -48.35 37.54 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.333 -0.854 . . . . 0.0 109.619 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 2.9 tt -68.69 -42.07 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.479 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 tt -57.85 -31.88 67.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.107 . . . . 0.0 109.183 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.7 OUTLIER -73.5 -46.07 50.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.12 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.09 -23.26 65.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.109 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.04 -16.54 20.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.98 38.12 1.78 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.568 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 144' ' ' ASP . 7.2 t80 -52.29 -39.75 60.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -59.03 -29.38 67.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -76.62 -46.51 25.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 mm -56.4 -50.22 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 9.3 t80 -62.57 -42.49 99.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -61.7 -17.23 54.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -83.22 -68.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.535 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.73 -55.47 14.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.624 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 57.4 177.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -81.07 -15.3 56.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -91.75 90.78 1.55 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.05 -67.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.182 -1.187 . . . . 0.0 109.43 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.8 mttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.467 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.438 ' O ' ' N ' ' B' ' 221' ' ' ASP . 3.9 m 50.18 81.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.391 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -48.61 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 219' ' ' SER . 1.8 m-20 -78.49 133.4 37.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 3.6 t 50.45 87.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.907 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 42.0 p -83.2 40.35 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -152.17 69.59 7.54 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.597 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.75 -41.64 17.93 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.302 1.335 . . . . 0.0 112.48 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -47.5 73.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.82 -42.67 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.9 t -58.26 -56.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.316 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.23 21.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 108.947 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.81 66.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.01 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.5 t-20 -68.48 -63.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.54 -36.49 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.116 -0.99 . . . . 0.0 108.425 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 22.5 mt -58.4 -42.55 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.58 84.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -56.1 -52.11 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.105 -1.232 . . . . 0.0 108.672 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.35 74.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.449 -0.782 . . . . 0.0 109.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.619 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -52.73 -46.78 67.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.075 -1.016 . . . . 0.0 109.449 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.619 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.7 tp -67.5 -37.63 83.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.764 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.8 mm -49.37 -39.86 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.817 -1.177 . . . . 0.0 108.028 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.97 -35.67 66.96 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.92 -57.28 13.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.573 -0.704 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 11.3 tt -60.05 -37.86 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.583 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.19 -58.96 5.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.488 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' B' ' 244' ' ' ASP . 4.5 m-20 -55.55 -51.06 68.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -49.73 -28.1 5.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.334 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.73 -59.37 2.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -92.11 125.13 36.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.2 131.29 45.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -51.78 -83.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.13 143.58 26.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.0 mm -83.62 118.18 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -65.34 156.93 30.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 49.81 86.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 254' ' ' PHE . 0.1 OUTLIER -76.56 -55.51 5.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.957 . . . . 0.0 109.434 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 1.4 t80 67.23 126.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.15 -62.24 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 171.5 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.47 110.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -1.129 . . . . 0.0 109.395 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 20.4 mttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.534 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 88.8 p -167.93 95.74 0.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . 0.434 ' H ' ' ND2' ' C' ' 320' ' ' ASN . 0.2 OUTLIER -58.35 -55.81 30.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -157.97 -9.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 22.8 t 48.42 31.44 2.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 32.1 t -74.89 -173.06 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.426 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -148.54 69.69 10.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.709 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.25 -29.4 55.14 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.293 1.329 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.84 -44.85 46.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.598 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.62 -56.74 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.631 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' C' ' 329' ' ' ALA . 33.1 m -57.99 -50.79 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.657 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.466 ' N ' ' CG2' ' C' ' 328' ' ' VAL . . . -64.0 -13.86 49.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 109.809 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -93.18 -48.6 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.965 . . . . 0.0 110.198 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.484 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -80.18 -44.84 19.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 0.0 110.033 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.6 mm -51.72 -42.62 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.504 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 13.2 tt -75.99 -42.14 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -51.32 -45.8 52.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.33 -57.34 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -1.111 . . . . 0.0 109.227 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.42 -34.3 16.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.165 -0.96 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.595 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.18 -60.71 3.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.329 -0.857 . . . . 0.0 109.143 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.595 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 12.2 mt -50.84 -44.58 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.484 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.72 -32.85 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.66 -56.24 4.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.574 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.3 t-105 -49.02 -47.98 44.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.606 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 2.8 tt -69.05 -41.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -57.73 -32.04 67.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.7 OUTLIER -73.57 -45.92 50.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.183 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.06 -23.26 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.889 . . . . 0.0 109.15 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.01 -16.48 20.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.648 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.97 38.03 1.78 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 109.56 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 344' ' ' ASP . 7.1 t80 -52.26 -39.83 60.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.455 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -58.94 -29.41 67.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 6.3 t -76.63 -46.57 25.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 109.407 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 10.2 mm -56.3 -50.25 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 9.3 t80 -62.58 -42.55 99.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -61.65 -17.37 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -83.11 -69.08 0.66 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.67 -55.41 15.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.641 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 57.42 177.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -81.13 -15.41 55.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.515 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -91.68 90.75 1.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.96 -67.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 20.9 mttt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.442 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 419' ' ' SER . . . . . 0.448 ' O ' ' N ' ' D' ' 421' ' ' ASP . 3.9 m 50.08 81.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -48.63 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' D' ' 419' ' ' SER . 1.8 m-20 -78.39 133.31 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 3.7 t 50.53 87.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.532 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 41.9 p -83.08 40.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.449 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -152.31 69.59 7.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.81 -41.57 17.84 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.308 1.339 . . . . 0.0 112.492 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.77 -47.41 73.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.78 -42.7 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.611 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.9 t -58.25 -56.61 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.87 -40.4 21.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 108.936 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.7 66.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 109.029 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.5 t-20 -68.52 -63.81 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.5 -36.54 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 22.7 mt -58.4 -42.48 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.72 -47.54 84.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' D' ' 435' ' ' ILE . 1.8 mp -56.18 -52.06 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.138 -1.213 . . . . 0.0 108.629 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.36 74.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.547 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.623 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -52.69 -46.81 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.095 -1.003 . . . . 0.0 109.402 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.623 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.8 tp -67.55 -37.53 82.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.78 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.2 mm -49.38 -39.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.857 -1.152 . . . . 0.0 108.045 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.99 -35.66 66.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.69 -57.39 13.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.679 . . . . 0.0 109.629 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.25 -37.73 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.12 -58.95 5.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 0.0 109.414 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' D' ' 444' ' ' ASP . 4.5 m-20 -55.71 -50.94 68.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -49.86 -27.98 5.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.296 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.68 -59.51 2.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.503 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -91.97 125.07 36.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.22 131.31 45.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.46 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -51.77 -83.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.02 143.58 26.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.476 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 9.9 mm -83.67 118.32 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -65.38 156.91 30.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 49.81 86.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' D' ' 454' ' ' PHE . 0.1 OUTLIER -76.57 -55.51 5.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 1.4 t80 67.31 127.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 171.42 0.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 154.32 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.51 110.52 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -1.106 . . . . 0.0 109.408 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 20.3 mttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.481 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.288 0.566 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -62.66 1.42 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.518 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -167.1 -172.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -162.88 -53.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.331 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 m 54.23 179.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.554 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.9 p -79.86 156.04 27.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -153.18 70.16 6.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.74 -28.51 51.74 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.328 1.352 . . . . 0.0 112.447 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.5 mt -72.64 -45.7 57.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.57 -57.39 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.491 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 34.7 m -57.78 -54.84 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.553 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.491 ' H ' ' CG2' ' A' ' 128' ' ' VAL . . . -54.2 -23.18 13.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.126 -0.984 . . . . 0.0 109.226 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.05 -17.34 27.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.444 -0.785 . . . . 0.0 109.386 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -80.76 -42.68 21.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 109.641 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 131' ' ' ASN . 4.4 mt -50.12 -44.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.42 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.1 tt -76.16 -47.24 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.227 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -47.75 -43.27 22.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.18 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -1.186 . . . . 0.0 109.254 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.7 -31.96 5.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.588 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.17 -58.81 5.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.364 -0.835 . . . . 0.0 109.0 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.588 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 13.0 mt -48.98 -50.99 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.18 -33.47 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.59 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.63 -58.42 3.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.975 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -53.09 -46.03 68.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.29 -0.882 . . . . 0.0 109.996 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -67.59 -42.44 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.816 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.465 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 tt -55.63 -34.64 65.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.082 -1.012 . . . . 0.0 108.811 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 13.9 t70 -74.3 -35.12 63.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.512 -0.743 . . . . 0.0 109.222 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -32.61 72.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.2 -14.72 23.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.65 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -137.81 40.62 2.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 32.7 p90 -61.79 -37.91 86.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.984 . . . . 0.0 109.498 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.2 tttm -64.82 -20.98 66.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.925 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -82.8 -57.55 3.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.3 mt -64.0 -28.83 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.22 -51.8 9.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.489 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -64.19 -27.25 68.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.405 ' C ' ' H ' ' A' ' 156' ' ' GLU . 61.8 t80 -76.41 -63.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.555 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.44 -8.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 154' ' ' PHE . 3.0 tm-20 -54.08 -37.32 64.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.405 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -65.6 -78.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 157.99 168.9 20.96 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.07 116.87 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -1.154 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 35.5 mttm . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.504 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.429 ' H2 ' ' H ' ' B' ' 219' ' ' SER . 2.3 mpt_? . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.282 0.563 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.429 ' H ' ' H2 ' ' B' ' 218' ' ' ARG . 1.4 p -70.29 -18.61 63.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.35 88.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -59.43 -27.32 65.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' B' ' 223' ' ' SER . 0.6 OUTLIER -166.92 179.88 5.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 0.0 109.601 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' B' ' 222' ' ' SER . 4.3 p 60.92 153.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.14 70.2 6.92 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.669 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.78 -26.8 59.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.352 1.368 . . . . 0.0 112.519 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.02 -61.25 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.968 . . . . 0.0 109.575 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 11.0 t -51.39 -40.52 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.25 -58.0 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.217 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.19 -36.26 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 108.977 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.5 -30.93 64.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.379 -0.826 . . . . 0.0 109.187 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -59.61 3.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 tp -55.44 -36.94 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 0.0 108.689 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 12.7 mt -56.64 -42.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.255 -0.903 . . . . 0.0 108.679 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.35 95.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 81.3 mt -59.71 -53.27 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 0.0 108.76 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.63 -37.0 70.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.373 -0.829 . . . . 0.0 109.22 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -54.2 -47.43 72.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.295 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 8.0 tp -67.11 -37.56 84.11 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.683 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 41.0 mm -49.36 -39.4 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.848 -1.157 . . . . 0.0 107.994 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -35.32 65.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -60.12 -57.93 10.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.514 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 9.5 tt -61.27 -35.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.2 -32.72 73.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.3 -36.76 69.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -72.55 -47.1 50.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' B' ' 248' ' ' PHE . 0.8 OUTLIER -62.19 -41.52 98.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . 0.465 ' CD2' ' N ' ' B' ' 248' ' ' PHE . 73.8 t80 49.55 -93.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' B' ' 246' ' ' LEU . 0.2 OUTLIER 60.61 -175.94 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.499 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -151.38 150.68 30.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 109.49 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 8.9 p -161.92 11.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.93 3.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.895 . . . . 0.0 109.533 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.85 113.53 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.538 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -170.45 81.92 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.0 OUTLIER -154.99 -37.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' B' ' 254' ' ' PHE . 38.9 t80 -91.13 -64.47 1.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.33 147.96 42.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 0.0 109.416 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 47.95 -150.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -164.16 -117.6 0.41 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.08 -52.6 62.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.135 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 27.0 mttm . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.424 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -167.14 -172.3 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -162.83 -53.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 8.6 m 54.28 179.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 13.1 p -79.89 156.05 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -153.25 70.19 6.85 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.608 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.68 -28.66 52.13 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.319 1.346 . . . . 0.0 112.48 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.59 -45.57 58.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.641 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 69.3 t -59.63 -57.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' C' ' 329' ' ' ALA . 34.7 m -57.7 -54.7 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.484 ' H ' ' CG2' ' C' ' 328' ' ' VAL . . . -54.24 -23.31 14.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.263 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -90.06 -17.28 28.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' C' ' 332' ' ' ILE . 0.2 OUTLIER -80.61 -42.85 21.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.578 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' C' ' 331' ' ' ASN . 4.4 mt -50.02 -44.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.437 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 11.2 tt -76.04 -47.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 109.286 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -47.95 -43.36 23.91 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 98.2 mt -68.19 -59.1 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -1.129 . . . . 0.0 109.27 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.84 -31.89 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 108.867 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.6 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.21 -58.62 6.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.6 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 13.1 mt -49.02 -51.06 33.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -0.877 . . . . 0.0 109.73 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.11 -33.64 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -57.87 3.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 109.916 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -53.71 -45.82 70.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 110.01 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 1.0 OUTLIER -67.71 -42.25 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 109.665 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -55.8 -34.55 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.999 -1.063 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' C' ' 348' ' ' PHE . 13.7 t70 -74.54 -34.95 63.09 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.402 -0.811 . . . . 0.0 109.139 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -32.59 71.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.118 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.31 -14.57 23.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.877 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -138.0 40.76 2.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.413 -0.804 . . . . 0.0 109.647 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' C' ' 344' ' ' ASP . 32.3 p90 -61.93 -37.81 86.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -64.91 -20.86 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 -57.63 3.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 15.5 mt -63.98 -28.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.439 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -78.14 -51.99 9.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.883 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -63.95 -27.34 69.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.629 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' C' ' 356' ' ' GLU . 61.8 t80 -76.44 -63.91 1.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -58.5 -8.67 1.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' C' ' 354' ' ' PHE . 3.0 tm-20 -54.18 -37.25 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -65.64 -78.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.489 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 157.94 168.89 20.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.11 116.92 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.402 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 35.4 mttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.484 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 -18.71 63.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.31 88.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.55 -27.18 65.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 422' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' D' ' 423' ' ' SER . 0.6 OUTLIER -166.99 179.92 4.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 423' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' D' ' 422' ' ' SER . 4.3 p 60.91 153.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.12 70.17 6.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.721 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.87 -26.8 59.3 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.252 1.301 . . . . 0.0 112.46 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.04 -61.09 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.638 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 11.3 t -51.55 -40.42 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.6 t -57.31 -57.99 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.26 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.1 -36.35 13.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 108.958 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.46 -30.96 65.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.1 OUTLIER -68.13 -59.6 3.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.656 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.0 tp -55.43 -36.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.973 -1.08 . . . . 0.0 108.667 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 12.7 mt -56.68 -42.6 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.579 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.07 -45.35 95.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 81.8 mt -59.68 -53.19 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -1.116 . . . . 0.0 108.823 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.73 -36.93 70.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.228 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.628 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -54.21 -47.41 72.18 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.229 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 8.0 tp -67.1 -37.69 84.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.62 -1.232 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.8 mm -49.23 -39.59 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -35.19 65.69 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -59.97 -58.0 10.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.512 -0.743 . . . . 0.0 109.493 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 9.7 tt -61.41 -35.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 0.0 109.615 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.24 -32.65 73.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.31 -36.76 68.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -72.55 -47.14 50.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.468 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' D' ' 448' ' ' PHE . 0.8 OUTLIER -62.15 -41.65 98.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' D' ' 448' ' ' PHE . 74.0 t80 49.67 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.363 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' D' ' 446' ' ' LEU . 0.2 OUTLIER 60.64 -175.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -151.46 150.72 30.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.439 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 8.7 p -161.95 11.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.98 3.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.89 113.57 5.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -170.43 82.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.947 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' D' ' 455' ' ' PHE . 0.0 OUTLIER -155.08 -37.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.439 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' D' ' 454' ' ' PHE . 39.1 t80 -91.1 -64.53 1.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.31 147.95 42.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 47.94 -150.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.521 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -164.13 -117.65 0.42 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.0 -52.7 61.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -1.142 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 27.0 mttm . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.506 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.7 t -71.41 163.52 27.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 122' ' ' SER . 54.0 m-20 -69.23 -26.43 64.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER 56.16 9.21 0.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 120' ' ' ASN . 34.2 t -70.35 5.62 1.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 121' ' ' ASP . 5.9 t -61.19 -172.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.4 70.93 0.97 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.75 -28.27 51.77 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.393 1.395 . . . . 0.0 112.501 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.0 mp -72.48 -46.17 56.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.78 -56.33 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.487 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 35.5 m -58.92 -54.47 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.701 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.487 ' H ' ' CG2' ' A' ' 128' ' ' VAL . . . -54.43 -23.44 15.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.61 -20.97 23.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -39.48 61.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.6 mt -52.86 -45.17 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.273 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.46 -26.87 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 0.0 109.018 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.85 -55.75 29.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.32 -48.17 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -1.085 . . . . 0.0 108.702 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 tp -50.03 -40.04 43.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 108.59 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.556 ' HE2' ' HE2' ' C' ' 337' ' ' HIS . 0.0 OUTLIER -60.11 -52.89 63.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.409 -0.807 . . . . 0.0 108.882 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.508 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 12.4 mt -56.84 -49.76 74.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.401 -0.812 . . . . 0.0 109.568 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.62 -33.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.336 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.64 -59.7 2.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -48.57 -53.3 18.86 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 3.4 tt -60.15 -43.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.488 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 7.0 mt -54.8 -31.68 59.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.134 . . . . 0.0 108.952 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 17.8 t70 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.19 -33.49 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mp -93.48 -16.51 24.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.888 . . . . 0.0 109.707 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -147.4 39.72 1.0 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.63 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.52 -27.76 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -68.59 -44.04 75.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.138 -0.976 . . . . 0.0 109.404 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 m -62.81 -44.04 97.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.343 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.484 ' CG2' ' HE ' ' B' ' 245' ' ' ARG . 1.7 mp -59.25 -50.06 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.91 -40.96 95.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.475 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -69.54 -29.16 66.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -63.83 -61.24 2.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.78 -42.27 75.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.04 116.79 19.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.94 137.91 39.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.34 32.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.29 134.73 10.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -1.136 . . . . 0.0 109.343 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 mttt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.486 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.81 127.5 6.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . 0.404 HD21 ' N ' ' B' ' 220' ' ' ASN . 1.6 m-80 -86.73 -62.54 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' B' ' 222' ' ' SER . 18.9 t0 -79.19 -113.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' SER . . . . . 0.439 ' H ' ' CG ' ' B' ' 221' ' ' ASP . 0.7 OUTLIER 58.52 22.57 9.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 1.9 m -61.15 -89.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -151.38 70.92 8.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.2 -28.17 48.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.337 1.358 . . . . 0.0 112.374 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' B' ' 226' ' ' LEU . 10.8 mp -63.44 -57.58 9.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -36.34 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.2 -0.937 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -57.38 -59.31 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.218 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.28 16.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.92 -29.75 66.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -0.823 . . . . 0.0 109.098 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' B' ' 228' ' ' VAL . 33.8 m-20 -67.74 -63.62 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 7.2 tp -50.34 -36.46 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 108.534 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 17.9 mt -57.85 -43.44 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.212 -0.93 . . . . 0.0 108.579 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.81 88.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.94 -50.85 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 108.707 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.35 -38.44 77.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -53.2 -46.69 69.14 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.957 -1.089 . . . . 0.0 109.278 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.8 tp -67.82 -36.87 81.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.746 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -49.62 -39.83 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.29 -38.08 68.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -57.21 -56.09 26.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.507 -0.746 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.47 -47.23 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.18 -15.4 63.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.955 . . . . 0.0 109.495 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -58.18 3.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.524 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.56 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -61.17 -31.78 71.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.631 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.47 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 8.4 t80 55.87 16.73 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 52.47 -174.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -149.16 132.82 16.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' SER . . . . . 0.435 ' OG ' ' CG ' ' B' ' 255' ' ' PHE . 0.3 OUTLIER 55.91 177.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.474 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.2 tt -168.64 -31.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -70.28 160.37 32.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -88.54 12.8 13.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -151.06 26.77 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' B' ' 256' ' ' GLU . 58.8 t80 -59.14 156.63 11.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' B' ' 255' ' ' PHE . 11.0 tt0 -168.94 131.81 1.32 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -69.82 155.42 40.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 164.07 96.99 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.0 110.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -1.097 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 86.4 mttt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.489 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.279 0.562 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 6.6 t -71.34 163.62 27.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.909 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' C' ' 322' ' ' SER . 54.5 m-20 -69.36 -26.49 64.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' C' ' 323' ' ' SER . 1.0 OUTLIER 56.29 9.09 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 322' ' ' SER . . . . . 0.446 ' H ' ' C ' ' C' ' 320' ' ' ASN . 33.8 t -70.23 5.57 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 323' ' ' SER . . . . . 0.442 ' H ' ' C ' ' C' ' 321' ' ' ASP . 5.9 t -61.22 -172.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.37 71.01 0.97 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.82 -28.28 51.19 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.386 1.391 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 10.0 mp -72.38 -46.18 56.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.738 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.8 -56.41 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 109.574 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.481 ' CG2' ' H ' ' C' ' 329' ' ' ALA . 35.6 m -58.81 -54.53 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.481 ' H ' ' CG2' ' C' ' 328' ' ' VAL . . . -54.55 -23.42 16.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.321 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.68 -20.78 23.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.326 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -39.4 61.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.89 -45.2 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.225 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 12.6 tt -78.3 -27.16 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.79 -55.73 29.2 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 4.1 tp -65.32 -48.02 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -1.106 . . . . 0.0 108.78 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 2.1 tp -50.11 -39.99 44.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.556 ' HE2' ' HE2' ' A' ' 137' ' ' HIS . 0.0 OUTLIER -60.11 -52.83 63.69 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.519 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 12.3 mt -56.88 -49.92 74.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.795 . . . . 0.0 109.488 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 36.0 mt -52.49 -33.16 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -79.7 -59.01 2.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -49.13 -52.93 23.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.697 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 3.4 tt -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.486 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 7.1 mt -54.81 -31.64 59.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.953 -1.092 . . . . 0.0 109.101 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' C' ' 348' ' ' PHE . 17.9 t70 -77.36 -32.63 55.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.514 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -72.24 -33.59 67.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.542 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.35 -16.68 24.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.659 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -147.39 39.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.581 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.64 -27.8 2.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 12.2 m -62.86 -43.99 97.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . 0.501 ' CG2' ' HE ' ' D' ' 445' ' ' ARG . 1.7 mp -59.25 -50.14 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.338 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.81 -41.0 94.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -69.61 -29.05 66.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.5 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.96 -61.08 2.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.04 -42.14 76.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.404 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.0 116.78 19.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.91 137.81 39.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -74.65 144.28 32.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.26 134.77 10.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.334 -1.098 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 12.1 mttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.93 127.42 6.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . 0.4 ' N ' HD21 ' D' ' 420' ' ' ASN . 1.6 m-80 -86.65 -62.61 1.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -0.915 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . 0.46 ' C ' ' HG ' ' D' ' 422' ' ' SER . 18.9 t0 -79.11 -113.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 422' ' ' SER . . . . . 0.46 ' HG ' ' C ' ' D' ' 421' ' ' ASP . 0.7 OUTLIER 58.52 22.63 9.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -61.18 -89.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -151.38 70.83 8.32 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.674 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.13 -28.19 48.83 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.308 1.339 . . . . 0.0 112.442 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' D' ' 426' ' ' LEU . 10.8 mp -63.42 -57.59 9.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.93 -36.36 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.429 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -57.44 -59.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.942 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.35 16.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 108.59 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -69.85 -29.82 67.15 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.451 -0.78 . . . . 0.0 109.123 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' D' ' 428' ' ' VAL . 33.5 m-20 -67.65 -63.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 7.3 tp -50.47 -36.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.125 -0.985 . . . . 0.0 108.569 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 17.7 mt -57.8 -43.52 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.523 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.77 87.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.98 -50.77 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -1.175 . . . . 0.0 108.741 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.42 -38.43 77.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.392 -0.817 . . . . 0.0 109.499 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.626 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -53.2 -46.64 69.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.9 tp -67.78 -36.97 81.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.759 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 37.0 mm -49.61 -39.74 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.81 -1.181 . . . . 0.0 107.836 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.38 -37.9 68.62 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.4 t90 -57.31 -55.89 28.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.507 -0.746 . . . . 0.0 109.091 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.71 -47.25 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.93 -15.6 63.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -58.09 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.558 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -61.23 -31.78 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.47 -64.43 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 8.3 t80 55.8 16.67 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 52.46 -174.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -149.11 132.86 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 450' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' D' ' 455' ' ' PHE . 0.3 OUTLIER 55.81 177.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 16.2 tt -168.75 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -70.18 160.4 32.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -88.71 12.9 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -151.05 26.82 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.441 ' CG ' ' N ' ' D' ' 456' ' ' GLU . 58.7 t80 -59.18 156.62 11.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' D' ' 455' ' ' PHE . 11.0 tt0 -168.86 131.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -69.82 155.41 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 164.04 96.97 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.07 110.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.493 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.5 t -62.92 144.75 56.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 120' ' ' ASN . 4.1 p30 -152.27 58.67 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.11 -172.29 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.48 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -63.04 -75.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.52 126.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -159.53 70.31 3.28 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.96 -27.73 50.39 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.421 1.414 . . . . 0.0 112.559 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.82 -40.94 62.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.136 -0.977 . . . . 0.0 109.67 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.21 -55.06 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.484 ' O ' ' ND2' ' A' ' 131' ' ' ASN . 34.0 m -60.73 -52.7 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 128' ' ' VAL . . . -55.5 -25.09 35.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.261 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.23 -20.98 24.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -74.67 -43.07 57.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -50.74 -45.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 tt -73.0 -34.97 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.223 -0.923 . . . . 0.0 108.894 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -41.86 81.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.59 -58.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.342 -1.093 . . . . 0.0 108.999 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.91 -33.62 11.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.925 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.421 ' ND1' ' C ' ' A' ' 137' ' ' HIS . 0.0 OUTLIER -64.12 -51.02 65.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.031 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.454 ' CD2' ' CE1' ' D' ' 437' ' ' HIS . 5.6 mt -59.45 -40.77 87.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.85 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.6 tt -82.81 -54.1 5.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 109.541 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -50.77 -43.7 58.49 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.281 -0.887 . . . . 0.0 109.737 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 10.0 tp -72.21 -46.68 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.2 mt -48.88 -32.51 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 109.062 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 148' ' ' PHE . 11.4 t70 -76.04 -54.27 7.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -50.56 -23.27 2.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.34 -17.57 16.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.812 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.01 42.36 1.21 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 144' ' ' ASP . 24.8 p90 -47.67 -28.73 2.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -69.15 -42.28 76.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -64.58 -49.56 70.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.97 -44.08 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.423 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -59.58 -45.6 91.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -0.905 . . . . 0.0 109.536 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -65.18 -42.58 93.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -59.6 5.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -30.9 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -82.21 28.73 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.61 113.9 3.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.52 98.89 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.38 125.71 33.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.5 mttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.467 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 4.3 t -161.21 -0.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -70.96 96.53 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.551 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.69 127.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 81.0 p -79.06 148.03 32.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.24 150.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -170.23 69.97 0.59 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.09 -25.87 58.23 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.333 1.355 . . . . 0.0 112.494 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.63 -47.99 28.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.89 -38.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.96 -58.83 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.49 15.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.45 67.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.297 -0.877 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.438 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.6 tp -50.12 -37.69 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.123 -0.986 . . . . 0.0 108.519 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.0 mt -55.92 -43.81 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.182 -0.949 . . . . 0.0 108.497 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.11 -44.29 93.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.9 -41.39 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -1.204 . . . . 0.0 108.561 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -68.04 -33.79 75.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.275 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.476 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -57.37 -48.06 80.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.019 -1.051 . . . . 0.0 109.163 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.476 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 9.4 tp -68.23 -35.55 78.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.65 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.42 -41.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.643 -1.286 . . . . 0.0 108.227 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.36 -38.66 71.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -55.45 -54.51 42.87 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.27 -52.45 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.0 109.225 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.03 -41.62 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -62.66 -47.19 84.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.494 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.54 -37.97 82.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.28 -62.53 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 5.6 t80 60.07 107.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -65.44 161.54 19.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -167.23 -179.48 4.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 48.3 t -170.79 92.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.5 pt -80.84 150.05 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.413 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . 0.443 ' O ' ' CB ' ' B' ' 253' ' ' ARG . 0.2 OUTLIER -154.51 -46.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.52 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' B' ' 252' ' ' TYR . 9.9 ttt180 71.13 111.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.81 129.4 35.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' B' ' 256' ' ' GLU . 73.3 t80 -159.84 178.61 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.537 ' N ' ' CD2' ' B' ' 255' ' ' PHE . 15.5 tt0 -74.01 103.59 4.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -156.2 101.63 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 160.74 -175.13 37.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.29 127.9 36.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -1.18 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 4.3 t -62.96 144.7 56.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.173 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' C' ' 320' ' ' ASN . 4.1 p30 -152.17 58.61 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.19 -172.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 322' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' C' ' 323' ' ' SER . 6.9 m -63.05 -75.89 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.396 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 323' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' C' ' 322' ' ' SER . 1.0 OUTLIER 68.57 126.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -159.5 70.34 3.29 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.96 -27.59 50.5 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.36 1.373 . . . . 0.0 112.529 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.91 -40.96 62.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.23 -55.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.937 . . . . 0.0 109.549 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.483 ' O ' ' ND2' ' C' ' 331' ' ' ASN . 34.0 m -60.72 -52.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.472 ' N ' ' CG2' ' C' ' 328' ' ' VAL . . . -55.6 -25.24 37.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.12 -0.987 . . . . 0.0 109.216 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -88.33 -20.59 25.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 0.3 OUTLIER -74.75 -43.07 56.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.3 mt -50.65 -46.02 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.9 tt -72.74 -35.09 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.196 -0.94 . . . . 0.0 108.951 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.88 81.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.59 -58.37 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 109.062 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.89 -33.63 11.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.94 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' C' ' 337' ' ' HIS . 0.0 OUTLIER -64.12 -50.97 66.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.433 -0.792 . . . . 0.0 109.034 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' B' ' 237' ' ' HIS . 5.5 mt -59.58 -40.69 88.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.523 -0.736 . . . . 0.0 109.609 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.582 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.79 -53.44 5.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 109.581 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -51.34 -43.43 61.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.917 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 9.9 tp -72.43 -46.52 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 mt -48.74 -32.7 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.139 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' C' ' 348' ' ' PHE . 11.5 t70 -76.19 -54.17 7.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.378 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -50.48 -23.18 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.398 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.48 -17.53 16.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.0 42.43 1.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 109.719 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' C' ' 344' ' ' ASP . 24.4 p90 -47.8 -28.68 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -69.18 -42.3 76.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 16.8 t -64.41 -49.83 70.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.81 -44.06 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.66 -45.6 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -65.13 -42.6 93.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -59.58 5.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.59 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -30.93 29.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -82.26 28.84 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.65 113.92 3.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.521 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 176.48 98.9 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 18.6 mt -85.43 125.81 33.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.137 . . . . 0.0 109.429 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 17.5 mttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.438 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 4.2 t -161.2 -0.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.596 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -71.04 96.55 1.33 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.76 127.14 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 81.1 p -79.21 147.96 32.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.399 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.32 150.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -170.28 70.02 0.58 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.22 -25.81 57.29 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.338 1.359 . . . . 0.0 112.414 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.57 -48.04 28.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.85 -38.65 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.9 -58.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -39.44 15.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.09 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.77 -32.38 67.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.229 -0.919 . . . . 0.0 109.175 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -63.45 1.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.7 tp -50.13 -37.63 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.132 -0.98 . . . . 0.0 108.525 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 9.9 mt -56.1 -43.66 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.14 -0.975 . . . . 0.0 108.467 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.33 93.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.87 -41.49 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.111 -1.229 . . . . 0.0 108.54 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.95 -33.81 75.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.426 -0.796 . . . . 0.0 109.261 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.48 ' ND1' ' C ' ' D' ' 437' ' ' HIS . 0.3 OUTLIER -57.4 -48.15 79.85 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.027 -1.045 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.477 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 9.7 tp -68.05 -35.8 78.82 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.618 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 17.0 mt -50.45 -41.69 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.725 -1.234 . . . . 0.0 108.21 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.41 -38.55 71.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -55.35 -54.59 41.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.43 -0.794 . . . . 0.0 109.073 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.32 -52.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.328 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -41.73 17.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -62.68 -47.2 84.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.55 -37.98 83.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.23 -62.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 5.6 t80 60.17 107.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -65.46 161.55 19.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -167.22 -179.49 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 48.3 t -170.79 92.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.5 pt -80.7 150.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' D' ' 453' ' ' ARG . 0.2 OUTLIER -154.54 -46.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' D' ' 452' ' ' TYR . 9.9 ttt180 71.08 111.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.537 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 129.42 35.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.402 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' D' ' 456' ' ' GLU . 73.4 t80 -159.85 178.69 9.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' D' ' 455' ' ' PHE . 15.6 tt0 -74.05 103.65 4.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -156.28 101.63 2.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 160.77 -175.09 37.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 127.9 36.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.142 . . . . 0.0 109.526 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.46 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 t -157.86 169.78 23.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 50.83 -147.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -156.5 -41.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.411 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.8 t -158.29 -50.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.549 ' HG ' ' HG ' ' C' ' 323' ' ' SER . 58.9 p -166.49 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -148.72 70.74 10.46 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.26 -27.87 55.8 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.355 1.37 . . . . 0.0 112.361 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.13 -55.13 30.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.68 -35.77 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.44 ' C ' ' N ' ' A' ' 130' ' ' ALA . 8.9 t -66.05 -67.59 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.67 -17.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.44 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -87.53 -27.03 22.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.585 -0.697 . . . . 0.0 109.271 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.626 ' ND2' ' N ' ' A' ' 132' ' ' ILE . 0.0 OUTLIER -76.03 -39.79 54.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.457 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.626 ' N ' ' ND2' ' A' ' 131' ' ' ASN . 7.2 mt -53.55 -44.3 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 109.378 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.1 tt -74.64 -36.41 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.127 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.59 91.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.05 -60.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.344 -1.092 . . . . 0.0 109.136 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.98 -24.96 7.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.267 -0.896 . . . . 0.0 108.899 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.468 ' HE2' ' HE2' ' C' ' 337' ' ' HIS . 0.0 OUTLIER -67.86 -55.51 12.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.159 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.464 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 2.4 mt -55.33 -48.27 74.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mt -58.41 -30.96 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 tt -75.96 -46.28 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.377 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CZ3' ' C' ' 341' ' ' TRP . 1.0 OUTLIER -50.65 -47.09 58.66 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 110.032 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.635 ' CG2' ' HE2' ' D' ' 437' ' ' HIS . 9.5 tt -71.16 -42.91 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.04 -1.037 . . . . 0.0 109.908 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.83 -36.74 17.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.63 -53.05 9.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.83 . . . . 0.0 109.592 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 66.9 ttt180 -50.48 -23.14 2.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.57 -17.42 15.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.724 . . . . 0.0 109.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -148.91 41.85 0.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 144' ' ' ASP . 50.9 p90 -47.29 -25.57 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -71.36 -38.69 71.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.428 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.6 t -70.18 -49.38 50.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 109.368 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 151' ' ' ILE . 1.7 mp -59.75 -32.0 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -74.3 -54.69 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.41 ' O ' ' O ' ' A' ' 156' ' ' GLU . 65.1 mtm180 -61.43 -32.3 72.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -56.53 -53.61 55.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -63.2 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.481 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 153' ' ' ARG . 88.2 tt0 -65.04 123.67 20.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.454 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.49 -50.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -151.36 -146.15 4.28 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.13 -36.98 66.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 109.467 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.443 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' B' ' 218' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.13 -178.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' B' ' 220' ' ' ASN . 3.1 p30 -60.89 -21.91 63.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.55 161.94 7.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 5.8 m -88.08 66.06 8.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 23.2 p -152.89 152.89 32.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -163.52 70.82 1.84 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.69 -25.59 61.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.31 1.34 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.38 -41.62 39.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.595 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.611 ' CG1' HD22 ' C' ' 331' ' ' ASN . 13.8 t -61.05 -42.97 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.564 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.6 t -57.91 -58.63 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.431 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.74 -37.43 13.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.22 -31.2 67.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.137 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.0 t-20 -67.71 -64.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.41 -36.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.127 -0.983 . . . . 0.0 108.565 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.78 -45.12 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.28 -46.53 86.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.4 ' CD1' ' N ' ' B' ' 235' ' ' ILE . 1.8 mp -56.44 -40.43 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.313 . . . . 0.0 108.533 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -35.44 75.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.461 -0.774 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.621 ' HE2' ' CG2' ' C' ' 342' ' ' ILE . 3.1 t-80 -54.07 -52.07 62.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.064 -1.022 . . . . 0.0 109.164 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.85 -32.37 70.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.888 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.09 -38.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.516 -1.365 . . . . 0.0 107.864 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.85 62.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -50.5 -52.63 36.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.425 -0.797 . . . . 0.0 109.433 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.8 tt -68.0 -33.7 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.4 -58.3 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -58.9 -42.08 88.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -20.77 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.32 -52.59 7.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.947 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . 0.517 ' C ' ' H ' ' B' ' 249' ' ' LYS . 2.3 m-85 -58.3 -55.07 39.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.52 -4.12 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' B' ' 247' ' ' PHE . 40.3 mttp -81.32 133.07 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' SER . . . . . 0.436 ' C ' ' H ' ' B' ' 252' ' ' TYR . 11.5 t -167.96 71.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.8 pt -78.9 21.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' B' ' 250' ' ' SER . 61.1 t80 -74.09 -0.85 17.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -82.87 32.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -148.29 -117.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.1 OUTLIER -66.43 120.52 13.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.01 -57.76 7.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 11.9 t60 48.75 -145.53 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 260' ' ' LYS . . . 79.74 1.17 86.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.2 mt 51.08 14.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.413 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' B' ' 258' ' ' GLY . 25.2 ttpt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.491 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 2.9 t -157.89 169.84 23.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 50.81 -147.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -156.44 -41.26 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 42.9 t -158.26 -50.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.419 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 323' ' ' SER . . . . . 0.549 ' HG ' ' HG ' ' A' ' 123' ' ' SER . 57.9 p -166.49 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -148.76 70.73 10.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.21 -27.89 56.23 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.373 1.382 . . . . 0.0 112.39 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.12 -55.21 29.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 93.1 t -52.62 -35.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' C' ' 330' ' ' ALA . 9.9 t -65.9 -67.79 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 109.481 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -50.65 -17.3 0.5 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 108.764 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -87.8 -26.41 22.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.279 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.612 ' ND2' ' N ' ' C' ' 332' ' ' ILE . 0.0 OUTLIER -76.16 -39.83 54.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.612 ' N ' ' ND2' ' C' ' 331' ' ' ASN . 7.3 mt -53.56 -44.37 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -74.61 -36.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.42 91.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.07 -60.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.119 . . . . 0.0 109.103 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.0 -24.84 7.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 108.844 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.468 ' HE2' ' HE2' ' A' ' 137' ' ' HIS . 0.0 OUTLIER -68.07 -55.33 12.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.358 -0.839 . . . . 0.0 109.149 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.448 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 2.4 mt -55.35 -48.37 74.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.38 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 24.2 mt -58.44 -31.0 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -76.16 -45.45 33.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CZ3' ' CH2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -51.42 -46.72 63.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.436 -0.79 . . . . 0.0 110.063 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.621 ' CG2' ' HE2' ' B' ' 237' ' ' HIS . 9.8 tt -71.42 -42.77 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 0.0 109.946 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.81 -36.7 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.192 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.92 -52.89 9.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' C' ' 344' ' ' ASP . 67.0 ttt180 -50.4 -23.13 2.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 109.494 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.66 -17.36 15.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 109.858 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -148.9 41.93 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 344' ' ' ASP . 51.2 p90 -47.42 -25.55 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.324 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -71.39 -38.64 71.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 10.7 t -70.15 -49.44 50.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' C' ' 351' ' ' ILE . 1.7 mp -59.83 -31.86 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.354 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -74.26 -54.69 7.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.455 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' C' ' 356' ' ' GLU . 64.9 mtm180 -61.42 -32.27 72.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -56.56 -53.61 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -63.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' C' ' 353' ' ' ARG . 88.1 tt0 -64.96 123.64 19.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.47 -50.13 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.945 . . . . 0.0 109.55 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -151.38 -146.09 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.17 -37.09 66.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' D' ' 418' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.04 -178.08 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.551 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . 0.44 ' N ' ' OD1' ' D' ' 420' ' ' ASN . 3.1 p30 -60.91 -21.88 63.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.51 162.0 7.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 5.6 m -88.04 66.09 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.317 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 23.5 p -152.89 152.9 32.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.94 . . . . 0.0 109.553 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -163.48 70.74 1.84 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -64.68 -25.61 61.45 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.417 1.411 . . . . 0.0 112.453 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -41.6 39.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.596 ' CG1' HD22 ' A' ' 131' ' ' ASN . 14.3 t -61.16 -42.82 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.569 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.6 t -58.09 -58.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.89 -37.32 13.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.21 67.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 109.059 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.0 t-20 -67.71 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.1 tp -50.42 -36.79 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 108.552 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 8.6 mt -55.85 -44.99 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 108.325 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.48 86.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -56.41 -40.41 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.058 -1.26 . . . . 0.0 108.577 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -35.49 75.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.353 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.635 ' HE2' ' CG2' ' A' ' 142' ' ' ILE . 3.0 t-80 -53.96 -52.07 61.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.099 -1.0 . . . . 0.0 109.185 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . . . . . . . . . 11.3 tp -69.77 -32.43 70.92 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.976 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.14 -38.21 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.514 -1.366 . . . . 0.0 107.858 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.83 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.5 t90 -50.4 -52.57 36.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 109.487 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.9 tt -68.3 -33.43 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.46 -58.28 9.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -58.84 -42.19 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.558 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -63.19 -20.75 65.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.528 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.28 -52.67 7.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . 0.519 ' C ' ' H ' ' D' ' 449' ' ' LYS . 2.3 m-85 -58.31 -55.07 39.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.548 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.57 -4.22 0.6 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.472 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' D' ' 447' ' ' PHE . 40.3 mttp -81.24 133.07 35.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.598 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 450' ' ' SER . . . . . 0.441 ' C ' ' H ' ' D' ' 452' ' ' TYR . 11.5 t -168.04 71.77 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.8 pt -78.92 21.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.386 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' D' ' 450' ' ' SER . 60.9 t80 -74.09 -0.79 17.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.885 . . . . 0.0 109.377 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -82.76 32.11 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.439 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -148.26 -117.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' D' ' 455' ' ' PHE . 0.1 OUTLIER -66.43 120.46 13.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.96 -57.82 7.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 11.8 t60 48.76 -145.66 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' D' ' 460' ' ' LYS . . . 79.76 1.15 86.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.1 mt 51.1 14.06 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' D' ' 458' ' ' GLY . 25.3 ttpt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.46 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' ASN . 62.9 ttt180 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.256 0.551 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -62.32 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 p30 -66.01 -173.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.1 128.32 2.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 123' ' ' SER . 1.6 t -164.38 118.86 1.43 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 122' ' ' SER . 1.1 p 70.22 27.61 4.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 48.54 71.06 1.72 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.6 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -68.17 -23.52 39.31 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.363 1.375 . . . . 0.0 112.52 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.38 -56.15 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.478 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 128' ' ' VAL . 4.2 p -55.9 -42.75 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.483 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 34.5 m -71.59 -54.36 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.055 . . . . 0.0 109.636 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.483 ' H ' ' CG2' ' A' ' 128' ' ' VAL . . . -54.3 -23.8 16.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.954 . . . . 0.0 109.18 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.56 -21.0 21.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 0.0 109.427 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.484 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -72.92 -42.19 63.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.597 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.463 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -51.06 -46.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.504 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 tt -72.17 -34.15 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 108.768 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.69 -41.93 83.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.37 -57.1 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.45 -1.029 . . . . 0.0 109.054 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -39.52 43.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 108.694 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.532 ' NE2' ' CD2' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -55.65 -55.37 32.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.518 ' CD2' ' NE2' ' C' ' 337' ' ' HIS . 4.3 mt -58.24 -53.54 57.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 81.8 mt -52.92 -29.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.47 -57.6 3.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.589 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.4 OUTLIER -50.01 -54.69 18.45 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -58.39 -44.93 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.466 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 mt -48.64 -36.27 15.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.0 -1.062 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.5 -37.04 60.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -0.872 . . . . 0.0 109.604 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -64.37 -28.67 69.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.22 -14.18 18.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.799 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -146.84 40.17 1.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 0.0 109.779 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 144' ' ' ASP . 19.7 p90 -47.42 -22.15 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.19 -0.944 . . . . 0.0 109.403 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -75.88 -46.96 27.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.486 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -60.49 -48.11 83.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 151' ' ' ILE . 11.1 mm -64.82 -35.68 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 109.386 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -49.4 74.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -72.62 -22.7 60.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.354 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.76 -46.39 85.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 0.0 109.334 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.45 -43.05 91.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.314 -0.866 . . . . 0.0 109.422 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -80.6 117.41 21.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.484 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -65.33 -96.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -151.93 158.96 28.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.31 146.79 50.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -1.143 . . . . 0.0 109.517 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.4 mttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.498 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.63 -24.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.397 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 21.2 t30 59.83 159.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -38.62 70.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.449 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.67 30.1 6.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.85 165.38 35.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' B' ' 224' ' ' ASP . 12.2 p-10 -161.64 69.83 2.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.32 -28.35 63.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.292 1.328 . . . . 0.0 112.36 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.81 -53.91 28.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.501 ' CG1' HD22 ' C' ' 331' ' ' ASN . 21.3 t -56.9 -43.64 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' B' ' 231' ' ' ASN . 9.0 t -57.3 -55.36 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.82 23.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.228 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -67.69 -26.26 66.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.208 -0.932 . . . . 0.0 109.16 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' B' ' 228' ' ' VAL . 0.2 OUTLIER -69.97 -65.73 0.68 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.0 tp -50.31 -36.17 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.736 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 28.6 mt -57.95 -44.04 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.95 -43.17 95.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.8 -44.03 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -1.221 . . . . 0.0 108.739 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.06 -36.03 82.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.297 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -55.87 -48.27 75.85 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 8.5 tp -67.93 -36.06 79.49 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.767 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 10.6 mt -50.11 -40.48 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.183 . . . . 0.0 108.006 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.06 -39.21 69.19 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -55.51 -55.75 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.469 -0.77 . . . . 0.0 109.047 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.9 mt -55.49 -48.7 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.75 -50.42 66.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.452 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -48.99 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -53.55 -44.15 69.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -62.9 1.45 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 0.0 109.438 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -67.04 -167.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.582 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.15 -23.3 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -168.32 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.07 -178.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 2.8 tt -163.71 150.41 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -72.0 -143.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.338 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -164.03 -19.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.92 -4.12 8.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.76 80.12 7.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -86.03 128.78 34.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -159.46 20.49 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -83.7 101.79 2.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.64 -25.08 18.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 45.1 tttt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.445 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' C' ' 320' ' ' ASN . 63.3 ttt180 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 89.4 p -62.31 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' C' ' 318' ' ' ARG . 6.0 p30 -66.1 -172.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.9 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.14 128.36 2.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.465 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 322' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' C' ' 323' ' ' SER . 1.7 t -164.39 118.83 1.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 323' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' C' ' 322' ' ' SER . 1.1 p 70.24 27.58 4.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.522 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 48.5 71.04 1.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.866 . . . . 0.0 109.657 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -68.2 -23.33 39.36 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.406 1.404 . . . . 0.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.55 -56.15 4.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.423 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' C' ' 328' ' ' VAL . 4.2 p -55.88 -42.83 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 0.0 110.261 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.474 ' CG2' ' H ' ' C' ' 329' ' ' ALA . 34.6 m -71.59 -54.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.594 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.474 ' H ' ' CG2' ' C' ' 328' ' ' VAL . . . -54.33 -23.94 17.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -91.54 -20.71 21.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.428 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.501 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.09 -42.37 63.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.1 mt -50.77 -46.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.8 tt -71.97 -34.24 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.092 -1.005 . . . . 0.0 108.815 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.9 83.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.41 -57.13 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.343 -1.092 . . . . 0.0 109.071 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.02 -39.72 42.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 108.691 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.518 ' NE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -55.41 -55.5 30.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 109.044 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.532 ' CD2' ' NE2' ' A' ' 137' ' ' HIS . 4.3 mt -58.24 -53.57 56.74 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.537 -0.727 . . . . 0.0 109.735 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 82.3 mt -52.92 -29.93 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.57 -56.92 4.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -50.66 -54.67 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 109.738 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 0.8 OUTLIER -58.33 -44.87 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.245 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.465 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 mt -48.49 -36.5 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 0.0 109.197 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.6 -36.85 60.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.527 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -64.39 -28.62 69.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.26 -14.24 18.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.786 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -146.86 40.36 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.73 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' C' ' 344' ' ' ASP . 19.5 p90 -47.54 -22.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -75.78 -47.05 27.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.534 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -48.06 83.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 11.0 mm -64.83 -35.65 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.372 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 1.0 OUTLIER -63.02 -49.26 75.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.441 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -72.7 -22.73 60.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.68 -46.47 85.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 109.289 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.42 -43.18 91.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -80.51 117.38 21.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -65.29 -96.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -152.07 158.99 28.11 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 6.8 mt -70.36 146.84 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -1.131 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 39.3 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.39 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 -24.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 21.1 t30 59.93 159.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -38.6 70.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.63 30.1 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.9 165.42 35.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' D' ' 424' ' ' ASP . 12.2 p-10 -161.68 69.8 2.39 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.32 -28.3 63.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.294 1.329 . . . . 0.0 112.4 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.67 -54.01 26.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.484 ' CG1' HD22 ' A' ' 131' ' ' ASN . 21.4 t -56.89 -43.75 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.616 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' D' ' 431' ' ' ASN . 9.5 t -57.27 -55.34 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.78 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -67.92 -25.97 65.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.238 -0.914 . . . . 0.0 109.157 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.2 OUTLIER -70.06 -65.79 0.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.0 tp -50.22 -36.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 28.4 mt -58.04 -43.91 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 108.468 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.06 -43.08 95.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.82 -44.1 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -1.234 . . . . 0.0 108.626 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.14 -35.88 81.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.217 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.06 -48.18 76.53 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.98 -1.075 . . . . 0.0 109.439 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.83 -36.25 80.03 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.81 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 10.5 mt -50.02 -40.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 108.059 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.01 -39.14 69.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -55.52 -55.66 29.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.086 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.8 mt -55.79 -48.52 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.43 -0.794 . . . . 0.0 109.146 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.69 -50.54 65.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -48.91 69.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -53.62 -44.15 69.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -62.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.14 -167.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -147.12 -23.21 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.51 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' D' ' 450' ' ' SER . 74.7 tttt -168.34 -23.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 450' ' ' SER . . . . . 0.402 ' O ' ' O ' ' D' ' 449' ' ' LYS . 0.2 OUTLIER 51.04 -178.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.348 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 2.8 tt -163.71 150.46 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -72.08 -143.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -164.02 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.89 -4.01 8.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.69 80.03 7.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -86.06 128.82 34.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -159.49 20.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -83.63 101.8 2.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.6 -25.06 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 44.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.441 ' H2 ' ' H ' ' A' ' 119' ' ' SER . 11.8 mpt_? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.441 ' H ' ' H2 ' ' A' ' 118' ' ' ARG . 13.1 m -78.9 17.05 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 120' ' ' ASN . 15.0 p-10 -82.98 34.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.99 170.2 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.45 -8.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -60.43 -98.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -152.72 70.09 7.21 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.87 -28.16 58.8 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.273 1.315 . . . . 0.0 112.382 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 10.8 mp -54.89 -50.17 69.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.36 -36.97 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 131' ' ' ASN . 61.1 t -69.53 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.91 -19.74 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.932 . . . . 0.0 108.674 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.21 -27.08 19.76 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.564 HD22 ' CG1' ' D' ' 427' ' ' VAL . 0.3 OUTLIER -69.07 -38.81 79.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.481 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.46 -47.89 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.8 tt -77.75 -27.08 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -0.922 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.09 -55.12 32.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 mm -65.24 -48.67 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.023 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.5 -38.69 60.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.982 . . . . 0.0 108.735 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.55 ' NE2' ' CD2' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -59.59 -52.35 65.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.025 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.539 ' CD2' ' NE2' ' C' ' 337' ' ' HIS . 3.5 mt -57.34 -49.43 76.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.78 . . . . 0.0 109.674 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.34 -34.69 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 109.86 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -77.93 -45.14 24.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.06 -1.025 . . . . 0.0 109.918 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 2.1 t-105 -48.7 -51.45 28.56 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 109.948 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -71.33 -39.9 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.53 -40.27 18.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.094 -1.004 . . . . 0.0 109.252 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 148' ' ' PHE . 12.0 t0 -77.31 -43.64 32.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.428 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.25 -34.41 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.74 -49.37 5.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.753 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -96.01 36.58 1.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.715 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 144' ' ' ASP . 17.9 t80 -53.2 -34.33 56.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -63.68 -34.7 78.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 154' ' ' PHE . 4.4 m -71.57 -54.35 10.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 mm -52.26 -32.14 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.92 -48.69 13.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -73.11 -14.93 61.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 150' ' ' SER . 67.3 t80 -81.83 -54.8 5.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -71.4 -42.2 68.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -88.97 167.55 13.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 158' ' ' GLY . 4.8 t-80 57.74 -143.85 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.452 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.502 ' H ' ' CG ' ' A' ' 157' ' ' HIS . . . 64.92 82.47 0.1 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 115.64 6.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.656 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.481 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.15 -179.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -166.97 -175.63 3.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -60.58 132.09 52.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 72.5 m -160.78 146.8 14.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 26.0 m -151.8 108.35 3.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 50.23 69.64 2.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.656 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.6 -28.58 52.78 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.295 1.33 . . . . 0.0 112.305 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -59.89 3.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.581 ' CG1' HD22 ' C' ' 331' ' ' ASN . 12.7 t -53.5 -39.5 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.32 -54.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.7 -42.37 24.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.15 -32.62 70.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -65.13 -65.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.706 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.3 tp -50.01 -39.22 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.143 -0.973 . . . . 0.0 108.777 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 12.9 mt -53.77 -43.3 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.83 -43.33 98.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -60.83 -43.55 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -1.143 . . . . 0.0 108.979 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -33.08 73.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.523 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.5 OUTLIER -57.12 -51.42 69.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.018 -1.051 . . . . 0.0 109.281 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.523 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 11.7 tp -68.19 -33.62 74.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.73 -39.94 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.741 -1.224 . . . . 0.0 108.06 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.5 tt -73.28 -39.52 65.29 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -52.97 -52.17 59.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.48 -33.78 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.571 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.11 -62.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.94 . . . . 0.0 109.406 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -53.06 -47.84 68.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -48.23 -50.43 29.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.598 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.4 mp -56.57 -45.95 81.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.86 109.9 18.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.244 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.3 142.64 30.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -79.58 85.01 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 10.9 t -149.71 -54.19 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 76.1 mt -88.72 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.955 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -164.82 25.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' B' ' 253' ' ' ARG . 0.0 OUTLIER -89.27 89.65 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 56.1 -174.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.88 -44.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -86.17 123.08 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . 0.491 ' N ' ' ND1' ' B' ' 257' ' ' HIS . 1.6 m-70 -60.03 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.96 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -89.92 -174.35 45.4 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.65 -53.91 52.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -1.174 . . . . 0.0 109.352 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 17.3 tttp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.491 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.422 ' H1 ' ' H ' ' C' ' 319' ' ' SER . 11.8 mpt_? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 319' ' ' SER . . . . . 0.422 ' H ' ' H1 ' ' C' ' 318' ' ' ARG . 13.5 m -79.11 17.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' C' ' 320' ' ' ASN . 15.0 p-10 -83.0 34.16 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.06 170.14 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.39 -8.27 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 71.5 m -60.52 -98.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -152.85 70.01 7.11 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.608 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.76 -28.17 59.79 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.236 1.29 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' C' ' 326' ' ' LEU . 10.8 mp -54.88 -50.11 69.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.49 -37.02 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' C' ' 331' ' ' ASN . 60.3 t -69.48 -63.01 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.95 -19.82 0.44 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.435 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.38 -26.54 19.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.581 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.3 OUTLIER -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.841 . . . . 0.0 109.516 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.28 -48.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.404 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.9 tt -77.63 -27.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 108.782 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.12 -55.09 32.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.7 mm -65.38 -48.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 108.995 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.45 -38.75 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 108.757 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.539 ' NE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.56 -52.24 66.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 109.093 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.55 ' CD2' ' NE2' ' A' ' 137' ' ' HIS . 3.5 mt -57.33 -49.56 75.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 14.4 mt -52.35 -34.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 0.0 109.912 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.21 -44.22 26.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.81 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 2.1 t-105 -49.56 -51.07 39.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 110.06 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -71.65 -39.79 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.49 -40.23 17.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 0.0 109.299 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' C' ' 348' ' ' PHE . 12.0 t0 -77.48 -43.56 31.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.27 -34.37 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.76 -49.61 5.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.64 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.88 36.66 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.855 . . . . 0.0 109.733 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' C' ' 344' ' ' ASP . 17.7 t80 -53.32 -34.28 56.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.94 . . . . 0.0 109.438 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -63.56 -34.82 78.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 350' ' ' SER . . . . . 0.445 ' O ' ' N ' ' C' ' 354' ' ' PHE . 4.4 m -71.53 -54.44 10.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 12.4 mm -52.11 -32.18 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.424 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.99 -48.77 12.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -73.03 -14.95 61.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' C' ' 350' ' ' SER . 67.4 t80 -81.91 -54.72 5.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -71.42 -42.12 68.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -89.05 167.52 13.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.85 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' C' ' 358' ' ' GLY . 4.9 t-80 57.69 -143.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . 0.502 ' H ' ' CG ' ' C' ' 357' ' ' HIS . . . 64.9 82.52 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.05 115.82 7.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 109.501 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 2.2 tttp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 419' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' D' ' 420' ' ' ASN . 0.2 OUTLIER 56.07 -179.72 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.537 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . 0.6 ' N ' ' HG ' ' D' ' 419' ' ' SER . 3.5 p30 -166.96 -175.63 3.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -60.61 132.09 52.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.435 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 72.6 m -160.71 146.82 15.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 26.5 m -151.82 108.33 3.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 50.28 69.63 2.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.63 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.65 -28.59 52.37 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.236 1.291 . . . . 0.0 112.244 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -59.9 3.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.564 ' CG1' HD22 ' A' ' 131' ' ' ASN . 12.3 t -53.52 -39.4 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.373 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 9.3 t -60.34 -54.65 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 109.427 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.81 -42.26 25.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.139 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -70.35 -32.44 70.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.252 -0.905 . . . . 0.0 109.188 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -65.23 -65.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.726 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.3 tp -49.88 -39.36 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 0.0 108.774 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 12.9 mt -53.77 -43.18 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.251 -0.906 . . . . 0.0 108.691 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.3 98.19 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -60.98 -43.4 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -1.188 . . . . 0.0 108.914 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -33.08 73.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.339 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.523 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.5 OUTLIER -57.12 -51.36 69.61 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.049 -1.032 . . . . 0.0 109.314 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.523 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 12.0 tp -68.15 -33.65 74.88 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.643 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.71 -39.95 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.658 -1.277 . . . . 0.0 108.125 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.36 -39.43 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -52.86 -52.29 57.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.58 -33.64 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.01 -62.83 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.08 -47.95 68.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -48.09 -50.45 28.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.618 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.64 -46.05 81.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.386 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.76 109.9 18.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.35 142.57 30.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -79.52 84.93 5.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 10.9 t -149.71 -54.11 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 75.7 mt -88.73 138.03 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -164.71 25.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' D' ' 453' ' ' ARG . 0.0 OUTLIER -89.25 89.57 7.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 56.22 -174.36 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.375 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.95 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -86.26 123.16 31.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . 0.508 ' N ' ' ND1' ' D' ' 457' ' ' HIS . 1.6 m-70 -60.08 -175.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -89.91 -174.4 45.42 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.55 -54.05 50.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.143 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 17.3 tttp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.53 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.73 -164.0 0.25 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.406 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -61.72 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.76 97.06 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 123' ' ' SER . 98.6 p -95.29 55.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.515 ' HG ' ' H ' ' A' ' 124' ' ' ASP . 23.2 t -63.55 -134.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.942 . . . . 0.0 109.472 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' H ' ' HG ' ' A' ' 123' ' ' SER . 24.6 m-20 -148.99 71.02 10.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.8 -29.82 50.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.389 1.392 . . . . 0.0 112.468 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.77 -42.67 60.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.82 -52.52 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.705 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.49 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 34.5 m -63.81 -54.28 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 109.66 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.49 ' H ' ' CG2' ' A' ' 128' ' ' VAL . . . -54.56 -27.99 42.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.132 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -85.17 -21.06 29.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.422 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -73.53 -40.99 63.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.3 mt -50.85 -42.86 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.45 -29.1 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.977 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.46 -53.53 44.71 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -65.26 -50.21 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -1.154 . . . . 0.0 108.892 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 tp -50.24 -40.12 46.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 108.585 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.593 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.93 -58.95 6.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.427 -0.795 . . . . 0.0 108.939 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.593 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 17.1 mt -49.23 -48.74 45.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.693 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.81 -32.37 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.52 -58.44 3.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.042 . . . . 0.0 109.705 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -50.45 -44.04 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.763 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 1.6 tt -71.41 -41.46 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.989 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.469 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.3 tt -58.29 -29.32 65.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 0.0 109.02 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 148' ' ' PHE . 4.7 t70 -77.77 -44.03 28.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.882 . . . . 0.0 109.367 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.516 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 22.3 ttt180 -54.62 -36.3 64.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 -50.53 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.697 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -98.72 36.86 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.462 -0.774 . . . . 0.0 109.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 144' ' ' ASP . 1.8 t80 -52.52 -36.88 56.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.305 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -60.03 -36.1 76.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.298 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 149' ' ' LYS . 15.7 m -69.15 -53.03 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 151' ' ' ILE . 15.5 mm -57.11 -23.59 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -84.65 -41.51 16.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -73.81 -21.26 60.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 109.574 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -83.21 -61.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.37 -27.77 63.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.506 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 49.99 -106.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.389 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.6 172.69 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' LYS . . . -87.28 -134.89 4.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 mt 47.45 18.77 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -1.124 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' GLY . 33.7 mtpt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 77.4 p -65.81 -173.14 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' B' ' 221' ' ' ASP . 2.2 t-20 -59.23 -72.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.495 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' B' ' 220' ' ' ASN . 12.6 t0 -168.7 145.97 3.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.586 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -4.73 56.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.56 153.54 40.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.363 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.41 163.5 23.2 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -54.28 -28.03 50.62 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.066 1.177 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.45 -59.26 5.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.432 ' CG1' HD22 ' C' ' 331' ' ' ASN . 25.5 t -50.66 -47.58 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -48.79 -58.63 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.123 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.73 -36.44 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.28 -32.53 68.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 109.067 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.3 m120 -66.63 -62.64 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 7.9 tp -50.94 -37.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.074 -1.016 . . . . 0.0 108.494 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.05 -42.22 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.16 -47.72 85.42 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.28 -39.15 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.237 -1.155 . . . . 0.0 108.6 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.5 mp -68.46 -36.83 79.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.421 -0.799 . . . . 0.0 109.276 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -54.28 -46.93 72.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.019 -1.05 . . . . 0.0 108.982 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.6 tp -68.74 -37.74 79.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.31 -37.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.973 -1.079 . . . . 0.0 108.095 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.54 -37.37 63.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . 0.56 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -58.52 -57.0 14.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.688 . . . . 0.0 109.436 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 16.4 tt -63.72 -40.17 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.544 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.29 -48.03 81.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.593 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -41.1 90.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -68.67 -25.36 64.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.22 -69.49 0.62 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -72.14 150.92 43.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -75.93 129.86 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -10.56 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.47 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 3.3 m -157.1 132.72 9.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.7 pt -54.68 162.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -53.39 147.39 10.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.23 148.8 47.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' B' ' 255' ' ' PHE . 97.3 m-85 -57.37 -14.3 4.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.361 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' B' ' 254' ' ' PHE . 2.1 t80 59.5 110.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.573 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -55.41 131.41 45.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -62.57 -46.31 88.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 61.44 5.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -38.42 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -1.16 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.568 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.64 -163.94 0.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -61.74 133.62 55.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -151.74 97.12 2.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 322' ' ' SER . . . . . 0.405 ' O ' ' O ' ' C' ' 323' ' ' SER . 97.7 p -95.32 55.61 1.77 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 323' ' ' SER . . . . . 0.405 ' O ' ' O ' ' C' ' 322' ' ' SER . 23.0 t -63.55 -134.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -149.0 70.96 10.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.67 -29.91 51.27 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.392 1.394 . . . . 0.0 112.536 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.58 -42.81 61.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.669 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.77 -52.6 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.482 ' CG2' ' H ' ' C' ' 329' ' ' ALA . 34.5 m -63.82 -54.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.482 ' H ' ' CG2' ' C' ' 328' ' ' VAL . . . -54.45 -28.18 42.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.169 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.91 29.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.431 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.432 HD22 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.57 -41.09 63.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.419 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.4 mt -50.84 -42.93 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.313 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.33 -29.17 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.034 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.52 -53.39 45.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 3.7 tp -65.3 -50.21 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -1.136 . . . . 0.0 108.89 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.3 tp -50.3 -40.17 47.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 108.57 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.603 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.92 -58.81 6.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.603 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 17.1 mt -49.26 -48.86 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.76 -32.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.514 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.68 -58.13 3.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.607 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -50.74 -43.63 58.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 109.905 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 1.6 tt -71.88 -41.11 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.077 -1.014 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -58.36 -29.34 65.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' C' ' 348' ' ' PHE . 4.6 t70 -77.85 -44.0 28.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 22.5 ttt180 -54.58 -36.2 64.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -50.67 6.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -98.57 36.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.408 -0.807 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' C' ' 344' ' ' ASP . 1.8 t80 -52.52 -36.84 56.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -0.973 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . 0.403 ' CG ' ' N ' ' C' ' 350' ' ' SER . 0.4 OUTLIER -59.92 -36.23 76.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.309 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 350' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' C' ' 349' ' ' LYS . 15.8 m -69.14 -52.98 22.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.01 -23.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -84.68 -41.51 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' C' ' 353' ' ' ARG . 0.1 OUTLIER -73.81 -21.34 60.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -83.14 -61.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -71.28 -27.86 63.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 50.07 -106.64 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.32 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.57 172.77 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' C' ' 360' ' ' LYS . . . -87.34 -134.91 4.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 6.6 mt 47.42 18.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' C' ' 358' ' ' GLY . 33.6 mtpt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 77.6 p -65.89 -173.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' D' ' 421' ' ' ASP . 2.1 t-20 -59.18 -72.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' D' ' 420' ' ' ASN . 12.7 t0 -168.69 146.0 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -4.7 56.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.57 153.57 40.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.46 163.47 23.22 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.3 -28.06 50.99 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.07 1.18 . . . . 0.0 112.387 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.42 -59.22 5.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.405 ' CG1' HD22 ' A' ' 131' ' ' ASN . 26.9 t -50.63 -47.53 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -48.8 -58.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.148 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.5 11.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.31 -32.4 68.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 109.085 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.4 m120 -66.7 -62.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 7.8 tp -50.89 -37.37 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 108.584 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 11.9 mt -57.0 -42.29 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.88 83.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.18 -39.12 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -1.155 . . . . 0.0 108.548 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.59 -36.79 79.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.356 -0.84 . . . . 0.0 109.184 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -54.3 -46.91 72.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.975 -1.078 . . . . 0.0 108.878 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.614 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.8 tp -68.77 -37.76 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.574 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.36 -37.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.66 -37.3 62.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . 0.516 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.1 t90 -58.37 -56.96 15.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.594 -0.691 . . . . 0.0 109.528 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 16.5 tt -63.92 -39.98 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 tt -58.33 -48.0 81.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.86 -41.01 90.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -68.77 -25.34 64.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.377 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.22 -69.39 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.32 150.95 43.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -75.86 129.81 37.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -10.5 2.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.533 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 3.3 m -157.18 132.81 9.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.41 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 7.6 pt -54.77 162.5 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -53.19 147.31 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.44 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -63.21 148.8 47.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.38 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -57.5 -14.16 4.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.386 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.36 110.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -55.55 131.41 46.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -62.53 -46.39 88.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 109.427 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 67.51 61.53 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -38.56 73.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -1.142 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.495 -179.931 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 m -72.08 -53.44 12.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -80.57 49.96 1.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.456 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -89.98 -5.08 57.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.36 166.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.1 t -177.4 -46.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 54.67 70.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.0 -31.47 46.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.405 1.403 . . . . 0.0 112.31 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.9 -48.59 75.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 109.495 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.4 t -51.04 -38.05 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.918 . . . . 0.0 109.4 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 131' ' ' ASN . 49.0 t -66.99 -64.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.95 -17.42 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.544 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.42 -27.5 19.25 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.573 -0.704 . . . . 0.0 109.406 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.4 OUTLIER -73.64 -37.32 65.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.97 -44.77 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 tt -78.12 -32.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.255 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.85 97.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 82.3 mt -68.22 -57.0 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.314 -1.11 . . . . 0.0 109.058 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.21 -33.67 13.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.142 -0.974 . . . . 0.0 108.7 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.551 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.4 -55.76 27.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.85 . . . . 0.0 108.99 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.551 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 18.0 mt -54.16 -48.07 71.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.675 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.23 -33.67 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -82.31 -57.6 3.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.7 OUTLIER -50.58 -43.69 56.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.849 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 3.0 tt -68.94 -44.73 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.861 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 0.7 OUTLIER -52.88 -34.68 55.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.74 -1.225 . . . . 0.0 108.741 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.439 ' O ' ' CA ' ' A' ' 148' ' ' PHE . 12.6 t70 -78.21 -31.2 49.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.446 -0.784 . . . . 0.0 109.523 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.1 -42.98 95.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.641 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -50.11 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -96.39 38.05 1.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.522 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.439 ' CA ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -49.48 -24.69 2.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -74.19 -43.64 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.1 m -60.2 -49.14 78.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.39 -38.3 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.192 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.93 -40.9 97.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -76.3 -35.26 58.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.07 -36.64 68.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -28.23 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.95 . . . . 0.0 109.432 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.0 -41.52 98.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -171.21 110.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -87.12 -167.26 43.53 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.92 -32.36 71.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -1.147 . . . . 0.0 109.412 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.36 2.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -151.84 -166.98 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 221' ' ' ASP . 0.6 OUTLIER -157.15 75.42 0.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.8 m -161.31 81.2 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -161.51 -173.98 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -148.08 70.58 11.06 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.83 -27.18 51.76 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.36 1.373 . . . . 0.0 112.477 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.12 -45.36 52.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 0.0 109.74 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.87 -35.85 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 109.557 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.57 -56.91 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.09 -39.08 19.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.009 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.85 68.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.212 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -63.41 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.443 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.5 tp -49.93 -39.5 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.054 -1.028 . . . . 0.0 108.613 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 8.6 mt -53.98 -45.02 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.169 -0.957 . . . . 0.0 108.444 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.1 -49.34 68.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' B' ' 235' ' ' ILE . 1.8 mp -53.38 -38.02 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.069 -1.254 . . . . 0.0 108.487 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.31 -37.36 80.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.279 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.604 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.2 OUTLIER -55.32 -48.28 74.39 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.094 -1.004 . . . . 0.0 109.314 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 8.3 tp -67.16 -39.49 86.48 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.697 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . 0.405 ' C ' ' O ' ' B' ' 238' ' ' LEU . 11.4 mt -47.46 -40.01 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.321 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.73 -34.42 64.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . 0.42 ' N ' ' O ' ' B' ' 238' ' ' LEU . 84.9 t90 -60.1 -54.88 40.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.403 -0.81 . . . . 0.0 109.636 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -51.79 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.257 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.89 -53.57 31.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.609 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -54.85 18.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.598 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -58.02 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.489 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -40.47 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.37 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.572 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -85.19 -58.65 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -49.81 129.53 20.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 40.7 t -153.28 3.85 0.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 mt 54.31 71.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.171 -0.956 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -90.12 -22.91 21.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 50.52 -159.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 0.0 109.396 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.41 -30.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.39 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.36 147.93 50.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 109.358 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.78 -175.4 5.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . 0.645 ' N ' ' HD1' ' B' ' 257' ' ' HIS . 0.0 OUTLIER -73.8 126.25 29.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 153.51 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.79 179.97 8.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.123 . . . . 0.0 109.431 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 49.7 mttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.524 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 7.6 m -72.03 -53.56 12.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.482 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -80.54 49.91 1.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -89.93 -5.1 57.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.49 166.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 7.1 t -177.42 -46.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 54.55 70.37 1.7 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.1 -31.39 45.69 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.318 1.345 . . . . 0.0 112.297 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mt -55.84 -48.69 75.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.02 -38.35 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.39 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' C' ' 331' ' ' ASN . 48.9 t -66.44 -64.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.84 -17.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 108.624 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.453 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.65 -26.85 19.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.731 . . . . 0.0 109.327 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.5 OUTLIER -73.83 -37.44 64.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.82 -44.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.492 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.8 tt -78.03 -33.04 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.7 97.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 82.2 mt -68.39 -56.96 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.316 -1.108 . . . . 0.0 109.006 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mt -49.26 -33.49 12.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.557 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.59 -55.67 28.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.87 . . . . 0.0 108.976 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.557 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 18.0 mt -54.14 -48.11 71.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 55.3 mt -54.38 -33.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -82.35 -57.33 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.044 -1.035 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -50.75 -43.63 58.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.867 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 2.9 tt -69.13 -44.56 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 0.8 OUTLIER -52.88 -34.77 56.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.7 -1.25 . . . . 0.0 108.835 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.445 ' O ' ' CA ' ' C' ' 348' ' ' PHE . 12.5 t70 -78.37 -30.97 48.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.11 -43.04 95.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.06 -50.09 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -96.4 38.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.842 . . . . 0.0 109.426 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.445 ' CA ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -49.54 -24.71 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -74.15 -43.72 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 21.4 m -60.15 -49.2 78.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.39 -38.16 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.962 . . . . 0.0 109.195 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -64.02 -40.91 97.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -76.34 -35.23 58.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.487 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -56.07 -36.62 68.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -28.08 39.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.13 -41.51 98.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -171.2 110.9 0.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -87.14 -167.21 43.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.93 -32.44 71.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.443 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.393 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.38 2.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -151.87 -166.98 2.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.469 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' D' ' 421' ' ' ASP . 0.6 OUTLIER -157.12 75.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.8 m -161.32 81.11 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 2.4 p -161.41 -173.98 4.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 109.436 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -148.12 70.65 11.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.82 -27.18 51.82 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.309 1.339 . . . . 0.0 112.448 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -45.32 54.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.91 -35.86 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.52 -56.89 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.16 -39.11 19.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.019 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.08 -33.79 68.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.205 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.29 -63.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.5 tp -49.97 -39.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.087 -1.008 . . . . 0.0 108.577 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 8.6 mt -54.06 -44.99 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.478 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.07 -49.34 67.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.47 -37.94 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -1.228 . . . . 0.0 108.476 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.41 -37.24 80.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.547 -0.72 . . . . 0.0 109.244 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.616 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.2 OUTLIER -55.42 -48.09 74.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.039 -1.038 . . . . 0.0 109.346 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 8.4 tp -67.14 -39.62 86.58 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.716 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' D' ' 438' ' ' LEU . 11.4 mt -47.47 -39.97 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 0.0 108.353 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.7 -34.41 64.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' D' ' 438' ' ' LEU . 85.4 t90 -60.03 -54.87 40.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.518 -0.739 . . . . 0.0 109.62 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -51.66 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.121 -0.987 . . . . 0.0 109.368 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.92 -53.57 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -54.79 19.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.553 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.09 -20.09 37.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.89 -40.61 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.51 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -85.12 -58.78 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.401 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -49.81 129.5 20.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 40.7 t -153.22 3.78 0.31 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.881 . . . . 0.0 109.451 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 13.4 mt 54.33 71.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -90.2 -22.77 21.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 50.51 -159.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.46 -30.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.42 147.88 50.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 109.369 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.75 -175.27 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . 0.637 ' HD1' ' N ' ' D' ' 457' ' ' HIS . 0.0 OUTLIER -73.94 126.23 29.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 153.6 -96.75 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.81 179.95 8.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -1.115 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 50.1 mttt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.439 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -153.5 165.95 34.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.367 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -146.45 36.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.05 -36.56 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.18 30.02 5.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.492 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -53.55 161.64 0.99 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -173.54 70.84 0.36 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.691 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.27 -25.77 49.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.418 1.412 . . . . 0.0 112.3 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.44 -42.74 58.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.52 -53.49 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 109.636 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 34.0 m -61.57 -52.5 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.472 ' N ' ' CG2' ' A' ' 128' ' ' VAL . . . -54.82 -24.8 24.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 109.133 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.92 -21.82 23.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.392 -0.817 . . . . 0.0 109.351 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.478 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -72.7 -43.75 62.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 5.0 mt -48.49 -47.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.1 tt -71.35 -33.44 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 108.776 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.2 64.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.3 mm -70.2 -55.28 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.8 mt -48.89 -34.49 12.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 108.66 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.568 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.18 -57.61 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.568 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 3.5 mt -56.35 -51.48 68.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.707 -0.62 . . . . 0.0 110.031 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.07 -28.72 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.5 tt -78.92 -58.72 3.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.73 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -50.19 -52.49 35.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.448 ' N ' ' CG ' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.054 . . . . 0.0 109.249 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 2.6 mt -49.46 -35.83 20.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.927 -1.108 . . . . 0.0 109.174 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.72 -36.11 60.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.494 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -67.1 -28.15 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.97 -16.33 19.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 109.699 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -146.17 41.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.583 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 144' ' ' ASP . 2.8 p90 -47.62 -23.42 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -73.24 -45.87 53.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 m -61.44 -50.73 71.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 151' ' ' ILE . 11.7 mm -64.12 -37.53 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.877 . . . . 0.0 109.397 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.14 -37.29 86.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.943 . . . . 0.0 109.421 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.38 -39.22 93.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.09 -48.63 80.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.79 -42.29 46.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -67.01 165.56 15.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 109.465 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -77.15 -110.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.78 -179.93 44.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 130.59 36.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.0 tttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.499 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 8.3 t -152.11 150.74 30.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.51 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.73 -35.3 55.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 0.0 109.393 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.48 168.74 25.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.7 t -85.94 -140.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 21.8 t 50.73 -175.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -148.59 70.53 10.54 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.627 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.24 -30.0 46.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.322 1.348 . . . . 0.0 112.41 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.73 -60.34 2.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 t -52.35 -34.56 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.99 -58.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.01 -41.16 15.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.259 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.13 68.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 109.147 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -59.5 4.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.811 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.16 -33.93 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.066 -1.022 . . . . 0.0 109.14 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.99 -49.11 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.126 -0.984 . . . . 0.0 108.815 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.12 -45.13 96.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -49.13 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -1.203 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.6 -36.55 84.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.68 -49.04 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 109.236 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' B' ' 239' ' ' ILE . 11.0 tp -67.65 -35.53 79.06 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.821 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' B' ' 238' ' ' LEU . 3.1 mm -50.05 -37.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.35 -38.3 60.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -54.52 -50.53 67.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.81 -38.74 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.719 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -44.0 97.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.524 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.59 35.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.2 OUTLIER -53.99 -42.51 69.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.45 -78.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -67.31 -175.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.52 175.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -148.18 41.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.562 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.14 -159.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.22 163.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.516 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.81 160.97 31.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -82.74 108.79 16.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 109.415 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -70.49 -38.31 74.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -58.86 -62.46 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.94 149.25 49.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . 0.454 ' HD1' ' C ' ' B' ' 257' ' ' HIS . 1.6 p80 -61.96 173.42 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.555 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -75.22 171.5 54.0 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.67 156.82 23.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -1.126 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 37.9 tttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.456 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.31 0.576 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 50.1 m -153.49 165.98 34.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -146.48 36.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -48.93 -36.72 17.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 51.32 30.01 5.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.397 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 8.2 m -53.6 161.63 1.01 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -173.48 70.84 0.37 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.28 -25.71 49.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.427 1.418 . . . . 0.0 112.303 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.43 -42.7 58.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.72 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.67 -53.42 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.599 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' C' ' 329' ' ' ALA . 33.9 m -61.56 -52.55 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.545 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' C' ' 328' ' ' VAL . . . -54.81 -24.79 24.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 109.195 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.02 -21.69 23.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.276 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.477 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.1 OUTLIER -72.63 -43.93 62.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.477 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 5.1 mt -48.39 -48.11 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 6.3 tt -71.17 -33.5 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.866 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -53.34 -46.04 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.29 -55.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.81 -34.49 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.668 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.571 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.1 OUTLIER -62.15 -57.58 10.98 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.571 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 3.4 mt -56.5 -51.35 68.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.638 -0.664 . . . . 0.0 110.041 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.02 -28.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.06 -58.23 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -50.55 -52.61 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.447 ' N ' ' CG ' ' C' ' 341' ' ' TRP . 0.9 OUTLIER -59.88 -43.85 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.126 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.446 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 2.6 mt -49.48 -35.75 20.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 109.211 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.79 -36.03 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.887 . . . . 0.0 109.491 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -67.18 -28.15 67.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.93 -16.4 19.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.634 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.08 41.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 109.531 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' C' ' 344' ' ' ASP . 2.9 p90 -47.75 -23.28 0.68 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.849 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -73.26 -45.86 53.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 14.8 m -61.56 -50.68 71.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . 0.403 HG23 HD11 ' C' ' 351' ' ' ILE . 11.7 mm -64.04 -37.59 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.935 . . . . 0.0 109.394 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -65.23 -37.28 86.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.374 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -63.28 -39.31 94.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.358 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.06 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.8 -42.32 46.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.0 165.6 15.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -77.17 -110.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -173.77 -179.98 44.77 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.52 130.67 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.484 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.509 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 8.4 t -152.1 150.77 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -52.75 -35.31 56.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.349 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.48 168.65 25.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.6 t -85.85 -140.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 22.0 t 50.71 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.54 70.55 10.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.18 -30.05 46.76 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.345 1.363 . . . . 0.0 112.381 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.83 -60.34 2.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 9.1 t -52.24 -34.63 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.94 -58.09 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.11 15.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.99 68.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.122 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -59.35 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.843 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.8 tp -58.12 -34.07 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.146 -0.971 . . . . 0.0 109.104 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.9 -49.11 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.03 96.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.68 -49.06 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.273 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.65 -36.52 84.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.219 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.69 -49.1 68.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 109.244 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' D' ' 439' ' ' ILE . 11.1 tp -67.69 -35.47 78.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.633 -1.227 . . . . 0.0 109.832 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' D' ' 438' ' ' LEU . 3.1 mm -50.03 -37.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.793 -1.192 . . . . 0.0 107.877 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.32 -38.33 60.28 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -54.41 -50.59 67.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.483 -0.76 . . . . 0.0 109.605 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.92 -38.57 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.73 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -43.94 97.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.045 -1.034 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.69 34.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.2 OUTLIER -54.0 -42.46 69.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.508 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.41 -78.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -67.3 -175.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.517 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.61 175.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -148.28 41.52 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.08 -159.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.31 163.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.485 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.01 31.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -82.74 108.84 16.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.48 -38.33 74.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -58.88 -62.48 1.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.93 149.29 49.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . 0.45 ' C ' ' HD1' ' D' ' 457' ' ' HIS . 1.6 p80 -61.93 173.32 1.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -75.14 171.52 53.94 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.67 156.9 23.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -1.163 . . . . 0.0 109.386 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 37.9 tttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.475 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m -79.61 -66.92 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.51 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 0.9 OUTLIER -50.98 -52.6 41.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' ASN . 0.5 OUTLIER 73.3 -13.77 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.614 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 120' ' ' ASN . 34.3 t -59.62 -38.89 82.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.0 m -50.09 -27.04 5.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 47.9 69.86 2.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.2 -25.78 57.47 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.24 1.294 . . . . 0.0 112.357 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.9 mp -51.23 -45.79 62.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.5 t -51.47 -44.12 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 131' ' ' ASN . 78.0 t -62.5 -62.02 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.406 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.73 -18.34 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 128' ' ' VAL . . . -89.88 -27.75 19.68 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER -70.4 -36.22 73.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.368 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.6 mt -53.91 -48.12 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.402 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 tt -72.24 -30.77 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 108.76 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.38 -44.64 84.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.6 mt -69.68 -55.04 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -1.102 . . . . 0.0 109.126 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.83 -36.7 27.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 108.963 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.518 ' NE2' ' CD2' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -64.83 -43.5 92.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.504 ' CD2' ' HE2' ' C' ' 337' ' ' HIS . 3.6 mt -69.42 -47.27 64.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.775 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.5 mt -54.88 -34.41 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.626 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.69 -47.55 18.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.728 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.6 t-105 -46.42 -48.88 18.69 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.5 tt -72.48 -41.92 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.948 . . . . 0.0 109.96 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 tp -47.83 -40.46 21.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 109.345 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 148' ' ' PHE . 7.8 t0 -76.95 -43.83 33.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.92 -33.52 17.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.54 -49.52 5.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.1 35.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 144' ' ' ASP . 33.5 p90 -48.67 -25.94 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.32 -47.07 45.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -57.4 -49.16 77.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.378 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.408 HG22 HD12 ' A' ' 151' ' ' ILE . 13.9 mm -59.61 -50.53 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.268 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -52.53 -53.89 40.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -61.64 -33.09 73.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -51.8 -39.5 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -73.53 -41.25 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.07 -52.64 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -93.1 172.39 8.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.416 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 160' ' ' LYS . . . 89.24 64.4 1.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.81 79.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.143 . . . . 0.0 109.407 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 158' ' ' GLY . 17.8 tttp . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.319 0.581 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.98 168.4 27.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.857 . . . . 0.0 109.415 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -54.36 -30.07 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -147.55 160.77 42.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.73 92.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 67.7 p -83.54 175.31 9.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.597 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -153.94 69.99 6.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 109.596 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.32 -27.3 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.34 1.36 . . . . 0.0 112.502 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.09 -49.7 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.435 ' CG1' HD22 ' C' ' 331' ' ' ASN . 61.3 t -59.82 -37.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.37 -57.25 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -33.77 8.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.47 -33.59 67.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.897 . . . . 0.0 109.241 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . 0.486 ' CG ' ' N ' ' B' ' 232' ' ' ILE . 0.1 OUTLIER -66.56 -61.05 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.486 ' N ' ' CG ' ' B' ' 231' ' ' ASN . 8.6 tp -52.43 -38.39 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 0.0 108.687 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.14 -44.22 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.9 -43.79 96.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.02 -41.75 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -1.221 . . . . 0.0 108.679 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -35.16 78.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.83 . . . . 0.0 109.106 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.532 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.4 OUTLIER -56.5 -50.78 70.77 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.088 -1.007 . . . . 0.0 109.416 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.532 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 11.1 tp -68.16 -33.83 75.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.521 -1.272 . . . . 0.0 109.79 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' B' ' 238' ' ' LEU . 16.9 mt -50.58 -40.1 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.68 -1.263 . . . . 0.0 107.831 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.15 -42.15 66.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -50.25 -48.04 54.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 108.927 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.12 -52.11 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.279 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.33 -31.94 46.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.88 -33.48 64.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.388 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -77.57 -25.95 50.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.04 -59.7 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -47.95 74.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 8.1 t80 48.23 24.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.699 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -149.56 133.81 17.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 143.51 24.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.88 172.7 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.352 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.09 126.71 30.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.436 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -90.33 -77.09 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -59.56 109.35 0.88 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.504 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -64.81 112.14 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 49.0 -120.32 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -154.78 -11.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.95 67.94 1.86 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 14.7 mt -70.36 106.65 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -1.179 . . . . 0.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 45.3 tttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.456 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.577 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 1.9 m -79.59 -67.02 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' C' ' 322' ' ' SER . 0.9 OUTLIER -50.88 -52.68 39.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.579 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' C' ' 320' ' ' ASN . 0.5 OUTLIER 73.31 -13.75 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 322' ' ' SER . . . . . 0.471 ' H ' ' C ' ' C' ' 320' ' ' ASN . 33.8 t -59.54 -39.04 82.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 50.1 m -50.03 -26.96 4.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 47.84 69.9 2.41 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.34 -25.71 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.345 1.363 . . . . 0.0 112.278 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 8.9 mp -51.19 -45.82 61.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 54.7 t -51.58 -44.12 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' C' ' 331' ' ' ASN . 79.5 t -62.38 -62.04 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.81 -18.34 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.214 -0.929 . . . . 0.0 108.641 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' C' ' 328' ' ' VAL . . . -90.12 -27.29 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.491 -0.756 . . . . 0.0 109.076 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.2 OUTLIER -70.45 -36.26 73.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.8 mt -53.79 -48.33 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.2 tt -72.05 -30.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 108.742 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.66 84.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 6.6 mt -69.66 -55.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -1.122 . . . . 0.0 109.054 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.79 -36.56 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.989 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.504 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -64.86 -43.63 92.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.518 ' CD2' ' NE2' ' A' ' 137' ' ' HIS . 3.6 mt -69.3 -47.4 64.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.766 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.7 mt -54.83 -34.53 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.74 -46.97 20.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.6 t-105 -46.95 -48.71 21.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . . . . . . . . . 11.0 tt -72.71 -41.76 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 3.3 tp -47.75 -40.59 20.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.357 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' C' ' 348' ' ' PHE . 7.8 t0 -76.97 -43.9 33.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.88 -33.49 17.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.626 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.5 -49.63 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.05 35.52 1.42 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' C' ' 344' ' ' ASP . 33.8 p90 -48.63 -26.02 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.31 -47.04 45.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 23.3 p -57.39 -49.1 77.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . 0.41 HG22 HD12 ' C' ' 351' ' ' ILE . 13.7 mm -59.68 -50.49 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.332 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.48 -53.9 39.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.499 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.68 -33.0 73.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.86 -39.45 58.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -73.57 -41.17 63.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.07 -52.61 64.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.863 . . . . 0.0 109.396 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -93.14 172.39 8.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.424 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' C' ' 360' ' ' LYS . . . 89.34 64.19 1.29 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.7 79.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.448 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' C' ' 358' ' ' GLY . 17.9 tttp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.06 168.38 27.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -54.36 -30.11 50.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -147.53 160.69 42.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.63 92.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 68.8 p -83.54 175.35 9.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -153.89 69.83 6.39 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.19 -27.3 48.92 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.381 1.387 . . . . 0.0 112.496 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.19 -49.64 51.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.439 ' CG1' HD22 ' A' ' 131' ' ' ASN . 60.9 t -59.82 -37.77 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 0.0 109.545 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.7 t -64.25 -57.36 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.098 -1.001 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.96 -33.93 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.888 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.54 -33.54 66.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.487 ' CG ' ' N ' ' D' ' 432' ' ' ILE . 0.1 OUTLIER -66.51 -61.11 2.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' D' ' 431' ' ' ASN . 8.6 tp -52.36 -38.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 108.654 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 9.4 mt -54.13 -44.2 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.213 -0.929 . . . . 0.0 108.525 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.99 -43.67 96.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.14 -41.61 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.11 -1.229 . . . . 0.0 108.761 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -35.24 78.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.099 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.4 OUTLIER -56.44 -50.71 70.9 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.192 -0.942 . . . . 0.0 109.501 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.531 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 11.6 tp -68.22 -33.85 75.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.738 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 16.9 mt -50.64 -40.12 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.637 -1.29 . . . . 0.0 107.81 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.06 -42.12 66.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -50.13 -48.04 53.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.004 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.29 -52.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.18 -32.07 45.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.91 -33.38 63.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -77.56 -26.03 50.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.05 -59.68 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -47.85 74.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 8.1 t80 48.2 24.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.697 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -149.54 133.78 17.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.63 143.51 24.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.3 pt -74.76 172.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.05 126.63 30.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.928 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -90.29 -77.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -59.51 109.36 0.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -64.79 112.13 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 49.12 -120.37 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -154.78 -12.01 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 64.04 67.84 1.89 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.34 106.7 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.438 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 45.3 tttp . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.453 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -53.29 -28.49 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.492 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.8 t30 54.84 73.84 0.39 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -62.46 -33.06 74.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.97 -178.68 0.21 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.561 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.9 m -150.94 -76.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.383 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -151.36 69.77 8.16 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 -27.38 55.2 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.318 1.346 . . . . 0.0 112.36 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.1 mt -53.69 -55.13 28.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.645 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.0 t -53.02 -34.03 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.965 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 131' ' ' ASN . 10.5 t -72.23 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.16 -19.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.65 -25.52 20.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.609 -0.682 . . . . 0.0 109.181 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -72.01 -38.34 69.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 0.0 109.54 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.55 -44.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.308 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tt -78.43 -28.71 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 108.763 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.1 27.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 136' ' ' LEU . 6.2 tp -63.34 -50.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -1.227 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 135' ' ' ILE . 3.7 mt -52.1 -37.75 55.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.085 -1.009 . . . . 0.0 108.74 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.57 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -60.03 -56.03 26.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 108.981 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.57 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 6.3 mt -50.16 -38.62 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.768 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.39 -30.06 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.604 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.63 -53.27 6.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -52.77 -41.46 64.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 10.1 tp -74.36 -47.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.039 -1.038 . . . . 0.0 110.007 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.477 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 2.3 tp -50.2 -30.49 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.006 -1.059 . . . . 0.0 109.032 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 148' ' ' PHE . 6.0 t0 -78.35 -46.6 19.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 109.539 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.37 -33.8 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.42 -51.54 4.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.784 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 147' ' ' PHE . 34.7 m-85 -97.08 35.57 1.56 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 109.616 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.8 OUTLIER -47.82 -35.53 10.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.596 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.85 -45.81 87.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -57.62 -47.5 82.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.9 mm -55.1 -50.03 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.31 -49.85 68.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.552 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -65.07 -43.2 92.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -53.74 -36.08 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.58 -51.43 12.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.532 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -146.44 131.36 18.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.466 ' H ' ' HD1' ' A' ' 157' ' ' HIS . 10.3 m80 -76.11 -54.53 6.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.82 128.07 0.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 mp -84.58 164.79 18.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.318 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.41 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 3.9 t 56.79 171.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -163.68 175.2 10.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.5 t0 57.24 166.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 7.2 m -72.49 171.21 12.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 54.8 m -77.76 -10.34 59.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.913 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -156.78 69.53 4.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.43 -31.17 52.26 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.31 1.34 . . . . 0.0 112.394 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.79 -62.29 1.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.42 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.472 ' CG1' ' OD1' ' C' ' 331' ' ' ASN . 39.3 t -50.22 -45.97 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.0 t -48.89 -56.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.042 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.65 18.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.85 -34.64 73.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.431 -0.793 . . . . 0.0 109.145 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -60.8 3.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.067 -1.021 . . . . 0.0 109.254 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.21 -42.0 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.114 -0.991 . . . . 0.0 109.054 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 18.3 mt -50.49 -37.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -63.63 -44.67 96.12 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.65 -39.69 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -1.208 . . . . 0.0 108.533 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.04 -36.23 77.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.381 -0.824 . . . . 0.0 109.138 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.505 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -54.59 -48.79 71.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.972 -1.08 . . . . 0.0 108.954 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.505 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 8.3 tp -66.7 -38.53 86.93 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.695 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.91 -38.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.916 -1.115 . . . . 0.0 108.205 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -36.46 64.34 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -59.77 -56.53 20.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.0 109.566 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.6 tt -61.12 -39.05 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.666 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.3 -54.87 41.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.003 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.83 -50.81 55.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.13 -41.19 87.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.445 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.0 -48.7 67.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.61 151.69 29.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -91.1 66.64 5.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -67.59 171.99 5.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 11.8 t -153.18 69.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -73.03 -20.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -55.6 -59.52 4.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -82.28 134.4 35.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.69 -170.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.558 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -149.09 -42.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.97 149.36 34.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.29 58.84 5.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 79.76 -154.93 38.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' B' ' 259' ' ' LEU . 9.9 mp 51.49 -172.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.372 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 90.5 mttt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.46 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 88.1 p -53.26 -28.42 27.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 51.6 t30 54.82 73.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . 0.507 ' C ' ' HG ' ' C' ' 322' ' ' SER . 48.6 m-20 -62.51 -32.95 73.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 322' ' ' SER . . . . . 0.507 ' HG ' ' C ' ' C' ' 321' ' ' ASP . 0.6 OUTLIER 66.92 -178.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.53 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 58.1 m -151.04 -76.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -151.32 69.83 8.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.605 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.46 -27.33 54.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.286 1.324 . . . . 0.0 112.371 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.81 -55.21 28.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 66.6 t -52.81 -34.25 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' C' ' 331' ' ' ASN . 11.3 t -72.05 -66.07 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.03 -19.1 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.156 -0.965 . . . . 0.0 108.623 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.431 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.91 -25.17 19.93 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.474 -0.766 . . . . 0.0 109.116 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.5 OUTLIER -71.95 -38.61 69.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.48 -44.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.963 . . . . 0.0 109.286 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . 0.42 HG22 HD12 ' C' ' 333' ' ' ILE . 9.0 tt -78.42 -28.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 108.743 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -63.59 -54.97 27.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' C' ' 336' ' ' LEU . 6.3 tp -63.28 -50.2 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -1.227 . . . . 0.0 108.823 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . 0.43 ' N ' ' CG2' ' C' ' 335' ' ' ILE . 3.7 mt -52.07 -37.85 55.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.103 -0.998 . . . . 0.0 108.756 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.558 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -60.0 -55.89 28.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.027 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.558 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 6.3 mt -50.27 -38.7 42.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.415 -0.803 . . . . 0.0 109.676 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.37 -30.05 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -81.91 -52.64 6.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -53.14 -41.44 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.148 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 10.1 tp -74.39 -47.87 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.97 -1.081 . . . . 0.0 109.872 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.478 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 2.3 tp -50.12 -30.5 11.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.046 -1.034 . . . . 0.0 109.141 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 348' ' ' PHE . 6.0 t0 -78.6 -46.41 19.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.36 -33.88 22.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.461 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.3 -51.73 4.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' C' ' 347' ' ' PHE . 34.5 m-85 -96.95 35.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.8 OUTLIER -47.87 -35.62 10.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.823 . . . . 0.0 109.536 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -63.7 -45.99 87.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.634 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 6.5 t -57.51 -47.57 81.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.6 mm -55.06 -50.09 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 109.542 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.22 -49.91 68.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -65.02 -43.26 93.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 109.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -53.73 -36.05 61.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -51.46 12.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -146.41 131.34 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.456 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . 0.467 ' H ' ' HD1' ' C' ' 357' ' ' HIS . 10.4 m80 -76.07 -54.61 6.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.396 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.96 128.07 0.32 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 3.4 mp -84.52 164.74 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -1.133 . . . . 0.0 109.37 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 89.4 mttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.423 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.293 0.568 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.9 t 56.74 171.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.52 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -163.66 175.21 10.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 2.5 t0 57.17 166.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 7.1 m -72.59 171.24 12.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 56.2 m -77.8 -10.33 59.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -156.77 69.59 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.653 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.54 -31.09 51.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.257 1.304 . . . . 0.0 112.359 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.88 -62.19 1.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.463 ' CG1' ' OD1' ' A' ' 131' ' ' ASN . 39.4 t -50.26 -45.94 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.912 . . . . 0.0 109.208 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.84 -56.88 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.005 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.7 -37.56 18.96 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -69.87 -34.64 73.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.112 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -60.8 3.25 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.079 -1.013 . . . . 0.0 109.27 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.12 -41.96 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.177 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 18.7 mt -50.58 -37.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -63.62 -44.7 96.09 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.59 -39.71 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -1.206 . . . . 0.0 108.483 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.02 -36.33 77.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.387 -0.82 . . . . 0.0 109.175 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.499 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.3 OUTLIER -54.49 -48.76 71.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.041 -1.037 . . . . 0.0 108.998 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.499 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 8.4 tp -66.69 -38.55 87.0 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.687 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.93 -38.1 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 108.163 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -36.5 64.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.7 -56.39 22.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.684 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.8 tt -61.33 -38.99 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.22 -54.89 41.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.81 -50.87 55.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -59.06 -41.31 87.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.92 -48.74 67.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.64 151.68 29.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.405 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -91.12 66.62 5.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.161 -0.962 . . . . 0.0 109.593 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -67.61 171.95 5.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 11.9 t -153.13 69.12 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 13.5 pt -73.02 -20.88 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 109.465 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -55.55 -59.48 4.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -82.38 134.47 35.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.58 -170.62 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.07 -42.65 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.03 149.38 34.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -84.29 58.95 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 79.66 -154.92 38.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' D' ' 459' ' ' LEU . 9.9 mp 51.47 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.417 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.447 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.473 HH22 ' CB ' ' B' ' 219' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -68.16 -15.03 63.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.21 -77.79 0.24 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 11.1 p30 -167.24 148.13 5.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.568 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.4 134.3 37.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.0 t -170.96 -171.33 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -146.77 70.78 12.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.88 -26.87 51.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.315 1.343 . . . . 0.0 112.524 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.7 -50.23 74.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.662 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.3 t -54.42 -35.86 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.504 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 131' ' ' ASN . 80.7 t -65.36 -62.89 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.92 -18.67 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.965 . . . . 0.0 108.52 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.429 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -88.95 -23.03 22.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.592 -0.692 . . . . 0.0 109.36 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -78.06 -38.01 45.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.608 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.14 -44.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 tt -79.53 -38.98 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 0.0 109.179 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -54.24 -44.46 75.09 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.8 mt -69.82 -54.98 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -1.07 . . . . 0.0 109.164 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.3 -33.48 13.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.09 -1.006 . . . . 0.0 108.67 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.77 -59.01 5.1 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.569 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 5.6 mt -49.73 -37.72 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.483 -0.76 . . . . 0.0 109.697 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.9 mt -68.99 -30.71 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.08 -54.95 4.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.697 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.2 OUTLIER -50.25 -44.06 53.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.256 -0.903 . . . . 0.0 109.89 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 4.2 tp -72.17 -45.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.617 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.476 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 2.7 mt -49.46 -31.77 10.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.95 -1.094 . . . . 0.0 108.961 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 148' ' ' PHE . 8.2 t70 -77.62 -45.62 24.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.4 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -50.33 -34.46 23.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.86 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.637 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.78 36.49 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.548 ' CE1' ' NH2' ' B' ' 245' ' ' ARG . 2.9 t80 -51.33 -34.15 32.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -64.45 -38.24 90.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.7 m -67.43 -53.47 28.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.49 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 mm -53.02 -35.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -69.91 -53.36 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -62.19 -33.91 75.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -60.48 -60.32 4.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -79.8 -69.64 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 65.48 174.96 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 155.99 38.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 86.18 92.44 0.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.68 -28.13 68.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mttm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.54 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.473 ' CB ' HH22 ' A' ' 118' ' ' ARG . 29.1 t -167.17 63.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 109.415 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -78.87 -6.91 57.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -169.84 67.92 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 7.7 t -72.7 -39.65 66.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -83.92 -32.31 25.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 26.8 t0 53.55 70.51 1.74 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.69 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -65.17 -26.34 57.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.412 1.408 . . . . 0.0 112.466 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.03 -41.37 25.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -39.75 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.43 -57.82 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.942 . . . . 0.0 109.481 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -46.92 -40.21 13.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.202 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.47 68.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.6 tp -49.55 -38.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.166 -0.959 . . . . 0.0 108.681 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.44 -41.38 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 108.486 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.96 95.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' B' ' 235' ' ' ILE . 1.8 mp -58.97 -51.53 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.293 . . . . 0.0 108.503 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.8 -37.95 77.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.757 . . . . 0.0 109.545 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.2 OUTLIER -52.61 -48.58 66.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.991 -1.068 . . . . 0.0 109.094 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.521 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 8.1 tp -65.84 -38.26 88.41 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.713 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 38.5 mm -49.44 -38.34 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.764 -1.21 . . . . 0.0 108.094 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.98 -34.87 64.39 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -60.99 -56.56 19.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.485 -0.76 . . . . 0.0 109.346 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.5 tt -62.94 -38.57 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.5 -0.75 . . . . 0.0 109.619 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.18 -38.37 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.539 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.42 -48.13 71.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.349 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 148' ' ' PHE . 0.5 OUTLIER -58.43 -40.74 83.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.413 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.15 -37.46 87.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.32 176.12 7.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.687 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.96 147.58 26.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.427 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -89.6 29.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 1.3 p -59.31 -16.36 21.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 9.7 mm -66.21 128.43 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.909 . . . . 0.0 109.44 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -63.26 171.74 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -82.94 164.2 20.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.02 168.05 24.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -147.19 161.47 40.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.51 170.78 14.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 54.28 66.06 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -166.08 4.3 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.39 168.89 17.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -1.163 . . . . 0.0 109.463 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.543 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.474 HH22 ' CB ' ' D' ' 419' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 99.2 p -68.17 -15.02 63.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.29 -77.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.381 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' C' ' 321' ' ' ASP . 11.0 p30 -167.36 148.05 5.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.502 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.25 134.31 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 323' ' ' SER . . . . . 0.46 ' HG ' ' H ' ' C' ' 324' ' ' ASP . 47.0 t -171.06 -171.52 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.409 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . 0.46 ' H ' ' HG ' ' C' ' 323' ' ' SER . 2.7 m-20 -146.65 70.84 12.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.574 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.86 -26.86 51.74 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.431 1.421 . . . . 0.0 112.569 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.8 -50.14 74.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.6 -35.8 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' C' ' 331' ' ' ASN . 89.1 t -65.18 -62.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.313 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -50.92 -18.79 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.143 -0.973 . . . . 0.0 108.529 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.416 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -89.12 -22.62 22.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.5 OUTLIER -78.15 -38.08 44.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 3.2 mt -51.08 -44.41 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 12.5 tt -79.46 -39.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.168 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -54.18 -44.45 74.43 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 86.5 mt -69.8 -55.02 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.333 -1.098 . . . . 0.0 109.115 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.31 -33.52 13.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.665 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.615 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.67 -58.98 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.428 -0.795 . . . . 0.0 108.92 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.615 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 5.6 mt -49.78 -37.68 30.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 50.7 mt -69.13 -30.68 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.07 -54.64 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 109.666 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -50.38 -44.18 54.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.97 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 4.2 tp -72.18 -45.42 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 109.6 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.478 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 2.7 mt -49.48 -31.82 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 108.891 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' C' ' 348' ' ' PHE . 8.2 t70 -77.78 -45.47 24.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.785 . . . . 0.0 109.457 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -50.23 -34.55 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.654 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -96.7 36.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.572 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.543 ' CE1' ' NH2' ' D' ' 445' ' ' ARG . 2.9 t80 -51.26 -34.2 31.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.578 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -64.42 -38.2 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 4.7 m -67.33 -53.46 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.566 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 16.3 mm -53.19 -35.72 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -69.97 -53.47 17.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -62.14 -33.9 75.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -60.46 -60.34 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -79.78 -69.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 65.43 174.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 155.92 39.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 92.49 0.89 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.76 -28.07 68.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 38.1 mttm . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.494 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 419' ' ' SER . . . . . 0.474 ' CB ' HH22 ' C' ' 318' ' ' ARG . 29.1 t -167.25 63.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -78.99 -6.9 57.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -169.85 67.88 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 7.6 t -72.64 -39.69 66.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -83.94 -32.32 25.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.422 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 26.8 t0 53.58 70.51 1.74 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.602 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.18 -26.39 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.423 1.416 . . . . 0.0 112.411 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.02 -41.25 25.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.55 -39.65 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.138 -0.976 . . . . 0.0 109.597 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.56 -57.77 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -46.89 -40.22 13.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 109.219 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.31 -35.57 68.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -63.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.6 tp -49.55 -38.24 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.166 -0.959 . . . . 0.0 108.632 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.42 -41.41 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.151 -0.968 . . . . 0.0 108.469 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.94 95.92 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . 0.422 ' N ' ' CD1' ' D' ' 435' ' ' ILE . 1.8 mp -58.92 -51.49 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.062 -1.258 . . . . 0.0 108.523 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.84 -37.85 77.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.594 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.519 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.2 OUTLIER -52.67 -48.58 66.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 109.046 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.519 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 8.3 tp -65.76 -38.38 88.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.751 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 38.1 mm -49.38 -38.41 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.762 -1.211 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.0 -34.74 64.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -61.05 -56.38 21.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.7 tt -63.26 -38.4 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.03 -38.62 89.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -66.32 -48.12 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.543 ' NH2' ' CE1' ' C' ' 348' ' ' PHE . 0.5 OUTLIER -58.4 -40.76 83.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.23 -37.4 87.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.39 176.12 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.69 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.06 147.57 26.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.902 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -89.63 29.96 1.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 1.3 p -59.24 -16.47 21.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 9.7 mm -66.16 128.44 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -63.31 171.58 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -82.83 164.24 20.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.11 168.03 25.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 0.0 109.492 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -147.19 161.46 40.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.51 170.78 14.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 54.28 66.13 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -166.16 4.26 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 5.3 mt -82.4 169.03 16.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -1.126 . . . . 0.0 109.337 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.504 -179.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.8 m -154.56 70.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -156.06 -176.46 5.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -167.26 56.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -58.76 -72.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.4 m -152.28 13.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.7 t0 47.49 69.76 2.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.607 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.26 -27.15 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.342 1.362 . . . . 0.0 112.363 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.59 -55.36 19.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.479 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.55 -54.29 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 131' ' ' ASN . 62.3 t -48.5 -64.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.269 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.76 -19.42 0.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.949 . . . . 0.0 108.704 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -83.46 -29.41 28.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.251 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' D' ' 431' ' ' ASN . 0.1 OUTLIER -74.72 -42.88 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.933 . . . . 0.0 109.39 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.424 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mt -51.16 -43.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.604 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.3 tt -74.06 -36.26 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.005 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -50.89 -42.79 47.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.2 mt -71.46 -53.06 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.4 -1.059 . . . . 0.0 109.17 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.17 -37.9 23.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.188 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 137' ' ' HIS . 0.0 OUTLIER -67.54 -44.17 78.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.27 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.464 ' CD2' ' CE1' ' D' ' 437' ' ' HIS . 4.5 mt -60.61 -49.69 76.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.485 -0.759 . . . . 0.0 109.983 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.91 -24.05 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 tt -80.96 -59.95 2.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -0.94 . . . . 0.0 109.894 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.0 OUTLIER -50.59 -42.49 55.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.261 -0.9 . . . . 0.0 109.962 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 3.7 tp -72.77 -42.38 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.85 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 4.9 mt -48.69 -40.69 29.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 0.0 109.096 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.5 OUTLIER -75.04 -39.1 61.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 145' ' ' ARG . 0.2 OUTLIER -51.03 -37.6 46.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.473 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.9 -48.49 6.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -94.99 35.27 1.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.461 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' ASP . 2.0 t80 -51.95 -33.7 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -68.73 -37.63 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 109.546 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.9 -57.81 3.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mm -52.53 -33.16 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -75.42 -56.67 4.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.14 -25.24 66.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -69.82 -39.44 76.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.34 97.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -52.16 -28.98 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.452 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -71.85 146.39 47.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 133.68 4.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.9 -33.32 68.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.8 mttp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.463 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.433 ' C ' HD21 ' B' ' 220' ' ' ASN . 80.4 p -158.92 152.71 23.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.391 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . 0.433 HD21 ' C ' ' B' ' 219' ' ' SER . 1.0 OUTLIER 51.8 46.22 26.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.424 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' B' ' 222' ' ' SER . 21.8 t0 -91.6 151.59 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.47 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' SER . . . . . 0.468 ' N ' ' OD1' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -148.32 -58.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 109.392 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 3.6 m -83.44 -1.66 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.13 70.29 1.89 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.56 -29.25 61.27 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.323 1.348 . . . . 0.0 112.524 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.15 -51.5 53.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.422 ' CG1' HD22 ' C' ' 331' ' ' ASN . 23.6 t -57.31 -41.55 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.4 -56.29 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.25 -38.43 12.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.248 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.28 66.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 109.375 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . 0.437 ' OD1' ' ND2' ' C' ' 331' ' ' ASN . 0.1 OUTLIER -67.3 -58.46 4.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.444 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.3 tp -54.01 -36.48 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.067 . . . . 0.0 108.565 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 8.4 mt -58.54 -44.44 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 108.728 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.84 -41.56 91.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.18 -36.31 71.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.113 -1.227 . . . . 0.0 108.702 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.72 -35.47 78.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.868 . . . . 0.0 108.858 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -58.53 -51.85 68.15 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.58 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 14.0 tp -63.27 -38.99 93.33 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.619 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 13.9 mt -48.68 -43.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.901 -1.125 . . . . 0.0 108.464 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.88 -42.5 90.22 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -57.9 -43.89 86.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.32 -56.08 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 108.969 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.76 -21.17 62.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 109.532 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.33 -60.67 2.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.375 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.03 -34.5 71.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.66 -47.98 57.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 17.3 t80 55.31 61.47 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.75 109.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -93.25 -170.09 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 17.7 t 49.75 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.22 -43.4 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.403 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -67.74 -132.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -155.84 1.69 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.8 -66.56 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.0 157.95 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -81.78 -39.6 23.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -158.38 132.24 7.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 164.31 -52.49 0.29 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.3 tt -164.02 108.81 1.01 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -1.128 . . . . 0.0 109.431 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 49.4 mttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.499 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 73.8 m -154.45 70.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -156.02 -176.42 5.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -167.22 56.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 2.5 p -58.76 -72.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 74.9 m -152.43 13.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 40.8 t0 47.53 69.76 2.49 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.29 -27.07 48.35 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.349 1.366 . . . . 0.0 112.394 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.66 -55.29 20.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' C' ' 330' ' ' ALA . 60.0 t -51.59 -54.38 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 109.197 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.42 ' C ' ' N ' ' C' ' 330' ' ' ALA . 65.9 t -48.44 -64.43 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.73 -19.54 0.65 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 108.733 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -83.64 -29.07 27.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.393 -0.817 . . . . 0.0 109.208 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' B' ' 231' ' ' ASN . 0.1 OUTLIER -74.65 -43.01 57.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.7 mt -51.02 -43.84 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -0.831 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 6.6 tt -73.9 -36.3 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -50.93 -42.73 47.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 6.1 mt -71.46 -53.17 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.374 -1.074 . . . . 0.0 109.181 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.09 -37.91 22.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.173 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.475 ' ND1' ' C ' ' C' ' 337' ' ' HIS . 0.0 OUTLIER -67.54 -44.2 78.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.443 ' CD2' ' CE1' ' B' ' 237' ' ' HIS . 4.4 mt -60.6 -49.84 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.71 -24.25 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.965 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 2.7 tt -81.06 -59.47 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.854 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -50.97 -42.59 60.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 110.006 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 3.8 tp -72.57 -42.57 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 109.611 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.477 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 4.9 mt -48.62 -40.64 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 109.192 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.5 OUTLIER -75.16 -38.96 60.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 109.369 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' C' ' 345' ' ' ARG . 0.3 OUTLIER -51.11 -37.47 46.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.429 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.03 -48.48 6.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -94.9 35.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 344' ' ' ASP . 2.0 t80 -51.95 -33.68 38.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.554 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -68.72 -37.64 79.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -57.93 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 1.6 mm -52.43 -33.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -75.44 -56.76 4.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -61.11 -25.13 66.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -69.93 -39.23 76.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -44.36 97.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.96 . . . . 0.0 109.432 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -52.18 -28.95 20.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -71.73 146.23 48.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -147.3 133.68 4.85 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.92 -33.31 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.419 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 419' ' ' SER . . . . . 0.575 ' HG ' HD21 ' D' ' 420' ' ' ASN . 79.6 p -158.93 152.73 23.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . 0.575 HD21 ' HG ' ' D' ' 419' ' ' SER . 1.0 OUTLIER 51.83 46.17 27.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.434 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' D' ' 422' ' ' SER . 21.8 t0 -91.55 151.6 20.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.497 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 422' ' ' SER . . . . . 0.461 ' N ' ' OD1' ' D' ' 421' ' ' ASP . 0.0 OUTLIER -148.31 -58.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.373 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 3.6 m -83.47 -1.69 54.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.373 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.15 70.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.517 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.56 -29.2 61.35 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.34 1.36 . . . . 0.0 112.495 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -51.56 52.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 24.3 t -57.3 -41.52 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.41 -56.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.49 13.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.176 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.97 -35.31 66.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 109.383 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.448 ' OD1' ' ND2' ' A' ' 131' ' ' ASN . 0.1 OUTLIER -67.22 -58.46 4.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.3 tp -53.95 -36.54 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 108.602 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 8.4 mt -58.45 -44.45 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.152 -0.968 . . . . 0.0 108.762 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.77 -41.65 90.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 23.1 mm -61.24 -36.26 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -1.187 . . . . 0.0 108.645 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.7 -35.44 78.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.341 -0.849 . . . . 0.0 108.913 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.582 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.2 OUTLIER -58.56 -51.89 67.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.107 -0.995 . . . . 0.0 108.977 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.582 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 14.4 tp -63.09 -39.23 94.1 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.562 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 14.0 mt -48.62 -43.35 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.814 -1.179 . . . . 0.0 108.453 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -42.55 89.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.94 -43.67 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.758 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.57 -55.88 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 108.994 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.81 -21.13 62.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.39 -60.66 2.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.98 -34.53 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 0.0 109.343 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.73 -47.94 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 17.0 t80 55.23 61.51 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.493 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.76 109.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -93.21 -170.09 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 17.8 t 49.75 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.16 -43.44 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -67.71 -132.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.415 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -155.83 1.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.84 -66.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.48 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.02 158.01 3.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -81.83 -39.57 23.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -158.4 132.24 7.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 164.32 -52.55 0.29 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.3 tt -163.99 108.8 1.01 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 49.0 mttp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.547 -179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -53.97 111.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -149.47 -67.71 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.47 120.55 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -52.3 64.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.47 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.5 p -161.34 43.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.402 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 48.71 70.41 2.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.439 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.05 -28.7 57.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.32 1.347 . . . . 0.0 112.518 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.8 mp -76.31 -44.68 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.883 . . . . 0.0 109.766 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.65 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 110.079 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 129' ' ' ALA . 32.9 m -69.43 -51.43 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 128' ' ' VAL . . . -64.17 -14.97 58.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.44 -48.65 5.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.484 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.0 OUTLIER -77.84 -50.4 12.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.8 mm -47.61 -44.54 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.469 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.1 tt -72.41 -37.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.012 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -52.17 -49.8 48.59 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.0 mm -65.23 -55.05 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -1.217 . . . . 0.0 109.289 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.4 -33.83 14.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.581 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.97 -60.25 3.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 109.401 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.581 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 4.7 mt -49.05 -39.68 28.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.712 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.7 mt -69.18 -27.72 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.78 -54.11 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.12 -0.988 . . . . 0.0 109.627 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.89 -42.49 62.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 10.3 tp -72.82 -45.26 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.476 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 3.0 mt -49.12 -33.73 12.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.276 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 3.9 t70 -78.78 -43.57 25.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.855 . . . . 0.0 109.655 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.565 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 25.5 ttt180 -50.1 -39.51 42.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.877 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.13 -53.52 3.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 109.854 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -96.04 36.47 1.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.88 -29.15 3.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -69.03 -33.38 73.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.1 t -75.21 -52.34 11.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 mm -65.59 -21.24 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 157' ' ' HIS . 82.4 t80 -84.57 -47.91 10.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.307 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.98 -57.53 3.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.24 -58.3 8.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.38 142.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.512 ' NE2' ' OH ' ' A' ' 152' ' ' TYR . 10.2 m80 -58.64 143.9 44.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' N ' ' A' ' 160' ' ' LYS . . . -83.74 -112.3 0.57 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 49.54 15.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 0.0 109.351 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' N ' ' C ' ' A' ' 158' ' ' GLY . 17.7 pttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.95 110.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -167.15 50.64 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -153.23 89.38 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 1.6 t 62.01 104.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -153.37 127.45 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -148.41 69.17 10.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.33 -40.18 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.28 1.32 . . . . 0.0 112.343 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . 0.419 ' CG1' ' OD1' ' C' ' 331' ' ' ASN . 16.7 t -52.48 -44.63 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.361 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' B' ' 231' ' ' ASN . 4.8 t -53.86 -56.67 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -38.42 17.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 108.806 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.52 -28.83 65.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.327 -0.858 . . . . 0.0 109.076 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.2 m-20 -69.04 -63.79 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.215 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.7 tp -49.05 -36.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 20.2 mt -58.96 -41.07 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 231' ' ' ASN . . . -56.87 -42.86 92.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' B' ' 235' ' ' ILE . 1.7 mp -61.22 -41.03 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -1.23 . . . . 0.0 108.662 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -35.28 78.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 0.0 109.089 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.486 ' ND1' ' N ' ' B' ' 238' ' ' LEU . 0.3 OUTLIER -56.87 -48.96 76.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.167 -0.958 . . . . 0.0 109.414 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.486 ' N ' ' ND1' ' B' ' 237' ' ' HIS . 9.5 tp -68.1 -35.13 77.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.701 -1.2 . . . . 0.0 109.761 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.56 -41.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.726 -1.233 . . . . 0.0 108.104 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tt -69.96 -40.59 75.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . 0.553 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 88.3 t90 -54.45 -55.93 23.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.05 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.1 mt -53.12 -54.48 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.04 -53.98 23.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.564 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -52.88 -28.13 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -74.64 -48.37 26.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.888 . . . . 0.0 109.516 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.29 -47.47 82.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -86.73 86.13 7.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.529 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' B' ' 250' ' ' SER . 48.0 p90 -69.4 -5.52 24.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.07 18.06 0.54 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' SER . . . . . 0.433 ' H ' ' C ' ' B' ' 248' ' ' PHE . 23.3 t -47.88 -32.02 5.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.76 117.03 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -87.12 124.26 33.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.477 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -85.42 44.91 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 50.39 -169.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 49.79 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.79 78.6 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 109.557 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 52.33 -175.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.587 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.66 -84.79 0.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.96 148.84 36.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 83.5 tttt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.49 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . 0.41 ' H1 ' ' H ' ' C' ' 319' ' ' SER . 36.3 mtt180 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 319' ' ' SER . . . . . 0.41 ' H ' ' H1 ' ' C' ' 318' ' ' ARG . 3.5 p -54.06 111.28 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -149.48 -67.75 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -71.48 120.62 17.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.27 -52.25 65.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 80.5 p -161.34 43.73 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 48.82 70.39 2.11 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.408 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.08 -28.64 56.92 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.345 1.363 . . . . 0.0 112.484 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 10.8 mp -76.43 -44.68 34.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.742 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.73 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' C' ' 329' ' ' ALA . 32.9 m -69.4 -51.53 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.963 . . . . 0.0 109.8 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' C' ' 328' ' ' VAL . . . -64.19 -14.82 57.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -95.78 -48.3 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.069 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.479 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.0 OUTLIER -77.92 -50.57 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.998 -179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.479 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.9 mm -47.31 -44.84 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 11.2 tt -72.19 -38.01 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.083 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -52.19 -49.75 48.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 11.5 mm -65.36 -55.01 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -1.22 . . . . 0.0 109.279 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.36 -33.91 14.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.587 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.89 -60.4 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.84 . . . . 0.0 109.297 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.587 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 4.8 mt -48.91 -39.64 26.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 11.0 mt -69.33 -27.73 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.0 tt -82.98 -53.53 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.637 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -52.28 -42.51 63.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 10.3 tp -72.72 -45.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.475 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.0 mt -49.14 -33.69 12.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 109.313 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' C' ' 348' ' ' PHE . 3.7 t70 -78.94 -43.41 24.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . 0.553 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 25.4 ttt180 -50.2 -39.51 44.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.04 -53.75 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -95.92 36.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.81 -29.13 2.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -69.21 -33.31 73.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 32.1 t -75.15 -52.25 11.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.63 -21.25 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . 0.509 ' OH ' ' NE2' ' C' ' 357' ' ' HIS . 82.7 t80 -84.58 -47.83 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.893 . . . . 0.0 109.426 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -64.44 -24.64 67.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.315 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -72.99 -57.61 3.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.14 -58.32 8.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.38 142.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . 0.509 ' NE2' ' OH ' ' C' ' 352' ' ' TYR . 10.1 m80 -58.72 143.93 45.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . 0.449 ' C ' ' N ' ' C' ' 360' ' ' LYS . . . -83.89 -112.29 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 49.62 15.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 109.319 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . 0.449 ' N ' ' C ' ' C' ' 358' ' ' GLY . 17.6 pttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.94 110.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -167.23 50.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -153.28 89.3 1.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.424 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 1.6 t 62.03 104.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 6.3 t -153.45 127.43 8.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -148.45 69.13 10.36 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.704 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.31 -40.17 33.64 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.276 1.318 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' D' ' 431' ' ' ASN . 16.9 t -52.46 -44.59 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.352 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' D' ' 431' ' ' ASN . 4.8 t -53.9 -56.72 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.345 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.0 -38.57 17.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 108.859 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -70.5 -28.81 65.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.2 m-20 -68.98 -63.88 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.194 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.7 tp -48.93 -36.39 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 20.2 mt -59.01 -41.03 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' D' ' 431' ' ' ASN . . . -56.99 -42.8 93.06 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' D' ' 435' ' ' ILE . 1.7 mp -61.22 -40.97 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.14 -1.212 . . . . 0.0 108.631 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -35.16 78.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.062 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' D' ' 438' ' ' LEU . 0.3 OUTLIER -56.77 -49.21 75.99 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.362 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.487 ' N ' ' ND1' ' D' ' 437' ' ' HIS . 9.9 tp -67.92 -35.27 78.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.712 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.52 -41.9 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.708 -1.245 . . . . 0.0 108.104 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.0 tt -70.0 -40.56 75.2 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . 0.565 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 89.0 t90 -54.31 -55.98 22.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.102 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 65.8 mt -53.18 -54.46 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.01 -53.99 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -52.82 -28.27 21.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.341 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -74.56 -48.31 27.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.598 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.37 -47.46 82.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -86.66 86.18 7.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . 0.43 ' C ' ' H ' ' D' ' 450' ' ' SER . 48.1 p90 -69.48 -5.55 24.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.02 18.08 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.35 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 450' ' ' SER . . . . . 0.43 ' H ' ' C ' ' D' ' 448' ' ' PHE . 23.3 t -47.93 -31.97 5.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 89.8 mt -79.74 117.07 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 109.445 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -87.24 124.29 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -85.44 44.97 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.572 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 50.33 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 109.561 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 49.88 88.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.409 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.82 78.7 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 52.31 -175.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 70.57 -84.72 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.95 148.82 36.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.454 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.1 m -68.65 -81.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -61.76 -31.02 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 t70 53.0 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.494 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.6 p -167.4 164.25 15.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.56 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.447 ' H ' ' HG ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -83.12 -8.19 59.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -165.07 70.9 1.41 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.07 -27.51 49.75 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.385 1.39 . . . . 0.0 112.53 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -74.06 -45.48 49.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.868 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.91 -51.18 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.701 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.488 ' CG2' ' H ' ' A' ' 129' ' ' ALA . 35.0 m -64.84 -54.73 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.716 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.488 ' H ' ' CG2' ' A' ' 128' ' ' VAL . . . -54.92 -23.53 19.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.99 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.47 -20.34 22.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 0.4 OUTLIER -74.75 -43.66 53.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.482 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 8.7 mt -51.06 -45.8 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.489 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.74 -36.36 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 108.891 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -40.66 78.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.0 mt -67.96 -56.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.419 -1.048 . . . . 0.0 109.071 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.56 -35.87 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 108.792 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.573 ' CG ' ' N ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -58.5 -59.25 5.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.12 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' A' ' 137' ' ' HIS . 11.2 mt -53.25 -51.42 62.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 75.4 mt -54.01 -31.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.15 -58.63 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.552 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.5 OUTLIER -50.95 -50.94 56.96 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 143' ' ' LEU . 2.0 tt -61.72 -41.99 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.469 ' N ' ' CG2' ' A' ' 142' ' ' ILE . 4.8 mt -54.2 -35.9 62.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.075 . . . . 0.0 108.978 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -76.35 -29.36 57.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.416 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.32 -35.28 79.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.27 -15.33 20.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.714 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.11 39.17 1.32 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 109.649 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.1 OUTLIER -47.86 -33.33 7.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.75 -39.29 93.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.392 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.0 m -67.13 -48.59 67.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.94 -30.24 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -73.07 -50.37 23.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.87 -38.46 83.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.41 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -59.21 -42.25 90.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.04 -11.43 60.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -148.87 116.09 6.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.447 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -151.23 -24.45 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.03 100.81 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.93 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.252 -1.146 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.422 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 3.0 m 57.46 102.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' B' ' 220' ' ' ASN . 0.1 OUTLIER -83.29 104.5 13.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.405 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -85.12 106.48 16.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.487 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.9 t -74.88 109.32 8.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.09 150.49 11.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.79 70.84 5.31 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.31 -27.01 55.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.33 1.353 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.92 -60.59 2.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.957 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 t -55.51 -39.02 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.481 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.39 -56.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.45 -43.28 23.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.239 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.35 68.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.337 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.31 -65.16 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 tp -49.92 -37.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.177 -0.952 . . . . 0.0 108.675 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 13.2 mt -54.75 -45.89 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.47 -46.2 88.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.0 -53.93 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -1.167 . . . . 0.0 108.93 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.35 -38.18 71.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 0.0 109.424 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' B' ' 238' ' ' LEU . 0.1 OUTLIER -53.51 -47.21 70.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.088 -1.008 . . . . 0.0 109.375 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' B' ' 237' ' ' HIS . 7.4 tp -67.81 -36.36 80.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.04 -39.89 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.764 -1.21 . . . . 0.0 107.894 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -37.47 69.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.4 -57.61 12.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.63 -54.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.258 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.65 -52.17 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.77 -33.8 57.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -65.29 -52.98 50.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' B' ' 247' ' ' PHE . 10.9 mp -60.16 -33.13 71.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' PHE . . . . . 0.421 ' CB ' ' O ' ' B' ' 246' ' ' LEU . 2.2 t80 71.21 -3.52 2.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.2 t80 62.49 154.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -89.68 124.02 34.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 1.5 m -85.64 -9.58 57.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 69.4 mt 47.91 87.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.25 91.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -52.02 161.67 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 37.9 t80 -148.96 167.65 25.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.24 140.69 22.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.908 . . . . 0.0 109.513 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.26 168.41 13.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.62 154.91 39.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -80.6 -149.08 5.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.16 167.93 20.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -1.071 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 tttp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.427 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.304 0.574 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 33.0 m -68.65 -81.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.494 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.76 -31.03 71.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.97 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 1.6 p -167.35 164.36 15.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -7.97 59.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -165.22 70.94 1.38 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.544 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.03 -27.5 50.04 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.407 1.404 . . . . 0.0 112.55 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 7.8 mt -74.13 -45.49 48.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.88 -51.23 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.716 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . 0.48 ' CG2' ' H ' ' C' ' 329' ' ' ALA . 34.8 m -64.77 -54.85 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 329' ' ' ALA . . . . . 0.48 ' H ' ' CG2' ' C' ' 328' ' ' VAL . . . -54.85 -23.48 18.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.248 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -90.63 -20.17 22.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 331' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 0.4 OUTLIER -74.8 -43.66 53.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 8.8 mt -50.96 -46.0 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.52 -36.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 108.986 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.56 -40.64 79.06 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 82.0 mt -67.93 -56.29 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.343 -1.093 . . . . 0.0 109.057 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.51 -35.93 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.928 . . . . 0.0 108.766 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 337' ' ' HIS . . . . . 0.578 ' CG ' ' N ' ' C' ' 338' ' ' LEU . 0.0 OUTLIER -58.41 -59.18 5.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.184 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 338' ' ' LEU . . . . . 0.578 ' N ' ' CG ' ' C' ' 337' ' ' HIS . 11.1 mt -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 75.6 mt -54.24 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.38 -58.1 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.494 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -51.37 -50.76 58.9 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 342' ' ' ILE . . . . . 0.47 ' CG2' ' N ' ' C' ' 343' ' ' LEU . 2.0 tt -61.94 -41.94 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 343' ' ' LEU . . . . . 0.47 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 4.9 mt -53.95 -36.14 62.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.968 -1.083 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 344' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -76.28 -29.33 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.36 -35.3 79.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.21 -15.28 20.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.0 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.13 39.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.672 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 348' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.1 OUTLIER -47.95 -33.29 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.457 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.75 -39.34 94.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 25.6 m -67.04 -48.7 67.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.91 -30.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -73.15 -50.38 22.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -67.8 -38.5 83.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.08 -42.3 90.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.15 -11.39 59.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.898 . . . . 0.0 109.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -148.9 116.09 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.519 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -151.2 -24.51 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 178.01 100.93 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.81 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -1.161 . . . . 0.0 109.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.469 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.0 m 57.54 102.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 420' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' D' ' 420' ' ' ASN . 0.1 OUTLIER -83.23 104.52 13.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.22 106.52 16.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.9 t -74.94 109.3 8.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.03 150.57 11.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.88 70.68 5.25 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.23 -27.09 56.37 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.306 1.337 . . . . 0.0 112.406 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.8 -60.66 2.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 4.9 t -55.48 -39.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.499 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.32 -56.82 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.37 23.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -69.54 -30.3 68.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.3 -65.09 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 8.4 tp -49.89 -37.97 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 108.612 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 13.3 mt -54.67 -45.86 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 108.572 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.51 -46.22 88.37 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.05 -53.9 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 108.885 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.37 -38.16 71.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.44 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 437' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' D' ' 438' ' ' LEU . 0.1 OUTLIER -53.54 -47.16 70.25 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.101 -0.999 . . . . 0.0 109.272 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 438' ' ' LEU . . . . . 0.621 ' N ' ' CD2' ' D' ' 437' ' ' HIS . 7.7 tp -67.87 -36.44 80.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.713 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.1 mm -50.03 -39.88 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 107.862 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -37.33 68.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.31 -57.69 11.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.738 . . . . 0.0 109.168 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 67.0 mt -54.77 -53.9 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.64 -52.21 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.79 -33.73 56.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 445' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -65.36 -52.97 50.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 446' ' ' LEU . . . . . 0.434 ' O ' ' CB ' ' D' ' 447' ' ' PHE . 10.9 mp -60.11 -33.05 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 447' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' D' ' 446' ' ' LEU . 2.2 t80 70.99 -3.37 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.607 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.2 t80 62.43 154.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -89.66 124.05 34.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.338 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 1.4 m -85.68 -9.6 56.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 69.3 mt 47.99 87.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.18 91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -52.03 161.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 454' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' D' ' 455' ' ' PHE . 38.0 t80 -148.97 167.63 25.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.332 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 455' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' D' ' 454' ' ' PHE . 0.0 OUTLIER -150.24 140.71 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.29 168.3 13.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.43 154.98 39.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.465 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -80.57 -149.05 5.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 167.91 20.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 18.7 tttp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.434 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.456 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -74.88 -41.97 58.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.557 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.7 mt -51.85 -42.93 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.66 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.0 109.002 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.53 96.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.525 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.3 mt -66.6 -57.29 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.242 -1.152 . . . . 0.0 109.091 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.39 -36.89 23.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 108.73 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.938 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.26 -57.28 13.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.914 HD21 ' NE2' ' C' ' 337' ' ' HIS . 18.3 mt -51.75 -50.35 60.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.833 . . . . 0.0 109.745 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mt -53.05 -31.95 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.3 -59.15 2.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -49.81 -42.85 47.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.584 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.2 tt -72.72 -42.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.485 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 tt -59.78 -28.5 67.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.048 . . . . 0.0 109.064 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -45.43 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.51 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 61.5 ttt180 -55.76 -34.95 65.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.38 -51.07 6.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 -179.894 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 CA-C-O 121.178 0.407 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.42 ' N ' HD12 ' B' ' 226' ' ' LEU . 11.0 mp -60.64 -47.64 85.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.586 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 t -62.63 -33.58 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.31 -59.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.68 -39.53 17.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.933 . . . . 0.0 108.957 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -71.26 -32.0 68.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.387 -0.821 . . . . 0.0 109.247 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -63.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.442 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -50.94 -38.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.031 -1.043 . . . . 0.0 108.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.442 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.8 mt -54.92 -44.18 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -55.5 -48.41 70.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.553 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -55.91 -38.29 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -1.148 . . . . 0.0 108.705 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.15 -35.91 76.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.247 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.866 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.2 OUTLIER -55.68 -47.98 75.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.046 -1.034 . . . . 0.0 109.025 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.709 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.6 tp -67.79 -36.96 81.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.629 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.827 -1.171 . . . . 0.0 108.145 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.7 -35.13 65.12 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' TRP . . . . . 0.526 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -60.7 -56.12 25.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 109.419 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 242' ' ' ILE . . . . . 0.492 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.1 tt -65.32 -41.11 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.375 -0.828 . . . . 0.0 109.575 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.492 ' N ' HG23 ' B' ' 242' ' ' ILE . 0.6 OUTLIER -60.69 -36.86 79.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.441 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.4 -50.58 58.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.62 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.73 -28.69 68.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.553 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.456 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 1.0 OUTLIER -74.9 -42.1 58.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.9 mt -51.81 -43.01 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.5 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -59.23 -44.5 96.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.561 HG21 ' HB1' ' B' ' 230' ' ' ALA . 83.4 mt -66.63 -57.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -1.111 . . . . 0.0 109.082 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.4 mt -49.31 -36.83 22.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 108.802 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.914 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.36 -57.26 13.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.043 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.938 HD21 ' NE2' ' A' ' 137' ' ' HIS . 18.5 mt -51.7 -50.34 60.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -0.784 . . . . 0.0 109.772 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 19.2 mt -53.09 -32.07 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.626 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.21 -58.81 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.16 -0.962 . . . . 0.0 109.682 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -50.22 -42.59 51.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.869 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.588 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.2 tt -73.03 -41.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 109.6 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.2 tt -59.8 -28.54 67.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 -45.36 30.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 109.421 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 345' ' ' ARG . . . . . 0.526 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 61.6 ttt180 -55.73 -34.99 65.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.35 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.4 -51.23 6.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.391 -0.818 . . . . 0.0 109.554 -179.817 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 121.216 0.423 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 426' ' ' LEU . . . . . 0.412 ' N ' HD12 ' D' ' 426' ' ' LEU . 11.0 mp -60.61 -47.56 85.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.69 -33.48 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.41 -59.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.72 -39.52 17.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 108.972 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.525 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -71.32 -31.84 67.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.522 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.421 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.7 tp -50.92 -38.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.112 -0.993 . . . . 0.0 108.394 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.421 ' N ' HG23 ' D' ' 432' ' ' ILE . 10.8 mt -54.92 -44.25 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -55.33 -48.53 68.79 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.548 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -55.88 -38.33 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -1.128 . . . . 0.0 108.644 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.06 -36.05 77.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.883 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.58 -48.04 75.46 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.923 -1.11 . . . . 0.0 108.976 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.69 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.7 tp -67.77 -36.96 81.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.821 -1.151 . . . . 0.0 109.665 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.13 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.873 -1.142 . . . . 0.0 108.089 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.74 -35.12 65.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 441' ' ' TRP . . . . . 0.51 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.2 t90 -60.5 -56.09 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.517 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 442' ' ' ILE . . . . . 0.491 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.2 tt -65.56 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.624 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 443' ' ' LEU . . . . . 0.491 ' N ' HG23 ' D' ' 442' ' ' ILE . 0.6 OUTLIER -60.57 -36.89 79.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.437 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.46 -50.52 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.82 -28.72 69.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 121.508 0.671 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -37.5 71.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 109.525 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.85 -46.11 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.518 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.5 tt -75.57 -31.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 108.864 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.03 85.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.632 HG21 ' HB1' ' D' ' 430' ' ' ALA . 63.0 mt -68.32 -52.97 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -1.048 . . . . 0.0 108.936 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -50.02 -35.01 23.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 108.904 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.94 -58.07 7.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.7 mt -55.35 -46.8 76.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.602 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.2 mt -55.27 -34.89 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.53 -57.4 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -50.38 -54.51 21.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.317 -0.864 . . . . 0.0 109.576 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.659 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.8 tt -58.93 -42.7 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.49 ' N ' HG23 ' A' ' 142' ' ' ILE . 6.3 mt -54.41 -31.06 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 0.0 109.043 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.2 -34.92 56.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 109.486 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -29.87 67.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.576 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.04 -15.73 20.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.645 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.686 -179.728 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.489 1.209 0 CA-C-O 121.235 0.431 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.0 mp -50.42 -41.45 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.445 ' H ' HG23 ' B' ' 227' ' ' VAL . 2.7 t -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.23 -58.87 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.07 -39.61 13.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.101 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.65 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.69 -33.68 66.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.865 . . . . 0.0 109.163 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.44 -62.02 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.977 . . . . 0.0 109.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.447 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.2 tp -51.28 -38.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.718 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.447 ' N ' HG23 ' B' ' 232' ' ' ILE . 7.3 mt -54.03 -46.45 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 108.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.67 88.73 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.476 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -57.64 -52.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -1.148 . . . . 0.0 108.715 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.7 -38.32 72.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 109.551 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.825 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.49 -47.44 69.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.036 -1.04 . . . . 0.0 109.352 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.744 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.8 tp -67.16 -36.74 82.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.13 -40.11 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.99 -34.43 66.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.72 -55.19 36.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.6 tt -63.51 -35.5 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.778 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.465 ' C ' HD23 ' B' ' 243' ' ' LEU . 2.0 tt -67.5 -62.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -46.76 -50.85 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.605 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.1 OUTLIER -57.12 -35.41 69.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -37.58 71.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.526 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.81 -46.28 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 tt -75.35 -31.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.115 -0.991 . . . . 0.0 108.978 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.11 -45.92 86.39 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.65 HG21 ' HB1' ' B' ' 230' ' ' ALA . 63.0 mt -68.32 -53.11 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.374 -1.074 . . . . 0.0 108.911 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.4 tp -49.78 -35.22 21.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.7 -58.2 7.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.7 mt -55.33 -46.68 76.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -0.819 . . . . 0.0 109.704 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.28 -35.06 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.56 -56.83 4.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -50.79 -54.3 24.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.68 HD12 ' ND1' ' B' ' 237' ' ' HIS . 3.9 tt -59.18 -42.53 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.09 -1.006 . . . . 0.0 109.436 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.483 ' N ' HG23 ' C' ' 342' ' ' ILE . 6.3 mt -54.49 -31.04 55.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.39 -34.75 54.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -29.87 67.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.58 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.05 -15.69 20.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.702 -179.754 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 121.19 0.412 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mp -50.4 -41.39 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.07 -35.98 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.629 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.22 -58.91 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.23 -39.55 14.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.632 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.61 -33.72 66.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.184 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.49 -61.98 1.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.417 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.442 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.2 tp -51.32 -38.57 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 108.688 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.442 ' N ' HG23 ' D' ' 432' ' ' ILE . 7.4 mt -53.95 -46.43 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.67 -46.73 88.71 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.471 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.7 mp -57.58 -52.97 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -1.136 . . . . 0.0 108.744 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.65 -38.45 72.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.827 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.35 -47.54 69.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.054 -1.029 . . . . 0.0 109.334 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.733 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.0 tp -67.05 -36.91 83.09 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.11 -39.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.855 -1.153 . . . . 0.0 107.925 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.13 -34.35 66.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -60.46 -55.32 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.638 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.62 -35.38 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 443' ' ' LEU . . . . . 0.459 ' C ' HD23 ' D' ' 443' ' ' LEU . 2.0 tt -67.5 -62.48 1.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.533 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -46.77 -50.86 17.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.1 OUTLIER -57.13 -35.29 69.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.469 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.497 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.391 0.615 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -74.91 -38.03 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.623 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 132' ' ' ILE . 4.1 mt -50.42 -44.95 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.414 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.0 tt -77.91 -35.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 109.025 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.86 -46.65 90.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' D' ' 430' ' ' ALA . 79.2 mt -67.23 -56.4 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -1.072 . . . . 0.0 109.177 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mt -49.93 -33.58 17.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.007 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.777 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.12 -52.71 61.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 109.122 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.784 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.9 mt -55.37 -38.06 68.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.736 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.5 mt -68.77 -29.7 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.65 -55.25 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 109.826 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.12 -43.39 61.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.77 HD13 ' NE2' ' D' ' 437' ' ' HIS . 4.0 tp -72.79 -44.39 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.033 -1.042 . . . . 0.0 109.697 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.561 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 mt -48.52 -35.5 13.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 109.218 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -47.22 23.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -28.16 6.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -16.39 15.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.029 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.872 -179.525 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.49 1.316 0 CA-C-O 121.159 0.4 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.84 -37.81 32.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.64 -35.89 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.57 -58.11 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 109.339 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.33 -37.27 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.946 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -73.11 -35.28 66.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.021 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.497 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -64.99 -62.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.481 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.0 tp -51.02 -40.22 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.05 -1.031 . . . . 0.0 108.585 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.481 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.1 mt -53.73 -42.31 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.12 -46.7 92.37 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.543 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -57.28 -39.12 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 0.0 108.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.31 -35.27 73.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.422 -0.799 . . . . 0.0 109.371 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.787 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.3 OUTLIER -55.07 -49.81 70.72 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.934 -1.104 . . . . 0.0 109.014 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 137' ' ' HIS . 12.0 tp -67.68 -36.6 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.66 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.74 -37.56 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.859 -1.151 . . . . 0.0 108.293 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.29 -40.62 62.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -53.74 -53.19 55.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.502 -0.749 . . . . 0.0 109.415 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 14.9 tt -67.39 -33.57 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.18 -59.51 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -52.54 -43.14 64.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -62.85 -30.96 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 330' ' ' ALA . . . . . 0.486 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -75.09 -38.07 61.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.529 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.405 HG21 HD13 ' C' ' 332' ' ' ILE . 4.4 mt -50.43 -45.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 tt -77.7 -35.49 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.104 -0.998 . . . . 0.0 108.932 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.79 88.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.549 HG21 ' HB1' ' B' ' 230' ' ' ALA . 79.9 mt -67.06 -56.54 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.276 -1.132 . . . . 0.0 109.198 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 mt -49.84 -33.67 17.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 108.981 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.784 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.15 -52.6 61.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.135 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.777 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.9 mt -55.43 -37.98 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.773 . . . . 0.0 109.753 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 7.7 mt -68.88 -29.63 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.83 -54.66 5.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.819 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -51.55 -43.45 62.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.055 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.787 HD13 ' NE2' ' B' ' 237' ' ' HIS . 4.1 tp -72.62 -44.39 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.555 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.46 -35.65 13.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.014 -1.054 . . . . 0.0 109.21 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -47.16 23.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -28.23 6.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.99 . . . . 0.0 109.565 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.94 -16.34 15.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.528 -0.733 . . . . 0.0 110.017 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 109.853 -179.607 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.489 1.242 0 CA-C-O 121.298 0.458 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.87 -37.79 32.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 7.0 t -64.69 -35.87 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.69 -58.08 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.274 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.37 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.136 -0.978 . . . . 0.0 108.933 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -73.09 -35.21 66.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.058 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.486 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.8 OUTLIER -64.99 -62.74 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.468 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.0 tp -51.01 -40.26 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.21 -0.932 . . . . 0.0 108.573 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.468 ' N ' HG23 ' D' ' 432' ' ' ILE . 10.3 mt -53.6 -42.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.171 -0.955 . . . . 0.0 108.475 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.09 -46.82 92.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.533 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -57.13 -39.23 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.34 -35.19 73.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.459 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.77 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -55.06 -49.8 70.7 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.014 -1.054 . . . . 0.0 109.082 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.717 HD13 ' CE1' ' C' ' 337' ' ' HIS . 12.4 tp -67.62 -36.72 81.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.78 -1.168 . . . . 0.0 109.663 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.7 -37.62 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 108.211 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.2 -40.59 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -53.77 -53.03 57.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 109.481 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.6 -33.4 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.14 -59.65 4.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -52.47 -43.16 64.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -62.91 -30.86 71.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.53 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -40.11 28.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 109.585 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.52 -45.21 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.347 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.486 HG21 HD11 ' B' ' 235' ' ' ILE . 11.0 tt -76.73 -44.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.173 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -48.11 -45.19 26.86 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.506 HG21 ' HB1' ' D' ' 430' ' ' ALA . 95.6 mt -67.1 -55.66 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.01 -33.16 17.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.94 . . . . 0.0 108.929 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.925 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -62.33 -55.12 31.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.91 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.1 mt -55.06 -45.85 75.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.24 -35.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.39 -57.06 3.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.4 t-105 -48.9 -51.76 28.19 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.205 -0.935 . . . . 0.0 109.682 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.508 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.6 tt -65.26 -41.85 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 0.0 110.077 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -59.42 -30.69 68.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.04 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -37.77 59.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.18 73.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.32 -47.38 8.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.662 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 121.203 0.418 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -59.0 5.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.595 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.38 -35.08 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.62 -59.59 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.371 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.27 -37.48 10.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.526 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.45 -32.43 66.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.861 . . . . 0.0 109.233 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -58.51 4.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.71 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.82 -35.41 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.037 -1.039 . . . . 0.0 108.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.12 -44.17 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.75 -45.14 95.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.486 HD11 HG21 ' A' ' 133' ' ' ILE . 75.3 mt -60.56 -53.81 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.224 -1.163 . . . . 0.0 108.961 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.53 -35.41 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.299 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.821 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -56.06 -48.74 75.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.766 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.8 tp -64.48 -37.71 88.5 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.638 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.36 -38.98 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' B' ' 240' ' ' LEU . 52.3 tp -72.85 -32.7 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.31 -57.77 8.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.501 -0.75 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' ILE . . . . . 0.456 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.5 tt -62.11 -38.12 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.63 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.456 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.2 tp -69.3 -26.84 64.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.66 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.53 -43.15 23.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -64.42 -55.75 18.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.596 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 -40.24 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 mt -51.47 -45.29 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.327 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 333' ' ' ILE . . . . . 0.481 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -76.54 -44.6 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.249 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 334' ' ' GLY . . . . . 0.481 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -48.32 -44.98 28.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.526 HG21 ' HB1' ' B' ' 230' ' ' ALA . 95.6 mt -67.25 -55.58 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -1.115 . . . . 0.0 109.211 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.07 -33.07 17.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.91 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.4 -55.07 31.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 108.893 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.925 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.0 mt -55.14 -45.84 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.394 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.28 -35.5 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.41 -56.36 4.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.4 t-105 -49.44 -51.6 34.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -0.863 . . . . 0.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.509 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.5 tt -65.49 -41.85 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.847 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.4 tt -59.22 -30.9 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.036 -1.04 . . . . 0.0 109.2 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -37.66 59.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -32.14 73.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.35 -47.38 8.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.643 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.571 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 121.235 0.431 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -58.95 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.602 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.32 -35.15 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.7 -59.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.417 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -37.35 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.214 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.53 -32.4 66.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -58.38 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.732 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.7 tp -56.97 -35.34 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 108.89 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.3 mt -57.04 -44.24 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 108.568 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.63 -45.26 94.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.469 HD11 HG21 ' C' ' 333' ' ' ILE . 75.2 mt -60.48 -53.75 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -1.146 . . . . 0.0 108.978 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.83 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -55.98 -48.85 75.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.742 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.0 tp -64.41 -37.8 88.8 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.637 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.3 -39.01 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.91 -32.6 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.26 -57.77 8.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.418 -0.801 . . . . 0.0 109.59 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 442' ' ' ILE . . . . . 0.449 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.6 tt -62.22 -38.0 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 443' ' ' LEU . . . . . 0.449 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.2 tp -69.23 -26.96 65.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -79.43 -43.26 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -64.41 -55.72 19.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.535 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.578 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.49 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER -80.22 -44.7 19.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 109.989 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.49 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mm -51.77 -42.55 32.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.533 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 134' ' ' GLY . 13.2 tt -76.12 -42.08 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.226 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -51.31 -45.92 52.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.699 HG21 ' HB1' ' D' ' 430' ' ' ALA . 76.0 mt -66.31 -57.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -1.11 . . . . 0.0 109.277 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.52 -34.33 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.154 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.927 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.2 -60.62 3.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.225 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.944 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.3 mt -50.9 -44.55 59.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -57.66 -32.9 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.59 -56.74 3.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.602 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.3 t-105 -48.44 -48.35 37.54 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.333 -0.854 . . . . 0.0 109.619 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.558 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.9 tt -68.69 -42.07 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.518 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -57.85 -31.88 67.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.107 . . . . 0.0 109.183 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -46.07 50.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.12 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.09 -23.26 65.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.109 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.04 -16.54 20.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.568 -179.804 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.223 0.426 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -47.5 73.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.82 -42.67 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.9 t -58.26 -56.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.316 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.23 21.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 108.947 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.743 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -69.39 -28.81 66.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.01 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.5 t-20 -68.48 -63.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.54 -36.49 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.116 -0.99 . . . . 0.0 108.425 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' B' ' 230' ' ' ALA . 22.5 mt -58.4 -42.55 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.58 84.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.577 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.1 -52.11 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.105 -1.232 . . . . 0.0 108.672 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.35 74.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.449 -0.782 . . . . 0.0 109.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.824 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -52.73 -46.78 67.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.075 -1.016 . . . . 0.0 109.449 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.732 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.7 tp -67.5 -37.63 83.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.764 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.8 mm -49.37 -39.86 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.817 -1.177 . . . . 0.0 108.028 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.97 -35.67 66.96 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.92 -57.28 13.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.573 -0.704 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' ILE . . . . . 0.402 HG23 ' N ' ' B' ' 243' ' ' LEU . 11.3 tt -60.05 -37.86 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.583 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.402 ' N ' HG23 ' B' ' 242' ' ' ILE . 1.0 OUTLIER -56.19 -58.96 5.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.488 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 244' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' B' ' 244' ' ' ASP . 4.5 m-20 -55.55 -51.06 68.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -49.73 -28.1 5.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.334 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.18 0.514 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.484 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -80.18 -44.84 19.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 0.0 110.033 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.6 mm -51.72 -42.62 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.504 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 333' ' ' ILE . . . . . 0.493 HG23 ' N ' ' C' ' 334' ' ' GLY . 13.2 tt -75.99 -42.14 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 334' ' ' GLY . . . . . 0.493 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -51.32 -45.8 52.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.743 HG21 ' HB1' ' B' ' 230' ' ' ALA . 74.8 mt -66.33 -57.34 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -1.111 . . . . 0.0 109.227 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.42 -34.3 16.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.165 -0.96 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.944 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.18 -60.71 3.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.329 -0.857 . . . . 0.0 109.143 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.927 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.2 mt -50.84 -44.58 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.484 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.72 -32.85 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.66 -56.24 4.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.574 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.3 t-105 -49.02 -47.98 44.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.606 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.567 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.8 tt -69.05 -41.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.499 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tt -57.73 -32.04 67.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.57 -45.92 50.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.183 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.06 -23.26 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.889 . . . . 0.0 109.15 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.01 -16.48 20.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.648 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 109.56 -179.763 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 CA-C-O 121.257 0.44 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.77 -47.41 73.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.78 -42.7 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.611 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 428' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.9 t -58.25 -56.61 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.87 -40.4 21.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 108.936 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -69.38 -28.7 66.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 109.029 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.5 t-20 -68.52 -63.81 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.5 -36.54 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' D' ' 430' ' ' ALA . 22.7 mt -58.4 -42.48 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.72 -47.54 84.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.571 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -56.18 -52.06 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.138 -1.213 . . . . 0.0 108.629 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.36 74.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.547 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.83 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -52.69 -46.81 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.095 -1.003 . . . . 0.0 109.402 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.725 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.8 tp -67.55 -37.53 82.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.78 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.2 mm -49.38 -39.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.857 -1.152 . . . . 0.0 108.045 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.99 -35.66 66.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.69 -57.39 13.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.679 . . . . 0.0 109.629 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.25 -37.73 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.12 -58.95 5.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 0.0 109.414 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 444' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' D' ' 444' ' ' ASP . 4.5 m-20 -55.71 -50.94 68.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -49.86 -27.98 5.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.296 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.503 179.857 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -80.76 -42.68 21.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 109.641 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 131' ' ' ASN . 4.4 mt -50.12 -44.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.42 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 134' ' ' GLY . 11.1 tt -76.16 -47.24 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.227 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.525 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -47.75 -43.27 22.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.561 HG21 ' HB1' ' D' ' 430' ' ' ALA . 98.1 mt -68.18 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -1.186 . . . . 0.0 109.254 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.7 -31.96 5.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.924 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.17 -58.81 5.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.364 -0.835 . . . . 0.0 109.0 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.929 HD21 ' NE2' ' C' ' 337' ' ' HIS . 13.0 mt -48.98 -50.99 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 139' ' ' ILE . 1.7 mp -55.18 -33.47 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.59 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.63 -58.42 3.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.975 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -53.09 -46.03 68.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.29 -0.882 . . . . 0.0 109.996 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.487 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.0 OUTLIER -67.59 -42.44 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.816 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.483 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -55.63 -34.64 65.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.082 -1.012 . . . . 0.0 108.811 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.3 -35.12 63.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.512 -0.743 . . . . 0.0 109.222 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -32.61 72.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.2 -14.72 23.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.65 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.496 1.825 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.798 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.244 0 CA-C-O 121.234 0.431 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.02 -61.25 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.968 . . . . 0.0 109.575 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.437 ' H ' HG23 ' B' ' 227' ' ' VAL . 11.0 t -51.39 -40.52 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 109.432 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.25 -58.0 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.217 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.19 -36.26 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 108.977 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.5 -30.93 64.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.379 -0.826 . . . . 0.0 109.187 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -59.61 3.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.415 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.0 tp -55.44 -36.94 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 0.0 108.689 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.415 ' N ' HG23 ' B' ' 232' ' ' ILE . 12.7 mt -56.64 -42.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.255 -0.903 . . . . 0.0 108.679 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.35 95.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 133' ' ' ILE . 81.3 mt -59.71 -53.27 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 0.0 108.76 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.63 -37.0 70.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.373 -0.829 . . . . 0.0 109.22 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.838 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -54.2 -47.43 72.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.295 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.737 HD13 ' ND1' ' A' ' 137' ' ' HIS . 8.0 tp -67.11 -37.56 84.11 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.683 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 41.0 mm -49.36 -39.4 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.848 -1.157 . . . . 0.0 107.994 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -35.32 65.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -60.12 -57.93 10.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.514 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 9.5 tt -61.27 -35.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.2 -32.72 73.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.3 -36.76 69.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -72.55 -47.1 50.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' C' ' 332' ' ' ILE . 0.2 OUTLIER -80.61 -42.85 21.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.578 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' C' ' 331' ' ' ASN . 4.4 mt -50.02 -44.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.437 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 333' ' ' ILE . . . . . 0.531 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -76.04 -47.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 109.286 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 334' ' ' GLY . . . . . 0.531 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -47.95 -43.36 23.91 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.568 HG21 ' HB1' ' B' ' 230' ' ' ALA . 98.2 mt -68.19 -59.1 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -1.129 . . . . 0.0 109.27 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.84 -31.89 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 108.867 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.929 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.21 -58.62 6.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.924 HD21 ' NE2' ' A' ' 137' ' ' HIS . 13.1 mt -49.02 -51.06 33.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -0.877 . . . . 0.0 109.73 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 339' ' ' ILE . . . . . 0.457 HD12 ' N ' ' C' ' 339' ' ' ILE . 1.7 mp -55.11 -33.64 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -57.87 3.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 109.916 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -53.71 -45.82 70.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 110.01 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.481 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.0 OUTLIER -67.71 -42.25 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 109.665 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tt -55.8 -34.55 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.999 -1.063 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.54 -34.95 63.09 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.402 -0.811 . . . . 0.0 109.139 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -32.59 71.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.118 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.31 -14.57 23.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.877 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.413 -0.804 . . . . 0.0 109.647 -179.817 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.49 1.286 0 CA-C-O 121.188 0.412 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.04 -61.09 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.638 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.42 HG23 ' H ' ' D' ' 427' ' ' VAL . 11.3 t -51.55 -40.42 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 428' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.6 t -57.31 -57.99 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.26 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.1 -36.35 13.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 108.958 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.46 -30.96 65.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.1 OUTLIER -68.13 -59.6 3.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.656 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.409 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.0 tp -55.43 -36.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.973 -1.08 . . . . 0.0 108.667 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.409 ' N ' HG23 ' D' ' 432' ' ' ILE . 12.7 mt -56.68 -42.6 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.579 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.07 -45.35 95.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.455 HD11 HG21 ' C' ' 333' ' ' ILE . 81.8 mt -59.68 -53.19 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -1.116 . . . . 0.0 108.823 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.73 -36.93 70.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.228 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.845 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -54.21 -47.41 72.18 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.229 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.723 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.0 tp -67.1 -37.69 84.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.62 -1.232 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.8 mm -49.23 -39.59 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -35.19 65.69 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -59.97 -58.0 10.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.512 -0.743 . . . . 0.0 109.493 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 9.7 tt -61.41 -35.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 0.0 109.615 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.24 -32.65 73.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.31 -36.76 68.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -72.55 -47.14 50.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.468 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.336 0.589 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -39.48 61.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.6 mt -52.86 -45.17 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.273 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.46 -26.87 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 0.0 109.018 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.85 -55.75 29.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 136' ' ' LEU . 4.1 tp -65.32 -48.17 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -1.085 . . . . 0.0 108.702 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 135' ' ' ILE . 2.2 tp -50.03 -40.04 43.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 108.59 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.913 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -60.11 -52.89 63.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.409 -0.807 . . . . 0.0 108.882 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.902 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.4 mt -56.84 -49.76 74.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.401 -0.812 . . . . 0.0 109.568 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.62 -33.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.336 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.64 -59.7 2.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -48.57 -53.3 18.86 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.65 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.4 tt -60.15 -43.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.506 ' N ' HG23 ' A' ' 142' ' ' ILE . 7.0 mt -54.8 -31.68 59.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.134 . . . . 0.0 108.952 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.19 -33.49 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mp -93.48 -16.51 24.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.888 . . . . 0.0 109.707 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.63 -179.87 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 121.303 0.46 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 226' ' ' LEU . 10.8 mp -63.44 -57.58 9.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -36.34 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.2 -0.937 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -57.38 -59.31 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.218 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.28 16.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.51 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -69.92 -29.75 66.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -0.823 . . . . 0.0 109.098 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' B' ' 228' ' ' VAL . 33.8 m-20 -67.74 -63.62 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 7.2 tp -50.34 -36.46 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 108.534 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' B' ' 230' ' ' ALA . 17.9 mt -57.85 -43.44 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.212 -0.93 . . . . 0.0 108.579 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.81 88.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.545 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.94 -50.85 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 108.707 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.35 -38.44 77.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.821 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.2 -46.69 69.14 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.957 -1.089 . . . . 0.0 109.278 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.764 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.8 tp -67.82 -36.87 81.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.746 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -49.62 -39.83 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.29 -38.08 68.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -57.21 -56.09 26.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.507 -0.746 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.47 -47.23 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.18 -15.4 63.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.955 . . . . 0.0 109.495 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -58.18 3.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.524 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -61.17 -31.78 71.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.631 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 109.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -39.4 61.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.89 -45.2 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.225 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 12.6 tt -78.3 -27.16 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.79 -55.73 29.2 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.543 HG23 ' N ' ' C' ' 336' ' ' LEU . 4.1 tp -65.32 -48.02 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -1.106 . . . . 0.0 108.78 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 336' ' ' LEU . . . . . 0.543 ' N ' HG23 ' C' ' 335' ' ' ILE . 2.1 tp -50.11 -39.99 44.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.902 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -60.11 -52.83 63.69 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.913 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.3 mt -56.88 -49.92 74.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.795 . . . . 0.0 109.488 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 36.0 mt -52.49 -33.16 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -79.7 -59.01 2.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -49.13 -52.93 23.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.697 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.662 HD12 ' ND1' ' B' ' 237' ' ' HIS . 3.4 tt -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.5 ' N ' HG23 ' C' ' 342' ' ' ILE . 7.1 mt -54.81 -31.64 59.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.953 -1.092 . . . . 0.0 109.101 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -77.36 -32.63 55.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -72.24 -33.59 67.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.542 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.35 -16.68 24.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.659 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.581 -179.791 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.243 0 CA-C-O 121.238 0.432 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 426' ' ' LEU . . . . . 0.504 ' N ' HD12 ' D' ' 426' ' ' LEU . 10.8 mp -63.42 -57.59 9.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.93 -36.36 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.429 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 428' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -57.44 -59.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.942 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.35 16.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 108.59 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -69.85 -29.82 67.15 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.451 -0.78 . . . . 0.0 109.123 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' D' ' 428' ' ' VAL . 33.5 m-20 -67.65 -63.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 7.3 tp -50.47 -36.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.125 -0.985 . . . . 0.0 108.569 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' D' ' 430' ' ' ALA . 17.7 mt -57.8 -43.52 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.523 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.77 87.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.539 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -56.98 -50.77 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -1.175 . . . . 0.0 108.741 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.42 -38.43 77.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.392 -0.817 . . . . 0.0 109.499 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.815 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.2 -46.64 69.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.747 HD13 ' ND1' ' C' ' 337' ' ' HIS . 7.9 tp -67.78 -36.97 81.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.759 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 439' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' D' ' 439' ' ' ILE . 37.0 mm -49.61 -39.74 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.81 -1.181 . . . . 0.0 107.836 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.38 -37.9 68.62 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.4 t90 -57.31 -55.89 28.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.507 -0.746 . . . . 0.0 109.091 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.71 -47.25 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.93 -15.6 63.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -58.09 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -61.23 -31.78 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -74.67 -43.07 57.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -50.74 -45.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 tt -73.0 -34.97 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.223 -0.923 . . . . 0.0 108.894 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -41.86 81.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' D' ' 430' ' ' ALA . 69.0 mt -69.59 -58.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.342 -1.093 . . . . 0.0 108.999 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.91 -33.62 11.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.925 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.842 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -64.12 -51.02 65.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.031 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.761 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.6 mt -59.45 -40.77 87.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.85 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.6 tt -82.81 -54.1 5.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 109.541 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -50.77 -43.7 58.49 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.281 -0.887 . . . . 0.0 109.737 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.0 tp -72.21 -46.68 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.604 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 mt -48.88 -32.51 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 109.062 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.04 -54.27 7.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -50.56 -23.27 2.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.34 -17.57 16.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.812 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 121.324 0.468 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.63 -47.99 28.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.416 ' H ' HG23 ' B' ' 227' ' ' VAL . 2.3 t -62.89 -38.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.96 -58.83 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.49 15.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.635 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -71.72 -32.45 67.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.297 -0.877 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -67.27 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.438 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.431 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -50.12 -37.69 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.123 -0.986 . . . . 0.0 108.519 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.431 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.0 mt -55.92 -43.81 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.182 -0.949 . . . . 0.0 108.497 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.11 -44.29 93.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.532 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -59.9 -41.39 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -1.204 . . . . 0.0 108.561 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 236' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' B' ' 239' ' ' ILE . 3.7 tt -68.04 -33.79 75.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.275 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.578 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -57.37 -48.06 80.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.019 -1.051 . . . . 0.0 109.163 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.842 HD13 ' CE1' ' A' ' 137' ' ' HIS . 9.4 tp -68.23 -35.55 78.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.65 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 239' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' B' ' 236' ' ' LEU . 16.9 mt -50.42 -41.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.643 -1.286 . . . . 0.0 108.227 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.36 -38.66 71.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -55.45 -54.51 42.87 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.27 -52.45 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.0 109.225 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.03 -41.62 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -62.66 -47.19 84.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.494 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.54 -37.97 82.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.3 OUTLIER -74.75 -43.07 56.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.3 mt -50.65 -46.02 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.9 tt -72.74 -35.09 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.196 -0.94 . . . . 0.0 108.951 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.88 81.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.635 HG21 ' HB1' ' B' ' 230' ' ' ALA . 68.4 mt -69.59 -58.37 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 109.062 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.89 -33.63 11.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.94 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.835 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -64.12 -50.97 66.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.433 -0.792 . . . . 0.0 109.034 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.783 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.5 mt -59.58 -40.69 88.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.523 -0.736 . . . . 0.0 109.609 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.582 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.79 -53.44 5.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 109.581 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -51.34 -43.43 61.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.917 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.61 HG23 ' N ' ' C' ' 343' ' ' LEU . 9.9 tp -72.43 -46.52 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.61 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.74 -32.7 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.139 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -76.19 -54.17 7.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.378 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -50.48 -23.18 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.398 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.48 -17.53 16.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 109.719 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.294 0.456 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.57 -48.04 28.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.405 ' H ' HG23 ' D' ' 427' ' ' VAL . 2.3 t -62.85 -38.65 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.9 -58.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -39.44 15.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.09 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -71.77 -32.38 67.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.229 -0.919 . . . . 0.0 109.175 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -63.45 1.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.421 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.7 tp -50.13 -37.63 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.132 -0.98 . . . . 0.0 108.525 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.421 ' N ' HG23 ' D' ' 432' ' ' ILE . 9.9 mt -56.1 -43.66 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.14 -0.975 . . . . 0.0 108.467 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.33 93.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.532 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -59.87 -41.49 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.111 -1.229 . . . . 0.0 108.54 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 436' ' ' LEU . . . . . 0.554 ' HA ' HD12 ' D' ' 439' ' ' ILE . 3.7 tt -67.95 -33.81 75.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.426 -0.796 . . . . 0.0 109.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.585 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -57.4 -48.15 79.85 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.027 -1.045 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.835 HD13 ' CE1' ' C' ' 337' ' ' HIS . 9.7 tp -68.05 -35.8 78.82 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.618 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 439' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' D' ' 436' ' ' LEU . 17.0 mt -50.45 -41.69 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.725 -1.234 . . . . 0.0 108.21 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.41 -38.55 71.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -55.35 -54.59 41.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.43 -0.794 . . . . 0.0 109.073 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.32 -52.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.328 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -41.73 17.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -62.68 -47.2 84.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.55 -37.98 83.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.525 ' HB1' ' ND2' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.577 ' ND2' HD11 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -76.03 -39.79 54.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.457 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.475 ' N ' ' OD1' ' A' ' 131' ' ' ASN . 7.2 mt -53.55 -44.3 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 109.378 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.424 HD13 HG13 ' B' ' 235' ' ' ILE . 8.1 tt -74.64 -36.41 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.59 91.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.577 HD11 ' ND2' ' A' ' 131' ' ' ASN . 17.5 mt -70.05 -60.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.344 -1.092 . . . . 0.0 109.136 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.98 -24.96 7.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.267 -0.896 . . . . 0.0 108.899 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.646 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -67.86 -55.51 12.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.159 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.559 HD22 ' ND1' ' D' ' 437' ' ' HIS . 2.4 mt -55.33 -48.27 74.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mt -58.41 -30.96 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 HD21 ' B' ' 238' ' ' LEU . 3.7 tt -75.96 -46.28 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.377 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CZ3' ' C' ' 341' ' ' TRP . 1.0 OUTLIER -50.65 -47.09 58.66 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 110.032 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 143' ' ' LEU . 9.5 tt -71.16 -42.91 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.04 -1.037 . . . . 0.0 109.908 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' N ' HG23 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -48.83 -36.74 17.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -75.63 -53.05 9.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.83 . . . . 0.0 109.592 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 66.9 ttt180 -50.48 -23.14 2.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.57 -17.42 15.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.724 . . . . 0.0 109.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 109.996 -179.63 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.207 0 CA-C-O 121.336 0.473 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.38 -41.62 39.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.595 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.499 HG12 HD22 ' C' ' 331' ' ' ASN . 13.8 t -61.05 -42.97 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.564 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.6 t -57.91 -58.63 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.431 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.74 -37.43 13.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.22 -31.2 67.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.137 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.525 ' ND2' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -67.71 -64.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.405 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.1 tp -50.41 -36.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.127 -0.983 . . . . 0.0 108.565 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.405 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.8 mt -55.78 -45.12 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.28 -46.53 86.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.543 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.44 -40.43 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.313 . . . . 0.0 108.533 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -35.44 75.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.461 -0.774 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.608 ' HD1' ' C ' ' B' ' 237' ' ' HIS . 3.1 t-80 -54.07 -52.07 62.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.064 -1.022 . . . . 0.0 109.164 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.646 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.0 tp -69.85 -32.37 70.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.888 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.09 -38.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.516 -1.365 . . . . 0.0 107.864 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.85 62.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -50.5 -52.63 36.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.425 -0.797 . . . . 0.0 109.433 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.8 tt -68.0 -33.7 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.43 ' O ' HD23 ' B' ' 243' ' ' LEU . 1.6 tt -58.4 -58.3 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -58.9 -42.08 88.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -20.77 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.947 . . . . 0.0 109.607 -179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 330' ' ' ALA . . . . . 0.511 ' HB1' ' ND2' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.584 ' ND2' HD11 ' C' ' 335' ' ' ILE . 0.1 OUTLIER -76.16 -39.83 54.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.475 ' N ' ' OD1' ' C' ' 331' ' ' ASN . 7.3 mt -53.56 -44.37 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 333' ' ' ILE . . . . . 0.43 HD13 HG13 ' D' ' 435' ' ' ILE . 8.3 tt -74.61 -36.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.42 91.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.584 HD11 ' ND2' ' C' ' 331' ' ' ASN . 17.5 mt -70.07 -60.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.119 . . . . 0.0 109.103 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.0 -24.84 7.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 108.844 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -68.07 -55.33 12.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.358 -0.839 . . . . 0.0 109.149 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.569 HD22 ' ND1' ' B' ' 237' ' ' HIS . 2.4 mt -55.35 -48.37 74.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.38 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 24.2 mt -58.44 -31.0 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -76.16 -45.45 33.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CZ3' ' CH2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -51.42 -46.72 63.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.436 -0.79 . . . . 0.0 110.063 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.46 HG23 ' N ' ' C' ' 343' ' ' LEU . 9.8 tt -71.42 -42.77 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 0.0 109.946 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.46 ' N ' HG23 ' C' ' 342' ' ' ILE . 0.5 OUTLIER -48.81 -36.7 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.192 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 344' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' C' ' 345' ' ' ARG . 0.0 OUTLIER -75.92 -52.89 9.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 345' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' C' ' 344' ' ' ASP . 67.0 ttt180 -50.4 -23.13 2.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 109.494 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.66 -17.36 15.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 109.858 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.625 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.245 0.436 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -41.6 39.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.494 HG12 HD22 ' A' ' 131' ' ' ASN . 14.3 t -61.16 -42.82 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.569 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 428' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.6 t -58.09 -58.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.89 -37.32 13.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.21 67.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 109.059 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.511 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -67.71 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.411 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.1 tp -50.42 -36.79 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 108.552 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.411 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.6 mt -55.85 -44.99 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 108.325 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.48 86.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.544 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -56.41 -40.41 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.058 -1.26 . . . . 0.0 108.577 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -35.49 75.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.353 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.613 ' C ' ' HD1' ' D' ' 437' ' ' HIS . 3.0 t-80 -53.96 -52.07 61.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.099 -1.0 . . . . 0.0 109.185 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.633 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.3 tp -69.77 -32.43 70.92 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.976 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.14 -38.21 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.514 -1.366 . . . . 0.0 107.858 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.83 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.5 t90 -50.4 -52.57 36.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 109.487 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.9 tt -68.3 -33.43 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 443' ' ' LEU . . . . . 0.44 ' O ' HD23 ' D' ' 443' ' ' LEU . 1.6 tt -58.46 -58.28 9.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -58.84 -42.19 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.558 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -63.19 -20.75 65.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.528 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.463 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -72.92 -42.19 63.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.597 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.463 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -51.06 -46.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.504 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 tt -72.17 -34.15 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 108.768 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.69 -41.93 83.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.647 HG21 ' HB1' ' D' ' 430' ' ' ALA . 68.0 mt -68.37 -57.1 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.45 -1.029 . . . . 0.0 109.054 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -39.52 43.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 108.694 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.847 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -55.65 -55.37 32.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.816 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.3 mt -58.24 -53.54 57.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 81.8 mt -52.92 -29.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.47 -57.6 3.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.589 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.4 OUTLIER -50.01 -54.69 18.45 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -58.39 -44.93 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.557 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 mt -48.64 -36.27 15.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.0 -1.062 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -37.04 60.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -0.872 . . . . 0.0 109.604 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -64.37 -28.67 69.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.22 -14.18 18.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.799 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 0.0 109.779 -179.749 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.244 0.435 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.81 -53.91 28.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.9 -43.64 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.609 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' B' ' 231' ' ' ASN . 9.0 t -57.3 -55.36 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.82 23.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.228 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -67.69 -26.26 66.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.208 -0.932 . . . . 0.0 109.16 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.5 t-20 -69.97 -65.73 0.68 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.0 tp -50.31 -36.17 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.736 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' B' ' 230' ' ' ALA . 28.6 mt -57.95 -44.04 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.95 -43.17 95.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.484 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.8 -44.03 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -1.221 . . . . 0.0 108.739 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 236' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' B' ' 239' ' ' ILE . 6.0 mp -66.06 -36.03 82.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.812 ' ND1' HD22 ' C' ' 338' ' ' LEU . 1.8 t-80 -55.87 -48.27 75.85 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.847 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.5 tp -67.93 -36.06 79.49 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.767 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 239' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' B' ' 236' ' ' LEU . 10.6 mt -50.11 -40.48 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.183 . . . . 0.0 108.006 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.06 -39.21 69.19 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -55.51 -55.75 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.469 -0.77 . . . . 0.0 109.047 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.9 mt -55.49 -48.7 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.75 -50.42 66.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.452 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -48.99 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -53.55 -44.15 69.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 0.0 109.438 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 1.1 p30 -73.09 -42.37 63.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.1 mt -50.77 -46.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.8 tt -71.97 -34.24 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.092 -1.005 . . . . 0.0 108.815 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.9 83.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.691 HG21 ' HB1' ' B' ' 230' ' ' ALA . 67.5 mt -68.41 -57.13 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.343 -1.092 . . . . 0.0 109.071 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.02 -39.72 42.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 108.691 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.825 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -55.41 -55.5 30.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 109.044 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.822 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.3 mt -58.24 -53.57 56.74 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.537 -0.727 . . . . 0.0 109.735 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 82.3 mt -52.92 -29.93 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.57 -56.92 4.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -50.66 -54.67 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 109.738 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.572 HG23 ' N ' ' C' ' 343' ' ' LEU . 0.8 OUTLIER -58.33 -44.87 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.245 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.572 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.49 -36.5 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 0.0 109.197 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -36.85 60.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -64.39 -28.62 69.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.26 -14.24 18.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.786 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.73 -179.779 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.263 0.443 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.67 -54.01 26.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.89 -43.75 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.616 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 428' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' D' ' 431' ' ' ASN . 9.5 t -57.27 -55.34 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.78 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -67.92 -25.97 65.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.238 -0.914 . . . . 0.0 109.157 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.6 t-20 -70.06 -65.79 0.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' D' ' 432' ' ' ILE . 8.0 tp -50.22 -36.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' D' ' 430' ' ' ALA . 28.4 mt -58.04 -43.91 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 108.468 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.06 -43.08 95.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.482 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -58.82 -44.1 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -1.234 . . . . 0.0 108.626 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 436' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' D' ' 439' ' ' ILE . 6.0 mp -66.14 -35.88 81.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.217 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.798 ' ND1' HD22 ' A' ' 138' ' ' LEU . 1.8 t-80 -56.06 -48.18 76.53 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.98 -1.075 . . . . 0.0 109.439 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.825 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.7 tp -67.83 -36.25 80.03 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.81 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 439' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' D' ' 436' ' ' LEU . 10.5 mt -50.02 -40.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 108.059 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.01 -39.14 69.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -55.52 -55.66 29.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.086 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.8 mt -55.79 -48.52 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.43 -0.794 . . . . 0.0 109.146 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.69 -50.54 65.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -48.91 69.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -53.62 -44.15 69.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -69.07 -38.81 79.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.481 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.508 ' N ' ' ND2' ' A' ' 131' ' ' ASN . 2.7 mt -47.46 -47.89 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 109.31 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.8 tt -77.75 -27.08 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -0.922 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.09 -55.12 32.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 mm -65.24 -48.67 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.023 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.5 -38.69 60.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.982 . . . . 0.0 108.735 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.795 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -59.59 -52.35 65.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.025 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.803 HD21 ' CE1' ' C' ' 337' ' ' HIS . 3.5 mt -57.34 -49.43 76.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.78 . . . . 0.0 109.674 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.34 -34.69 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 109.86 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -77.93 -45.14 24.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.06 -1.025 . . . . 0.0 109.918 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 2.1 t-105 -48.7 -51.45 28.56 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 109.948 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -71.33 -39.9 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.53 -40.27 18.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.094 -1.004 . . . . 0.0 109.252 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.31 -43.64 32.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.428 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.25 -34.41 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.74 -49.37 5.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.753 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.715 -179.814 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.294 0.456 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -59.89 3.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.415 ' H ' HG23 ' B' ' 227' ' ' VAL . 12.7 t -53.5 -39.5 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.32 -54.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.7 -42.37 24.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.15 -32.62 70.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -65.13 -65.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.706 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.474 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.3 tp -50.01 -39.22 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.143 -0.973 . . . . 0.0 108.777 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.474 ' N ' HG23 ' B' ' 232' ' ' ILE . 12.9 mt -53.77 -43.3 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.83 -43.33 98.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.499 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -60.83 -43.55 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -1.143 . . . . 0.0 108.979 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -33.08 73.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.565 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.5 OUTLIER -57.12 -51.42 69.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.018 -1.051 . . . . 0.0 109.281 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.784 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.7 tp -68.19 -33.62 74.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.73 -39.94 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.741 -1.224 . . . . 0.0 108.06 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.5 tt -73.28 -39.52 65.29 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -52.97 -52.17 59.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.48 -33.78 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.571 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.11 -62.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.94 . . . . 0.0 109.406 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -53.06 -47.84 68.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -48.23 -50.43 29.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.598 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 109.475 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' C' ' 332' ' ' ILE . 0.1 OUTLIER -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.841 . . . . 0.0 109.516 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.501 ' N ' ' ND2' ' C' ' 331' ' ' ASN . 2.7 mt -47.28 -48.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.404 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.9 tt -77.63 -27.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 108.782 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.12 -55.09 32.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.7 mm -65.38 -48.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 108.995 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.45 -38.75 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 108.757 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.803 ' CE1' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.56 -52.24 66.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 109.093 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.795 HD21 ' NE2' ' A' ' 137' ' ' HIS . 3.5 mt -57.33 -49.56 75.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 14.4 mt -52.35 -34.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 0.0 109.912 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.21 -44.22 26.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.81 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 2.1 t-105 -49.56 -51.07 39.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 110.06 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.529 HG22 ' O ' ' C' ' 338' ' ' LEU . 0.8 OUTLIER -71.65 -39.79 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.0 109.543 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.49 -40.23 17.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 0.0 109.299 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.48 -43.56 31.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.27 -34.37 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.76 -49.61 5.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.64 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.855 . . . . 0.0 109.733 -179.755 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.267 0.445 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -59.9 3.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 12.3 t -53.52 -39.4 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.373 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 9.3 t -60.34 -54.65 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 109.427 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.81 -42.26 25.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.139 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -70.35 -32.44 70.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.252 -0.905 . . . . 0.0 109.188 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -65.23 -65.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.726 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.458 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.3 tp -49.88 -39.36 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 0.0 108.774 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.458 ' N ' HG23 ' D' ' 432' ' ' ILE . 12.9 mt -53.77 -43.18 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.251 -0.906 . . . . 0.0 108.691 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.3 98.19 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.493 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -60.98 -43.4 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -1.188 . . . . 0.0 108.914 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -33.08 73.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.339 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.582 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -57.12 -51.36 69.61 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.049 -1.032 . . . . 0.0 109.314 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.783 HD13 ' CE1' ' C' ' 337' ' ' HIS . 12.0 tp -68.15 -33.65 74.88 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.643 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.71 -39.95 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.658 -1.277 . . . . 0.0 108.125 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.36 -39.43 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -52.86 -52.29 57.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.58 -33.64 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.01 -62.83 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.08 -47.95 68.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -48.09 -50.45 28.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.618 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.386 -179.89 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -73.53 -40.99 63.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.3 mt -50.85 -42.86 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.45 -29.1 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.977 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.46 -53.53 44.71 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 136' ' ' LEU . 3.8 tp -65.26 -50.21 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -1.154 . . . . 0.0 108.892 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 135' ' ' ILE . 4.3 tp -50.24 -40.12 46.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 108.585 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.935 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.93 -58.95 6.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.427 -0.795 . . . . 0.0 108.939 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.919 HD21 ' NE2' ' C' ' 337' ' ' HIS . 17.1 mt -49.23 -48.74 45.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.693 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.81 -32.37 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.52 -58.44 3.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.042 . . . . 0.0 109.705 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -50.45 -44.04 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.763 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.504 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.6 tt -71.41 -41.46 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.989 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -58.29 -29.32 65.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 0.0 109.02 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.77 -44.03 28.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.882 . . . . 0.0 109.367 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.516 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 22.3 ttt180 -54.62 -36.3 64.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 -50.53 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.697 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.462 -0.774 . . . . 0.0 109.524 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.489 1.236 0 CA-C-O 121.182 0.409 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.45 -59.26 5.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.66 -47.58 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -48.79 -58.63 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.123 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.73 -36.44 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.535 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -71.28 -32.53 68.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 109.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' B' ' 228' ' ' VAL . 53.7 m-20 -66.63 -62.64 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.406 HG23 ' N ' ' B' ' 233' ' ' ILE . 7.9 tp -50.94 -37.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.074 -1.016 . . . . 0.0 108.494 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.406 ' N ' HG23 ' B' ' 232' ' ' ILE . 11.9 mt -57.05 -42.22 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.16 -47.72 85.42 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -55.28 -39.15 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.237 -1.155 . . . . 0.0 108.6 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.5 mp -68.46 -36.83 79.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.421 -0.799 . . . . 0.0 109.276 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.862 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -54.28 -46.93 72.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.019 -1.05 . . . . 0.0 108.982 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.716 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.6 tp -68.74 -37.74 79.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.31 -37.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.973 -1.079 . . . . 0.0 108.095 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.54 -37.37 63.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 241' ' ' TRP . . . . . 0.56 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -58.52 -57.0 14.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.688 . . . . 0.0 109.436 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' ILE . . . . . 0.48 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.4 tt -63.72 -40.17 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.544 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.48 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.5 tt -58.29 -48.03 81.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.593 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -41.1 90.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -68.67 -25.36 64.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.419 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.6 OUTLIER -73.57 -41.09 63.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.419 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.4 mt -50.84 -42.93 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.313 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.33 -29.17 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.034 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.52 -53.39 45.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.565 HG23 ' N ' ' C' ' 336' ' ' LEU . 3.7 tp -65.3 -50.21 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -1.136 . . . . 0.0 108.89 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 336' ' ' LEU . . . . . 0.565 ' N ' HG23 ' C' ' 335' ' ' ILE . 4.3 tp -50.3 -40.17 47.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 108.57 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.919 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.92 -58.81 6.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.935 HD21 ' NE2' ' A' ' 137' ' ' HIS . 17.1 mt -49.26 -48.86 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.76 -32.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.514 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.68 -58.13 3.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.607 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -50.74 -43.63 58.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 109.905 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.512 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.6 tt -71.88 -41.11 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.077 -1.014 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -58.36 -29.34 65.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.85 -44.0 28.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 345' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 22.5 ttt180 -54.58 -36.2 64.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -50.67 6.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.408 -0.807 . . . . 0.0 109.554 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.488 1.156 0 CA-C-O 121.247 0.436 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.42 -59.22 5.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 26.9 t -50.63 -47.53 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 428' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -48.8 -58.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.148 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.5 11.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.505 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -71.31 -32.4 68.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 109.085 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' D' ' 428' ' ' VAL . 53.7 m-20 -66.7 -62.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.415 HG23 ' N ' ' D' ' 433' ' ' ILE . 7.8 tp -50.89 -37.37 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.415 ' N ' HG23 ' D' ' 432' ' ' ILE . 11.9 mt -57.0 -42.29 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.88 83.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.531 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -55.18 -39.12 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -1.155 . . . . 0.0 108.548 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.59 -36.79 79.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.356 -0.84 . . . . 0.0 109.184 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.88 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -54.3 -46.91 72.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.975 -1.078 . . . . 0.0 108.878 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.696 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.8 tp -68.77 -37.76 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.574 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.36 -37.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.66 -37.3 62.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 441' ' ' TRP . . . . . 0.516 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.1 t90 -58.37 -56.96 15.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.594 -0.691 . . . . 0.0 109.528 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 442' ' ' ILE . . . . . 0.477 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.5 tt -63.92 -39.98 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 443' ' ' LEU . . . . . 0.477 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.5 tt -58.33 -48.0 81.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.86 -41.01 90.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -68.77 -25.34 64.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.377 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.466 179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.39 0.614 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -37.32 65.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.97 -44.77 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 tt -78.12 -32.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.255 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.85 97.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' D' ' 430' ' ' ALA . 82.3 mt -68.22 -57.0 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.314 -1.11 . . . . 0.0 109.058 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.21 -33.67 13.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.142 -0.974 . . . . 0.0 108.7 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.939 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.4 -55.76 27.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.85 . . . . 0.0 108.99 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' C' ' 337' ' ' HIS . 18.0 mt -54.16 -48.07 71.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.675 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.23 -33.67 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -82.31 -57.6 3.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.7 OUTLIER -50.58 -43.69 56.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.849 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.609 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.0 tt -68.94 -44.73 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.861 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.522 ' N ' HG23 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -52.88 -34.68 55.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.74 -1.225 . . . . 0.0 108.741 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -78.21 -31.2 49.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.446 -0.784 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.1 -42.98 95.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.641 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -50.11 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 143' ' ' LEU . 37.8 m-85 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.522 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 CA-C-O 121.2 0.417 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.12 -45.36 52.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 0.0 109.74 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.87 -35.85 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 109.557 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.57 -56.91 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.09 -39.08 19.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.009 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.09 -33.85 68.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.212 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.443 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -66.28 -63.41 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.443 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.457 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.5 tp -49.93 -39.5 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.054 -1.028 . . . . 0.0 108.613 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.457 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.6 mt -53.98 -45.02 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.169 -0.957 . . . . 0.0 108.444 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.1 -49.34 68.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.544 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -53.38 -38.02 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.069 -1.254 . . . . 0.0 108.487 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 236' ' ' LEU . . . . . 0.606 ' O ' HD23 ' B' ' 236' ' ' LEU . 1.3 tt -68.31 -37.36 80.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.279 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.867 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.2 OUTLIER -55.32 -48.28 74.39 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.094 -1.004 . . . . 0.0 109.314 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.3 tp -67.16 -39.49 86.48 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.697 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 239' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' B' ' 236' ' ' LEU . 11.4 mt -47.46 -40.01 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.321 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.73 -34.42 64.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' TRP . . . . . 0.42 ' N ' ' O ' ' B' ' 238' ' ' LEU . 84.9 t90 -60.1 -54.88 40.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.403 -0.81 . . . . 0.0 109.636 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -51.79 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.257 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.89 -53.57 31.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.609 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -54.85 18.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.598 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -58.02 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.489 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 330' ' ' ALA . . . . . 0.433 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.83 -37.44 64.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.403 HG13 ' H ' ' C' ' 332' ' ' ILE . 2.8 mt -51.82 -44.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.492 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.8 tt -78.03 -33.04 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.7 97.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' B' ' 230' ' ' ALA . 82.2 mt -68.39 -56.96 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.316 -1.108 . . . . 0.0 109.006 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mt -49.26 -33.49 12.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.59 -55.67 28.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.87 . . . . 0.0 108.976 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.939 HD21 ' NE2' ' A' ' 137' ' ' HIS . 18.0 mt -54.14 -48.11 71.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 55.3 mt -54.38 -33.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -82.35 -57.33 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.044 -1.035 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -50.75 -43.63 58.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.867 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.6 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.9 tt -69.13 -44.56 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.513 ' N ' HG23 ' C' ' 342' ' ' ILE . 0.8 OUTLIER -52.88 -34.77 56.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.7 -1.25 . . . . 0.0 108.835 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.37 -30.97 48.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.11 -43.04 95.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.06 -50.09 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 347' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' C' ' 343' ' ' LEU . 37.4 m-85 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.842 . . . . 0.0 109.426 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.2 0.417 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -45.32 54.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.91 -35.86 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.52 -56.89 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.16 -39.11 19.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.019 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.08 -33.79 68.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.205 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.433 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.8 OUTLIER -66.29 -63.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.46 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.5 tp -49.97 -39.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.087 -1.008 . . . . 0.0 108.577 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.46 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.6 mt -54.06 -44.99 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.478 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.07 -49.34 67.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.535 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -53.47 -37.94 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -1.228 . . . . 0.0 108.476 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 436' ' ' LEU . . . . . 0.605 ' O ' HD23 ' D' ' 436' ' ' LEU . 1.3 tt -68.41 -37.24 80.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.547 -0.72 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.887 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.42 -48.09 74.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.039 -1.038 . . . . 0.0 109.346 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.709 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.4 tp -67.14 -39.62 86.58 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.716 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 439' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' D' ' 436' ' ' LEU . 11.4 mt -47.47 -39.97 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 0.0 108.353 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.7 -34.41 64.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 441' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' D' ' 438' ' ' LEU . 85.4 t90 -60.03 -54.87 40.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.518 -0.739 . . . . 0.0 109.62 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -51.66 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.121 -0.987 . . . . 0.0 109.368 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.92 -53.57 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -54.79 19.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.553 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.09 -20.09 37.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.321 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.461 0.648 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.478 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 1.0 OUTLIER -72.7 -43.75 62.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 5.0 mt -48.49 -47.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.1 tt -71.35 -33.44 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 108.776 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.2 64.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.3 mm -70.2 -55.28 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.8 mt -48.89 -34.49 12.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 108.66 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.944 ' CE1' HD21 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -62.18 -57.61 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.047 HD22 ' HD2' ' D' ' 437' ' ' HIS . 3.5 mt -56.35 -51.48 68.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.707 -0.62 . . . . 0.0 110.031 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.07 -28.72 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.4 HD22 HD21 ' B' ' 238' ' ' LEU . 4.5 tt -78.92 -58.72 3.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.73 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -50.19 -52.49 35.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.542 HG23 ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.054 . . . . 0.0 109.249 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.542 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.6 mt -49.46 -35.83 20.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.927 -1.108 . . . . 0.0 109.174 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -36.11 60.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.494 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -67.1 -28.15 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.97 -16.33 19.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 109.699 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.583 -179.686 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 121.273 0.447 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.73 -60.34 2.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 t -52.35 -34.56 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.99 -58.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.01 -41.16 15.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.259 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.13 68.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 109.147 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.2 -59.5 4.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.811 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 232' ' ' ILE . 8.8 tp -58.16 -33.93 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.066 -1.022 . . . . 0.0 109.14 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.99 -49.11 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.126 -0.984 . . . . 0.0 108.815 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.12 -45.13 96.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -49.13 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -1.203 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.6 -36.55 84.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 1.042 ' HD2' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -53.68 -49.04 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 109.236 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.761 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.0 tp -67.65 -35.53 79.06 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.821 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 239' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' B' ' 238' ' ' LEU . 3.1 mm -50.05 -37.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.35 -38.3 60.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -54.52 -50.53 67.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.81 -38.74 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.719 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -44.0 97.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.524 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.59 35.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.2 OUTLIER -53.99 -42.51 69.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.477 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 1.0 OUTLIER -72.63 -43.93 62.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.477 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 5.1 mt -48.39 -48.11 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 6.3 tt -71.17 -33.5 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.866 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -53.34 -46.04 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.29 -55.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.81 -34.49 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.668 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.964 ' CE1' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.15 -57.58 10.98 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 1.042 HD22 ' HD2' ' B' ' 237' ' ' HIS . 3.4 mt -56.5 -51.35 68.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.638 -0.664 . . . . 0.0 110.041 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.02 -28.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.06 -58.23 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -50.55 -52.61 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.548 HG23 ' N ' ' C' ' 343' ' ' LEU . 0.9 OUTLIER -59.88 -43.85 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.126 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.548 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.6 mt -49.48 -35.75 20.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 109.211 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -36.03 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.887 . . . . 0.0 109.491 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -67.18 -28.15 67.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.93 -16.4 19.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.634 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 109.531 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 CA-C-O 121.276 0.448 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.83 -60.34 2.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.424 HG23 ' H ' ' D' ' 427' ' ' VAL . 9.1 t -52.24 -34.63 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.94 -58.09 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.11 15.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.99 68.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.122 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.35 -59.35 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.843 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' D' ' 432' ' ' ILE . 8.8 tp -58.12 -34.07 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.146 -0.971 . . . . 0.0 109.104 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.9 -49.11 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.03 96.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.68 -49.06 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.273 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.65 -36.52 84.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.219 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 1.047 ' HD2' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -53.69 -49.1 68.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 109.244 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.748 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.1 tp -67.69 -35.47 78.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.633 -1.227 . . . . 0.0 109.832 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 439' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' D' ' 438' ' ' LEU . 3.1 mm -50.03 -37.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.793 -1.192 . . . . 0.0 107.877 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.32 -38.33 60.28 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -54.41 -50.59 67.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.483 -0.76 . . . . 0.0 109.605 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.92 -38.57 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.73 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -43.94 97.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.045 -1.034 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.69 34.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.2 OUTLIER -54.0 -42.46 69.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.508 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.467 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.734 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.471 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.2 OUTLIER -70.4 -36.22 73.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.368 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 132' ' ' ILE . 2.6 mt -53.91 -48.12 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.402 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 tt -72.24 -30.77 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 108.76 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.38 -44.64 84.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.419 HG21 ' HB1' ' D' ' 430' ' ' ALA . 6.6 mt -69.68 -55.04 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -1.102 . . . . 0.0 109.126 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.83 -36.7 27.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 108.963 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.85 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -64.83 -43.5 92.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.833 HD21 ' NE2' ' C' ' 337' ' ' HIS . 3.6 mt -69.42 -47.27 64.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.775 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.5 mt -54.88 -34.41 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.626 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.69 -47.55 18.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.728 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.6 t-105 -46.42 -48.88 18.69 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 143' ' ' LEU . 11.5 tt -72.48 -41.92 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.948 . . . . 0.0 109.96 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tp -47.83 -40.46 21.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 109.345 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.95 -43.83 33.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.92 -33.52 17.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.54 -49.52 5.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.483 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 121.247 0.436 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.09 -49.7 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.82 -37.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.557 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.37 -57.25 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -33.77 8.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.47 -33.59 67.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.897 . . . . 0.0 109.241 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.734 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -66.56 -61.05 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.486 ' N ' ' CG ' ' B' ' 231' ' ' ASN . 8.6 tp -52.43 -38.39 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 0.0 108.687 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.437 ' N ' HG23 ' B' ' 232' ' ' ILE . 9.4 mt -54.14 -44.22 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.9 -43.79 96.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.482 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -61.02 -41.75 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -1.221 . . . . 0.0 108.679 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 236' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' B' ' 239' ' ' ILE . 0.5 OUTLIER -67.54 -35.16 78.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.83 . . . . 0.0 109.106 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.559 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.4 OUTLIER -56.5 -50.78 70.77 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.088 -1.007 . . . . 0.0 109.416 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.814 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.1 tp -68.16 -33.83 75.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.521 -1.272 . . . . 0.0 109.79 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 239' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' B' ' 236' ' ' LEU . 16.9 mt -50.58 -40.1 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.68 -1.263 . . . . 0.0 107.831 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.15 -42.15 66.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -50.25 -48.04 54.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 108.927 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.12 -52.11 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.279 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.33 -31.94 46.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.88 -33.48 64.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.388 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -77.57 -25.95 50.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.439 179.849 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 330' ' ' ALA . . . . . 0.742 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' C' ' 332' ' ' ILE . 0.0 OUTLIER -70.45 -36.26 73.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.427 ' N ' ' ND2' ' C' ' 331' ' ' ASN . 2.8 mt -53.79 -48.33 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.2 tt -72.05 -30.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 108.742 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.66 84.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.418 HG21 ' HB1' ' B' ' 230' ' ' ALA . 6.6 mt -69.66 -55.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -1.122 . . . . 0.0 109.054 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.79 -36.56 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.989 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.833 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -64.86 -43.63 92.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.85 HD21 ' NE2' ' A' ' 137' ' ' HIS . 3.6 mt -69.3 -47.4 64.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.766 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.7 mt -54.83 -34.53 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.74 -46.97 20.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.6 t-105 -46.95 -48.71 21.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.47 HG23 ' N ' ' C' ' 343' ' ' LEU . 11.0 tt -72.71 -41.76 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.47 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tp -47.75 -40.59 20.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.357 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.97 -43.9 33.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.88 -33.49 17.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.626 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.5 -49.63 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 121.256 0.44 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.19 -49.64 51.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.471 ' CG1' HD21 ' A' ' 131' ' ' ASN . 60.9 t -59.82 -37.77 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 0.0 109.545 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 428' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.7 t -64.25 -57.36 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.098 -1.001 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.96 -33.93 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.888 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.54 -33.54 66.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.742 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -66.51 -61.11 2.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' D' ' 431' ' ' ASN . 8.6 tp -52.36 -38.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 108.654 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.434 ' N ' HG23 ' D' ' 432' ' ' ILE . 9.4 mt -54.13 -44.2 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.213 -0.929 . . . . 0.0 108.525 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.99 -43.67 96.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.484 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.7 mp -61.14 -41.61 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.11 -1.229 . . . . 0.0 108.761 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 436' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' D' ' 439' ' ' ILE . 0.5 OUTLIER -67.56 -35.24 78.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.099 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.567 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.4 OUTLIER -56.44 -50.71 70.9 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.192 -0.942 . . . . 0.0 109.501 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.803 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.6 tp -68.22 -33.85 75.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.738 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 439' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' D' ' 436' ' ' LEU . 16.9 mt -50.64 -40.12 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.637 -1.29 . . . . 0.0 107.81 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.06 -42.12 66.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -50.13 -48.04 53.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.004 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.29 -52.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.18 -32.07 45.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.91 -33.38 63.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -77.56 -26.03 50.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.821 HD21 HG11 ' D' ' 427' ' ' VAL . 0.5 OUTLIER -72.01 -38.34 69.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 0.0 109.54 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.55 -44.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.308 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tt -78.43 -28.71 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 108.763 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.1 27.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.616 HG23 ' N ' ' A' ' 136' ' ' LEU . 6.2 tp -63.34 -50.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -1.227 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.616 ' N ' HG23 ' A' ' 135' ' ' ILE . 3.7 mt -52.1 -37.75 55.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.085 -1.009 . . . . 0.0 108.74 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.754 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -60.03 -56.03 26.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 108.981 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.724 HD21 ' NE2' ' C' ' 337' ' ' HIS . 6.3 mt -50.16 -38.62 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.768 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.39 -30.06 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.604 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.63 -53.27 6.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -52.77 -41.46 64.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.1 tp -74.36 -47.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.039 -1.038 . . . . 0.0 110.007 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.609 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.3 tp -50.2 -30.49 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.006 -1.059 . . . . 0.0 109.032 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.505 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 6.0 t0 -78.35 -46.6 19.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 109.539 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.37 -33.8 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.42 -51.54 4.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.784 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 147' ' ' PHE . 34.7 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 109.616 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.256 0.44 . . . . 0.0 112.394 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.448 ' N ' HD12 ' B' ' 226' ' ' LEU . 11.0 mp -64.79 -62.29 1.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.83 HG11 HD21 ' C' ' 331' ' ' ASN . 39.3 t -50.22 -45.97 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.0 t -48.89 -56.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.042 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.65 18.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.628 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -69.85 -34.64 73.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.431 -0.793 . . . . 0.0 109.145 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -60.8 3.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.067 -1.021 . . . . 0.0 109.254 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.21 -42.0 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.114 -0.991 . . . . 0.0 109.054 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' B' ' 230' ' ' ALA . 18.3 mt -50.49 -37.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -63.63 -44.67 96.12 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.5 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -58.65 -39.69 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -1.208 . . . . 0.0 108.533 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.04 -36.23 77.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.381 -0.824 . . . . 0.0 109.138 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.589 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -54.59 -48.79 71.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.972 -1.08 . . . . 0.0 108.954 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.754 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.3 tp -66.7 -38.53 86.93 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.695 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.91 -38.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.916 -1.115 . . . . 0.0 108.205 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -36.46 64.34 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -59.77 -56.53 20.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.0 109.566 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' ILE . . . . . 0.433 HG23 ' N ' ' B' ' 243' ' ' LEU . 12.6 tt -61.12 -39.05 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.666 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.433 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.5 mt -59.3 -54.87 41.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.003 . . . . 0.0 109.524 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.83 -50.81 55.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.13 -41.19 87.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.445 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.83 HD21 HG11 ' B' ' 227' ' ' VAL . 0.5 OUTLIER -71.95 -38.61 69.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.48 -44.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.963 . . . . 0.0 109.286 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.42 -28.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 108.743 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -63.59 -54.97 27.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.628 HG12 ' HB1' ' B' ' 230' ' ' ALA . 6.3 tp -63.28 -50.2 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -1.227 . . . . 0.0 108.823 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 336' ' ' LEU . . . . . 0.608 ' N ' HG23 ' C' ' 335' ' ' ILE . 3.7 mt -52.07 -37.85 55.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.103 -0.998 . . . . 0.0 108.756 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.736 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -60.0 -55.89 28.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.027 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.727 HD21 ' NE2' ' A' ' 137' ' ' HIS . 6.3 mt -50.27 -38.7 42.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.415 -0.803 . . . . 0.0 109.676 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.37 -30.05 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -81.91 -52.64 6.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -53.14 -41.44 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.148 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.612 HG23 ' N ' ' C' ' 343' ' ' LEU . 10.1 tp -74.39 -47.87 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.97 -1.081 . . . . 0.0 109.872 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.612 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.3 tp -50.12 -30.5 11.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.046 -1.034 . . . . 0.0 109.141 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 344' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' D' ' 445' ' ' ARG . 6.0 t0 -78.6 -46.41 19.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.36 -33.88 22.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.461 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.3 -51.73 4.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 347' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' C' ' 347' ' ' PHE . 34.5 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 121.242 0.434 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 426' ' ' LEU . . . . . 0.44 ' N ' HD12 ' D' ' 426' ' ' LEU . 11.0 mp -64.88 -62.19 1.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.821 HG11 HD21 ' A' ' 131' ' ' ASN . 39.4 t -50.26 -45.94 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.912 . . . . 0.0 109.208 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.84 -56.88 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.005 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.7 -37.56 18.96 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.603 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -69.87 -34.64 73.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.112 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -60.8 3.25 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.079 -1.013 . . . . 0.0 109.27 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.12 -41.96 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.177 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' D' ' 430' ' ' ALA . 18.7 mt -50.58 -37.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -63.62 -44.7 96.09 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.496 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.7 mp -58.59 -39.71 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -1.206 . . . . 0.0 108.483 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.02 -36.33 77.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.387 -0.82 . . . . 0.0 109.175 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.591 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -54.49 -48.76 71.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.041 -1.037 . . . . 0.0 108.998 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.4 tp -66.69 -38.55 87.0 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.687 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.93 -38.1 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 108.163 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -36.5 64.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.7 -56.39 22.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.684 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 442' ' ' ILE . . . . . 0.431 HG23 ' N ' ' D' ' 443' ' ' LEU . 12.8 tt -61.33 -38.99 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 443' ' ' LEU . . . . . 0.431 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.5 mt -59.22 -54.89 41.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.81 -50.87 55.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -59.06 -41.31 87.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.492 ' HB1' ' ND2' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.427 0.632 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 -38.01 45.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.14 -44.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 134' ' ' GLY . 12.4 tt -79.53 -38.98 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 0.0 109.179 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -54.24 -44.46 75.09 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.554 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.8 mt -69.82 -54.98 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -1.07 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.3 -33.48 13.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.09 -1.006 . . . . 0.0 108.67 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.721 ' ND1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -63.77 -59.01 5.1 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.645 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.6 mt -49.73 -37.72 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.483 -0.76 . . . . 0.0 109.697 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.9 mt -68.99 -30.71 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.08 -54.95 4.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.697 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.2 OUTLIER -50.25 -44.06 53.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.256 -0.903 . . . . 0.0 109.89 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.76 HD13 ' NE2' ' D' ' 437' ' ' HIS . 4.2 tp -72.17 -45.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.617 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.578 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.7 mt -49.46 -31.77 10.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.95 -1.094 . . . . 0.0 108.961 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.62 -45.62 24.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -50.33 -34.46 23.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.86 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 146' ' ' LEU . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.637 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 121.24 0.433 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.03 -41.37 25.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -39.75 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.43 -57.82 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.942 . . . . 0.0 109.481 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -46.92 -40.21 13.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.202 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.38 -35.47 68.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.492 ' ND2' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -65.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -49.55 -38.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.166 -0.959 . . . . 0.0 108.681 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.437 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.1 mt -56.44 -41.38 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 108.486 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.96 95.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.572 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.97 -51.53 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.293 . . . . 0.0 108.503 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.8 -37.95 77.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.757 . . . . 0.0 109.545 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.766 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.2 OUTLIER -52.61 -48.58 66.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.991 -1.068 . . . . 0.0 109.094 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.721 HD13 ' ND1' ' A' ' 137' ' ' HIS . 8.1 tp -65.84 -38.26 88.41 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.713 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 38.5 mm -49.44 -38.34 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.764 -1.21 . . . . 0.0 108.094 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.98 -34.87 64.39 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -60.99 -56.56 19.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.485 -0.76 . . . . 0.0 109.346 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' ILE . . . . . 0.449 HG23 ' N ' ' B' ' 243' ' ' LEU . 12.5 tt -62.94 -38.57 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.5 -0.75 . . . . 0.0 109.619 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.449 ' N ' HG23 ' B' ' 242' ' ' ILE . 4.7 tp -62.18 -38.37 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.42 -48.13 71.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.349 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.43 -40.74 83.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.413 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -38.08 44.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.415 HG13 ' H ' ' C' ' 332' ' ' ILE . 3.2 mt -51.08 -44.41 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 333' ' ' ILE . . . . . 0.433 HG23 ' N ' ' C' ' 334' ' ' GLY . 12.5 tt -79.46 -39.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.168 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 334' ' ' GLY . . . . . 0.433 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -54.18 -44.45 74.43 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' B' ' 230' ' ' ALA . 86.5 mt -69.8 -55.02 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.333 -1.098 . . . . 0.0 109.115 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.31 -33.52 13.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.665 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.706 ' ND1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -63.67 -58.98 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.428 -0.795 . . . . 0.0 108.92 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.662 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.6 mt -49.78 -37.68 30.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 50.7 mt -69.13 -30.68 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.07 -54.64 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 109.666 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -50.38 -44.18 54.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.97 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.766 HD13 ' NE2' ' B' ' 237' ' ' HIS . 4.2 tp -72.18 -45.42 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 109.6 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.564 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.7 mt -49.48 -31.82 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 108.891 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.78 -45.47 24.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.785 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -50.23 -34.55 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 346' ' ' LEU . . . . . 0.47 ' O ' HD23 ' C' ' 346' ' ' LEU . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.572 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.277 0.449 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.02 -41.25 25.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 427' ' ' VAL . 4.5 t -64.55 -39.65 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.138 -0.976 . . . . 0.0 109.597 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.56 -57.77 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -46.89 -40.22 13.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 109.219 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.554 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.31 -35.57 68.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -65.7 -63.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.417 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.6 tp -49.55 -38.24 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.166 -0.959 . . . . 0.0 108.632 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.417 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.1 mt -56.42 -41.41 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.151 -0.968 . . . . 0.0 108.469 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.94 95.92 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.565 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -58.92 -51.49 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.062 -1.258 . . . . 0.0 108.523 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.84 -37.85 77.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.594 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.76 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -52.67 -48.58 66.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 109.046 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.706 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.3 tp -65.76 -38.38 88.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.751 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 38.1 mm -49.38 -38.41 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.762 -1.211 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.0 -34.74 64.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -61.05 -56.38 21.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 442' ' ' ILE . . . . . 0.447 HG23 ' N ' ' D' ' 443' ' ' LEU . 12.7 tt -63.26 -38.4 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 443' ' ' LEU . . . . . 0.447 ' N ' HG23 ' D' ' 442' ' ' ILE . 4.7 tp -62.03 -38.62 89.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -66.32 -48.12 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -40.76 83.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.299 179.9 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.549 ' HB1' ' CG ' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' D' ' 431' ' ' ASN . 0.1 OUTLIER -74.72 -42.88 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.933 . . . . 0.0 109.39 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.424 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mt -51.16 -43.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.604 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.535 ' CD1' HD12 ' B' ' 235' ' ' ILE . 6.3 tt -74.06 -36.26 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.005 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -50.89 -42.79 47.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.2 mt -71.46 -53.06 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.4 -1.059 . . . . 0.0 109.17 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.17 -37.9 23.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.188 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.856 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -67.54 -44.17 78.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.27 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.675 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.5 mt -60.61 -49.69 76.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.485 -0.759 . . . . 0.0 109.983 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.91 -24.05 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.55 HD22 HD21 ' B' ' 238' ' ' LEU . 2.6 tt -80.96 -59.95 2.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -0.94 . . . . 0.0 109.894 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.0 OUTLIER -50.59 -42.49 55.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.261 -0.9 . . . . 0.0 109.962 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.75 HD13 ' NE2' ' D' ' 437' ' ' HIS . 3.7 tp -72.77 -42.38 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.85 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.529 ' N ' HG23 ' A' ' 142' ' ' ILE . 4.9 mt -48.69 -40.69 29.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 0.0 109.096 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -39.1 61.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.609 HH11 ' CG ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -51.03 -37.6 46.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.473 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.9 -48.49 6.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.461 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.276 0 CA-C-O 121.185 0.41 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.15 -51.5 53.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.444 ' CG1' HD21 ' C' ' 331' ' ' ASN . 23.6 t -57.31 -41.55 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.4 -56.29 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.25 -38.43 12.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.248 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.28 66.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 109.375 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.549 ' CG ' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -67.3 -58.46 4.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.444 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.41 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.3 tp -54.01 -36.48 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.067 . . . . 0.0 108.565 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.41 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.4 mt -58.54 -44.44 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 108.728 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.84 -41.56 91.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.535 HD12 ' CD1' ' A' ' 133' ' ' ILE . 23.2 mm -61.18 -36.31 71.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.113 -1.227 . . . . 0.0 108.702 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 236' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' B' ' 239' ' ' ILE . 2.7 tt -67.72 -35.47 78.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.868 . . . . 0.0 108.858 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.753 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.3 OUTLIER -58.53 -51.85 68.15 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.856 HD13 ' CE1' ' A' ' 137' ' ' HIS . 14.0 tp -63.27 -38.99 93.33 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.619 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 239' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' B' ' 236' ' ' LEU . 13.9 mt -48.68 -43.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.901 -1.125 . . . . 0.0 108.464 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.88 -42.5 90.22 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -57.9 -43.89 86.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.32 -56.08 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 108.969 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.76 -21.17 62.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 109.532 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.33 -60.67 2.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.375 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.03 -34.5 71.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.951 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 330' ' ' ALA . . . . . 0.548 ' HB1' ' ND2' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.444 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -74.65 -43.01 57.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.7 mt -51.02 -43.84 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -0.831 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 333' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' D' ' 435' ' ' ILE . 6.6 tt -73.9 -36.3 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -50.93 -42.73 47.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 6.1 mt -71.46 -53.17 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.374 -1.074 . . . . 0.0 109.181 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.09 -37.91 22.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.173 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.844 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -67.54 -44.2 78.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.675 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.4 mt -60.6 -49.84 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.71 -24.25 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.965 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 340' ' ' LEU . . . . . 0.528 HD22 HD21 ' D' ' 438' ' ' LEU . 2.7 tt -81.06 -59.47 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -50.97 -42.59 60.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 110.006 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.753 HD13 ' NE2' ' B' ' 237' ' ' HIS . 3.8 tp -72.57 -42.57 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 109.611 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.536 ' N ' HG23 ' C' ' 342' ' ' ILE . 4.9 mt -48.62 -40.64 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 109.192 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.96 60.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 109.369 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 345' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' C' ' 345' ' ' ARG . 0.3 OUTLIER -51.11 -37.47 46.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.429 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.03 -48.48 6.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.489 1.221 0 CA-C-O 121.187 0.411 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -51.56 52.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.402 ' CG1' HD21 ' A' ' 131' ' ' ASN . 24.3 t -57.3 -41.52 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.41 -56.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.49 13.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.176 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.97 -35.31 66.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 109.383 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.548 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -67.22 -58.46 4.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.403 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.3 tp -53.95 -36.54 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 108.602 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.403 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.4 mt -58.45 -44.45 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.152 -0.968 . . . . 0.0 108.762 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.77 -41.65 90.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' C' ' 333' ' ' ILE . 23.1 mm -61.24 -36.26 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -1.187 . . . . 0.0 108.645 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 436' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' D' ' 439' ' ' ILE . 2.7 tt -67.7 -35.44 78.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.341 -0.849 . . . . 0.0 108.913 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.75 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -58.56 -51.89 67.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.107 -0.995 . . . . 0.0 108.977 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.844 HD13 ' CE1' ' C' ' 337' ' ' HIS . 14.4 tp -63.09 -39.23 94.1 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.562 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 439' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' D' ' 436' ' ' LEU . 14.0 mt -48.62 -43.35 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.814 -1.179 . . . . 0.0 108.453 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -42.55 89.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.94 -43.67 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.758 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.57 -55.88 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 108.994 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.81 -21.13 62.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.39 -60.66 2.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.98 -34.53 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 0.0 109.343 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.412 0.625 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.757 HD21 HG11 ' D' ' 427' ' ' VAL . 0.0 OUTLIER -77.84 -50.4 12.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.8 mm -47.61 -44.54 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.469 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 134' ' ' GLY . 11.1 tt -72.41 -37.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.012 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -52.17 -49.8 48.59 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.924 HG21 ' HB1' ' D' ' 430' ' ' ALA . 11.0 mm -65.23 -55.05 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -1.217 . . . . 0.0 109.289 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.4 -33.83 14.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.811 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -63.97 -60.25 3.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 109.401 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.7 mt -49.05 -39.68 28.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.712 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.7 mt -69.18 -27.72 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.413 HD22 HD21 ' B' ' 238' ' ' LEU . 4.2 tt -82.78 -54.11 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.12 -0.988 . . . . 0.0 109.627 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.89 -42.49 62.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.3 tp -72.82 -45.26 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.596 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.0 mt -49.12 -33.73 12.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.276 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.78 -43.57 25.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.855 . . . . 0.0 109.655 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.565 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 25.5 ttt180 -50.1 -39.51 42.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.877 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.13 -53.52 3.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 109.854 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.446 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.49 1.288 0 CA-C-O 121.208 0.42 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 227' ' ' VAL . . . . . 0.777 HG11 HD21 ' C' ' 331' ' ' ASN . 16.7 t -52.48 -44.63 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.361 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 228' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' B' ' 231' ' ' ASN . 4.8 t -53.86 -56.67 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -38.42 17.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 108.806 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -70.52 -28.83 65.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.327 -0.858 . . . . 0.0 109.076 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 231' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.2 m-20 -69.04 -63.79 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.215 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.7 tp -49.05 -36.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' B' ' 230' ' ' ALA . 20.2 mt -58.96 -41.07 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 231' ' ' ASN . . . -56.87 -42.86 92.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.597 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -61.22 -41.03 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -1.23 . . . . 0.0 108.662 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 236' ' ' LEU . . . . . 0.521 ' HA ' HD12 ' B' ' 239' ' ' ILE . 0.5 OUTLIER -67.45 -35.28 78.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 0.0 109.089 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.522 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -56.87 -48.96 76.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.167 -0.958 . . . . 0.0 109.414 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.811 HD13 ' CE1' ' A' ' 137' ' ' HIS . 9.5 tp -68.1 -35.13 77.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.701 -1.2 . . . . 0.0 109.761 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 239' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' B' ' 236' ' ' LEU . 13.5 mt -50.56 -41.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.726 -1.233 . . . . 0.0 108.104 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tt -69.96 -40.59 75.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' TRP . . . . . 0.553 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 88.3 t90 -54.45 -55.93 23.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.05 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.1 mt -53.12 -54.48 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.04 -53.98 23.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.564 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -52.88 -28.13 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -74.64 -48.37 26.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.888 . . . . 0.0 109.516 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 246' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.311 0.577 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.777 HD21 HG11 ' B' ' 227' ' ' VAL . 0.0 OUTLIER -77.92 -50.57 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.998 -179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.479 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.9 mm -47.31 -44.84 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 333' ' ' ILE . . . . . 0.411 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -72.19 -38.01 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 334' ' ' GLY . . . . . 0.411 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -52.19 -49.75 48.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.94 HG21 ' HB1' ' B' ' 230' ' ' ALA . 11.5 mm -65.36 -55.01 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -1.22 . . . . 0.0 109.279 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.36 -33.91 14.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.805 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -63.89 -60.4 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.84 . . . . 0.0 109.297 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.78 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.8 mt -48.91 -39.64 26.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 11.0 mt -69.33 -27.73 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 340' ' ' LEU . . . . . 0.401 HD22 HD21 ' D' ' 438' ' ' LEU . 4.0 tt -82.98 -53.53 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.637 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -52.28 -42.51 63.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.595 HG23 ' N ' ' C' ' 343' ' ' LEU . 10.3 tp -72.72 -45.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.595 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.0 mt -49.14 -33.69 12.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 109.313 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.94 -43.41 24.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 345' ' ' ARG . . . . . 0.553 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 25.4 ttt180 -50.2 -39.51 44.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.04 -53.75 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.227 0.428 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 131' ' ' ASN . 16.9 t -52.46 -44.59 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.352 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 428' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' D' ' 431' ' ' ASN . 4.8 t -53.9 -56.72 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.345 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.0 -38.57 17.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 108.859 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.924 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -70.5 -28.81 65.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 431' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.2 m-20 -68.98 -63.88 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.194 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.7 tp -48.93 -36.39 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' D' ' 430' ' ' ALA . 20.2 mt -59.01 -41.03 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 434' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' D' ' 431' ' ' ASN . . . -56.99 -42.8 93.06 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.594 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.7 mp -61.22 -40.97 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.14 -1.212 . . . . 0.0 108.631 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 436' ' ' LEU . . . . . 0.516 ' HA ' HD12 ' D' ' 439' ' ' ILE . 0.5 OUTLIER -67.59 -35.16 78.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.062 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.515 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -56.77 -49.21 75.99 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.362 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.805 HD13 ' CE1' ' C' ' 337' ' ' HIS . 9.9 tp -67.92 -35.27 78.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.712 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 439' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' D' ' 436' ' ' LEU . 13.5 mt -50.52 -41.9 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.708 -1.245 . . . . 0.0 108.104 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.0 tt -70.0 -40.56 75.2 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 441' ' ' TRP . . . . . 0.565 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 89.0 t90 -54.31 -55.98 22.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.102 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 65.8 mt -53.18 -54.46 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.01 -53.99 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -52.82 -28.27 21.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.341 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -74.56 -48.31 27.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.598 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 446' ' ' LEU . . . . . 0.423 ' N ' HD12 ' D' ' 446' ' ' LEU . 10.8 mp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.311 0.577 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.464 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -74.75 -43.66 53.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.482 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 8.7 mt -51.06 -45.8 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.489 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.74 -36.36 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 108.891 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -40.66 78.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.655 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.0 mt -67.96 -56.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.419 -1.048 . . . . 0.0 109.071 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.56 -35.87 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 108.792 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.916 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -58.5 -59.25 5.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.12 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.881 HD21 ' NE2' ' C' ' 337' ' ' HIS . 11.2 mt -53.25 -51.42 62.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 75.4 mt -54.01 -31.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.15 -58.63 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.552 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.5 OUTLIER -50.95 -50.94 56.96 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.553 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.0 tt -61.72 -41.99 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.488 ' N ' HG23 ' A' ' 142' ' ' ILE . 4.8 mt -54.2 -35.9 62.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.075 . . . . 0.0 108.978 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -29.36 57.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.416 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.32 -35.28 79.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.27 -15.33 20.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.714 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 109.649 -179.708 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.489 1.254 0 CA-C-O 121.323 0.468 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.92 -60.59 2.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.957 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 t -55.51 -39.02 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.481 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.39 -56.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.45 -43.28 23.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.239 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.736 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -69.53 -30.35 68.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.337 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.31 -65.16 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.427 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.4 tp -49.92 -37.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.177 -0.952 . . . . 0.0 108.675 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 233' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' B' ' 230' ' ' ALA . 13.2 mt -54.75 -45.89 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.47 -46.2 88.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.526 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.0 -53.93 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -1.167 . . . . 0.0 108.93 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.35 -38.18 71.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 0.0 109.424 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' HIS . . . . . 0.809 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.51 -47.21 70.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.088 -1.008 . . . . 0.0 109.375 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 238' ' ' LEU . . . . . 0.743 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.4 tp -67.81 -36.36 80.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.04 -39.89 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.764 -1.21 . . . . 0.0 107.894 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -37.47 69.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.4 -57.61 12.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.63 -54.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.258 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.65 -52.17 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.77 -33.8 57.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -65.29 -52.98 50.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.461 ' N ' HD12 ' B' ' 246' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 331' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -74.8 -43.66 53.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 8.8 mt -50.96 -46.0 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.52 -36.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 108.986 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.56 -40.64 79.06 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 335' ' ' ILE . . . . . 0.736 HG21 ' HB1' ' B' ' 230' ' ' ALA . 82.0 mt -67.93 -56.29 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.343 -1.093 . . . . 0.0 109.057 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.51 -35.93 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.928 . . . . 0.0 108.766 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 337' ' ' HIS . . . . . 0.881 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -58.41 -59.18 5.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.184 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 338' ' ' LEU . . . . . 0.916 HD21 ' NE2' ' A' ' 137' ' ' HIS . 11.1 mt -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 75.6 mt -54.24 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.38 -58.1 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.494 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -51.37 -50.76 58.9 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 342' ' ' ILE . . . . . 0.614 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.0 tt -61.94 -41.94 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' HG23 ' C' ' 342' ' ' ILE . 4.9 mt -53.95 -36.14 62.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.968 -1.083 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -29.33 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.36 -35.3 79.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.21 -15.28 20.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.0 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.672 -179.765 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 CA-C-O 121.308 0.462 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.8 -60.66 2.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 427' ' ' VAL . . . . . 0.431 HG23 ' H ' ' D' ' 427' ' ' VAL . 4.9 t -55.48 -39.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.499 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.32 -56.82 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.37 23.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 430' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -69.54 -30.3 68.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.3 -65.09 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 432' ' ' ILE . . . . . 0.426 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.4 tp -49.89 -37.97 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 108.612 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 433' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' D' ' 430' ' ' ALA . 13.3 mt -54.67 -45.86 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 108.572 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.51 -46.22 88.37 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 435' ' ' ILE . . . . . 0.523 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -58.05 -53.9 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 108.885 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.37 -38.16 71.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.44 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 437' ' ' HIS . . . . . 0.807 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.54 -47.16 70.25 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.101 -0.999 . . . . 0.0 109.272 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 438' ' ' LEU . . . . . 0.718 HD13 ' ND1' ' C' ' 337' ' ' HIS . 7.7 tp -67.87 -36.44 80.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.713 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.1 mm -50.03 -39.88 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 107.862 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -37.33 68.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.31 -57.69 11.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.738 . . . . 0.0 109.168 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 67.0 mt -54.77 -53.9 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.64 -52.21 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.79 -33.73 56.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -65.36 -52.97 50.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 446' ' ' LEU . . . . . 0.457 ' N ' HD12 ' D' ' 446' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -86.69 111.91 21.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -73.22 -16.68 61.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.06 168.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.9 p -81.09 150.74 28.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -87.64 -7.43 57.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.31 70.67 5.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.08 -27.29 57.43 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.409 1.406 . . . . 0.0 112.521 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 126' ' ' LEU . 10.5 mp -73.04 -44.6 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.737 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.31 -56.01 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.674 HG23 ' N ' ' A' ' 129' ' ' ALA . 35.0 m -59.86 -54.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.681 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.674 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.01 -24.31 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.195 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.05 -20.73 24.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -74.88 -41.97 58.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.557 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.7 mt -51.85 -42.93 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.66 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.0 109.002 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.53 96.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.525 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.3 mt -66.6 -57.29 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.242 -1.152 . . . . 0.0 109.091 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.39 -36.89 23.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 108.73 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.938 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.26 -57.28 13.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.914 HD21 ' NE2' ' C' ' 337' ' ' HIS . 18.3 mt -51.75 -50.35 60.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.833 . . . . 0.0 109.745 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mt -53.05 -31.95 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.3 -59.15 2.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -49.81 -42.85 47.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.584 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.2 tt -72.72 -42.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.485 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 tt -59.78 -28.5 67.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.048 . . . . 0.0 109.064 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.2 OUTLIER -76.55 -45.43 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.51 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 61.5 ttt180 -55.76 -34.95 65.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.38 -51.07 6.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -96.2 35.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' ASP . 30.1 t80 -47.35 -30.15 3.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -67.76 -48.83 65.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 m -55.75 -48.76 74.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.9 mm -53.86 -49.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -54.43 -39.97 67.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.05 -41.89 77.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.574 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -49.19 -54.78 14.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -43.98 96.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.36 100.87 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 157' ' ' HIS . 2.1 m-70 54.77 -135.07 1.46 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.13 -28.04 2.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 157' ' ' HIS . 11.5 mt -89.34 120.34 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -1.182 . . . . 0.0 109.359 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.8 tttm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.465 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 3.3 p -63.52 -27.87 69.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.445 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -83.0 129.46 35.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -162.37 63.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 21.7 p -164.04 129.35 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 70.5 m -86.0 -122.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -146.69 71.06 12.63 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.42 -36.42 27.03 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.447 1.431 . . . . 0.0 112.513 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.42 ' N ' HD12 ' B' ' 226' ' ' LEU . 11.0 mp -60.64 -47.64 85.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.586 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 11.4 t -62.63 -33.58 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.31 -59.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.68 -39.53 17.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.933 . . . . 0.0 108.957 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -71.26 -32.0 68.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.387 -0.821 . . . . 0.0 109.247 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -63.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.442 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -50.94 -38.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.031 -1.043 . . . . 0.0 108.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.442 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.8 mt -54.92 -44.18 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -55.5 -48.41 70.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.553 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -55.91 -38.29 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -1.148 . . . . 0.0 108.705 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.15 -35.91 76.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.247 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.866 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.2 OUTLIER -55.68 -47.98 75.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.046 -1.034 . . . . 0.0 109.025 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.709 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.6 tp -67.79 -36.96 81.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.629 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.827 -1.171 . . . . 0.0 108.145 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.7 -35.13 65.12 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' TRP . . . . . 0.526 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -60.7 -56.12 25.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 109.419 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 242' ' ' ILE . . . . . 0.492 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.1 tt -65.32 -41.11 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.375 -0.828 . . . . 0.0 109.575 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.492 ' N ' HG23 ' B' ' 242' ' ' ILE . 0.6 OUTLIER -60.69 -36.86 79.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.441 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.4 -50.58 58.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.62 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.73 -28.69 68.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -57.22 7.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.45 108.41 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.47 -86.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -144.55 -82.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 7.7 m -87.7 -142.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.378 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 62.1 mt 48.73 89.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.363 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -158.55 94.56 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.546 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -82.89 146.99 28.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -152.67 136.36 16.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.2 OUTLIER -91.64 116.3 28.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -62.2 108.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -168.75 96.93 0.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -164.3 -136.48 2.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 42.7 mt -83.34 -11.13 58.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.487 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.278 0.561 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 86.2 p -86.76 111.95 21.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.354 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -73.21 -16.71 61.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.14 168.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.418 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 86.7 p -81.16 150.83 28.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.922 . . . . 0.0 109.356 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 44.3 t -87.68 -7.48 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.877 . . . . 0.0 109.538 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.26 70.77 5.61 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.16 -27.35 56.77 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.426 1.418 . . . . 0.0 112.479 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 326' ' ' LEU . . . . . 0.561 HD12 ' N ' ' C' ' 326' ' ' LEU . 10.5 mp -72.96 -44.6 60.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.3 -56.02 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.682 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.67 HG23 ' N ' ' C' ' 329' ' ' ALA . 35.0 m -59.88 -54.4 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.669 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.67 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -53.85 -24.49 15.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.264 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.04 -20.53 24.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.337 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 1.0 OUTLIER -74.9 -42.1 58.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.9 mt -51.81 -43.01 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.5 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -59.23 -44.5 96.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.561 HG21 ' HB1' ' B' ' 230' ' ' ALA . 83.4 mt -66.63 -57.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -1.111 . . . . 0.0 109.082 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.4 mt -49.31 -36.83 22.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 108.802 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.914 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.36 -57.26 13.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.043 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.938 HD21 ' NE2' ' A' ' 137' ' ' HIS . 18.5 mt -51.7 -50.34 60.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -0.784 . . . . 0.0 109.772 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 19.2 mt -53.09 -32.07 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.626 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.21 -58.81 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.16 -0.962 . . . . 0.0 109.682 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -50.22 -42.59 51.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.869 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.588 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.2 tt -73.03 -41.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 109.6 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.2 tt -59.8 -28.54 67.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.2 OUTLIER -76.64 -45.36 30.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 109.421 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 345' ' ' ARG . . . . . 0.526 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 61.6 ttt180 -55.73 -34.99 65.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.35 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.4 -51.23 6.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -96.03 35.27 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.391 -0.818 . . . . 0.0 109.554 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' C' ' 344' ' ' ASP . 30.2 t80 -47.37 -30.03 2.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.388 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -67.8 -48.84 65.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.522 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 5.2 m -55.65 -48.72 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.8 -49.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.41 -40.04 67.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.06 -41.79 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.575 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -49.38 -54.55 16.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.98 96.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.503 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.41 100.99 4.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 357' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' C' ' 357' ' ' HIS . 2.1 m-70 54.65 -135.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.2 -28.09 2.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 359' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' C' ' 357' ' ' HIS . 11.7 mt -89.27 120.28 30.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 38.9 tttm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.506 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.289 0.566 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.3 p -63.44 -27.84 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -82.98 129.46 35.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.432 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -162.38 63.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 21.1 p -164.01 129.31 2.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 70.3 m -85.95 -122.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -146.71 71.09 12.61 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.41 -36.47 26.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.429 1.419 . . . . 0.0 112.526 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 426' ' ' LEU . . . . . 0.412 ' N ' HD12 ' D' ' 426' ' ' LEU . 11.0 mp -60.61 -47.56 85.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.69 -33.48 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.41 -59.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.72 -39.52 17.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 108.972 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.525 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -71.32 -31.84 67.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.522 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.421 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.7 tp -50.92 -38.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.112 -0.993 . . . . 0.0 108.394 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.421 ' N ' HG23 ' D' ' 432' ' ' ILE . 10.8 mt -54.92 -44.25 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -55.33 -48.53 68.79 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.548 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -55.88 -38.33 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -1.128 . . . . 0.0 108.644 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.06 -36.05 77.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.883 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.58 -48.04 75.46 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.923 -1.11 . . . . 0.0 108.976 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.69 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.7 tp -67.77 -36.96 81.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.821 -1.151 . . . . 0.0 109.665 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.13 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.873 -1.142 . . . . 0.0 108.089 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.74 -35.12 65.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 441' ' ' TRP . . . . . 0.51 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.2 t90 -60.5 -56.09 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.517 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 442' ' ' ILE . . . . . 0.491 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.2 tt -65.56 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.624 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 443' ' ' LEU . . . . . 0.491 ' N ' HG23 ' D' ' 442' ' ' ILE . 0.6 OUTLIER -60.57 -36.89 79.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.437 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.46 -50.52 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.82 -28.72 69.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.28 -57.21 7.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -82.49 108.32 15.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.46 -86.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -144.47 -82.39 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.818 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 7.9 m -87.58 -142.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 61.2 mt 48.69 89.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -158.49 94.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -82.86 147.04 28.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.327 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -152.67 136.32 16.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' D' ' 455' ' ' PHE . 0.2 OUTLIER -91.54 116.26 28.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -62.21 108.99 1.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -168.78 96.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.342 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -164.34 -136.48 2.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 42.9 mt -83.41 -11.05 58.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -1.145 . . . . 0.0 109.427 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.477 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.4 33.36 6.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 49.05 53.7 12.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.53 153.11 20.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.1 t -173.73 10.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.5 p -56.14 -17.21 6.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.901 . . . . 0.0 109.426 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 51.32 70.03 2.2 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.57 -26.53 54.14 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.273 1.315 . . . . 0.0 112.292 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.47 -54.64 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 109.642 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.01 -35.52 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.489 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 131' ' ' ASN . 5.8 t -70.35 -66.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.585 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.87 -17.78 0.22 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.461 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -89.88 -28.45 19.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.578 -0.701 . . . . 0.0 109.31 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -71.46 -37.5 71.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 109.525 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.85 -46.11 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.518 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.5 tt -75.57 -31.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 108.864 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.03 85.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.632 HG21 ' HB1' ' D' ' 430' ' ' ALA . 63.0 mt -68.32 -52.97 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -1.048 . . . . 0.0 108.936 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -50.02 -35.01 23.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 108.904 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.94 -58.07 7.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.7 mt -55.35 -46.8 76.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.602 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.2 mt -55.27 -34.89 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.53 -57.4 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -50.38 -54.51 21.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.317 -0.864 . . . . 0.0 109.576 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.659 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.8 tt -58.93 -42.7 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.49 ' N ' HG23 ' A' ' 142' ' ' ILE . 6.3 mt -54.41 -31.06 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 0.0 109.043 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 148' ' ' PHE . 11.8 t70 -77.2 -34.92 56.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -29.87 67.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.576 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.04 -15.73 20.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.645 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.37 39.06 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.686 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.93 -24.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.44 -38.64 68.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.902 . . . . 0.0 109.368 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 p -69.46 -45.77 68.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 151' ' ' ILE . 1.7 mp -58.81 -47.66 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.457 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.29 -40.83 95.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -75.0 -30.18 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -57.65 -39.9 78.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.502 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -31.32 46.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.544 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -59.27 111.72 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.491 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -65.91 -63.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.35 136.1 1.93 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.92 115.68 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.2 mttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.438 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 37.1 m -74.57 2.59 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.412 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -155.78 68.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.392 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -55.57 161.75 1.91 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.849 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.21 -16.75 58.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.63 -21.16 48.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.403 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 224' ' ' ASP . 1.3 m-20 56.47 70.74 1.35 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 109.569 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -64.96 -28.27 58.03 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.453 1.435 . . . . 0.0 112.359 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.0 mp -50.42 -41.45 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.445 ' H ' HG23 ' B' ' 227' ' ' VAL . 2.7 t -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.23 -58.87 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.07 -39.61 13.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.101 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.65 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.69 -33.68 66.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.865 . . . . 0.0 109.163 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.44 -62.02 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.977 . . . . 0.0 109.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.447 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.2 tp -51.28 -38.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.718 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.447 ' N ' HG23 ' B' ' 232' ' ' ILE . 7.3 mt -54.03 -46.45 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 108.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.67 88.73 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.476 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -57.64 -52.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -1.148 . . . . 0.0 108.715 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.7 -38.32 72.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 109.551 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.825 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.49 -47.44 69.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.036 -1.04 . . . . 0.0 109.352 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.744 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.8 tp -67.16 -36.74 82.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.13 -40.11 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.99 -34.43 66.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.72 -55.19 36.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.6 tt -63.51 -35.5 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.778 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.465 ' C ' HD23 ' B' ' 243' ' ' LEU . 2.0 tt -67.5 -62.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -46.76 -50.85 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.605 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.1 OUTLIER -57.12 -35.41 69.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -48.41 66.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.64 127.99 3.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -84.72 -39.17 18.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -64.49 152.57 41.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.877 . . . . 0.0 109.481 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 41.5 m -161.23 -53.63 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.85 116.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.619 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' B' ' 253' ' ' ARG . 31.3 m-85 -84.94 -33.95 22.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' B' ' 252' ' ' TYR . 99.2 mtt180 -56.5 -166.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.93 164.69 33.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.415 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.407 ' O ' ' O ' ' B' ' 256' ' ' GLU . 88.2 m-85 -86.92 54.64 3.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.456 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 255' ' ' PHE . 34.9 mt-10 48.56 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.418 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.59 151.71 30.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -172.58 126.37 1.26 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.29 119.67 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -1.173 . . . . 0.0 109.433 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 15.7 pttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.506 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.46 33.36 6.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.359 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 49.0 53.68 12.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.32 153.19 19.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 5.0 t -173.86 10.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 2.5 p -56.24 -17.13 6.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 26.5 t0 51.36 70.03 2.2 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.736 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.64 -26.48 53.71 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.307 1.338 . . . . 0.0 112.246 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.58 -54.55 39.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 88.9 t -52.11 -35.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' C' ' 331' ' ' ASN . 6.3 t -70.08 -66.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.457 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.87 -17.84 0.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.45 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.18 -27.85 19.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 109.214 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.0 OUTLIER -71.45 -37.58 71.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.526 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.81 -46.28 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 tt -75.35 -31.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.115 -0.991 . . . . 0.0 108.978 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.11 -45.92 86.39 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.65 HG21 ' HB1' ' B' ' 230' ' ' ALA . 63.0 mt -68.32 -53.11 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.374 -1.074 . . . . 0.0 108.911 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.4 tp -49.78 -35.22 21.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.7 -58.2 7.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.7 mt -55.33 -46.68 76.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -0.819 . . . . 0.0 109.704 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.28 -35.06 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.56 -56.83 4.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -50.79 -54.3 24.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.68 HD12 ' ND1' ' B' ' 237' ' ' HIS . 3.9 tt -59.18 -42.53 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.09 -1.006 . . . . 0.0 109.436 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.483 ' N ' HG23 ' C' ' 342' ' ' ILE . 6.3 mt -54.49 -31.04 55.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' C' ' 348' ' ' PHE . 11.9 t70 -77.39 -34.75 54.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -29.87 67.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.58 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.05 -15.69 20.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -147.38 39.03 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.702 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.89 -24.75 1.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.393 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.4 -38.55 68.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.424 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 57.9 p -69.47 -45.79 68.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.539 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 351' ' ' ILE . . . . . 0.501 ' N ' HD12 ' C' ' 351' ' ' ILE . 1.7 mp -58.81 -47.76 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.2 -40.87 95.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -74.98 -30.14 61.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.71 -39.89 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -31.31 46.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -59.24 111.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -66.05 -63.6 1.05 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.501 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.98 1.91 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 115.73 28.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -1.169 . . . . 0.0 109.504 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 18.3 mttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.422 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 37.2 m -74.59 2.65 9.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -155.85 68.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.54 161.88 1.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -16.62 58.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.6 -21.16 48.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 424' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' D' ' 424' ' ' ASP . 1.4 m-20 56.36 70.78 1.35 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.595 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -65.07 -28.13 57.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.402 1.401 . . . . 0.0 112.352 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mp -50.4 -41.39 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.07 -35.98 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.629 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.22 -58.91 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.23 -39.55 14.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.632 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.61 -33.72 66.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.184 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.49 -61.98 1.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.417 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.442 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.2 tp -51.32 -38.57 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 108.688 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.442 ' N ' HG23 ' D' ' 432' ' ' ILE . 7.4 mt -53.95 -46.43 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.67 -46.73 88.71 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.471 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.7 mp -57.58 -52.97 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -1.136 . . . . 0.0 108.744 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.65 -38.45 72.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.827 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.35 -47.54 69.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.054 -1.029 . . . . 0.0 109.334 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.733 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.0 tp -67.05 -36.91 83.09 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.11 -39.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.855 -1.153 . . . . 0.0 107.925 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.13 -34.35 66.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -60.46 -55.32 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.638 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.62 -35.38 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 443' ' ' LEU . . . . . 0.459 ' C ' HD23 ' D' ' 443' ' ' LEU . 2.0 tt -67.5 -62.48 1.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.533 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -46.77 -50.86 17.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.1 OUTLIER -57.13 -35.29 69.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.469 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -48.48 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.49 128.03 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.65 -39.24 18.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.504 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -64.41 152.62 40.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 40.9 m -161.33 -53.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 60.5 mt -49.76 116.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 452' ' ' TYR . . . . . 0.412 ' O ' ' O ' ' D' ' 453' ' ' ARG . 31.3 m-85 -84.92 -34.02 22.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 453' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' D' ' 452' ' ' TYR . 99.2 mtt180 -56.45 -166.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.84 164.7 33.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.409 ' O ' ' O ' ' D' ' 456' ' ' GLU . 88.3 m-85 -86.88 54.69 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 456' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' D' ' 455' ' ' PHE . 35.0 mt-10 48.48 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.6 151.66 30.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -172.48 126.34 1.26 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.26 119.66 22.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -1.204 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 15.8 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.479 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.06 160.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.499 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -169.59 21.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.46 164.14 38.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.137 -0.977 . . . . 0.0 109.578 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -74.67 81.69 2.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.4 p -150.24 163.62 37.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.0 70.21 8.5 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.568 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.43 -27.67 54.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.322 1.348 . . . . 0.0 112.321 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.25 -51.99 67.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.0 t -52.52 -35.2 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.366 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.557 ' O ' ' ND2' ' A' ' 131' ' ' ASN . 10.8 t -65.23 -65.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.49 -17.99 0.36 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 108.611 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.497 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . -88.22 -27.4 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.361 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.557 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 2.0 p30 -74.91 -38.03 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.623 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 132' ' ' ILE . 4.1 mt -50.42 -44.95 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.414 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.0 tt -77.91 -35.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 109.025 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.86 -46.65 90.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' D' ' 430' ' ' ALA . 79.2 mt -67.23 -56.4 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -1.072 . . . . 0.0 109.177 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mt -49.93 -33.58 17.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.007 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.777 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.12 -52.71 61.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 109.122 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.784 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.9 mt -55.37 -38.06 68.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.736 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.5 mt -68.77 -29.7 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.65 -55.25 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 109.826 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.12 -43.39 61.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.77 HD13 ' NE2' ' D' ' 437' ' ' HIS . 4.0 tp -72.79 -44.39 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.033 -1.042 . . . . 0.0 109.697 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.561 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 mt -48.52 -35.5 13.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 109.218 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -76.56 -47.22 23.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -28.16 6.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -16.39 15.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.029 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -146.4 42.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.872 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' ASP . 20.2 p90 -50.46 -37.31 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -59.94 -30.37 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.561 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.1 m -77.28 -51.97 9.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.42 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 151' ' ' ILE . 1.7 mp -59.55 -39.53 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.419 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -64.12 -52.47 59.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -57.89 -39.87 78.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.448 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.82 -55.63 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.65 -22.48 65.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.329 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 59.49 -163.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.346 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 -22.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.07 167.27 36.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 159' ' ' LEU . 10.9 mp -69.32 128.8 37.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -1.114 . . . . 0.0 109.503 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 pttm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.501 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.76 -177.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.563 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.16 144.18 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.448 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.59 107.68 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 109.415 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 77.8 p -75.01 -46.38 35.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.47 21.94 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.52 161.56 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.237 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -54.34 -27.48 48.59 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.091 1.194 . . . . 0.0 112.369 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.84 -37.81 32.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.64 -35.89 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.57 -58.11 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 109.339 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.33 -37.27 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.946 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -73.11 -35.28 66.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.021 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.497 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -64.99 -62.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.481 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.0 tp -51.02 -40.22 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.05 -1.031 . . . . 0.0 108.585 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.481 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.1 mt -53.73 -42.31 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.12 -46.7 92.37 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.543 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -57.28 -39.12 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 0.0 108.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.31 -35.27 73.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.422 -0.799 . . . . 0.0 109.371 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.787 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.3 OUTLIER -55.07 -49.81 70.72 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.934 -1.104 . . . . 0.0 109.014 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 137' ' ' HIS . 12.0 tp -67.68 -36.6 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.66 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.74 -37.56 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.859 -1.151 . . . . 0.0 108.293 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.29 -40.62 62.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -53.74 -53.19 55.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.502 -0.749 . . . . 0.0 109.415 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 14.9 tt -67.39 -33.57 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.18 -59.51 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -52.54 -43.14 64.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -62.85 -30.96 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -61.0 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 3.3 t80 54.01 -174.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' B' ' 248' ' ' PHE . 0.1 OUTLIER -88.07 179.61 6.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.452 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -56.55 149.23 17.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.94 . . . . 0.0 109.438 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 48.2 t -56.61 -34.57 67.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.406 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 9.1 mm -81.33 114.93 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' B' ' 252' ' ' TYR . 0.3 OUTLIER -63.43 141.17 58.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.543 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.02 114.66 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -82.91 -102.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' B' ' 255' ' ' PHE . 48.1 t80 -148.94 -14.82 0.31 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.362 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.14 153.12 21.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.512 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.23 -43.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 157.84 98.46 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 7.9 mt -63.42 -37.76 88.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -1.142 . . . . 0.0 109.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 79.0 mttt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.482 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.23 160.9 0.71 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.363 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -169.57 21.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.502 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -153.43 164.12 38.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 2.5 p -74.61 81.68 2.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 58.2 p -150.19 163.71 37.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.11 70.17 8.41 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.42 -27.51 54.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.345 1.363 . . . . 0.0 112.302 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.41 -51.99 67.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.51 -35.4 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.3 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.559 ' O ' ' ND2' ' C' ' 331' ' ' ASN . 11.5 t -65.02 -65.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.873 . . . . 0.0 109.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.42 -18.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 108.718 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.486 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . -88.48 -26.8 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.532 -0.73 . . . . 0.0 109.275 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.559 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 2.0 p30 -75.09 -38.07 61.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.529 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.405 HG21 HD13 ' C' ' 332' ' ' ILE . 4.4 mt -50.43 -45.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 tt -77.7 -35.49 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.104 -0.998 . . . . 0.0 108.932 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.79 88.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.549 HG21 ' HB1' ' B' ' 230' ' ' ALA . 79.9 mt -67.06 -56.54 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.276 -1.132 . . . . 0.0 109.198 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 mt -49.84 -33.67 17.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 108.981 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.784 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.15 -52.6 61.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.135 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.777 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.9 mt -55.43 -37.98 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.773 . . . . 0.0 109.753 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 7.7 mt -68.88 -29.63 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.83 -54.66 5.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.819 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -51.55 -43.45 62.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.055 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.787 HD13 ' NE2' ' B' ' 237' ' ' HIS . 4.1 tp -72.62 -44.39 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.555 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.46 -35.65 13.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.014 -1.054 . . . . 0.0 109.21 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -76.57 -47.16 23.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -28.23 6.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.99 . . . . 0.0 109.565 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.94 -16.34 15.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.528 -0.733 . . . . 0.0 110.017 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -146.43 43.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 109.853 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' C' ' 344' ' ' ASP . 20.3 p90 -50.64 -37.24 39.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.431 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -60.0 -30.35 69.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.498 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 18.9 m -77.25 -52.0 9.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 351' ' ' ILE . . . . . 0.45 ' N ' HD12 ' C' ' 351' ' ' ILE . 1.7 mp -59.55 -39.5 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -64.17 -52.5 58.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.379 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -57.85 -39.85 78.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.492 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -55.52 11.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.61 -22.57 65.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.373 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 59.58 -163.82 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.9 -22.16 0.16 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.03 167.34 36.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 359' ' ' LEU . . . . . 0.44 HD12 ' N ' ' C' ' 359' ' ' LEU . 10.9 mp -69.43 128.83 37.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.459 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 pttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.492 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 54.72 -177.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.27 144.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.49 107.73 10.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.485 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 77.8 p -75.06 -46.29 35.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.47 21.87 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.49 161.56 1.07 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.29 -27.47 48.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.042 1.161 . . . . 0.0 112.49 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.87 -37.79 32.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 7.0 t -64.69 -35.87 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.69 -58.08 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.274 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.37 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.136 -0.978 . . . . 0.0 108.933 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -73.09 -35.21 66.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.058 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.486 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.8 OUTLIER -64.99 -62.74 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.468 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.0 tp -51.01 -40.26 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.21 -0.932 . . . . 0.0 108.573 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.468 ' N ' HG23 ' D' ' 432' ' ' ILE . 10.3 mt -53.6 -42.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.171 -0.955 . . . . 0.0 108.475 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.09 -46.82 92.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.533 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -57.13 -39.23 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.34 -35.19 73.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.459 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.77 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -55.06 -49.8 70.7 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.014 -1.054 . . . . 0.0 109.082 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.717 HD13 ' CE1' ' C' ' 337' ' ' HIS . 12.4 tp -67.62 -36.72 81.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.78 -1.168 . . . . 0.0 109.663 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.7 -37.62 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 108.211 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.2 -40.59 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -53.77 -53.03 57.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 109.481 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.6 -33.4 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.14 -59.65 4.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -52.47 -43.16 64.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -62.91 -30.86 71.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.53 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -60.95 2.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 3.3 t80 53.91 -174.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 448' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' D' ' 448' ' ' PHE . 0.1 OUTLIER -88.07 179.52 6.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -56.46 149.18 17.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 109.39 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 48.1 t -56.59 -34.46 67.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 8.9 mm -81.38 114.9 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 452' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' D' ' 452' ' ' TYR . 0.3 OUTLIER -63.48 141.26 58.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.451 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -162.05 114.77 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -83.09 -102.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' D' ' 455' ' ' PHE . 47.9 t80 -148.95 -14.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.32 153.08 21.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.15 -43.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.361 -0.837 . . . . 0.0 109.458 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 157.81 98.42 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 7.9 mt -63.43 -37.81 88.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.542 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.35 12.86 2.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -56.67 -38.28 72.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -148.12 140.39 24.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.11 157.35 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.3 t -148.92 -98.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 1.8 p30 -157.24 69.52 4.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.58 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.54 -27.23 53.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.396 1.397 . . . . 0.0 112.435 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.8 mt -72.74 -43.45 62.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.695 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.3 -56.04 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.148 -0.97 . . . . 0.0 109.547 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.5 m -58.91 -53.29 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.121 -0.987 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.669 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -55.63 -26.32 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.15 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.15 -17.45 34.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.356 -0.84 . . . . 0.0 109.376 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -40.11 28.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 109.585 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.52 -45.21 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.347 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.486 HG21 HD11 ' B' ' 235' ' ' ILE . 11.0 tt -76.73 -44.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.173 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -48.11 -45.19 26.86 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.506 HG21 ' HB1' ' D' ' 430' ' ' ALA . 95.6 mt -67.1 -55.66 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.01 -33.16 17.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.94 . . . . 0.0 108.929 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.925 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -62.33 -55.12 31.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.91 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.1 mt -55.06 -45.85 75.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.24 -35.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.39 -57.06 3.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.4 t-105 -48.9 -51.76 28.19 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.205 -0.935 . . . . 0.0 109.682 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.508 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.6 tt -65.26 -41.85 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 0.0 110.077 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -59.42 -30.69 68.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.04 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -37.77 59.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.18 73.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.32 -47.38 8.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.662 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -93.03 35.47 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.42 ' CE2' ' NH2' ' B' ' 245' ' ' ARG . 32.8 t80 -47.21 -26.73 1.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -69.19 -46.55 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.325 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -60.37 -44.77 95.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.0 -47.74 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -55.23 -43.71 74.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -64.86 -45.02 87.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.01 -46.68 78.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -30.86 70.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -69.14 135.64 51.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -160.84 93.07 0.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.16 101.41 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 159' ' ' LEU . 10.4 mp -67.12 -50.44 61.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -1.178 . . . . 0.0 109.367 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.353 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.7 t -160.65 -63.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.43 133.29 7.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -62.46 -52.63 62.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 59.5 p -84.17 152.27 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.438 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 22.4 t -60.6 -94.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -149.66 70.25 9.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.24 -33.61 38.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.402 1.401 . . . . 0.0 112.534 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -59.0 5.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.595 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.38 -35.08 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.62 -59.59 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.371 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.27 -37.48 10.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.526 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.45 -32.43 66.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.861 . . . . 0.0 109.233 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -58.51 4.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.71 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.82 -35.41 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.037 -1.039 . . . . 0.0 108.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.12 -44.17 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.75 -45.14 95.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.486 HD11 HG21 ' A' ' 133' ' ' ILE . 75.3 mt -60.56 -53.81 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.224 -1.163 . . . . 0.0 108.961 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.53 -35.41 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.299 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.821 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -56.06 -48.74 75.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.766 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.8 tp -64.48 -37.71 88.5 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.638 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.36 -38.98 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' B' ' 240' ' ' LEU . 52.3 tp -72.85 -32.7 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.31 -57.77 8.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.501 -0.75 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' ILE . . . . . 0.456 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.5 tt -62.11 -38.12 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.63 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.456 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.2 tp -69.3 -26.84 64.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.66 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.53 -43.15 23.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -64.42 -55.75 18.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.11 -43.43 98.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.596 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 3.2 t80 64.86 173.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -172.4 152.35 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.868 . . . . 0.0 109.469 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -173.55 8.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 46.3 p 49.32 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 4.3 tt -62.02 -24.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -51.41 130.95 28.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -74.8 -29.51 61.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' B' ' 255' ' ' PHE . 0.3 OUTLIER -67.45 163.54 20.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' B' ' 254' ' ' PHE . 2.1 t80 71.46 30.1 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.424 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -163.53 163.56 24.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' B' ' 257' ' ' HIS . 0.0 OUTLIER -85.29 -59.86 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.482 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.18 167.8 14.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 13.9 mt -78.59 161.49 26.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -1.104 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 43.3 tttt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.432 -179.907 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.328 0.585 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.31 12.88 2.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -56.72 -38.29 72.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.06 140.25 24.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.91 157.29 26.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 -98.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 324' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' C' ' 324' ' ' ASP . 1.8 p30 -157.21 69.39 4.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.47 -27.17 54.53 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.363 1.375 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 35.8 mt -72.83 -43.38 62.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.31 -56.1 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.641 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.3 m -58.8 -53.3 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.394 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.641 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -55.6 -26.39 43.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.28 -17.16 35.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.284 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 -40.24 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 mt -51.47 -45.29 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.327 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 333' ' ' ILE . . . . . 0.481 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -76.54 -44.6 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.249 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 334' ' ' GLY . . . . . 0.481 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -48.32 -44.98 28.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.526 HG21 ' HB1' ' B' ' 230' ' ' ALA . 95.6 mt -67.25 -55.58 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -1.115 . . . . 0.0 109.211 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.07 -33.07 17.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.91 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.4 -55.07 31.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 108.893 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.925 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.0 mt -55.14 -45.84 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.394 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.28 -35.5 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.41 -56.36 4.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.4 t-105 -49.44 -51.6 34.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -0.863 . . . . 0.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.509 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.5 tt -65.49 -41.85 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.847 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.4 tt -59.22 -30.9 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.036 -1.04 . . . . 0.0 109.2 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -37.66 59.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -32.14 73.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.35 -47.38 8.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.643 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -93.03 35.44 1.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.571 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.418 ' CE2' ' NH2' ' D' ' 445' ' ' ARG . 32.7 t80 -47.11 -26.71 1.17 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -69.4 -46.37 67.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 7.7 t -60.4 -44.72 95.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.37 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.01 -47.62 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 352' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 0.9 OUTLIER -55.39 -43.65 75.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.419 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -64.92 -44.99 87.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.0 -46.79 78.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -30.77 70.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -69.17 135.75 51.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.584 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -160.93 92.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -177.13 101.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 359' ' ' LEU . . . . . 0.484 HD12 ' N ' ' C' ' 359' ' ' LEU . 10.4 mp -67.07 -50.49 61.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -1.106 . . . . 0.0 109.433 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.401 179.872 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 31.1 t -160.61 -63.63 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.516 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.5 133.32 7.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -62.64 -52.4 63.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 59.3 p -84.26 152.14 24.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.498 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 21.7 t -60.54 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -149.7 70.07 9.49 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.22 -33.5 39.43 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.319 1.346 . . . . 0.0 112.608 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -58.95 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.602 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.32 -35.15 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.7 -59.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.417 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -37.35 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.214 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.53 -32.4 66.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -58.38 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.732 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.7 tp -56.97 -35.34 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 108.89 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.3 mt -57.04 -44.24 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 108.568 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.63 -45.26 94.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.469 HD11 HG21 ' C' ' 333' ' ' ILE . 75.2 mt -60.48 -53.75 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -1.146 . . . . 0.0 108.978 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.83 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -55.98 -48.85 75.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.742 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.0 tp -64.41 -37.8 88.8 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.637 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.3 -39.01 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.91 -32.6 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.26 -57.77 8.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.418 -0.801 . . . . 0.0 109.59 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 442' ' ' ILE . . . . . 0.449 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.6 tt -62.22 -38.0 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 443' ' ' LEU . . . . . 0.449 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.2 tp -69.23 -26.96 65.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -79.43 -43.26 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -64.41 -55.72 19.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.13 -43.52 98.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 3.3 t80 64.95 173.69 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.376 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -172.44 152.3 2.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 109.483 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -173.46 8.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 450' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' D' ' 450' ' ' SER . 45.7 p 49.35 92.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.92 -24.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.674 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -51.36 130.95 28.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -74.72 -29.65 61.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 454' ' ' PHE . . . . . 0.422 ' O ' ' CB ' ' D' ' 455' ' ' PHE . 0.3 OUTLIER -67.44 163.6 20.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' D' ' 454' ' ' PHE . 2.0 t80 71.5 29.93 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -163.34 163.64 25.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -59.96 2.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 149.15 167.77 14.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 14.0 mt -78.58 161.47 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.14 . . . . 0.0 109.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 43.4 tttt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.452 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -167.96 95.76 0.42 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.37 -55.8 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -157.94 -9.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t 48.37 31.49 2.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.3 t -74.96 -173.03 1.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 128' ' ' VAL . 5.3 m-20 -148.58 69.76 10.38 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.21 -29.61 55.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.289 1.326 . . . . 0.0 112.376 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.57 -44.96 48.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.42 -56.95 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.088 -1.008 . . . . 0.0 109.739 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 129' ' ' ALA . 33.2 m -57.83 -50.94 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.669 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -63.83 -14.05 49.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.806 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.93 -48.75 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.49 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER -80.22 -44.7 19.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 109.989 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.49 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mm -51.77 -42.55 32.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.533 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 134' ' ' GLY . 13.2 tt -76.12 -42.08 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.226 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -51.31 -45.92 52.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.699 HG21 ' HB1' ' D' ' 430' ' ' ALA . 76.0 mt -66.31 -57.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -1.11 . . . . 0.0 109.277 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.52 -34.33 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.154 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.927 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.2 -60.62 3.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.225 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.944 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.3 mt -50.9 -44.55 59.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -57.66 -32.9 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.59 -56.74 3.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.602 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.3 t-105 -48.44 -48.35 37.54 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.333 -0.854 . . . . 0.0 109.619 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.558 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.9 tt -68.69 -42.07 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.518 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -57.85 -31.88 67.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.107 . . . . 0.0 109.183 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.7 OUTLIER -73.5 -46.07 50.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.12 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.09 -23.26 65.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.109 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.04 -16.54 20.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.98 38.12 1.78 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.568 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 144' ' ' ASP . 7.2 t80 -52.29 -39.75 60.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -59.03 -29.38 67.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -76.62 -46.51 25.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 mm -56.4 -50.22 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 9.3 t80 -62.57 -42.49 99.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -61.7 -17.23 54.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -83.22 -68.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.535 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.73 -55.47 14.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.624 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 57.4 177.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -81.07 -15.3 56.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -91.75 90.78 1.55 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 159' ' ' LEU . 10.9 mp -80.05 -67.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.182 -1.187 . . . . 0.0 109.43 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.8 mttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.467 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.438 ' O ' ' N ' ' B' ' 221' ' ' ASP . 3.9 m 50.18 81.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.391 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -48.61 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 219' ' ' SER . 1.8 m-20 -78.49 133.4 37.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 3.6 t 50.45 87.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.907 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 42.0 p -83.2 40.35 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -152.17 69.59 7.54 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.597 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.75 -41.64 17.93 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.302 1.335 . . . . 0.0 112.48 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -47.5 73.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.82 -42.67 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.9 t -58.26 -56.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.316 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.23 21.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 108.947 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.743 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -69.39 -28.81 66.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.01 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.5 t-20 -68.48 -63.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.54 -36.49 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.116 -0.99 . . . . 0.0 108.425 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' B' ' 230' ' ' ALA . 22.5 mt -58.4 -42.55 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.58 84.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.577 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.1 -52.11 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.105 -1.232 . . . . 0.0 108.672 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.35 74.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.449 -0.782 . . . . 0.0 109.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.824 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -52.73 -46.78 67.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.075 -1.016 . . . . 0.0 109.449 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.732 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.7 tp -67.5 -37.63 83.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.764 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.8 mm -49.37 -39.86 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.817 -1.177 . . . . 0.0 108.028 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.97 -35.67 66.96 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.92 -57.28 13.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.573 -0.704 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' ILE . . . . . 0.402 HG23 ' N ' ' B' ' 243' ' ' LEU . 11.3 tt -60.05 -37.86 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.583 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.402 ' N ' HG23 ' B' ' 242' ' ' ILE . 1.0 OUTLIER -56.19 -58.96 5.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.488 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 244' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' B' ' 244' ' ' ASP . 4.5 m-20 -55.55 -51.06 68.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -49.73 -28.1 5.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.334 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.73 -59.37 2.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -92.11 125.13 36.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.2 131.29 45.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -51.78 -83.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.13 143.58 26.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.0 mm -83.62 118.18 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -65.34 156.93 30.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 49.81 86.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 254' ' ' PHE . 0.1 OUTLIER -76.56 -55.51 5.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.957 . . . . 0.0 109.434 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 1.4 t80 67.23 126.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.15 -62.24 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 171.5 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.47 110.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -1.129 . . . . 0.0 109.395 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 20.4 mttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.534 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 88.8 p -167.93 95.74 0.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -55.81 30.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -157.97 -9.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 22.8 t 48.42 31.44 2.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 32.1 t -74.89 -173.06 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.426 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 324' ' ' ASP . . . . . 0.409 ' O ' HG22 ' C' ' 328' ' ' VAL . 5.3 m-20 -148.54 69.69 10.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.709 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.25 -29.4 55.14 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.293 1.329 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.84 -44.85 46.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.598 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.62 -56.74 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.631 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.656 HG23 ' N ' ' C' ' 329' ' ' ALA . 33.1 m -57.99 -50.79 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.657 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.656 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -64.0 -13.86 49.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 109.809 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -93.18 -48.6 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.965 . . . . 0.0 110.198 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.484 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -80.18 -44.84 19.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 0.0 110.033 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.6 mm -51.72 -42.62 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.504 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 333' ' ' ILE . . . . . 0.493 HG23 ' N ' ' C' ' 334' ' ' GLY . 13.2 tt -75.99 -42.14 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 334' ' ' GLY . . . . . 0.493 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -51.32 -45.8 52.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.743 HG21 ' HB1' ' B' ' 230' ' ' ALA . 74.8 mt -66.33 -57.34 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -1.111 . . . . 0.0 109.227 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.42 -34.3 16.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.165 -0.96 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.944 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.18 -60.71 3.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.329 -0.857 . . . . 0.0 109.143 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.927 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.2 mt -50.84 -44.58 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.484 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.72 -32.85 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.66 -56.24 4.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.574 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.3 t-105 -49.02 -47.98 44.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.606 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.567 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.8 tt -69.05 -41.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.499 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tt -57.73 -32.04 67.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.7 OUTLIER -73.57 -45.92 50.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.183 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.06 -23.26 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.889 . . . . 0.0 109.15 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.01 -16.48 20.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.648 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.97 38.03 1.78 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 109.56 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 344' ' ' ASP . 7.1 t80 -52.26 -39.83 60.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.455 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -58.94 -29.41 67.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 6.3 t -76.63 -46.57 25.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 109.407 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 10.2 mm -56.3 -50.25 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 352' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 9.3 t80 -62.58 -42.55 99.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -61.65 -17.37 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -83.11 -69.08 0.66 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.67 -55.41 15.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.641 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 57.42 177.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -81.13 -15.41 55.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.515 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -91.68 90.75 1.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 359' ' ' LEU . . . . . 0.421 HD12 ' N ' ' C' ' 359' ' ' LEU . 10.9 mp -79.96 -67.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.507 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 20.9 mttt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.442 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 419' ' ' SER . . . . . 0.448 ' O ' ' N ' ' D' ' 421' ' ' ASP . 3.9 m 50.08 81.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -48.63 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 421' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' D' ' 419' ' ' SER . 1.8 m-20 -78.39 133.31 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 3.7 t 50.53 87.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.532 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 41.9 p -83.08 40.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.449 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -152.31 69.59 7.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.81 -41.57 17.84 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.308 1.339 . . . . 0.0 112.492 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.77 -47.41 73.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.78 -42.7 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.611 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 428' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.9 t -58.25 -56.61 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.87 -40.4 21.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 108.936 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -69.38 -28.7 66.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 109.029 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.5 t-20 -68.52 -63.81 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.5 -36.54 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' D' ' 430' ' ' ALA . 22.7 mt -58.4 -42.48 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.72 -47.54 84.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.571 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -56.18 -52.06 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.138 -1.213 . . . . 0.0 108.629 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.36 74.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.547 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.83 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -52.69 -46.81 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.095 -1.003 . . . . 0.0 109.402 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.725 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.8 tp -67.55 -37.53 82.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.78 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.2 mm -49.38 -39.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.857 -1.152 . . . . 0.0 108.045 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.99 -35.66 66.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.69 -57.39 13.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.679 . . . . 0.0 109.629 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.25 -37.73 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.12 -58.95 5.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 0.0 109.414 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 444' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' D' ' 444' ' ' ASP . 4.5 m-20 -55.71 -50.94 68.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -49.86 -27.98 5.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.296 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.68 -59.51 2.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.503 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -91.97 125.07 36.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.22 131.31 45.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.46 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -51.77 -83.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.02 143.58 26.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.476 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 9.9 mm -83.67 118.32 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -65.38 156.91 30.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 49.81 86.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 454' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' D' ' 454' ' ' PHE . 0.1 OUTLIER -76.57 -55.51 5.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 1.4 t80 67.31 127.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 171.42 0.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 154.32 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.51 110.52 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -1.106 . . . . 0.0 109.408 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 20.3 mttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.481 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.288 0.566 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -62.66 1.42 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.518 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -167.1 -172.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -162.88 -53.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.331 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 m 54.23 179.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.554 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.9 p -79.86 156.04 27.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -153.18 70.16 6.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.74 -28.51 51.74 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.328 1.352 . . . . 0.0 112.447 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.5 mt -72.64 -45.7 57.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.57 -57.39 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.678 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.7 m -57.78 -54.84 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.553 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.678 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.2 -23.18 13.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.126 -0.984 . . . . 0.0 109.226 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.05 -17.34 27.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.444 -0.785 . . . . 0.0 109.386 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -80.76 -42.68 21.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 109.641 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 131' ' ' ASN . 4.4 mt -50.12 -44.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.42 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 134' ' ' GLY . 11.1 tt -76.16 -47.24 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.227 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.525 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -47.75 -43.27 22.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.561 HG21 ' HB1' ' D' ' 430' ' ' ALA . 98.1 mt -68.18 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -1.186 . . . . 0.0 109.254 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.7 -31.96 5.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.924 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.17 -58.81 5.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.364 -0.835 . . . . 0.0 109.0 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.929 HD21 ' NE2' ' C' ' 337' ' ' HIS . 13.0 mt -48.98 -50.99 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 139' ' ' ILE . 1.7 mp -55.18 -33.47 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.59 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.63 -58.42 3.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.975 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -53.09 -46.03 68.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.29 -0.882 . . . . 0.0 109.996 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.487 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.0 OUTLIER -67.59 -42.44 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.816 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.483 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -55.63 -34.64 65.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.082 -1.012 . . . . 0.0 108.811 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 13.9 t70 -74.3 -35.12 63.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.512 -0.743 . . . . 0.0 109.222 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -32.61 72.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.2 -14.72 23.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.65 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -137.81 40.62 2.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 32.7 p90 -61.79 -37.91 86.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.984 . . . . 0.0 109.498 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.2 tttm -64.82 -20.98 66.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.925 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -82.8 -57.55 3.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.3 mt -64.0 -28.83 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.22 -51.8 9.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.489 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -64.19 -27.25 68.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -76.41 -63.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.44 -8.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.08 -37.32 64.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.405 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -65.6 -78.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 157.99 168.9 20.96 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.07 116.87 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -1.154 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 35.5 mttm . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.504 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.282 0.563 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 1.4 p -70.29 -18.61 63.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -73.35 88.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -59.43 -27.32 65.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' SER . . . . . 0.401 ' O ' ' O ' ' B' ' 223' ' ' SER . 0.6 OUTLIER -166.92 179.88 5.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 0.0 109.601 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 223' ' ' SER . . . . . 0.401 ' O ' ' O ' ' B' ' 222' ' ' SER . 4.3 p 60.92 153.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.14 70.2 6.92 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.669 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.78 -26.8 59.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.352 1.368 . . . . 0.0 112.519 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.02 -61.25 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.968 . . . . 0.0 109.575 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.437 ' H ' HG23 ' B' ' 227' ' ' VAL . 11.0 t -51.39 -40.52 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 109.432 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.25 -58.0 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.217 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.19 -36.26 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 108.977 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.5 -30.93 64.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.379 -0.826 . . . . 0.0 109.187 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -59.61 3.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.415 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.0 tp -55.44 -36.94 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 0.0 108.689 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.415 ' N ' HG23 ' B' ' 232' ' ' ILE . 12.7 mt -56.64 -42.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.255 -0.903 . . . . 0.0 108.679 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.35 95.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 133' ' ' ILE . 81.3 mt -59.71 -53.27 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 0.0 108.76 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.63 -37.0 70.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.373 -0.829 . . . . 0.0 109.22 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.838 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -54.2 -47.43 72.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.295 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.737 HD13 ' ND1' ' A' ' 137' ' ' HIS . 8.0 tp -67.11 -37.56 84.11 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.683 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 41.0 mm -49.36 -39.4 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.848 -1.157 . . . . 0.0 107.994 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -35.32 65.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -60.12 -57.93 10.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.514 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 9.5 tt -61.27 -35.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.2 -32.72 73.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.3 -36.76 69.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -72.55 -47.1 50.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' B' ' 248' ' ' PHE . 0.8 OUTLIER -62.19 -41.52 98.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 247' ' ' PHE . . . . . 0.465 ' CD2' ' N ' ' B' ' 248' ' ' PHE . 73.8 t80 49.55 -93.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' B' ' 246' ' ' LEU . 0.2 OUTLIER 60.61 -175.94 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.499 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -151.38 150.68 30.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 109.49 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 8.9 p -161.92 11.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.93 3.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.895 . . . . 0.0 109.533 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.85 113.53 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.538 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -170.45 81.92 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.0 OUTLIER -154.99 -37.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' B' ' 254' ' ' PHE . 38.9 t80 -91.13 -64.47 1.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.33 147.96 42.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 0.0 109.416 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 47.95 -150.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -164.16 -117.6 0.41 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.08 -52.6 62.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.135 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 27.0 mttm . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.424 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -167.14 -172.3 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -162.83 -53.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 8.6 m 54.28 179.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 13.1 p -79.89 156.05 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -153.25 70.19 6.85 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.608 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.68 -28.66 52.13 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.319 1.346 . . . . 0.0 112.48 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.59 -45.57 58.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.641 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 69.3 t -59.63 -57.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.671 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.7 m -57.7 -54.7 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.671 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.24 -23.31 14.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.263 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -90.06 -17.28 28.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' C' ' 332' ' ' ILE . 0.2 OUTLIER -80.61 -42.85 21.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.578 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' C' ' 331' ' ' ASN . 4.4 mt -50.02 -44.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.437 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 333' ' ' ILE . . . . . 0.531 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -76.04 -47.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 109.286 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 334' ' ' GLY . . . . . 0.531 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -47.95 -43.36 23.91 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.568 HG21 ' HB1' ' B' ' 230' ' ' ALA . 98.2 mt -68.19 -59.1 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -1.129 . . . . 0.0 109.27 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.84 -31.89 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 108.867 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.929 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.21 -58.62 6.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.924 HD21 ' NE2' ' A' ' 137' ' ' HIS . 13.1 mt -49.02 -51.06 33.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -0.877 . . . . 0.0 109.73 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 339' ' ' ILE . . . . . 0.457 HD12 ' N ' ' C' ' 339' ' ' ILE . 1.7 mp -55.11 -33.64 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -57.87 3.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 109.916 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -53.71 -45.82 70.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 110.01 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.481 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.0 OUTLIER -67.71 -42.25 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 109.665 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tt -55.8 -34.55 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.999 -1.063 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' C' ' 348' ' ' PHE . 13.7 t70 -74.54 -34.95 63.09 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.402 -0.811 . . . . 0.0 109.139 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -32.59 71.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.118 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.31 -14.57 23.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.877 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -138.0 40.76 2.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.413 -0.804 . . . . 0.0 109.647 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' C' ' 344' ' ' ASP . 32.3 p90 -61.93 -37.81 86.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -64.91 -20.86 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 -57.63 3.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 15.5 mt -63.98 -28.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.439 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -78.14 -51.99 9.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.883 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -63.95 -27.34 69.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.629 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -76.44 -63.91 1.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -58.5 -8.67 1.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.18 -37.25 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -65.64 -78.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.489 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 157.94 168.89 20.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.11 116.92 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.402 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 35.4 mttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.484 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 -18.71 63.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -73.31 88.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.55 -27.18 65.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 422' ' ' SER . . . . . 0.402 ' O ' ' O ' ' D' ' 423' ' ' SER . 0.6 OUTLIER -166.99 179.92 4.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 423' ' ' SER . . . . . 0.402 ' O ' ' O ' ' D' ' 422' ' ' SER . 4.3 p 60.91 153.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.12 70.17 6.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.721 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.87 -26.8 59.3 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.252 1.301 . . . . 0.0 112.46 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.04 -61.09 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.638 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.42 HG23 ' H ' ' D' ' 427' ' ' VAL . 11.3 t -51.55 -40.42 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 428' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.6 t -57.31 -57.99 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.26 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.1 -36.35 13.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 108.958 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.46 -30.96 65.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.1 OUTLIER -68.13 -59.6 3.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.656 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.409 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.0 tp -55.43 -36.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.973 -1.08 . . . . 0.0 108.667 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.409 ' N ' HG23 ' D' ' 432' ' ' ILE . 12.7 mt -56.68 -42.6 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.579 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.07 -45.35 95.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.455 HD11 HG21 ' C' ' 333' ' ' ILE . 81.8 mt -59.68 -53.19 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -1.116 . . . . 0.0 108.823 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.73 -36.93 70.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.228 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.845 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -54.21 -47.41 72.18 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.229 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.723 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.0 tp -67.1 -37.69 84.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.62 -1.232 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.8 mm -49.23 -39.59 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -35.19 65.69 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -59.97 -58.0 10.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.512 -0.743 . . . . 0.0 109.493 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 9.7 tt -61.41 -35.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 0.0 109.615 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.24 -32.65 73.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.31 -36.76 68.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -72.55 -47.14 50.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.468 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 446' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' D' ' 448' ' ' PHE . 0.8 OUTLIER -62.15 -41.65 98.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 447' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' D' ' 448' ' ' PHE . 74.0 t80 49.67 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.363 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 448' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' D' ' 446' ' ' LEU . 0.2 OUTLIER 60.64 -175.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -151.46 150.72 30.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.439 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 8.7 p -161.95 11.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.98 3.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.89 113.57 5.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -170.43 82.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.947 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 454' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' D' ' 455' ' ' PHE . 0.0 OUTLIER -155.08 -37.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.439 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' D' ' 454' ' ' PHE . 39.1 t80 -91.1 -64.53 1.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.31 147.95 42.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 47.94 -150.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.521 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -164.13 -117.65 0.42 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.0 -52.7 61.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -1.142 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 27.0 mttm . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.506 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.7 t -71.41 163.52 27.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.41 ' C ' ' N ' ' A' ' 122' ' ' SER . 54.0 m-20 -69.23 -26.43 64.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER 56.16 9.21 0.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 120' ' ' ASN . 34.2 t -70.35 5.62 1.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 121' ' ' ASP . 5.9 t -61.19 -172.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.4 70.93 0.97 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.75 -28.27 51.77 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.393 1.395 . . . . 0.0 112.501 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.0 mp -72.48 -46.17 56.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.78 -56.33 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.682 HG23 ' N ' ' A' ' 129' ' ' ALA . 35.5 m -58.92 -54.47 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.701 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.682 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.43 -23.44 15.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.61 -20.97 23.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -39.48 61.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.6 mt -52.86 -45.17 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.273 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.46 -26.87 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 0.0 109.018 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.85 -55.75 29.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 136' ' ' LEU . 4.1 tp -65.32 -48.17 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -1.085 . . . . 0.0 108.702 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 135' ' ' ILE . 2.2 tp -50.03 -40.04 43.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 108.59 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.913 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -60.11 -52.89 63.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.409 -0.807 . . . . 0.0 108.882 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.902 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.4 mt -56.84 -49.76 74.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.401 -0.812 . . . . 0.0 109.568 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.62 -33.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.336 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.64 -59.7 2.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -48.57 -53.3 18.86 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.65 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.4 tt -60.15 -43.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.506 ' N ' HG23 ' A' ' 142' ' ' ILE . 7.0 mt -54.8 -31.68 59.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.134 . . . . 0.0 108.952 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 17.8 t70 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.19 -33.49 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mp -93.48 -16.51 24.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.888 . . . . 0.0 109.707 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -147.4 39.72 1.0 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.63 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.52 -27.76 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -68.59 -44.04 75.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.138 -0.976 . . . . 0.0 109.404 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 m -62.81 -44.04 97.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.343 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.521 ' CG2' ' HE ' ' B' ' 245' ' ' ARG . 1.7 mp -59.25 -50.06 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.91 -40.96 95.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.475 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -69.54 -29.16 66.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -63.83 -61.24 2.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.78 -42.27 75.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.04 116.79 19.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.94 137.91 39.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.34 32.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.29 134.73 10.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -1.136 . . . . 0.0 109.343 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 mttt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.486 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.81 127.5 6.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.73 -62.54 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.426 ' CG ' ' N ' ' B' ' 222' ' ' SER . 18.9 t0 -79.19 -113.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' SER . . . . . 0.426 ' N ' ' CG ' ' B' ' 221' ' ' ASP . 0.7 OUTLIER 58.52 22.57 9.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 1.9 m -61.15 -89.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -151.38 70.92 8.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.2 -28.17 48.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.337 1.358 . . . . 0.0 112.374 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 226' ' ' LEU . 10.8 mp -63.44 -57.58 9.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -36.34 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.2 -0.937 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -57.38 -59.31 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.218 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.28 16.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.51 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -69.92 -29.75 66.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -0.823 . . . . 0.0 109.098 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' B' ' 228' ' ' VAL . 33.8 m-20 -67.74 -63.62 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 7.2 tp -50.34 -36.46 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 108.534 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' B' ' 230' ' ' ALA . 17.9 mt -57.85 -43.44 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.212 -0.93 . . . . 0.0 108.579 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.81 88.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.545 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.94 -50.85 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 108.707 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.35 -38.44 77.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.821 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.2 -46.69 69.14 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.957 -1.089 . . . . 0.0 109.278 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.764 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.8 tp -67.82 -36.87 81.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.746 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -49.62 -39.83 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.29 -38.08 68.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -57.21 -56.09 26.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.507 -0.746 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.47 -47.23 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.18 -15.4 63.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.955 . . . . 0.0 109.495 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -58.18 3.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.524 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -61.17 -31.78 71.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.631 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.47 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 8.4 t80 55.87 16.73 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 52.47 -174.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -149.16 132.82 16.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' SER . . . . . 0.435 ' OG ' ' CG ' ' B' ' 255' ' ' PHE . 0.3 OUTLIER 55.91 177.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.474 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.2 tt -168.64 -31.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -70.28 160.37 32.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -88.54 12.8 13.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -151.06 26.77 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' B' ' 256' ' ' GLU . 58.8 t80 -59.14 156.63 11.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' B' ' 255' ' ' PHE . 11.0 tt0 -168.94 131.81 1.32 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -69.82 155.42 40.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 164.07 96.99 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.0 110.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -1.097 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 86.4 mttt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.489 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.279 0.562 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 6.6 t -71.34 163.62 27.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.909 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 320' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' C' ' 322' ' ' SER . 54.5 m-20 -69.36 -26.49 64.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 321' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' C' ' 323' ' ' SER . 1.0 OUTLIER 56.29 9.09 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 322' ' ' SER . . . . . 0.404 ' H ' ' C ' ' C' ' 320' ' ' ASN . 33.8 t -70.23 5.57 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 323' ' ' SER . . . . . 0.4 ' H ' ' C ' ' C' ' 321' ' ' ASP . 5.9 t -61.22 -172.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.37 71.01 0.97 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.82 -28.28 51.19 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.386 1.391 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 10.0 mp -72.38 -46.18 56.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.738 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.8 -56.41 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 109.574 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.671 HG23 ' N ' ' C' ' 329' ' ' ALA . 35.6 m -58.81 -54.53 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.671 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.55 -23.42 16.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.321 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.68 -20.78 23.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.326 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -39.4 61.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.89 -45.2 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.225 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 12.6 tt -78.3 -27.16 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.79 -55.73 29.2 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.543 HG23 ' N ' ' C' ' 336' ' ' LEU . 4.1 tp -65.32 -48.02 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -1.106 . . . . 0.0 108.78 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 336' ' ' LEU . . . . . 0.543 ' N ' HG23 ' C' ' 335' ' ' ILE . 2.1 tp -50.11 -39.99 44.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.902 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -60.11 -52.83 63.69 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.913 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.3 mt -56.88 -49.92 74.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.795 . . . . 0.0 109.488 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 36.0 mt -52.49 -33.16 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -79.7 -59.01 2.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -49.13 -52.93 23.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.697 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.662 HD12 ' ND1' ' B' ' 237' ' ' HIS . 3.4 tt -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.5 ' N ' HG23 ' C' ' 342' ' ' ILE . 7.1 mt -54.81 -31.64 59.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.953 -1.092 . . . . 0.0 109.101 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' C' ' 348' ' ' PHE . 17.9 t70 -77.36 -32.63 55.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.514 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -72.24 -33.59 67.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.542 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.35 -16.68 24.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.659 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -147.39 39.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.581 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.64 -27.8 2.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 12.2 m -62.86 -43.99 97.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 351' ' ' ILE . . . . . 0.539 ' CG2' ' HE ' ' D' ' 445' ' ' ARG . 1.7 mp -59.25 -50.14 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.338 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.81 -41.0 94.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -69.61 -29.05 66.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.5 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.96 -61.08 2.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.04 -42.14 76.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.404 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.0 116.78 19.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.91 137.81 39.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -74.65 144.28 32.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.26 134.77 10.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.334 -1.098 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 12.1 mttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.93 127.42 6.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.65 -62.61 1.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -0.915 . . . . 0.0 109.462 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 421' ' ' ASP . . . . . 0.43 ' CG ' ' N ' ' D' ' 422' ' ' SER . 18.9 t0 -79.11 -113.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 422' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' D' ' 421' ' ' ASP . 0.7 OUTLIER 58.52 22.63 9.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -61.18 -89.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -151.38 70.83 8.32 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.674 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.13 -28.19 48.83 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.308 1.339 . . . . 0.0 112.442 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 426' ' ' LEU . . . . . 0.504 ' N ' HD12 ' D' ' 426' ' ' LEU . 10.8 mp -63.42 -57.59 9.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.93 -36.36 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.429 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 428' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -57.44 -59.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.942 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.35 16.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 108.59 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -69.85 -29.82 67.15 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.451 -0.78 . . . . 0.0 109.123 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' D' ' 428' ' ' VAL . 33.5 m-20 -67.65 -63.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 7.3 tp -50.47 -36.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.125 -0.985 . . . . 0.0 108.569 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' D' ' 430' ' ' ALA . 17.7 mt -57.8 -43.52 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.523 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.77 87.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.539 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -56.98 -50.77 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -1.175 . . . . 0.0 108.741 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.42 -38.43 77.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.392 -0.817 . . . . 0.0 109.499 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.815 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.2 -46.64 69.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.747 HD13 ' ND1' ' C' ' 337' ' ' HIS . 7.9 tp -67.78 -36.97 81.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.759 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 439' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' D' ' 439' ' ' ILE . 37.0 mm -49.61 -39.74 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.81 -1.181 . . . . 0.0 107.836 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.38 -37.9 68.62 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.4 t90 -57.31 -55.89 28.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.507 -0.746 . . . . 0.0 109.091 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.71 -47.25 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.93 -15.6 63.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -58.09 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -61.23 -31.78 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.47 -64.43 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 8.3 t80 55.8 16.67 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 52.46 -174.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -149.11 132.86 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 450' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' D' ' 455' ' ' PHE . 0.3 OUTLIER 55.81 177.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 16.2 tt -168.75 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -70.18 160.4 32.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -88.71 12.9 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -151.05 26.82 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.441 ' CG ' ' N ' ' D' ' 456' ' ' GLU . 58.7 t80 -59.18 156.62 11.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 456' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' D' ' 455' ' ' PHE . 11.0 tt0 -168.86 131.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -69.82 155.41 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 164.04 96.97 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.07 110.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.493 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.5 t -62.92 144.75 56.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 120' ' ' ASN . 4.1 p30 -152.27 58.67 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.11 -172.29 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.48 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -63.04 -75.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.52 126.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -159.53 70.31 3.28 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.96 -27.73 50.39 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.421 1.414 . . . . 0.0 112.559 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.82 -40.94 62.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.136 -0.977 . . . . 0.0 109.67 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.21 -55.06 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.658 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.0 m -60.73 -52.7 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.658 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -55.5 -25.09 35.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.261 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.23 -20.98 24.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -74.67 -43.07 57.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -50.74 -45.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 tt -73.0 -34.97 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.223 -0.923 . . . . 0.0 108.894 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -41.86 81.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' D' ' 430' ' ' ALA . 69.0 mt -69.59 -58.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.342 -1.093 . . . . 0.0 108.999 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.91 -33.62 11.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.925 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.842 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -64.12 -51.02 65.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.031 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.761 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.6 mt -59.45 -40.77 87.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.85 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.6 tt -82.81 -54.1 5.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 109.541 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -50.77 -43.7 58.49 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.281 -0.887 . . . . 0.0 109.737 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.0 tp -72.21 -46.68 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.604 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 mt -48.88 -32.51 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 109.062 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 148' ' ' PHE . 11.4 t70 -76.04 -54.27 7.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -50.56 -23.27 2.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.34 -17.57 16.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.812 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.01 42.36 1.21 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 144' ' ' ASP . 24.8 p90 -47.67 -28.73 2.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -69.15 -42.28 76.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -64.58 -49.56 70.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 151' ' ' ILE . 1.7 mp -55.97 -44.08 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.423 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -59.58 -45.6 91.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -0.905 . . . . 0.0 109.536 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -65.18 -42.58 93.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -59.6 5.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -30.9 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -82.21 28.73 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.61 113.9 3.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.52 98.89 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.38 125.71 33.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.5 mttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.467 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 4.3 t -161.21 -0.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -70.96 96.53 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.551 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.69 127.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 81.0 p -79.06 148.03 32.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.24 150.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -170.23 69.97 0.59 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.09 -25.87 58.23 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.333 1.355 . . . . 0.0 112.494 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.63 -47.99 28.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.416 ' H ' HG23 ' B' ' 227' ' ' VAL . 2.3 t -62.89 -38.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.96 -58.83 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.49 15.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.635 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -71.72 -32.45 67.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.297 -0.877 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -67.27 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.438 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.431 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -50.12 -37.69 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.123 -0.986 . . . . 0.0 108.519 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.431 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.0 mt -55.92 -43.81 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.182 -0.949 . . . . 0.0 108.497 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.11 -44.29 93.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.532 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -59.9 -41.39 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -1.204 . . . . 0.0 108.561 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' B' ' 239' ' ' ILE . 3.7 tt -68.04 -33.79 75.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.275 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.578 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -57.37 -48.06 80.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.019 -1.051 . . . . 0.0 109.163 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.842 HD13 ' CE1' ' A' ' 137' ' ' HIS . 9.4 tp -68.23 -35.55 78.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.65 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' B' ' 236' ' ' LEU . 16.9 mt -50.42 -41.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.643 -1.286 . . . . 0.0 108.227 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.36 -38.66 71.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -55.45 -54.51 42.87 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.27 -52.45 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.0 109.225 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.03 -41.62 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -62.66 -47.19 84.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.494 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.54 -37.97 82.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.28 -62.53 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 5.6 t80 60.07 107.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -65.44 161.54 19.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -167.23 -179.48 4.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 48.3 t -170.79 92.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.5 pt -80.84 150.05 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.413 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' TYR . . . . . 0.443 ' O ' ' CB ' ' B' ' 253' ' ' ARG . 0.2 OUTLIER -154.51 -46.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.52 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' B' ' 252' ' ' TYR . 9.9 ttt180 71.13 111.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.81 129.4 35.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' B' ' 256' ' ' GLU . 73.3 t80 -159.84 178.61 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.537 ' N ' ' CD2' ' B' ' 255' ' ' PHE . 15.5 tt0 -74.01 103.59 4.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -156.2 101.63 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 160.74 -175.13 37.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.29 127.9 36.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -1.18 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 4.3 t -62.96 144.7 56.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.173 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 320' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' C' ' 320' ' ' ASN . 4.1 p30 -152.17 58.61 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.19 -172.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 322' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' C' ' 323' ' ' SER . 6.9 m -63.05 -75.89 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.396 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 323' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' C' ' 322' ' ' SER . 1.0 OUTLIER 68.57 126.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -159.5 70.34 3.29 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.96 -27.59 50.5 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.36 1.373 . . . . 0.0 112.529 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.91 -40.96 62.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.23 -55.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.937 . . . . 0.0 109.549 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.642 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.0 m -60.72 -52.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.642 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -55.6 -25.24 37.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.12 -0.987 . . . . 0.0 109.216 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -88.33 -20.59 25.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 0.3 OUTLIER -74.75 -43.07 56.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.3 mt -50.65 -46.02 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.9 tt -72.74 -35.09 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.196 -0.94 . . . . 0.0 108.951 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.88 81.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.635 HG21 ' HB1' ' B' ' 230' ' ' ALA . 68.4 mt -69.59 -58.37 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 109.062 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.89 -33.63 11.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.94 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.835 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -64.12 -50.97 66.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.433 -0.792 . . . . 0.0 109.034 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.783 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.5 mt -59.58 -40.69 88.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.523 -0.736 . . . . 0.0 109.609 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.582 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.79 -53.44 5.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 109.581 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -51.34 -43.43 61.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.917 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.61 HG23 ' N ' ' C' ' 343' ' ' LEU . 9.9 tp -72.43 -46.52 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.61 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.74 -32.7 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.139 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' C' ' 348' ' ' PHE . 11.5 t70 -76.19 -54.17 7.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.378 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -50.48 -23.18 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.398 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.48 -17.53 16.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.0 42.43 1.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 109.719 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' C' ' 344' ' ' ASP . 24.4 p90 -47.8 -28.68 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -69.18 -42.3 76.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 16.8 t -64.41 -49.83 70.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 351' ' ' ILE . . . . . 0.491 ' N ' HD12 ' C' ' 351' ' ' ILE . 1.7 mp -55.81 -44.06 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.66 -45.6 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -65.13 -42.6 93.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -59.58 5.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.59 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -30.93 29.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -82.26 28.84 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.65 113.92 3.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.521 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 176.48 98.9 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 18.6 mt -85.43 125.81 33.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.137 . . . . 0.0 109.429 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 17.5 mttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.438 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 4.2 t -161.2 -0.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.596 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -71.04 96.55 1.33 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.76 127.14 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 81.1 p -79.21 147.96 32.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.399 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.32 150.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -170.28 70.02 0.58 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.22 -25.81 57.29 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.338 1.359 . . . . 0.0 112.414 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.57 -48.04 28.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.405 ' H ' HG23 ' D' ' 427' ' ' VAL . 2.3 t -62.85 -38.65 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.9 -58.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -39.44 15.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.09 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -71.77 -32.38 67.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.229 -0.919 . . . . 0.0 109.175 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -63.45 1.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.421 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.7 tp -50.13 -37.63 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.132 -0.98 . . . . 0.0 108.525 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.421 ' N ' HG23 ' D' ' 432' ' ' ILE . 9.9 mt -56.1 -43.66 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.14 -0.975 . . . . 0.0 108.467 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.33 93.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.532 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -59.87 -41.49 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.111 -1.229 . . . . 0.0 108.54 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 436' ' ' LEU . . . . . 0.554 ' HA ' HD12 ' D' ' 439' ' ' ILE . 3.7 tt -67.95 -33.81 75.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.426 -0.796 . . . . 0.0 109.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.585 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -57.4 -48.15 79.85 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.027 -1.045 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.835 HD13 ' CE1' ' C' ' 337' ' ' HIS . 9.7 tp -68.05 -35.8 78.82 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.618 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 439' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' D' ' 436' ' ' LEU . 17.0 mt -50.45 -41.69 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.725 -1.234 . . . . 0.0 108.21 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.41 -38.55 71.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -55.35 -54.59 41.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.43 -0.794 . . . . 0.0 109.073 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.32 -52.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.328 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -41.73 17.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -62.68 -47.2 84.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.55 -37.98 83.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.23 -62.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 5.6 t80 60.17 107.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -65.46 161.55 19.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -167.22 -179.49 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 48.3 t -170.79 92.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.5 pt -80.7 150.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 452' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' D' ' 453' ' ' ARG . 0.2 OUTLIER -154.54 -46.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 453' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' D' ' 452' ' ' TYR . 9.9 ttt180 71.08 111.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.537 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 129.42 35.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.402 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' D' ' 456' ' ' GLU . 73.4 t80 -159.85 178.69 9.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 456' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' D' ' 455' ' ' PHE . 15.6 tt0 -74.05 103.65 4.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -156.28 101.63 2.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 160.77 -175.09 37.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 127.9 36.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.142 . . . . 0.0 109.526 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.46 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 t -157.86 169.78 23.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 50.83 -147.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -156.5 -41.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.411 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.8 t -158.29 -50.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.9 p -166.49 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -148.72 70.74 10.46 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.26 -27.87 55.8 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.355 1.37 . . . . 0.0 112.361 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.13 -55.13 30.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' C' ' 328' ' ' VAL . 90.5 t -52.68 -35.77 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.464 ' HA ' HG11 ' C' ' 327' ' ' VAL . 8.9 t -66.05 -67.59 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.67 -17.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.525 ' HB1' ' ND2' ' B' ' 231' ' ' ASN . . . -87.53 -27.03 22.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.585 -0.697 . . . . 0.0 109.271 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.577 ' ND2' HD11 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -76.03 -39.79 54.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.457 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.475 ' N ' ' OD1' ' A' ' 131' ' ' ASN . 7.2 mt -53.55 -44.3 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 109.378 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.424 HD13 HG13 ' B' ' 235' ' ' ILE . 8.1 tt -74.64 -36.41 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.59 91.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.577 HD11 ' ND2' ' A' ' 131' ' ' ASN . 17.5 mt -70.05 -60.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.344 -1.092 . . . . 0.0 109.136 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.98 -24.96 7.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.267 -0.896 . . . . 0.0 108.899 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.646 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -67.86 -55.51 12.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.159 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.559 HD22 ' ND1' ' D' ' 437' ' ' HIS . 2.4 mt -55.33 -48.27 74.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mt -58.41 -30.96 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 HD21 ' B' ' 238' ' ' LEU . 3.7 tt -75.96 -46.28 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.377 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CZ3' ' C' ' 341' ' ' TRP . 1.0 OUTLIER -50.65 -47.09 58.66 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 110.032 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 143' ' ' LEU . 9.5 tt -71.16 -42.91 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.04 -1.037 . . . . 0.0 109.908 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' N ' HG23 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -48.83 -36.74 17.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.63 -53.05 9.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.83 . . . . 0.0 109.592 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 66.9 ttt180 -50.48 -23.14 2.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.57 -17.42 15.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.724 . . . . 0.0 109.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -148.91 41.85 0.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 144' ' ' ASP . 50.9 p90 -47.29 -25.57 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -71.36 -38.69 71.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.428 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.6 t -70.18 -49.38 50.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 109.368 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 151' ' ' ILE . 1.7 mp -59.75 -32.0 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -74.3 -54.69 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.41 ' O ' ' O ' ' A' ' 156' ' ' GLU . 65.1 mtm180 -61.43 -32.3 72.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -56.53 -53.61 55.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -63.2 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.481 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 153' ' ' ARG . 88.2 tt0 -65.04 123.67 20.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.454 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.49 -50.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -151.36 -146.15 4.28 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.13 -36.98 66.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 109.467 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.443 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.606 HH11 ' CG ' ' B' ' 218' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.13 -178.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ASN . . . . . 0.432 ' N ' ' OD1' ' B' ' 220' ' ' ASN . 3.1 p30 -60.89 -21.91 63.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.55 161.94 7.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 5.8 m -88.08 66.06 8.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 23.2 p -152.89 152.89 32.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -163.52 70.82 1.84 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.69 -25.59 61.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.31 1.34 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.38 -41.62 39.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.595 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.499 HG12 HD22 ' C' ' 331' ' ' ASN . 13.8 t -61.05 -42.97 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.564 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.6 t -57.91 -58.63 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.431 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.74 -37.43 13.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.22 -31.2 67.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.137 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.525 ' ND2' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -67.71 -64.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.405 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.1 tp -50.41 -36.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.127 -0.983 . . . . 0.0 108.565 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.405 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.8 mt -55.78 -45.12 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.28 -46.53 86.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.543 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.44 -40.43 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.313 . . . . 0.0 108.533 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -35.44 75.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.461 -0.774 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.608 ' HD1' ' C ' ' B' ' 237' ' ' HIS . 3.1 t-80 -54.07 -52.07 62.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.064 -1.022 . . . . 0.0 109.164 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.646 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.0 tp -69.85 -32.37 70.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.888 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.09 -38.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.516 -1.365 . . . . 0.0 107.864 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.85 62.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -50.5 -52.63 36.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.425 -0.797 . . . . 0.0 109.433 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.8 tt -68.0 -33.7 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.43 ' O ' HD23 ' B' ' 243' ' ' LEU . 1.6 tt -58.4 -58.3 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -58.9 -42.08 88.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -20.77 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.32 -52.59 7.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.947 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' PHE . . . . . 0.477 ' C ' ' H ' ' B' ' 249' ' ' LYS . 2.3 m-85 -58.3 -55.07 39.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.52 -4.12 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 249' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' B' ' 247' ' ' PHE . 40.3 mttp -81.32 133.07 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 250' ' ' SER . . . . . 0.4 ' C ' ' H ' ' B' ' 252' ' ' TYR . 11.5 t -167.96 71.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.8 pt -78.9 21.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' B' ' 250' ' ' SER . 61.1 t80 -74.09 -0.85 17.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -82.87 32.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -148.29 -117.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.1 OUTLIER -66.43 120.52 13.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.01 -57.76 7.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 11.9 t60 48.75 -145.53 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.426 ' C ' ' N ' ' B' ' 260' ' ' LYS . . . 79.74 1.17 86.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.2 mt 51.08 14.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.413 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' LYS . . . . . 0.426 ' N ' ' C ' ' B' ' 258' ' ' GLY . 25.2 ttpt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.491 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 2.9 t -157.89 169.84 23.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 50.81 -147.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -156.44 -41.26 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 42.9 t -158.26 -50.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.419 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 57.9 p -166.49 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -148.76 70.73 10.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.21 -27.89 56.23 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.373 1.382 . . . . 0.0 112.39 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.12 -55.21 29.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 327' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 128' ' ' VAL . 93.1 t -52.62 -35.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.478 ' HA ' HG11 ' A' ' 127' ' ' VAL . 9.9 t -65.9 -67.79 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 109.481 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -50.65 -17.3 0.5 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 108.764 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.511 ' HB1' ' ND2' ' D' ' 431' ' ' ASN . . . -87.8 -26.41 22.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.279 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.584 ' ND2' HD11 ' C' ' 335' ' ' ILE . 0.1 OUTLIER -76.16 -39.83 54.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.475 ' N ' ' OD1' ' C' ' 331' ' ' ASN . 7.3 mt -53.56 -44.37 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 333' ' ' ILE . . . . . 0.43 HD13 HG13 ' D' ' 435' ' ' ILE . 8.3 tt -74.61 -36.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.42 91.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.584 HD11 ' ND2' ' C' ' 331' ' ' ASN . 17.5 mt -70.07 -60.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.119 . . . . 0.0 109.103 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.0 -24.84 7.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 108.844 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -68.07 -55.33 12.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.358 -0.839 . . . . 0.0 109.149 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.569 HD22 ' ND1' ' B' ' 237' ' ' HIS . 2.4 mt -55.35 -48.37 74.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.38 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 24.2 mt -58.44 -31.0 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -76.16 -45.45 33.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CZ3' ' CH2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -51.42 -46.72 63.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.436 -0.79 . . . . 0.0 110.063 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.46 HG23 ' N ' ' C' ' 343' ' ' LEU . 9.8 tt -71.42 -42.77 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 0.0 109.946 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.46 ' N ' HG23 ' C' ' 342' ' ' ILE . 0.5 OUTLIER -48.81 -36.7 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.192 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.92 -52.89 9.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 345' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' C' ' 344' ' ' ASP . 67.0 ttt180 -50.4 -23.13 2.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 109.494 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.66 -17.36 15.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 109.858 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -148.9 41.93 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 344' ' ' ASP . 51.2 p90 -47.42 -25.55 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.324 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -71.39 -38.64 71.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 10.7 t -70.15 -49.44 50.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 351' ' ' ILE . . . . . 0.501 ' N ' HD12 ' C' ' 351' ' ' ILE . 1.7 mp -59.83 -31.86 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.354 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -74.26 -54.69 7.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.455 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 353' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' C' ' 356' ' ' GLU . 64.9 mtm180 -61.42 -32.27 72.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -56.56 -53.61 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -63.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 356' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' C' ' 353' ' ' ARG . 88.1 tt0 -64.96 123.64 19.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.47 -50.13 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.945 . . . . 0.0 109.55 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -151.38 -146.09 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.17 -37.09 66.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 418' ' ' ARG . . . . . 0.613 HH11 ' CG ' ' D' ' 418' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.04 -178.08 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.551 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 420' ' ' ASN . . . . . 0.44 ' N ' ' OD1' ' D' ' 420' ' ' ASN . 3.1 p30 -60.91 -21.88 63.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.51 162.0 7.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 5.6 m -88.04 66.09 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.317 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 23.5 p -152.89 152.9 32.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.94 . . . . 0.0 109.553 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -163.48 70.74 1.84 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -64.68 -25.61 61.45 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.417 1.411 . . . . 0.0 112.453 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -41.6 39.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.494 HG12 HD22 ' A' ' 131' ' ' ASN . 14.3 t -61.16 -42.82 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.569 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 428' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.6 t -58.09 -58.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.89 -37.32 13.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.21 67.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 109.059 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.511 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -67.71 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.411 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.1 tp -50.42 -36.79 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 108.552 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.411 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.6 mt -55.85 -44.99 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 108.325 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.48 86.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.544 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -56.41 -40.41 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.058 -1.26 . . . . 0.0 108.577 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -35.49 75.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.353 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.613 ' C ' ' HD1' ' D' ' 437' ' ' HIS . 3.0 t-80 -53.96 -52.07 61.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.099 -1.0 . . . . 0.0 109.185 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.633 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.3 tp -69.77 -32.43 70.92 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.976 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.14 -38.21 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.514 -1.366 . . . . 0.0 107.858 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.83 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.5 t90 -50.4 -52.57 36.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 109.487 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.9 tt -68.3 -33.43 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 443' ' ' LEU . . . . . 0.44 ' O ' HD23 ' D' ' 443' ' ' LEU . 1.6 tt -58.46 -58.28 9.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -58.84 -42.19 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.558 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -63.19 -20.75 65.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.528 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.28 -52.67 7.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 447' ' ' PHE . . . . . 0.467 ' C ' ' H ' ' D' ' 449' ' ' LYS . 2.3 m-85 -58.31 -55.07 39.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.548 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.57 -4.22 0.6 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.472 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 449' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' D' ' 447' ' ' PHE . 40.3 mttp -81.24 133.07 35.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.598 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 11.5 t -168.04 71.77 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.8 pt -78.92 21.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.386 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -74.09 -0.79 17.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.885 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -82.76 32.11 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.439 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -148.26 -117.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' D' ' 455' ' ' PHE . 0.1 OUTLIER -66.43 120.46 13.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.96 -57.82 7.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 11.8 t60 48.76 -145.66 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 458' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' D' ' 460' ' ' LYS . . . 79.76 1.15 86.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.1 mt 51.1 14.06 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 460' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' D' ' 458' ' ' GLY . 25.3 ttpt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.46 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' ASN . 62.9 ttt180 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.256 0.551 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -62.32 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 p30 -66.01 -173.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.1 128.32 2.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 123' ' ' SER . 1.6 t -164.38 118.86 1.43 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 122' ' ' SER . 1.1 p 70.22 27.61 4.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 128' ' ' VAL . 28.6 m-20 48.54 71.06 1.72 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.6 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -68.17 -23.52 39.31 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.363 1.375 . . . . 0.0 112.52 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 126' ' ' LEU . 11.1 mp -77.38 -56.15 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.478 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 128' ' ' VAL . 4.2 p -55.9 -42.75 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.67 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.5 m -71.59 -54.36 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.055 . . . . 0.0 109.636 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.67 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.3 -23.8 16.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.954 . . . . 0.0 109.18 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.56 -21.0 21.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 0.0 109.427 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.521 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -72.92 -42.19 63.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.597 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.463 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -51.06 -46.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.504 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 tt -72.17 -34.15 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 108.768 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.69 -41.93 83.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.647 HG21 ' HB1' ' D' ' 430' ' ' ALA . 68.0 mt -68.37 -57.1 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.45 -1.029 . . . . 0.0 109.054 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -39.52 43.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 108.694 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.847 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -55.65 -55.37 32.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.816 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.3 mt -58.24 -53.54 57.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 81.8 mt -52.92 -29.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.47 -57.6 3.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.589 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.4 OUTLIER -50.01 -54.69 18.45 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -58.39 -44.93 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.557 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 mt -48.64 -36.27 15.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.0 -1.062 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.5 -37.04 60.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -0.872 . . . . 0.0 109.604 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -64.37 -28.67 69.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.22 -14.18 18.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.799 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -146.84 40.17 1.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 0.0 109.779 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 144' ' ' ASP . 19.7 p90 -47.42 -22.15 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.19 -0.944 . . . . 0.0 109.403 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -75.88 -46.96 27.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.486 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -60.49 -48.11 83.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.1 mm -64.82 -35.68 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 109.386 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -49.4 74.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -72.62 -22.7 60.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.354 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.76 -46.39 85.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 0.0 109.334 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.45 -43.05 91.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.314 -0.866 . . . . 0.0 109.422 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -80.6 117.41 21.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.484 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -65.33 -96.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -151.93 158.96 28.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.31 146.79 50.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -1.143 . . . . 0.0 109.517 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.4 mttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.498 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.63 -24.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.397 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 21.2 t30 59.83 159.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -38.62 70.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.449 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.67 30.1 6.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.85 165.38 35.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' B' ' 224' ' ' ASP . 12.2 p-10 -161.64 69.83 2.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.32 -28.35 63.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.292 1.328 . . . . 0.0 112.36 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.81 -53.91 28.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.539 ' CG1' HD21 ' C' ' 331' ' ' ASN . 21.3 t -56.9 -43.64 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' B' ' 231' ' ' ASN . 9.0 t -57.3 -55.36 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.82 23.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.228 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -67.69 -26.26 66.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.208 -0.932 . . . . 0.0 109.16 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.5 t-20 -69.97 -65.73 0.68 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.0 tp -50.31 -36.17 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.736 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' B' ' 230' ' ' ALA . 28.6 mt -57.95 -44.04 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.95 -43.17 95.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.484 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.8 -44.03 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -1.221 . . . . 0.0 108.739 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' B' ' 239' ' ' ILE . 6.0 mp -66.06 -36.03 82.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.812 ' ND1' HD22 ' C' ' 338' ' ' LEU . 1.8 t-80 -55.87 -48.27 75.85 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.847 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.5 tp -67.93 -36.06 79.49 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.767 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 239' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' B' ' 236' ' ' LEU . 10.6 mt -50.11 -40.48 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.183 . . . . 0.0 108.006 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.06 -39.21 69.19 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -55.51 -55.75 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.469 -0.77 . . . . 0.0 109.047 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.9 mt -55.49 -48.7 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.75 -50.42 66.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.452 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -48.99 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -53.55 -44.15 69.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -62.9 1.45 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 0.0 109.438 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -67.04 -167.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.582 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.15 -23.3 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -168.32 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.07 -178.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 2.8 tt -163.71 150.41 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -72.0 -143.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.338 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -164.03 -19.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.92 -4.12 8.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.76 80.12 7.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -86.03 128.78 34.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -159.46 20.49 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -83.7 101.79 2.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.64 -25.08 18.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 45.1 tttt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.445 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' C' ' 320' ' ' ASN . 63.3 ttt180 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 89.4 p -62.31 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 320' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' C' ' 318' ' ' ARG . 6.0 p30 -66.1 -172.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.9 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.14 128.36 2.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.465 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 322' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' C' ' 323' ' ' SER . 1.7 t -164.39 118.83 1.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 323' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' C' ' 322' ' ' SER . 1.1 p 70.24 27.58 4.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.522 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 324' ' ' ASP . . . . . 0.547 ' O ' HG22 ' C' ' 328' ' ' VAL . 28.7 m-20 48.5 71.04 1.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.866 . . . . 0.0 109.657 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -68.2 -23.33 39.36 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.406 1.404 . . . . 0.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 326' ' ' LEU . . . . . 0.498 HD12 ' N ' ' C' ' 326' ' ' LEU . 11.1 mp -77.55 -56.15 4.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.423 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 327' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' C' ' 328' ' ' VAL . 4.2 p -55.88 -42.83 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 0.0 110.261 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.664 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.6 m -71.59 -54.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.594 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.664 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.33 -23.94 17.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -91.54 -20.71 21.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.428 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.539 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.09 -42.37 63.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.1 mt -50.77 -46.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.8 tt -71.97 -34.24 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.092 -1.005 . . . . 0.0 108.815 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.9 83.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.691 HG21 ' HB1' ' B' ' 230' ' ' ALA . 67.5 mt -68.41 -57.13 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.343 -1.092 . . . . 0.0 109.071 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.02 -39.72 42.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 108.691 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.825 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -55.41 -55.5 30.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 109.044 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.822 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.3 mt -58.24 -53.57 56.74 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.537 -0.727 . . . . 0.0 109.735 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 82.3 mt -52.92 -29.93 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.57 -56.92 4.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -50.66 -54.67 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 109.738 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.572 HG23 ' N ' ' C' ' 343' ' ' LEU . 0.8 OUTLIER -58.33 -44.87 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.245 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.572 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.49 -36.5 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 0.0 109.197 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.6 -36.85 60.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.527 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -64.39 -28.62 69.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.26 -14.24 18.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.786 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -146.86 40.36 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.73 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' C' ' 344' ' ' ASP . 19.5 p90 -47.54 -22.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -75.78 -47.05 27.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.534 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -48.06 83.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 11.0 mm -64.83 -35.65 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.372 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 352' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 1.0 OUTLIER -63.02 -49.26 75.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.441 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -72.7 -22.73 60.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.68 -46.47 85.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 109.289 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.42 -43.18 91.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -80.51 117.38 21.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -65.29 -96.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -152.07 158.99 28.11 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 6.8 mt -70.36 146.84 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -1.131 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 39.3 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.39 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 -24.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 21.1 t30 59.93 159.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -38.6 70.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.63 30.1 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.9 165.42 35.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 424' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' D' ' 424' ' ' ASP . 12.2 p-10 -161.68 69.8 2.39 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.32 -28.3 63.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.294 1.329 . . . . 0.0 112.4 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.67 -54.01 26.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 131' ' ' ASN . 21.4 t -56.89 -43.75 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.616 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 428' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' D' ' 431' ' ' ASN . 9.5 t -57.27 -55.34 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.78 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -67.92 -25.97 65.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.238 -0.914 . . . . 0.0 109.157 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.6 t-20 -70.06 -65.79 0.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' D' ' 432' ' ' ILE . 8.0 tp -50.22 -36.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' D' ' 430' ' ' ALA . 28.4 mt -58.04 -43.91 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 108.468 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.06 -43.08 95.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.482 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -58.82 -44.1 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -1.234 . . . . 0.0 108.626 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 436' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' D' ' 439' ' ' ILE . 6.0 mp -66.14 -35.88 81.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.217 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.798 ' ND1' HD22 ' A' ' 138' ' ' LEU . 1.8 t-80 -56.06 -48.18 76.53 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.98 -1.075 . . . . 0.0 109.439 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.825 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.7 tp -67.83 -36.25 80.03 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.81 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 439' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' D' ' 436' ' ' LEU . 10.5 mt -50.02 -40.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 108.059 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.01 -39.14 69.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -55.52 -55.66 29.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.086 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.8 mt -55.79 -48.52 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.43 -0.794 . . . . 0.0 109.146 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.69 -50.54 65.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -48.91 69.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -53.62 -44.15 69.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -62.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.14 -167.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -147.12 -23.21 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.51 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 449' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' D' ' 450' ' ' SER . 74.7 tttt -168.34 -23.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 450' ' ' SER . . . . . 0.402 ' O ' ' O ' ' D' ' 449' ' ' LYS . 0.2 OUTLIER 51.04 -178.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.348 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 2.8 tt -163.71 150.46 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -72.08 -143.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -164.02 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.89 -4.01 8.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.69 80.03 7.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -86.06 128.82 34.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -159.49 20.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -83.63 101.8 2.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.6 -25.06 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 44.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.1 m -78.9 17.05 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 120' ' ' ASN . 15.0 p-10 -82.98 34.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.99 170.2 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.45 -8.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -60.43 -98.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -152.72 70.09 7.21 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.87 -28.16 58.8 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.273 1.315 . . . . 0.0 112.382 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 126' ' ' LEU . 10.8 mp -54.89 -50.17 69.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.36 -36.97 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 131' ' ' ASN . 61.1 t -69.53 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.91 -19.74 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.932 . . . . 0.0 108.674 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.21 -27.08 19.76 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -69.07 -38.81 79.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.481 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.508 ' N ' ' ND2' ' A' ' 131' ' ' ASN . 2.7 mt -47.46 -47.89 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 109.31 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.8 tt -77.75 -27.08 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -0.922 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.09 -55.12 32.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 mm -65.24 -48.67 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.023 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.5 -38.69 60.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.982 . . . . 0.0 108.735 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.795 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -59.59 -52.35 65.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.025 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.803 HD21 ' CE1' ' C' ' 337' ' ' HIS . 3.5 mt -57.34 -49.43 76.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.78 . . . . 0.0 109.674 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.34 -34.69 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 109.86 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -77.93 -45.14 24.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.06 -1.025 . . . . 0.0 109.918 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 2.1 t-105 -48.7 -51.45 28.56 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 109.948 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -71.33 -39.9 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.53 -40.27 18.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.094 -1.004 . . . . 0.0 109.252 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 148' ' ' PHE . 12.0 t0 -77.31 -43.64 32.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.428 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.25 -34.41 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.74 -49.37 5.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.753 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -96.01 36.58 1.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.715 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 144' ' ' ASP . 17.9 t80 -53.2 -34.33 56.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -63.68 -34.7 78.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 154' ' ' PHE . 4.4 m -71.57 -54.35 10.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 mm -52.26 -32.14 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.92 -48.69 13.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -73.11 -14.93 61.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 150' ' ' SER . 67.3 t80 -81.83 -54.8 5.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -71.4 -42.2 68.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -88.97 167.55 13.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.462 ' CG ' ' H ' ' A' ' 158' ' ' GLY . 4.8 t-80 57.74 -143.85 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.452 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 157' ' ' HIS . . . 64.92 82.47 0.1 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 115.64 6.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.656 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.481 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.15 -179.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -166.97 -175.63 3.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -60.58 132.09 52.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 72.5 m -160.78 146.8 14.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 26.0 m -151.8 108.35 3.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 50.23 69.64 2.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.656 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.6 -28.58 52.78 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.295 1.33 . . . . 0.0 112.305 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -59.89 3.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.415 ' H ' HG23 ' B' ' 227' ' ' VAL . 12.7 t -53.5 -39.5 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.32 -54.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.7 -42.37 24.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.15 -32.62 70.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -65.13 -65.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.706 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.474 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.3 tp -50.01 -39.22 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.143 -0.973 . . . . 0.0 108.777 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.474 ' N ' HG23 ' B' ' 232' ' ' ILE . 12.9 mt -53.77 -43.3 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.83 -43.33 98.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.499 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -60.83 -43.55 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -1.143 . . . . 0.0 108.979 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -33.08 73.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.565 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.5 OUTLIER -57.12 -51.42 69.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.018 -1.051 . . . . 0.0 109.281 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.784 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.7 tp -68.19 -33.62 74.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.73 -39.94 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.741 -1.224 . . . . 0.0 108.06 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.5 tt -73.28 -39.52 65.29 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -52.97 -52.17 59.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.48 -33.78 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.571 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.11 -62.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.94 . . . . 0.0 109.406 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -53.06 -47.84 68.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -48.23 -50.43 29.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.598 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.4 mp -56.57 -45.95 81.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.86 109.9 18.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.244 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.3 142.64 30.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -79.58 85.01 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 10.9 t -149.71 -54.19 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 76.1 mt -88.72 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.955 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -164.82 25.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 253' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' B' ' 253' ' ' ARG . 0.0 OUTLIER -89.27 89.65 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 56.1 -174.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.88 -44.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -86.17 123.08 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 257' ' ' HIS . . . . . 0.491 ' ND1' ' N ' ' B' ' 257' ' ' HIS . 1.6 m-70 -60.03 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.96 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -89.92 -174.35 45.4 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.65 -53.91 52.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -1.174 . . . . 0.0 109.352 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 17.3 tttp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.491 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 13.5 m -79.11 17.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 320' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' C' ' 320' ' ' ASN . 15.0 p-10 -83.0 34.16 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.06 170.14 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.39 -8.27 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 71.5 m -60.52 -98.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -152.85 70.01 7.11 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.608 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.76 -28.17 59.79 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.236 1.29 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 326' ' ' LEU . . . . . 0.48 HD12 ' N ' ' C' ' 326' ' ' LEU . 10.8 mp -54.88 -50.11 69.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.49 -37.02 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' C' ' 331' ' ' ASN . 60.3 t -69.48 -63.01 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.95 -19.82 0.44 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.435 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.38 -26.54 19.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' C' ' 332' ' ' ILE . 0.1 OUTLIER -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.841 . . . . 0.0 109.516 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.501 ' N ' ' ND2' ' C' ' 331' ' ' ASN . 2.7 mt -47.28 -48.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.404 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.9 tt -77.63 -27.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 108.782 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.12 -55.09 32.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.7 mm -65.38 -48.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 108.995 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.45 -38.75 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 108.757 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.803 ' CE1' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.56 -52.24 66.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 109.093 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.795 HD21 ' NE2' ' A' ' 137' ' ' HIS . 3.5 mt -57.33 -49.56 75.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 14.4 mt -52.35 -34.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 0.0 109.912 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.21 -44.22 26.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.81 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 2.1 t-105 -49.56 -51.07 39.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 110.06 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.529 HG22 ' O ' ' C' ' 338' ' ' LEU . 0.8 OUTLIER -71.65 -39.79 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.0 109.543 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.49 -40.23 17.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 0.0 109.299 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' C' ' 348' ' ' PHE . 12.0 t0 -77.48 -43.56 31.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.27 -34.37 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.76 -49.61 5.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.64 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.88 36.66 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.855 . . . . 0.0 109.733 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' C' ' 344' ' ' ASP . 17.7 t80 -53.32 -34.28 56.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.94 . . . . 0.0 109.438 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -63.56 -34.82 78.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 350' ' ' SER . . . . . 0.445 ' O ' ' N ' ' C' ' 354' ' ' PHE . 4.4 m -71.53 -54.44 10.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 12.4 mm -52.11 -32.18 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.424 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.99 -48.77 12.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -73.03 -14.95 61.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 354' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' C' ' 350' ' ' SER . 67.4 t80 -81.91 -54.72 5.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -71.42 -42.12 68.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -89.05 167.52 13.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.85 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 357' ' ' HIS . . . . . 0.45 ' CG ' ' H ' ' C' ' 358' ' ' GLY . 4.9 t-80 57.69 -143.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 358' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' C' ' 357' ' ' HIS . . . 64.9 82.52 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.05 115.82 7.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 109.501 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 2.2 tttp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.07 -179.72 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.537 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -166.96 -175.63 3.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -60.61 132.09 52.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.435 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 72.6 m -160.71 146.82 15.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 26.5 m -151.82 108.33 3.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 50.28 69.63 2.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.63 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.65 -28.59 52.37 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.236 1.291 . . . . 0.0 112.244 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -59.9 3.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 12.3 t -53.52 -39.4 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.373 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 9.3 t -60.34 -54.65 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 109.427 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.81 -42.26 25.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.139 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -70.35 -32.44 70.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.252 -0.905 . . . . 0.0 109.188 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -65.23 -65.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.726 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.458 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.3 tp -49.88 -39.36 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 0.0 108.774 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.458 ' N ' HG23 ' D' ' 432' ' ' ILE . 12.9 mt -53.77 -43.18 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.251 -0.906 . . . . 0.0 108.691 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.3 98.19 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.493 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -60.98 -43.4 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -1.188 . . . . 0.0 108.914 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -33.08 73.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.339 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.582 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -57.12 -51.36 69.61 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.049 -1.032 . . . . 0.0 109.314 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.783 HD13 ' CE1' ' C' ' 337' ' ' HIS . 12.0 tp -68.15 -33.65 74.88 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.643 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.71 -39.95 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.658 -1.277 . . . . 0.0 108.125 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.36 -39.43 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -52.86 -52.29 57.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.58 -33.64 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.01 -62.83 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.08 -47.95 68.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -48.09 -50.45 28.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.618 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.64 -46.05 81.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.386 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.76 109.9 18.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.35 142.57 30.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -79.52 84.93 5.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 10.9 t -149.71 -54.11 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 75.7 mt -88.73 138.03 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -164.71 25.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 453' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' D' ' 453' ' ' ARG . 0.0 OUTLIER -89.25 89.57 7.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 56.22 -174.36 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.375 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.95 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -86.26 123.16 31.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 457' ' ' HIS . . . . . 0.508 ' ND1' ' N ' ' D' ' 457' ' ' HIS . 1.6 m-70 -60.08 -175.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -89.91 -174.4 45.42 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.55 -54.05 50.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.143 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 17.3 tttp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.53 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.73 -164.0 0.25 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.406 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -61.72 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.76 97.06 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 123' ' ' SER . 98.6 p -95.29 55.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 122' ' ' SER . 23.2 t -63.55 -134.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.942 . . . . 0.0 109.472 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -148.99 71.02 10.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.8 -29.82 50.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.389 1.392 . . . . 0.0 112.468 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.77 -42.67 60.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.82 -52.52 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.705 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.676 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.5 m -63.81 -54.28 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 109.66 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.676 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.56 -27.99 42.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.132 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -85.17 -21.06 29.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.422 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 0.6 OUTLIER -73.53 -40.99 63.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.3 mt -50.85 -42.86 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.45 -29.1 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.977 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.46 -53.53 44.71 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 136' ' ' LEU . 3.8 tp -65.26 -50.21 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -1.154 . . . . 0.0 108.892 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 135' ' ' ILE . 4.3 tp -50.24 -40.12 46.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 108.585 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.935 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.93 -58.95 6.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.427 -0.795 . . . . 0.0 108.939 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.919 HD21 ' NE2' ' C' ' 337' ' ' HIS . 17.1 mt -49.23 -48.74 45.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.693 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.81 -32.37 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.52 -58.44 3.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.042 . . . . 0.0 109.705 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -50.45 -44.04 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.763 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.504 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.6 tt -71.41 -41.46 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.989 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -58.29 -29.32 65.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 0.0 109.02 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 148' ' ' PHE . 4.7 t70 -77.77 -44.03 28.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.882 . . . . 0.0 109.367 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.516 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 22.3 ttt180 -54.62 -36.3 64.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 -50.53 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.697 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -98.72 36.86 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.462 -0.774 . . . . 0.0 109.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 144' ' ' ASP . 1.8 t80 -52.52 -36.88 56.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.305 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -60.03 -36.1 76.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.298 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 149' ' ' LYS . 15.7 m -69.15 -53.03 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 mm -57.11 -23.59 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -84.65 -41.51 16.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' A' ' 153' ' ' ARG . 0.1 OUTLIER -73.81 -21.26 60.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 109.574 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -83.21 -61.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.37 -27.77 63.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.506 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 49.99 -106.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.389 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.6 172.69 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' LYS . . . -87.28 -134.89 4.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 mt 47.45 18.77 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -1.124 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' GLY . 33.7 mtpt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 77.4 p -65.81 -173.14 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' B' ' 221' ' ' ASP . 2.2 t-20 -59.23 -72.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.495 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' B' ' 220' ' ' ASN . 12.6 t0 -168.7 145.97 3.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.586 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -4.73 56.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.56 153.54 40.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.363 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.41 163.5 23.2 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -54.28 -28.03 50.62 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.066 1.177 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.45 -59.26 5.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.66 -47.58 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -48.79 -58.63 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.123 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.73 -36.44 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.535 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -71.28 -32.53 68.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 109.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' B' ' 228' ' ' VAL . 53.7 m-20 -66.63 -62.64 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.406 HG23 ' N ' ' B' ' 233' ' ' ILE . 7.9 tp -50.94 -37.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.074 -1.016 . . . . 0.0 108.494 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.406 ' N ' HG23 ' B' ' 232' ' ' ILE . 11.9 mt -57.05 -42.22 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.16 -47.72 85.42 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -55.28 -39.15 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.237 -1.155 . . . . 0.0 108.6 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.5 mp -68.46 -36.83 79.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.421 -0.799 . . . . 0.0 109.276 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.862 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -54.28 -46.93 72.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.019 -1.05 . . . . 0.0 108.982 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.716 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.6 tp -68.74 -37.74 79.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.31 -37.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.973 -1.079 . . . . 0.0 108.095 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.54 -37.37 63.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' TRP . . . . . 0.56 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -58.52 -57.0 14.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.688 . . . . 0.0 109.436 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' ILE . . . . . 0.48 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.4 tt -63.72 -40.17 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.544 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.48 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.5 tt -58.29 -48.03 81.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.593 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -41.1 90.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -68.67 -25.36 64.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.22 -69.49 0.62 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -72.14 150.92 43.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -75.93 129.86 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -10.56 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.47 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 3.3 m -157.1 132.72 9.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.7 pt -54.68 162.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -53.39 147.39 10.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.23 148.8 47.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' B' ' 255' ' ' PHE . 97.3 m-85 -57.37 -14.3 4.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.361 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' B' ' 254' ' ' PHE . 2.1 t80 59.5 110.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.573 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -55.41 131.41 45.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -62.57 -46.31 88.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 61.44 5.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -38.42 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -1.16 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.568 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.64 -163.94 0.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -61.74 133.62 55.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -151.74 97.12 2.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 322' ' ' SER . . . . . 0.405 ' O ' ' O ' ' C' ' 323' ' ' SER . 97.7 p -95.32 55.61 1.77 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 323' ' ' SER . . . . . 0.405 ' O ' ' O ' ' C' ' 322' ' ' SER . 23.0 t -63.55 -134.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -149.0 70.96 10.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.67 -29.91 51.27 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.392 1.394 . . . . 0.0 112.536 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.58 -42.81 61.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.669 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.77 -52.6 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.668 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.5 m -63.82 -54.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.668 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.45 -28.18 42.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.169 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.91 29.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.431 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 0.6 OUTLIER -73.57 -41.09 63.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.419 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.4 mt -50.84 -42.93 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.313 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.33 -29.17 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.034 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.52 -53.39 45.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.565 HG23 ' N ' ' C' ' 336' ' ' LEU . 3.7 tp -65.3 -50.21 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -1.136 . . . . 0.0 108.89 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 336' ' ' LEU . . . . . 0.565 ' N ' HG23 ' C' ' 335' ' ' ILE . 4.3 tp -50.3 -40.17 47.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 108.57 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.919 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.92 -58.81 6.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.935 HD21 ' NE2' ' A' ' 137' ' ' HIS . 17.1 mt -49.26 -48.86 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.76 -32.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.514 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.68 -58.13 3.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.607 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -50.74 -43.63 58.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 109.905 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.512 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.6 tt -71.88 -41.11 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.077 -1.014 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -58.36 -29.34 65.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' C' ' 348' ' ' PHE . 4.6 t70 -77.85 -44.0 28.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 345' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 22.5 ttt180 -54.58 -36.2 64.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -50.67 6.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -98.57 36.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.408 -0.807 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' C' ' 344' ' ' ASP . 1.8 t80 -52.52 -36.84 56.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -0.973 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 349' ' ' LYS . . . . . 0.403 ' CG ' ' N ' ' C' ' 350' ' ' SER . 0.4 OUTLIER -59.92 -36.23 76.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.309 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 350' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' C' ' 349' ' ' LYS . 15.8 m -69.14 -52.98 22.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.01 -23.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -84.68 -41.51 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 353' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' C' ' 353' ' ' ARG . 0.1 OUTLIER -73.81 -21.34 60.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -83.14 -61.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -71.28 -27.86 63.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 50.07 -106.64 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.32 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.57 172.77 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 358' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' C' ' 360' ' ' LYS . . . -87.34 -134.91 4.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 6.6 mt 47.42 18.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 360' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' C' ' 358' ' ' GLY . 33.6 mtpt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 77.6 p -65.89 -173.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 420' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' D' ' 421' ' ' ASP . 2.1 t-20 -59.18 -72.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 421' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' D' ' 420' ' ' ASN . 12.7 t0 -168.69 146.0 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -4.7 56.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.57 153.57 40.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.46 163.47 23.22 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.3 -28.06 50.99 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.07 1.18 . . . . 0.0 112.387 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.42 -59.22 5.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 26.9 t -50.63 -47.53 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 428' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -48.8 -58.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.148 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.5 11.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.505 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -71.31 -32.4 68.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 109.085 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' D' ' 428' ' ' VAL . 53.7 m-20 -66.7 -62.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.415 HG23 ' N ' ' D' ' 433' ' ' ILE . 7.8 tp -50.89 -37.37 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.415 ' N ' HG23 ' D' ' 432' ' ' ILE . 11.9 mt -57.0 -42.29 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.88 83.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.531 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -55.18 -39.12 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -1.155 . . . . 0.0 108.548 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.59 -36.79 79.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.356 -0.84 . . . . 0.0 109.184 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.88 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -54.3 -46.91 72.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.975 -1.078 . . . . 0.0 108.878 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.696 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.8 tp -68.77 -37.76 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.574 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.36 -37.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.66 -37.3 62.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 441' ' ' TRP . . . . . 0.516 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.1 t90 -58.37 -56.96 15.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.594 -0.691 . . . . 0.0 109.528 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 442' ' ' ILE . . . . . 0.477 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.5 tt -63.92 -39.98 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 443' ' ' LEU . . . . . 0.477 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.5 tt -58.33 -48.0 81.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.86 -41.01 90.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -68.77 -25.34 64.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.377 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.22 -69.39 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.32 150.95 43.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -75.86 129.81 37.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -10.5 2.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.533 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 3.3 m -157.18 132.81 9.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.41 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 7.6 pt -54.77 162.5 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -53.19 147.31 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.44 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -63.21 148.8 47.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.38 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -57.5 -14.16 4.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.386 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.36 110.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -55.55 131.41 46.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -62.53 -46.39 88.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 109.427 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 67.51 61.53 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -38.56 73.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -1.142 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.495 -179.931 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 m -72.08 -53.44 12.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -80.57 49.96 1.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.456 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -89.98 -5.08 57.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.36 166.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.1 t -177.4 -46.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 54.67 70.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.0 -31.47 46.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.405 1.403 . . . . 0.0 112.31 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.9 -48.59 75.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 109.495 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.4 t -51.04 -38.05 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.918 . . . . 0.0 109.4 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 131' ' ' ASN . 49.0 t -66.99 -64.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.95 -17.42 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.544 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.42 -27.5 19.25 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.573 -0.704 . . . . 0.0 109.406 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.4 OUTLIER -73.64 -37.32 65.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.97 -44.77 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 tt -78.12 -32.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.255 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.85 97.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' D' ' 430' ' ' ALA . 82.3 mt -68.22 -57.0 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.314 -1.11 . . . . 0.0 109.058 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.21 -33.67 13.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.142 -0.974 . . . . 0.0 108.7 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.939 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.4 -55.76 27.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.85 . . . . 0.0 108.99 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' C' ' 337' ' ' HIS . 18.0 mt -54.16 -48.07 71.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.675 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.23 -33.67 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -82.31 -57.6 3.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.7 OUTLIER -50.58 -43.69 56.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.849 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.609 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.0 tt -68.94 -44.73 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.861 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.522 ' N ' HG23 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -52.88 -34.68 55.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.74 -1.225 . . . . 0.0 108.741 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.439 ' O ' ' CA ' ' A' ' 148' ' ' PHE . 12.6 t70 -78.21 -31.2 49.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.446 -0.784 . . . . 0.0 109.523 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.1 -42.98 95.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.641 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -50.11 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 143' ' ' LEU . 37.8 m-85 -96.39 38.05 1.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.522 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.439 ' CA ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -49.48 -24.69 2.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -74.19 -43.64 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.1 m -60.2 -49.14 78.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 151' ' ' ILE . 1.7 mp -64.39 -38.3 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.192 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.93 -40.9 97.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -76.3 -35.26 58.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.07 -36.64 68.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -28.23 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.95 . . . . 0.0 109.432 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.0 -41.52 98.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -171.21 110.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -87.12 -167.26 43.53 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.92 -32.36 71.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -1.147 . . . . 0.0 109.412 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.36 2.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -151.84 -166.98 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 221' ' ' ASP . 0.6 OUTLIER -157.15 75.42 0.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.8 m -161.31 81.2 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -161.51 -173.98 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -148.08 70.58 11.06 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.83 -27.18 51.76 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.36 1.373 . . . . 0.0 112.477 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.12 -45.36 52.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 0.0 109.74 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.87 -35.85 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 109.557 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.57 -56.91 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.09 -39.08 19.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.009 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.09 -33.85 68.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.212 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.443 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -66.28 -63.41 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.443 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.457 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.5 tp -49.93 -39.5 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.054 -1.028 . . . . 0.0 108.613 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.457 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.6 mt -53.98 -45.02 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.169 -0.957 . . . . 0.0 108.444 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.1 -49.34 68.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.544 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -53.38 -38.02 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.069 -1.254 . . . . 0.0 108.487 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 236' ' ' LEU . . . . . 0.606 ' O ' HD23 ' B' ' 236' ' ' LEU . 1.3 tt -68.31 -37.36 80.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.279 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.867 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.2 OUTLIER -55.32 -48.28 74.39 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.094 -1.004 . . . . 0.0 109.314 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.3 tp -67.16 -39.49 86.48 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.697 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 239' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' B' ' 236' ' ' LEU . 11.4 mt -47.46 -40.01 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.321 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.73 -34.42 64.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' TRP . . . . . 0.42 ' N ' ' O ' ' B' ' 238' ' ' LEU . 84.9 t90 -60.1 -54.88 40.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.403 -0.81 . . . . 0.0 109.636 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -51.79 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.257 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.89 -53.57 31.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.609 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -54.85 18.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.598 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -58.02 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.489 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -40.47 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.37 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.572 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -85.19 -58.65 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -49.81 129.53 20.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 40.7 t -153.28 3.85 0.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 mt 54.31 71.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.171 -0.956 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -90.12 -22.91 21.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 50.52 -159.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 0.0 109.396 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.41 -30.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.39 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.36 147.93 50.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 109.358 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.78 -175.4 5.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 257' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' B' ' 257' ' ' HIS . 0.0 OUTLIER -73.8 126.25 29.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 153.51 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.79 179.97 8.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.123 . . . . 0.0 109.431 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 49.7 mttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.524 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 7.6 m -72.03 -53.56 12.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.482 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -80.54 49.91 1.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -89.93 -5.1 57.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.49 166.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 7.1 t -177.42 -46.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 54.55 70.37 1.7 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.1 -31.39 45.69 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.318 1.345 . . . . 0.0 112.297 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mt -55.84 -48.69 75.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.02 -38.35 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.39 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' C' ' 331' ' ' ASN . 48.9 t -66.44 -64.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.84 -17.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 108.624 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.453 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.65 -26.85 19.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.731 . . . . 0.0 109.327 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.5 OUTLIER -73.83 -37.44 64.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.403 HG13 ' H ' ' C' ' 332' ' ' ILE . 2.8 mt -51.82 -44.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.492 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.8 tt -78.03 -33.04 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.7 97.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' B' ' 230' ' ' ALA . 82.2 mt -68.39 -56.96 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.316 -1.108 . . . . 0.0 109.006 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mt -49.26 -33.49 12.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.59 -55.67 28.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.87 . . . . 0.0 108.976 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.939 HD21 ' NE2' ' A' ' 137' ' ' HIS . 18.0 mt -54.14 -48.11 71.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 55.3 mt -54.38 -33.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -82.35 -57.33 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.044 -1.035 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -50.75 -43.63 58.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.867 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.6 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.9 tt -69.13 -44.56 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.513 ' N ' HG23 ' C' ' 342' ' ' ILE . 0.8 OUTLIER -52.88 -34.77 56.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.7 -1.25 . . . . 0.0 108.835 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.445 ' O ' ' CA ' ' C' ' 348' ' ' PHE . 12.5 t70 -78.37 -30.97 48.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.11 -43.04 95.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.06 -50.09 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 347' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' C' ' 343' ' ' LEU . 37.4 m-85 -96.4 38.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.842 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.445 ' CA ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -49.54 -24.71 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -74.15 -43.72 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 21.4 m -60.15 -49.2 78.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 351' ' ' ILE . . . . . 0.45 ' N ' HD12 ' C' ' 351' ' ' ILE . 1.7 mp -64.39 -38.16 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.962 . . . . 0.0 109.195 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -64.02 -40.91 97.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -76.34 -35.23 58.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.487 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -56.07 -36.62 68.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -28.08 39.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.13 -41.51 98.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -171.2 110.9 0.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -87.14 -167.21 43.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.93 -32.44 71.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.443 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.393 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.38 2.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -151.87 -166.98 2.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.469 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 421' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' D' ' 421' ' ' ASP . 0.6 OUTLIER -157.12 75.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.8 m -161.32 81.11 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 2.4 p -161.41 -173.98 4.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 109.436 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -148.12 70.65 11.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.82 -27.18 51.82 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.309 1.339 . . . . 0.0 112.448 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -45.32 54.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.91 -35.86 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.52 -56.89 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.16 -39.11 19.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.019 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.08 -33.79 68.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.205 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.433 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.8 OUTLIER -66.29 -63.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.46 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.5 tp -49.97 -39.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.087 -1.008 . . . . 0.0 108.577 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.46 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.6 mt -54.06 -44.99 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.478 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.07 -49.34 67.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.535 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -53.47 -37.94 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -1.228 . . . . 0.0 108.476 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 436' ' ' LEU . . . . . 0.605 ' O ' HD23 ' D' ' 436' ' ' LEU . 1.3 tt -68.41 -37.24 80.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.547 -0.72 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.887 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.42 -48.09 74.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.039 -1.038 . . . . 0.0 109.346 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.709 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.4 tp -67.14 -39.62 86.58 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.716 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 439' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' D' ' 436' ' ' LEU . 11.4 mt -47.47 -39.97 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 0.0 108.353 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.7 -34.41 64.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 441' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' D' ' 438' ' ' LEU . 85.4 t90 -60.03 -54.87 40.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.518 -0.739 . . . . 0.0 109.62 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -51.66 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.121 -0.987 . . . . 0.0 109.368 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.92 -53.57 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -54.79 19.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.553 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.09 -20.09 37.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.89 -40.61 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.51 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -85.12 -58.78 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.401 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -49.81 129.5 20.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 40.7 t -153.22 3.78 0.31 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.881 . . . . 0.0 109.451 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 451' ' ' ILE . . . . . 0.411 HG21 HD13 ' D' ' 451' ' ' ILE . 13.4 mt 54.33 71.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -90.2 -22.77 21.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 50.51 -159.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.46 -30.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.42 147.88 50.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 109.369 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.75 -175.27 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 457' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' D' ' 457' ' ' HIS . 0.0 OUTLIER -73.94 126.23 29.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 153.6 -96.75 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.81 179.95 8.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -1.115 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 50.1 mttt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.439 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -153.5 165.95 34.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.367 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -146.45 36.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.05 -36.56 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.18 30.02 5.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.492 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -53.55 161.64 0.99 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -173.54 70.84 0.36 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.691 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.27 -25.77 49.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.418 1.412 . . . . 0.0 112.3 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.44 -42.74 58.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.52 -53.49 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 109.636 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.655 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.0 m -61.57 -52.5 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.655 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.82 -24.8 24.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 109.133 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.92 -21.82 23.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.392 -0.817 . . . . 0.0 109.351 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.478 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -72.7 -43.75 62.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 5.0 mt -48.49 -47.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.1 tt -71.35 -33.44 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 108.776 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.2 64.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.3 mm -70.2 -55.28 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.8 mt -48.89 -34.49 12.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 108.66 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.944 ' CE1' HD21 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -62.18 -57.61 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.047 HD22 ' HD2' ' D' ' 437' ' ' HIS . 3.5 mt -56.35 -51.48 68.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.707 -0.62 . . . . 0.0 110.031 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.07 -28.72 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.4 HD22 HD21 ' B' ' 238' ' ' LEU . 4.5 tt -78.92 -58.72 3.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.73 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -50.19 -52.49 35.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.542 HG23 ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.054 . . . . 0.0 109.249 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.542 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.6 mt -49.46 -35.83 20.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.927 -1.108 . . . . 0.0 109.174 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.72 -36.11 60.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.494 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -67.1 -28.15 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.97 -16.33 19.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 109.699 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -146.17 41.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.583 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 144' ' ' ASP . 2.8 p90 -47.62 -23.42 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -73.24 -45.87 53.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 m -61.44 -50.73 71.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.7 mm -64.12 -37.53 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.877 . . . . 0.0 109.397 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.14 -37.29 86.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.943 . . . . 0.0 109.421 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.38 -39.22 93.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.09 -48.63 80.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.79 -42.29 46.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -67.01 165.56 15.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 109.465 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -77.15 -110.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.78 -179.93 44.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 130.59 36.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.0 tttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.499 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 8.3 t -152.11 150.74 30.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.51 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.73 -35.3 55.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 0.0 109.393 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.48 168.74 25.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.7 t -85.94 -140.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 21.8 t 50.73 -175.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -148.59 70.53 10.54 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.627 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.24 -30.0 46.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.322 1.348 . . . . 0.0 112.41 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.73 -60.34 2.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 t -52.35 -34.56 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.99 -58.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.01 -41.16 15.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.259 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.13 68.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 109.147 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.2 -59.5 4.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.811 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 232' ' ' ILE . 8.8 tp -58.16 -33.93 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.066 -1.022 . . . . 0.0 109.14 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.99 -49.11 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.126 -0.984 . . . . 0.0 108.815 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.12 -45.13 96.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -49.13 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -1.203 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.6 -36.55 84.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 1.042 ' HD2' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -53.68 -49.04 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 109.236 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.761 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.0 tp -67.65 -35.53 79.06 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.821 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' B' ' 238' ' ' LEU . 3.1 mm -50.05 -37.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.35 -38.3 60.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -54.52 -50.53 67.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.81 -38.74 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.719 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -44.0 97.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.524 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.59 35.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.2 OUTLIER -53.99 -42.51 69.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.45 -78.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -67.31 -175.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.52 175.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -148.18 41.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.562 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.14 -159.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.22 163.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.516 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.81 160.97 31.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -82.74 108.79 16.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 109.415 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -70.49 -38.31 74.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -58.86 -62.46 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.94 149.25 49.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -61.96 173.42 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.555 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -75.22 171.5 54.0 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.67 156.82 23.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -1.126 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 37.9 tttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.456 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.31 0.576 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 50.1 m -153.49 165.98 34.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -146.48 36.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -48.93 -36.72 17.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 51.32 30.01 5.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.397 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 8.2 m -53.6 161.63 1.01 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -173.48 70.84 0.37 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.28 -25.71 49.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.427 1.418 . . . . 0.0 112.303 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.43 -42.7 58.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.72 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.67 -53.42 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.599 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.647 HG23 ' N ' ' C' ' 329' ' ' ALA . 33.9 m -61.56 -52.55 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.545 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.647 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.81 -24.79 24.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 109.195 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.02 -21.69 23.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.276 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.477 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.1 OUTLIER -72.63 -43.93 62.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.477 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 5.1 mt -48.39 -48.11 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 6.3 tt -71.17 -33.5 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.866 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -53.34 -46.04 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.29 -55.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.81 -34.49 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.668 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.964 ' CE1' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.15 -57.58 10.98 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 1.042 HD22 ' HD2' ' B' ' 237' ' ' HIS . 3.4 mt -56.5 -51.35 68.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.638 -0.664 . . . . 0.0 110.041 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.02 -28.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.06 -58.23 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -50.55 -52.61 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.548 HG23 ' N ' ' C' ' 343' ' ' LEU . 0.9 OUTLIER -59.88 -43.85 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.126 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.548 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.6 mt -49.48 -35.75 20.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 109.211 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.79 -36.03 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.887 . . . . 0.0 109.491 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -67.18 -28.15 67.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.93 -16.4 19.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.634 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.08 41.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 109.531 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' C' ' 344' ' ' ASP . 2.9 p90 -47.75 -23.28 0.68 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.849 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -73.26 -45.86 53.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 14.8 m -61.56 -50.68 71.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 11.7 mm -64.04 -37.59 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.935 . . . . 0.0 109.394 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -65.23 -37.28 86.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.374 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -63.28 -39.31 94.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.358 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.06 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.8 -42.32 46.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.0 165.6 15.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -77.17 -110.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -173.77 -179.98 44.77 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.52 130.67 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.484 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.509 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 8.4 t -152.1 150.77 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -52.75 -35.31 56.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.349 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.48 168.65 25.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.6 t -85.85 -140.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 22.0 t 50.71 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.54 70.55 10.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.18 -30.05 46.76 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.345 1.363 . . . . 0.0 112.381 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.83 -60.34 2.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.424 HG23 ' H ' ' D' ' 427' ' ' VAL . 9.1 t -52.24 -34.63 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.94 -58.09 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.11 15.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.99 68.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.122 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.35 -59.35 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.843 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' D' ' 432' ' ' ILE . 8.8 tp -58.12 -34.07 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.146 -0.971 . . . . 0.0 109.104 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.9 -49.11 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.03 96.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.68 -49.06 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.273 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.65 -36.52 84.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.219 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 1.047 ' HD2' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -53.69 -49.1 68.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 109.244 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.748 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.1 tp -67.69 -35.47 78.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.633 -1.227 . . . . 0.0 109.832 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 439' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' D' ' 438' ' ' LEU . 3.1 mm -50.03 -37.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.793 -1.192 . . . . 0.0 107.877 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.32 -38.33 60.28 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -54.41 -50.59 67.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.483 -0.76 . . . . 0.0 109.605 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.92 -38.57 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.73 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -43.94 97.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.045 -1.034 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.69 34.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.2 OUTLIER -54.0 -42.46 69.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.508 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.41 -78.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -67.3 -175.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.517 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.61 175.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -148.28 41.52 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.08 -159.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.31 163.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.485 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.01 31.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -82.74 108.84 16.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.48 -38.33 74.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -58.88 -62.48 1.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.93 149.29 49.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -61.93 173.32 1.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -75.14 171.52 53.94 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.67 156.9 23.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -1.163 . . . . 0.0 109.386 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 37.9 tttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.475 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m -79.61 -66.92 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.51 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 4.0 m-20 -50.98 -52.6 41.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' ASN . 0.5 OUTLIER 73.3 -13.77 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.614 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 120' ' ' ASN . 34.3 t -59.62 -38.89 82.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.0 m -50.09 -27.04 5.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 47.9 69.86 2.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.2 -25.78 57.47 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.24 1.294 . . . . 0.0 112.357 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.9 mp -51.23 -45.79 62.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 54.5 t -51.47 -44.12 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 131' ' ' ASN . 78.0 t -62.5 -62.02 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.406 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.73 -18.34 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.734 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . -89.88 -27.75 19.68 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -70.4 -36.22 73.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.368 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.427 ' N ' ' ND2' ' A' ' 131' ' ' ASN . 2.6 mt -53.91 -48.12 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.402 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 tt -72.24 -30.77 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 108.76 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.38 -44.64 84.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.419 HG21 ' HB1' ' D' ' 430' ' ' ALA . 6.6 mt -69.68 -55.04 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -1.102 . . . . 0.0 109.126 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.83 -36.7 27.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 108.963 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.85 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -64.83 -43.5 92.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.833 HD21 ' NE2' ' C' ' 337' ' ' HIS . 3.6 mt -69.42 -47.27 64.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.775 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.5 mt -54.88 -34.41 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.626 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.69 -47.55 18.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.728 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.6 t-105 -46.42 -48.88 18.69 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 143' ' ' LEU . 11.5 tt -72.48 -41.92 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.948 . . . . 0.0 109.96 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tp -47.83 -40.46 21.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 109.345 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 148' ' ' PHE . 7.8 t0 -76.95 -43.83 33.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.92 -33.52 17.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.54 -49.52 5.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.1 35.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 144' ' ' ASP . 33.5 p90 -48.67 -25.94 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.32 -47.07 45.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -57.4 -49.16 77.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.378 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.9 mm -59.61 -50.53 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.268 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -52.53 -53.89 40.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -61.64 -33.09 73.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -51.8 -39.5 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -73.53 -41.25 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.07 -52.64 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -93.1 172.39 8.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.416 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 160' ' ' LYS . . . 89.24 64.4 1.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.81 79.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.143 . . . . 0.0 109.407 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 158' ' ' GLY . 17.8 tttp . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.319 0.581 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.98 168.4 27.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.857 . . . . 0.0 109.415 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -54.36 -30.07 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -147.55 160.77 42.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.73 92.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 67.7 p -83.54 175.31 9.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.597 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -153.94 69.99 6.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 109.596 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.32 -27.3 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.34 1.36 . . . . 0.0 112.502 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.09 -49.7 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.82 -37.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.557 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.37 -57.25 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -33.77 8.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.47 -33.59 67.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.897 . . . . 0.0 109.241 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.734 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -66.56 -61.05 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.486 ' N ' ' CG ' ' B' ' 231' ' ' ASN . 8.6 tp -52.43 -38.39 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 0.0 108.687 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.437 ' N ' HG23 ' B' ' 232' ' ' ILE . 9.4 mt -54.14 -44.22 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.9 -43.79 96.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.482 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -61.02 -41.75 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -1.221 . . . . 0.0 108.679 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 236' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' B' ' 239' ' ' ILE . 0.5 OUTLIER -67.54 -35.16 78.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.83 . . . . 0.0 109.106 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.559 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.4 OUTLIER -56.5 -50.78 70.77 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.088 -1.007 . . . . 0.0 109.416 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.814 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.1 tp -68.16 -33.83 75.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.521 -1.272 . . . . 0.0 109.79 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 239' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' B' ' 236' ' ' LEU . 16.9 mt -50.58 -40.1 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.68 -1.263 . . . . 0.0 107.831 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.15 -42.15 66.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -50.25 -48.04 54.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 108.927 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.12 -52.11 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.279 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.33 -31.94 46.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.88 -33.48 64.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.388 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -77.57 -25.95 50.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.04 -59.7 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -47.95 74.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 8.1 t80 48.23 24.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.699 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -149.56 133.81 17.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 143.51 24.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.88 172.7 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.352 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.09 126.71 30.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.436 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -90.33 -77.09 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -59.56 109.35 0.88 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.504 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -64.81 112.14 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 49.0 -120.32 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -154.78 -11.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.95 67.94 1.86 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 14.7 mt -70.36 106.65 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -1.179 . . . . 0.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 45.3 tttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.456 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.577 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 1.9 m -79.59 -67.02 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 320' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' C' ' 321' ' ' ASP . 4.0 m-20 -50.88 -52.68 39.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.579 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 321' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' C' ' 320' ' ' ASN . 0.5 OUTLIER 73.31 -13.75 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 322' ' ' SER . . . . . 0.424 ' H ' ' C ' ' C' ' 320' ' ' ASN . 33.8 t -59.54 -39.04 82.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 50.1 m -50.03 -26.96 4.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 47.84 69.9 2.41 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.34 -25.71 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.345 1.363 . . . . 0.0 112.278 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 8.9 mp -51.19 -45.82 61.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 327' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' C' ' 330' ' ' ALA . 54.7 t -51.58 -44.12 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' C' ' 331' ' ' ASN . 79.5 t -62.38 -62.04 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.81 -18.34 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.214 -0.929 . . . . 0.0 108.641 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.742 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . -90.12 -27.29 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.491 -0.756 . . . . 0.0 109.076 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.0 OUTLIER -70.45 -36.26 73.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.427 ' N ' ' ND2' ' C' ' 331' ' ' ASN . 2.8 mt -53.79 -48.33 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.2 tt -72.05 -30.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 108.742 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.66 84.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.418 HG21 ' HB1' ' B' ' 230' ' ' ALA . 6.6 mt -69.66 -55.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -1.122 . . . . 0.0 109.054 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.79 -36.56 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.989 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.833 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -64.86 -43.63 92.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.85 HD21 ' NE2' ' A' ' 137' ' ' HIS . 3.6 mt -69.3 -47.4 64.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.766 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.7 mt -54.83 -34.53 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.74 -46.97 20.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.6 t-105 -46.95 -48.71 21.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.47 HG23 ' N ' ' C' ' 343' ' ' LEU . 11.0 tt -72.71 -41.76 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.47 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tp -47.75 -40.59 20.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.357 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' C' ' 348' ' ' PHE . 7.8 t0 -76.97 -43.9 33.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.88 -33.49 17.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.626 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.5 -49.63 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.05 35.52 1.42 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' C' ' 344' ' ' ASP . 33.8 p90 -48.63 -26.02 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.31 -47.04 45.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 23.3 p -57.39 -49.1 77.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.68 -50.49 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.332 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.48 -53.9 39.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.499 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.68 -33.0 73.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.86 -39.45 58.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -73.57 -41.17 63.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.07 -52.61 64.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.863 . . . . 0.0 109.396 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -93.14 172.39 8.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.424 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 358' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' C' ' 360' ' ' LYS . . . 89.34 64.19 1.29 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.7 79.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.448 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 360' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' C' ' 358' ' ' GLY . 17.9 tttp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.06 168.38 27.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -54.36 -30.11 50.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -147.53 160.69 42.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.63 92.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 68.8 p -83.54 175.35 9.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -153.89 69.83 6.39 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.19 -27.3 48.92 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.381 1.387 . . . . 0.0 112.496 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.19 -49.64 51.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.82 -37.77 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 0.0 109.545 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 428' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.7 t -64.25 -57.36 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.098 -1.001 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.96 -33.93 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.888 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.54 -33.54 66.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.742 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -66.51 -61.11 2.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' D' ' 431' ' ' ASN . 8.6 tp -52.36 -38.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 108.654 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.434 ' N ' HG23 ' D' ' 432' ' ' ILE . 9.4 mt -54.13 -44.2 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.213 -0.929 . . . . 0.0 108.525 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.99 -43.67 96.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.484 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.7 mp -61.14 -41.61 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.11 -1.229 . . . . 0.0 108.761 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 436' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' D' ' 439' ' ' ILE . 0.5 OUTLIER -67.56 -35.24 78.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.099 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.567 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.4 OUTLIER -56.44 -50.71 70.9 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.192 -0.942 . . . . 0.0 109.501 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.803 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.6 tp -68.22 -33.85 75.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.738 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 439' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' D' ' 436' ' ' LEU . 16.9 mt -50.64 -40.12 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.637 -1.29 . . . . 0.0 107.81 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.06 -42.12 66.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -50.13 -48.04 53.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.004 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.29 -52.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.18 -32.07 45.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.91 -33.38 63.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -77.56 -26.03 50.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.05 -59.68 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -47.85 74.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 8.1 t80 48.2 24.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.697 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -149.54 133.78 17.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.63 143.51 24.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.3 pt -74.76 172.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.05 126.63 30.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.928 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -90.29 -77.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -59.51 109.36 0.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -64.79 112.13 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 49.12 -120.37 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -154.78 -12.01 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 64.04 67.84 1.89 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.34 106.7 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.438 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 45.3 tttp . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.453 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -53.29 -28.49 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.492 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.8 t30 54.84 73.84 0.39 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -62.46 -33.06 74.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.97 -178.68 0.21 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.561 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.9 m -150.94 -76.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.383 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -151.36 69.77 8.16 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 -27.38 55.2 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.318 1.346 . . . . 0.0 112.36 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.1 mt -53.69 -55.13 28.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.645 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.0 t -53.02 -34.03 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.965 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 131' ' ' ASN . 10.5 t -72.23 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.16 -19.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.65 -25.52 20.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.609 -0.682 . . . . 0.0 109.181 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.821 HD21 HG11 ' D' ' 427' ' ' VAL . 0.5 OUTLIER -72.01 -38.34 69.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 0.0 109.54 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.55 -44.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.308 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tt -78.43 -28.71 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 108.763 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.1 27.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.616 HG23 ' N ' ' A' ' 136' ' ' LEU . 6.2 tp -63.34 -50.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -1.227 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.616 ' N ' HG23 ' A' ' 135' ' ' ILE . 3.7 mt -52.1 -37.75 55.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.085 -1.009 . . . . 0.0 108.74 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.754 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -60.03 -56.03 26.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 108.981 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.724 HD21 ' NE2' ' C' ' 337' ' ' HIS . 6.3 mt -50.16 -38.62 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.768 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.39 -30.06 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.604 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.63 -53.27 6.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -52.77 -41.46 64.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.1 tp -74.36 -47.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.039 -1.038 . . . . 0.0 110.007 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.609 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.3 tp -50.2 -30.49 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.006 -1.059 . . . . 0.0 109.032 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 148' ' ' PHE . 6.0 t0 -78.35 -46.6 19.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 109.539 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.37 -33.8 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.42 -51.54 4.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.784 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 147' ' ' PHE . 34.7 m-85 -97.08 35.57 1.56 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 109.616 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.8 OUTLIER -47.82 -35.53 10.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.596 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.85 -45.81 87.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -57.62 -47.5 82.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.9 mm -55.1 -50.03 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.31 -49.85 68.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.552 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -65.07 -43.2 92.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -53.74 -36.08 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.442 ' CE1' HD21 ' B' ' 246' ' ' LEU . 0.2 OUTLIER -75.58 -51.43 12.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.532 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -146.44 131.36 18.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -76.11 -54.53 6.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.82 128.07 0.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 mp -84.58 164.79 18.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.318 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.41 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 3.9 t 56.79 171.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -163.68 175.2 10.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.5 t0 57.24 166.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 7.2 m -72.49 171.21 12.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 54.8 m -77.76 -10.34 59.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.913 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -156.78 69.53 4.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.43 -31.17 52.26 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.31 1.34 . . . . 0.0 112.394 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.448 ' N ' HD12 ' B' ' 226' ' ' LEU . 11.0 mp -64.79 -62.29 1.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.83 HG11 HD21 ' C' ' 331' ' ' ASN . 39.3 t -50.22 -45.97 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.0 t -48.89 -56.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.042 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.65 18.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.628 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -69.85 -34.64 73.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.431 -0.793 . . . . 0.0 109.145 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -60.8 3.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.067 -1.021 . . . . 0.0 109.254 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.21 -42.0 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.114 -0.991 . . . . 0.0 109.054 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' B' ' 230' ' ' ALA . 18.3 mt -50.49 -37.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -63.63 -44.67 96.12 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.5 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -58.65 -39.69 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -1.208 . . . . 0.0 108.533 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.04 -36.23 77.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.381 -0.824 . . . . 0.0 109.138 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.589 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -54.59 -48.79 71.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.972 -1.08 . . . . 0.0 108.954 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.754 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.3 tp -66.7 -38.53 86.93 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.695 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.91 -38.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.916 -1.115 . . . . 0.0 108.205 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -36.46 64.34 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -59.77 -56.53 20.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.0 109.566 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' ILE . . . . . 0.433 HG23 ' N ' ' B' ' 243' ' ' LEU . 12.6 tt -61.12 -39.05 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.666 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.433 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.5 mt -59.3 -54.87 41.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.003 . . . . 0.0 109.524 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.83 -50.81 55.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.13 -41.19 87.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.445 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' A' ' 155' ' ' PHE . 0.5 OUTLIER -53.0 -48.7 67.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.61 151.69 29.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -91.1 66.64 5.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -67.59 171.99 5.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 11.8 t -153.18 69.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -73.03 -20.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -55.6 -59.52 4.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -82.28 134.4 35.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.69 -170.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.558 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -149.09 -42.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.97 149.36 34.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.29 58.84 5.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 79.76 -154.93 38.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.454 ' N ' HD12 ' B' ' 259' ' ' LEU . 9.9 mp 51.49 -172.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.372 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 90.5 mttt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.46 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 88.1 p -53.26 -28.42 27.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 51.6 t30 54.82 73.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -62.51 -32.95 73.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.92 -178.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.53 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 58.1 m -151.04 -76.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -151.32 69.83 8.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.605 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.46 -27.33 54.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.286 1.324 . . . . 0.0 112.371 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.81 -55.21 28.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 66.6 t -52.81 -34.25 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' C' ' 331' ' ' ASN . 11.3 t -72.05 -66.07 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.03 -19.1 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.156 -0.965 . . . . 0.0 108.623 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.431 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.91 -25.17 19.93 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.474 -0.766 . . . . 0.0 109.116 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.83 HD21 HG11 ' B' ' 227' ' ' VAL . 0.5 OUTLIER -71.95 -38.61 69.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.48 -44.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.963 . . . . 0.0 109.286 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.42 -28.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 108.743 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -63.59 -54.97 27.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.628 HG12 ' HB1' ' B' ' 230' ' ' ALA . 6.3 tp -63.28 -50.2 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -1.227 . . . . 0.0 108.823 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 336' ' ' LEU . . . . . 0.608 ' N ' HG23 ' C' ' 335' ' ' ILE . 3.7 mt -52.07 -37.85 55.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.103 -0.998 . . . . 0.0 108.756 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.736 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -60.0 -55.89 28.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.027 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.727 HD21 ' NE2' ' A' ' 137' ' ' HIS . 6.3 mt -50.27 -38.7 42.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.415 -0.803 . . . . 0.0 109.676 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.37 -30.05 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -81.91 -52.64 6.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -53.14 -41.44 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.148 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.612 HG23 ' N ' ' C' ' 343' ' ' LEU . 10.1 tp -74.39 -47.87 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.97 -1.081 . . . . 0.0 109.872 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.612 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.3 tp -50.12 -30.5 11.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.046 -1.034 . . . . 0.0 109.141 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 348' ' ' PHE . 6.0 t0 -78.6 -46.41 19.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.36 -33.88 22.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.461 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.3 -51.73 4.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 347' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' C' ' 347' ' ' PHE . 34.5 m-85 -96.95 35.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.8 OUTLIER -47.87 -35.62 10.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.823 . . . . 0.0 109.536 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -63.7 -45.99 87.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.634 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 6.5 t -57.51 -47.57 81.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.6 mm -55.06 -50.09 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 109.542 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.22 -49.91 68.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -65.02 -43.26 93.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 109.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -53.73 -36.05 61.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 355' ' ' PHE . . . . . 0.445 ' CE1' HD21 ' D' ' 446' ' ' LEU . 0.2 OUTLIER -75.62 -51.46 12.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.487 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -146.41 131.34 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.456 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 357' ' ' HIS . . . . . 0.402 ' ND1' ' N ' ' C' ' 357' ' ' HIS . 10.4 m80 -76.07 -54.61 6.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.396 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.96 128.07 0.32 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 3.4 mp -84.52 164.74 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -1.133 . . . . 0.0 109.37 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 89.4 mttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.423 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.293 0.568 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.9 t 56.74 171.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.52 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -163.66 175.21 10.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 2.5 t0 57.17 166.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 7.1 m -72.59 171.24 12.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 56.2 m -77.8 -10.33 59.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -156.77 69.59 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.653 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.54 -31.09 51.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.257 1.304 . . . . 0.0 112.359 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 426' ' ' LEU . . . . . 0.44 ' N ' HD12 ' D' ' 426' ' ' LEU . 11.0 mp -64.88 -62.19 1.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.821 HG11 HD21 ' A' ' 131' ' ' ASN . 39.4 t -50.26 -45.94 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.912 . . . . 0.0 109.208 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.84 -56.88 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.005 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.7 -37.56 18.96 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.603 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -69.87 -34.64 73.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.112 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -60.8 3.25 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.079 -1.013 . . . . 0.0 109.27 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.12 -41.96 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.177 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' D' ' 430' ' ' ALA . 18.7 mt -50.58 -37.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -63.62 -44.7 96.09 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.496 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.7 mp -58.59 -39.71 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -1.206 . . . . 0.0 108.483 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.02 -36.33 77.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.387 -0.82 . . . . 0.0 109.175 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.591 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -54.49 -48.76 71.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.041 -1.037 . . . . 0.0 108.998 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.4 tp -66.69 -38.55 87.0 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.687 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.93 -38.1 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 108.163 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -36.5 64.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.7 -56.39 22.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.684 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 442' ' ' ILE . . . . . 0.431 HG23 ' N ' ' D' ' 443' ' ' LEU . 12.8 tt -61.33 -38.99 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 443' ' ' LEU . . . . . 0.431 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.5 mt -59.22 -54.89 41.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.81 -50.87 55.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -59.06 -41.31 87.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 446' ' ' LEU . . . . . 0.445 HD21 ' CE1' ' C' ' 355' ' ' PHE . 0.5 OUTLIER -52.92 -48.74 67.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.64 151.68 29.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.405 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -91.12 66.62 5.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.161 -0.962 . . . . 0.0 109.593 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -67.61 171.95 5.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 11.9 t -153.13 69.12 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 13.5 pt -73.02 -20.88 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 109.465 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -55.55 -59.48 4.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -82.38 134.47 35.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.58 -170.62 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.07 -42.65 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.03 149.38 34.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -84.29 58.95 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 79.66 -154.92 38.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 459' ' ' LEU . . . . . 0.445 HD12 ' N ' ' D' ' 459' ' ' LEU . 9.9 mp 51.47 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.417 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.447 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.493 HH22 ' CB ' ' B' ' 219' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -68.16 -15.03 63.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.21 -77.79 0.24 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 11.1 p30 -167.24 148.13 5.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.568 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.4 134.3 37.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.0 t -170.96 -171.33 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -146.77 70.78 12.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.88 -26.87 51.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.315 1.343 . . . . 0.0 112.524 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 126' ' ' LEU . 11.0 mp -59.7 -50.23 74.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.662 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.3 t -54.42 -35.86 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.504 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 131' ' ' ASN . 80.7 t -65.36 -62.89 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.92 -18.67 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.965 . . . . 0.0 108.52 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.492 ' HB1' ' ND2' ' B' ' 231' ' ' ASN . . . -88.95 -23.03 22.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.592 -0.692 . . . . 0.0 109.36 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -78.06 -38.01 45.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.608 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.14 -44.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 134' ' ' GLY . 12.4 tt -79.53 -38.98 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 0.0 109.179 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -54.24 -44.46 75.09 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.554 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.8 mt -69.82 -54.98 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -1.07 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.3 -33.48 13.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.09 -1.006 . . . . 0.0 108.67 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.721 ' ND1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -63.77 -59.01 5.1 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.645 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.6 mt -49.73 -37.72 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.483 -0.76 . . . . 0.0 109.697 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.9 mt -68.99 -30.71 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.08 -54.95 4.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.697 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.2 OUTLIER -50.25 -44.06 53.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.256 -0.903 . . . . 0.0 109.89 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.76 HD13 ' NE2' ' D' ' 437' ' ' HIS . 4.2 tp -72.17 -45.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.617 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.578 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.7 mt -49.46 -31.77 10.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.95 -1.094 . . . . 0.0 108.961 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 148' ' ' PHE . 8.2 t70 -77.62 -45.62 24.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.4 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -50.33 -34.46 23.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.86 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 146' ' ' LEU . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.637 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.78 36.49 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.548 ' CE1' ' NH2' ' B' ' 245' ' ' ARG . 2.9 t80 -51.33 -34.15 32.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -64.45 -38.24 90.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.7 m -67.43 -53.47 28.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.49 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 mm -53.02 -35.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -69.91 -53.36 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -62.19 -33.91 75.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -60.48 -60.32 4.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -79.8 -69.64 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 65.48 174.96 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 155.99 38.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 86.18 92.44 0.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 159' ' ' LEU . 10.0 mp -66.68 -28.13 68.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mttm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.54 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.493 ' CB ' HH22 ' A' ' 118' ' ' ARG . 29.1 t -167.17 63.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 109.415 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -78.87 -6.91 57.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -169.84 67.92 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 7.7 t -72.7 -39.65 66.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -83.92 -32.31 25.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 26.8 t0 53.55 70.51 1.74 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.69 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -65.17 -26.34 57.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.412 1.408 . . . . 0.0 112.466 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.03 -41.37 25.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -39.75 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.43 -57.82 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.942 . . . . 0.0 109.481 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -46.92 -40.21 13.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.202 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.38 -35.47 68.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.492 ' ND2' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -65.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -49.55 -38.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.166 -0.959 . . . . 0.0 108.681 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.437 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.1 mt -56.44 -41.38 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 108.486 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.96 95.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.572 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.97 -51.53 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.293 . . . . 0.0 108.503 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.8 -37.95 77.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.757 . . . . 0.0 109.545 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.766 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.2 OUTLIER -52.61 -48.58 66.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.991 -1.068 . . . . 0.0 109.094 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.721 HD13 ' ND1' ' A' ' 137' ' ' HIS . 8.1 tp -65.84 -38.26 88.41 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.713 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 38.5 mm -49.44 -38.34 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.764 -1.21 . . . . 0.0 108.094 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.98 -34.87 64.39 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -60.99 -56.56 19.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.485 -0.76 . . . . 0.0 109.346 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' ILE . . . . . 0.449 HG23 ' N ' ' B' ' 243' ' ' LEU . 12.5 tt -62.94 -38.57 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.5 -0.75 . . . . 0.0 109.619 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.449 ' N ' HG23 ' B' ' 242' ' ' ILE . 4.7 tp -62.18 -38.37 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.42 -48.13 71.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.349 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 148' ' ' PHE . 0.5 OUTLIER -58.43 -40.74 83.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.413 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.15 -37.46 87.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.32 176.12 7.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.687 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.96 147.58 26.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.427 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -89.6 29.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 1.3 p -59.31 -16.36 21.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 9.7 mm -66.21 128.43 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.909 . . . . 0.0 109.44 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -63.26 171.74 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -82.94 164.2 20.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.02 168.05 24.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -147.19 161.47 40.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.51 170.78 14.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 54.28 66.06 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -166.08 4.3 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.39 168.89 17.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -1.163 . . . . 0.0 109.463 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.543 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 318' ' ' ARG . . . . . 0.494 HH22 ' CB ' ' D' ' 419' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 99.2 p -68.17 -15.02 63.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.29 -77.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.381 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 321' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' C' ' 321' ' ' ASP . 11.0 p30 -167.36 148.05 5.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.502 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.25 134.31 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 47.0 t -171.06 -171.52 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.409 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -146.65 70.84 12.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.574 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.86 -26.86 51.74 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.431 1.421 . . . . 0.0 112.569 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 326' ' ' LEU . . . . . 0.471 HD12 ' N ' ' C' ' 326' ' ' LEU . 11.0 mp -59.8 -50.14 74.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.628 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.6 -35.8 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' C' ' 331' ' ' ASN . 89.1 t -65.18 -62.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.313 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -50.92 -18.79 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.143 -0.973 . . . . 0.0 108.529 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.492 ' HB1' ' ND2' ' D' ' 431' ' ' ASN . . . -89.12 -22.62 22.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.5 OUTLIER -78.15 -38.08 44.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.415 HG13 ' H ' ' C' ' 332' ' ' ILE . 3.2 mt -51.08 -44.41 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 333' ' ' ILE . . . . . 0.433 HG23 ' N ' ' C' ' 334' ' ' GLY . 12.5 tt -79.46 -39.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.168 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 334' ' ' GLY . . . . . 0.433 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -54.18 -44.45 74.43 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' B' ' 230' ' ' ALA . 86.5 mt -69.8 -55.02 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.333 -1.098 . . . . 0.0 109.115 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.31 -33.52 13.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.665 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.706 ' ND1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -63.67 -58.98 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.428 -0.795 . . . . 0.0 108.92 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.662 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.6 mt -49.78 -37.68 30.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 50.7 mt -69.13 -30.68 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.07 -54.64 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 109.666 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -50.38 -44.18 54.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.97 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.766 HD13 ' NE2' ' B' ' 237' ' ' HIS . 4.2 tp -72.18 -45.42 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 109.6 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.564 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.7 mt -49.48 -31.82 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 108.891 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' C' ' 348' ' ' PHE . 8.2 t70 -77.78 -45.47 24.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.785 . . . . 0.0 109.457 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -50.23 -34.55 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 346' ' ' LEU . . . . . 0.47 ' O ' HD23 ' C' ' 346' ' ' LEU . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -96.7 36.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.572 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.543 ' CE1' ' NH2' ' D' ' 445' ' ' ARG . 2.9 t80 -51.26 -34.2 31.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.578 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -64.42 -38.2 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 4.7 m -67.33 -53.46 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.566 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 16.3 mm -53.19 -35.72 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -69.97 -53.47 17.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -62.14 -33.9 75.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -60.46 -60.34 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -79.78 -69.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 65.43 174.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 155.92 39.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 92.49 0.89 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 359' ' ' LEU . . . . . 0.433 HD12 ' N ' ' C' ' 359' ' ' LEU . 10.0 mp -66.76 -28.07 68.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 38.1 mttm . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.494 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 419' ' ' SER . . . . . 0.494 ' CB ' HH22 ' C' ' 318' ' ' ARG . 29.1 t -167.25 63.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -78.99 -6.9 57.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -169.85 67.88 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 7.6 t -72.64 -39.69 66.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -83.94 -32.32 25.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.422 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 26.8 t0 53.58 70.51 1.74 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.602 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.18 -26.39 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.423 1.416 . . . . 0.0 112.411 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.02 -41.25 25.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 427' ' ' VAL . 4.5 t -64.55 -39.65 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.138 -0.976 . . . . 0.0 109.597 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.56 -57.77 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -46.89 -40.22 13.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 109.219 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.554 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.31 -35.57 68.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.492 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -65.7 -63.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.417 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.6 tp -49.55 -38.24 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.166 -0.959 . . . . 0.0 108.632 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.417 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.1 mt -56.42 -41.41 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.151 -0.968 . . . . 0.0 108.469 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.94 95.92 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.565 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -58.92 -51.49 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.062 -1.258 . . . . 0.0 108.523 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.84 -37.85 77.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.594 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.76 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -52.67 -48.58 66.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 109.046 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.706 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.3 tp -65.76 -38.38 88.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.751 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 38.1 mm -49.38 -38.41 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.762 -1.211 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.0 -34.74 64.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -61.05 -56.38 21.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 442' ' ' ILE . . . . . 0.447 HG23 ' N ' ' D' ' 443' ' ' LEU . 12.7 tt -63.26 -38.4 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 443' ' ' LEU . . . . . 0.447 ' N ' HG23 ' D' ' 442' ' ' ILE . 4.7 tp -62.03 -38.62 89.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -66.32 -48.12 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.543 ' NH2' ' CE1' ' C' ' 348' ' ' PHE . 0.5 OUTLIER -58.4 -40.76 83.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.23 -37.4 87.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.39 176.12 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.69 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.06 147.57 26.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.902 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -89.63 29.96 1.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 1.3 p -59.24 -16.47 21.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 9.7 mm -66.16 128.44 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -63.31 171.58 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -82.83 164.24 20.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.11 168.03 25.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 0.0 109.492 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -147.19 161.46 40.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.51 170.78 14.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 54.28 66.13 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -166.16 4.26 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 5.3 mt -82.4 169.03 16.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -1.126 . . . . 0.0 109.337 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.504 -179.951 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.8 m -154.56 70.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -156.06 -176.46 5.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -167.26 56.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -58.76 -72.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.4 m -152.28 13.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.7 t0 47.49 69.76 2.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.607 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.26 -27.15 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.342 1.362 . . . . 0.0 112.363 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 126' ' ' LEU . 10.9 mp -51.59 -55.36 19.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.479 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 59.8 t -51.55 -54.29 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 131' ' ' ASN . 62.3 t -48.5 -64.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.269 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.76 -19.42 0.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.949 . . . . 0.0 108.704 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 127' ' ' VAL . . . -83.46 -29.41 28.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.251 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' D' ' 431' ' ' ASN . 0.1 OUTLIER -74.72 -42.88 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.933 . . . . 0.0 109.39 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.424 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mt -51.16 -43.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.604 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.535 ' CD1' HD12 ' B' ' 235' ' ' ILE . 6.3 tt -74.06 -36.26 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.005 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -50.89 -42.79 47.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.2 mt -71.46 -53.06 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.4 -1.059 . . . . 0.0 109.17 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.17 -37.9 23.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.188 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.856 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -67.54 -44.17 78.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.27 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.675 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.5 mt -60.61 -49.69 76.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.485 -0.759 . . . . 0.0 109.983 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.91 -24.05 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.55 HD22 HD21 ' B' ' 238' ' ' LEU . 2.6 tt -80.96 -59.95 2.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -0.94 . . . . 0.0 109.894 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.0 OUTLIER -50.59 -42.49 55.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.261 -0.9 . . . . 0.0 109.962 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.75 HD13 ' NE2' ' D' ' 437' ' ' HIS . 3.7 tp -72.77 -42.38 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.85 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.529 ' N ' HG23 ' A' ' 142' ' ' ILE . 4.9 mt -48.69 -40.69 29.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 0.0 109.096 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.5 OUTLIER -75.04 -39.1 61.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.609 HH11 ' CG ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -51.03 -37.6 46.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.473 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.9 -48.49 6.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -94.99 35.27 1.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.461 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' ASP . 2.0 t80 -51.95 -33.7 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -68.73 -37.63 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 109.546 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.9 -57.81 3.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mm -52.53 -33.16 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -75.42 -56.67 4.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.14 -25.24 66.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -69.82 -39.44 76.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.34 97.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -52.16 -28.98 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.452 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -71.85 146.39 47.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 133.68 4.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.9 -33.32 68.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.8 mttp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.463 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 80.4 p -158.92 152.71 23.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.391 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 5.1 m120 51.8 46.22 26.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.424 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' B' ' 222' ' ' SER . 21.8 t0 -91.6 151.59 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.47 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 222' ' ' SER . . . . . 0.468 ' N ' ' OD1' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -148.32 -58.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 109.392 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 3.6 m -83.44 -1.66 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.13 70.29 1.89 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.56 -29.25 61.27 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.323 1.348 . . . . 0.0 112.524 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.15 -51.5 53.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.444 ' CG1' HD21 ' C' ' 331' ' ' ASN . 23.6 t -57.31 -41.55 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.4 -56.29 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.25 -38.43 12.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.248 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.28 66.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 109.375 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.549 ' CG ' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -67.3 -58.46 4.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.444 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.41 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.3 tp -54.01 -36.48 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.067 . . . . 0.0 108.565 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.41 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.4 mt -58.54 -44.44 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 108.728 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.84 -41.56 91.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.535 HD12 ' CD1' ' A' ' 133' ' ' ILE . 23.2 mm -61.18 -36.31 71.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.113 -1.227 . . . . 0.0 108.702 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 236' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' B' ' 239' ' ' ILE . 2.7 tt -67.72 -35.47 78.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.868 . . . . 0.0 108.858 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.753 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.3 OUTLIER -58.53 -51.85 68.15 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.856 HD13 ' CE1' ' A' ' 137' ' ' HIS . 14.0 tp -63.27 -38.99 93.33 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.619 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 239' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' B' ' 236' ' ' LEU . 13.9 mt -48.68 -43.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.901 -1.125 . . . . 0.0 108.464 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.88 -42.5 90.22 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -57.9 -43.89 86.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.32 -56.08 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 108.969 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.76 -21.17 62.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 109.532 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.33 -60.67 2.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.375 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.03 -34.5 71.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.66 -47.98 57.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 17.3 t80 55.31 61.47 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.75 109.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -93.25 -170.09 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 17.7 t 49.75 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.22 -43.4 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.403 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -67.74 -132.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -155.84 1.69 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.8 -66.56 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.0 157.95 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -81.78 -39.6 23.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -158.38 132.24 7.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 164.31 -52.49 0.29 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.3 tt -164.02 108.81 1.01 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -1.128 . . . . 0.0 109.431 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 49.4 mttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.499 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 73.8 m -154.45 70.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -156.02 -176.42 5.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -167.22 56.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 2.5 p -58.76 -72.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 74.9 m -152.43 13.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 40.8 t0 47.53 69.76 2.49 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.29 -27.07 48.35 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.349 1.366 . . . . 0.0 112.394 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 326' ' ' LEU . . . . . 0.488 HD12 ' N ' ' C' ' 326' ' ' LEU . 10.9 mp -51.66 -55.29 20.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.515 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 327' ' ' VAL . . . . . 0.629 ' O ' ' HB3' ' C' ' 330' ' ' ALA . 60.0 t -51.59 -54.38 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 109.197 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.42 ' C ' ' N ' ' C' ' 330' ' ' ALA . 65.9 t -48.44 -64.43 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.73 -19.54 0.65 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 108.733 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 330' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' C' ' 327' ' ' VAL . . . -83.64 -29.07 27.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.393 -0.817 . . . . 0.0 109.208 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.444 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -74.65 -43.01 57.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.7 mt -51.02 -43.84 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -0.831 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 333' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' D' ' 435' ' ' ILE . 6.6 tt -73.9 -36.3 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -50.93 -42.73 47.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 6.1 mt -71.46 -53.17 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.374 -1.074 . . . . 0.0 109.181 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.09 -37.91 22.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.173 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.844 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -67.54 -44.2 78.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.675 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.4 mt -60.6 -49.84 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.71 -24.25 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.965 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 340' ' ' LEU . . . . . 0.528 HD22 HD21 ' D' ' 438' ' ' LEU . 2.7 tt -81.06 -59.47 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -50.97 -42.59 60.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 110.006 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.753 HD13 ' NE2' ' B' ' 237' ' ' HIS . 3.8 tp -72.57 -42.57 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 109.611 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.536 ' N ' HG23 ' C' ' 342' ' ' ILE . 4.9 mt -48.62 -40.64 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 109.192 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.5 OUTLIER -75.16 -38.96 60.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 109.369 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 345' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' C' ' 345' ' ' ARG . 0.3 OUTLIER -51.11 -37.47 46.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.429 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.03 -48.48 6.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -94.9 35.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 344' ' ' ASP . 2.0 t80 -51.95 -33.68 38.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.554 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -68.72 -37.64 79.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -57.93 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 1.6 mm -52.43 -33.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -75.44 -56.76 4.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -61.11 -25.13 66.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -69.93 -39.23 76.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -44.36 97.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.96 . . . . 0.0 109.432 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -52.18 -28.95 20.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -71.73 146.23 48.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -147.3 133.68 4.85 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.92 -33.31 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.419 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 79.6 p -158.93 152.73 23.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 5.1 m120 51.83 46.17 27.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.434 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 421' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' D' ' 422' ' ' SER . 21.8 t0 -91.55 151.6 20.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.497 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 422' ' ' SER . . . . . 0.461 ' N ' ' OD1' ' D' ' 421' ' ' ASP . 0.0 OUTLIER -148.31 -58.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.373 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 3.6 m -83.47 -1.69 54.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.373 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.15 70.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.517 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.56 -29.2 61.35 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.34 1.36 . . . . 0.0 112.495 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -51.56 52.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.402 ' CG1' HD21 ' A' ' 131' ' ' ASN . 24.3 t -57.3 -41.52 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.41 -56.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.49 13.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.176 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.97 -35.31 66.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 109.383 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.548 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -67.22 -58.46 4.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.403 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.3 tp -53.95 -36.54 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 108.602 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.403 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.4 mt -58.45 -44.45 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.152 -0.968 . . . . 0.0 108.762 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.77 -41.65 90.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' C' ' 333' ' ' ILE . 23.1 mm -61.24 -36.26 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -1.187 . . . . 0.0 108.645 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 436' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' D' ' 439' ' ' ILE . 2.7 tt -67.7 -35.44 78.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.341 -0.849 . . . . 0.0 108.913 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.75 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -58.56 -51.89 67.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.107 -0.995 . . . . 0.0 108.977 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.844 HD13 ' CE1' ' C' ' 337' ' ' HIS . 14.4 tp -63.09 -39.23 94.1 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.562 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 439' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' D' ' 436' ' ' LEU . 14.0 mt -48.62 -43.35 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.814 -1.179 . . . . 0.0 108.453 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -42.55 89.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.94 -43.67 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.758 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.57 -55.88 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 108.994 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.81 -21.13 62.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.39 -60.66 2.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.98 -34.53 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 0.0 109.343 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.73 -47.94 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 17.0 t80 55.23 61.51 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.493 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.76 109.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -93.21 -170.09 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 17.8 t 49.75 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.16 -43.44 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -67.71 -132.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.415 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -155.83 1.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.84 -66.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.48 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.02 158.01 3.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -81.83 -39.57 23.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -158.4 132.24 7.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 164.32 -52.55 0.29 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.3 tt -163.99 108.8 1.01 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 49.0 mttp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.547 -179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -53.97 111.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -149.47 -67.71 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.47 120.55 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -52.3 64.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.47 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.5 p -161.34 43.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.402 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 128' ' ' VAL . 2.2 m-20 48.71 70.41 2.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.05 -28.7 57.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.32 1.347 . . . . 0.0 112.518 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 126' ' ' LEU . 10.8 mp -76.31 -44.68 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.883 . . . . 0.0 109.766 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.65 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 110.079 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 129' ' ' ALA . 32.9 m -69.43 -51.43 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.669 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -64.17 -14.97 58.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.44 -48.65 5.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.757 HD21 HG11 ' D' ' 427' ' ' VAL . 0.0 OUTLIER -77.84 -50.4 12.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.8 mm -47.61 -44.54 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.469 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 134' ' ' GLY . 11.1 tt -72.41 -37.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.012 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -52.17 -49.8 48.59 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.924 HG21 ' HB1' ' D' ' 430' ' ' ALA . 11.0 mm -65.23 -55.05 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -1.217 . . . . 0.0 109.289 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.4 -33.83 14.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.811 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -63.97 -60.25 3.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 109.401 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.7 mt -49.05 -39.68 28.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.712 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.7 mt -69.18 -27.72 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.413 HD22 HD21 ' B' ' 238' ' ' LEU . 4.2 tt -82.78 -54.11 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.12 -0.988 . . . . 0.0 109.627 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.89 -42.49 62.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.3 tp -72.82 -45.26 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.596 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.0 mt -49.12 -33.73 12.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.276 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 3.9 t70 -78.78 -43.57 25.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.855 . . . . 0.0 109.655 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.565 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 25.5 ttt180 -50.1 -39.51 42.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.877 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.13 -53.52 3.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 109.854 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -96.04 36.47 1.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.88 -29.15 3.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -69.03 -33.38 73.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.1 t -75.21 -52.34 11.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 mm -65.59 -21.24 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.546 ' HH ' ' CE1' ' A' ' 157' ' ' HIS . 82.4 t80 -84.57 -47.91 10.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.307 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.98 -57.53 3.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.24 -58.3 8.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.38 142.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.546 ' CE1' ' HH ' ' A' ' 152' ' ' TYR . 10.2 m80 -58.64 143.9 44.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' N ' ' A' ' 160' ' ' LYS . . . -83.74 -112.3 0.57 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 49.54 15.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 0.0 109.351 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' N ' ' C ' ' A' ' 158' ' ' GLY . 17.7 pttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.95 110.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -167.15 50.64 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -153.23 89.38 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 1.6 t 62.01 104.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -153.37 127.45 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -148.41 69.17 10.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.33 -40.18 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.28 1.32 . . . . 0.0 112.343 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' VAL . . . . . 0.777 HG11 HD21 ' C' ' 331' ' ' ASN . 16.7 t -52.48 -44.63 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.361 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' B' ' 231' ' ' ASN . 4.8 t -53.86 -56.67 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -38.42 17.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 108.806 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -70.52 -28.83 65.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.327 -0.858 . . . . 0.0 109.076 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 231' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.2 m-20 -69.04 -63.79 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.215 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.7 tp -49.05 -36.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' B' ' 230' ' ' ALA . 20.2 mt -58.96 -41.07 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 231' ' ' ASN . . . -56.87 -42.86 92.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.597 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -61.22 -41.03 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -1.23 . . . . 0.0 108.662 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 236' ' ' LEU . . . . . 0.521 ' HA ' HD12 ' B' ' 239' ' ' ILE . 0.5 OUTLIER -67.45 -35.28 78.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 0.0 109.089 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.522 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -56.87 -48.96 76.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.167 -0.958 . . . . 0.0 109.414 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.811 HD13 ' CE1' ' A' ' 137' ' ' HIS . 9.5 tp -68.1 -35.13 77.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.701 -1.2 . . . . 0.0 109.761 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 239' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' B' ' 236' ' ' LEU . 13.5 mt -50.56 -41.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.726 -1.233 . . . . 0.0 108.104 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tt -69.96 -40.59 75.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' TRP . . . . . 0.553 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 88.3 t90 -54.45 -55.93 23.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.05 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.1 mt -53.12 -54.48 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.04 -53.98 23.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.564 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -52.88 -28.13 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -74.64 -48.37 26.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.888 . . . . 0.0 109.516 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 246' ' ' LEU . 10.9 mp -63.29 -47.47 82.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -86.73 86.13 7.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.529 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' PHE . . . . . 0.404 ' C ' ' H ' ' B' ' 250' ' ' SER . 48.0 p90 -69.4 -5.52 24.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.07 18.06 0.54 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 250' ' ' SER . . . . . 0.404 ' H ' ' C ' ' B' ' 248' ' ' PHE . 23.3 t -47.88 -32.02 5.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.76 117.03 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -87.12 124.26 33.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.477 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -85.42 44.91 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 50.39 -169.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 49.79 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.79 78.6 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 109.557 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 12.9 m80 52.33 -175.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.587 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.66 -84.79 0.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' LEU . . . . . 0.441 ' N ' HD12 ' B' ' 259' ' ' LEU . 10.9 mp -76.96 148.84 36.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 83.5 tttt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.49 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 3.5 p -54.06 111.28 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -149.48 -67.75 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -71.48 120.62 17.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.27 -52.25 65.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 80.5 p -161.34 43.73 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 324' ' ' ASP . . . . . 0.422 ' O ' HG22 ' C' ' 328' ' ' VAL . 2.2 m-20 48.82 70.39 2.11 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.408 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.08 -28.64 56.92 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.345 1.363 . . . . 0.0 112.484 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 326' ' ' LEU . . . . . 0.435 HD12 ' N ' ' C' ' 326' ' ' LEU . 10.8 mp -76.43 -44.68 34.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.742 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.73 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.658 HG23 ' N ' ' C' ' 329' ' ' ALA . 32.9 m -69.4 -51.53 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.963 . . . . 0.0 109.8 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.658 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -64.19 -14.82 57.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -95.78 -48.3 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.069 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.777 HD21 HG11 ' B' ' 227' ' ' VAL . 0.0 OUTLIER -77.92 -50.57 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.998 -179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.479 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.9 mm -47.31 -44.84 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 333' ' ' ILE . . . . . 0.411 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -72.19 -38.01 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 334' ' ' GLY . . . . . 0.411 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -52.19 -49.75 48.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.94 HG21 ' HB1' ' B' ' 230' ' ' ALA . 11.5 mm -65.36 -55.01 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -1.22 . . . . 0.0 109.279 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.36 -33.91 14.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.805 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -63.89 -60.4 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.84 . . . . 0.0 109.297 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.78 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.8 mt -48.91 -39.64 26.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 11.0 mt -69.33 -27.73 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 340' ' ' LEU . . . . . 0.401 HD22 HD21 ' D' ' 438' ' ' LEU . 4.0 tt -82.98 -53.53 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.637 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -52.28 -42.51 63.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.595 HG23 ' N ' ' C' ' 343' ' ' LEU . 10.3 tp -72.72 -45.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.595 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.0 mt -49.14 -33.69 12.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 109.313 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' C' ' 348' ' ' PHE . 3.7 t70 -78.94 -43.41 24.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 345' ' ' ARG . . . . . 0.553 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 25.4 ttt180 -50.2 -39.51 44.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.04 -53.75 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -95.92 36.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.81 -29.13 2.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -69.21 -33.31 73.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 32.1 t -75.15 -52.25 11.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.63 -21.25 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 352' ' ' TYR . . . . . 0.532 ' HH ' ' CE1' ' C' ' 357' ' ' HIS . 82.7 t80 -84.58 -47.83 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.893 . . . . 0.0 109.426 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -64.44 -24.64 67.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.315 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -72.99 -57.61 3.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.14 -58.32 8.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.38 142.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 357' ' ' HIS . . . . . 0.532 ' CE1' ' HH ' ' C' ' 352' ' ' TYR . 10.1 m80 -58.72 143.93 45.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 358' ' ' GLY . . . . . 0.449 ' C ' ' N ' ' C' ' 360' ' ' LYS . . . -83.89 -112.29 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 49.62 15.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 109.319 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 360' ' ' LYS . . . . . 0.449 ' N ' ' C ' ' C' ' 358' ' ' GLY . 17.6 pttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.94 110.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -167.23 50.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -153.28 89.3 1.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.424 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 1.6 t 62.03 104.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 6.3 t -153.45 127.43 8.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -148.45 69.13 10.36 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.704 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.31 -40.17 33.64 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.276 1.318 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 131' ' ' ASN . 16.9 t -52.46 -44.59 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.352 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 428' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' D' ' 431' ' ' ASN . 4.8 t -53.9 -56.72 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.345 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.0 -38.57 17.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 108.859 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.924 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -70.5 -28.81 65.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 431' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.2 m-20 -68.98 -63.88 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.194 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.7 tp -48.93 -36.39 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' D' ' 430' ' ' ALA . 20.2 mt -59.01 -41.03 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 434' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' D' ' 431' ' ' ASN . . . -56.99 -42.8 93.06 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.594 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.7 mp -61.22 -40.97 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.14 -1.212 . . . . 0.0 108.631 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 436' ' ' LEU . . . . . 0.516 ' HA ' HD12 ' D' ' 439' ' ' ILE . 0.5 OUTLIER -67.59 -35.16 78.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.062 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.515 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -56.77 -49.21 75.99 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.362 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.805 HD13 ' CE1' ' C' ' 337' ' ' HIS . 9.9 tp -67.92 -35.27 78.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.712 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 439' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' D' ' 436' ' ' LEU . 13.5 mt -50.52 -41.9 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.708 -1.245 . . . . 0.0 108.104 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.0 tt -70.0 -40.56 75.2 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 441' ' ' TRP . . . . . 0.565 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 89.0 t90 -54.31 -55.98 22.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.102 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 65.8 mt -53.18 -54.46 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.01 -53.99 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -52.82 -28.27 21.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.341 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -74.56 -48.31 27.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.598 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 446' ' ' LEU . . . . . 0.423 ' N ' HD12 ' D' ' 446' ' ' LEU . 10.8 mp -63.37 -47.46 82.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.553 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -86.66 86.18 7.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -69.48 -5.55 24.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.02 18.08 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.35 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 23.3 t -47.93 -31.97 5.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 89.8 mt -79.74 117.07 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 109.445 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -87.24 124.29 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -85.44 44.97 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.572 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 50.33 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 109.561 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 49.88 88.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.409 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.82 78.7 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 12.9 m80 52.31 -175.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 70.57 -84.72 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 459' ' ' LEU . . . . . 0.443 HD12 ' N ' ' D' ' 459' ' ' LEU . 10.9 mp -76.95 148.82 36.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.454 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.1 m -68.65 -81.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -61.76 -31.02 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 t70 53.0 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.494 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.6 p -167.4 164.25 15.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.56 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.12 -8.19 59.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -165.07 70.9 1.41 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.07 -27.51 49.75 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.385 1.39 . . . . 0.0 112.53 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -74.06 -45.48 49.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.868 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.91 -51.18 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.701 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.687 HG23 ' N ' ' A' ' 129' ' ' ALA . 35.0 m -64.84 -54.73 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.716 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.687 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.92 -23.53 19.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.99 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.47 -20.34 22.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 0.4 OUTLIER -74.75 -43.66 53.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.482 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 8.7 mt -51.06 -45.8 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.489 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.74 -36.36 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 108.891 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -40.66 78.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.655 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.0 mt -67.96 -56.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.419 -1.048 . . . . 0.0 109.071 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.56 -35.87 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 108.792 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.916 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -58.5 -59.25 5.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.12 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.881 HD21 ' NE2' ' C' ' 337' ' ' HIS . 11.2 mt -53.25 -51.42 62.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 75.4 mt -54.01 -31.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.15 -58.63 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.552 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.5 OUTLIER -50.95 -50.94 56.96 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.553 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.0 tt -61.72 -41.99 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.488 ' N ' HG23 ' A' ' 142' ' ' ILE . 4.8 mt -54.2 -35.9 62.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.075 . . . . 0.0 108.978 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -76.35 -29.36 57.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.416 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.32 -35.28 79.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.27 -15.33 20.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.714 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.11 39.17 1.32 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 109.649 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.1 OUTLIER -47.86 -33.33 7.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.75 -39.29 93.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.392 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.0 m -67.13 -48.59 67.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.474 HD12 ' N ' ' A' ' 151' ' ' ILE . 1.7 mp -63.94 -30.24 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -73.07 -50.37 23.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.87 -38.46 83.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.41 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -59.21 -42.25 90.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.04 -11.43 60.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -148.87 116.09 6.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.447 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -151.23 -24.45 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.03 100.81 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.93 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.252 -1.146 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.422 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 3.0 m 57.46 102.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' B' ' 220' ' ' ASN . 0.1 OUTLIER -83.29 104.5 13.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.405 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -85.12 106.48 16.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.487 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.9 t -74.88 109.32 8.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.09 150.49 11.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.79 70.84 5.31 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.31 -27.01 55.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.33 1.353 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.92 -60.59 2.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.957 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 t -55.51 -39.02 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.481 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.39 -56.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.45 -43.28 23.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.239 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.736 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -69.53 -30.35 68.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.337 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.31 -65.16 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.427 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.4 tp -49.92 -37.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.177 -0.952 . . . . 0.0 108.675 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' B' ' 230' ' ' ALA . 13.2 mt -54.75 -45.89 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.47 -46.2 88.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.526 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.0 -53.93 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -1.167 . . . . 0.0 108.93 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.35 -38.18 71.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 0.0 109.424 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' HIS . . . . . 0.809 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.51 -47.21 70.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.088 -1.008 . . . . 0.0 109.375 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 238' ' ' LEU . . . . . 0.743 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.4 tp -67.81 -36.36 80.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.04 -39.89 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.764 -1.21 . . . . 0.0 107.894 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -37.47 69.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.4 -57.61 12.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.63 -54.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.258 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.65 -52.17 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.77 -33.8 57.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -65.29 -52.98 50.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.461 ' N ' HD12 ' B' ' 246' ' ' LEU . 10.9 mp -60.16 -33.13 71.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 247' ' ' PHE . . . . . 0.421 ' CB ' ' O ' ' B' ' 246' ' ' LEU . 2.2 t80 71.21 -3.52 2.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.2 t80 62.49 154.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -89.68 124.02 34.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 1.5 m -85.64 -9.58 57.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 69.4 mt 47.91 87.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.25 91.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -52.02 161.67 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 37.9 t80 -148.96 167.65 25.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 255' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.24 140.69 22.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.908 . . . . 0.0 109.513 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.26 168.41 13.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.62 154.91 39.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -80.6 -149.08 5.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.16 167.93 20.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -1.071 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 tttp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.427 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.304 0.574 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 33.0 m -68.65 -81.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.494 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.76 -31.03 71.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.97 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 1.6 p -167.35 164.36 15.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -7.97 59.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -165.22 70.94 1.38 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.544 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.03 -27.5 50.04 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.407 1.404 . . . . 0.0 112.55 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 7.8 mt -74.13 -45.49 48.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.88 -51.23 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.716 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 328' ' ' VAL . . . . . 0.681 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.8 m -64.77 -54.85 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 329' ' ' ALA . . . . . 0.681 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.85 -23.48 18.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.248 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -90.63 -20.17 22.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 331' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 0.4 OUTLIER -74.8 -43.66 53.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 8.8 mt -50.96 -46.0 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.52 -36.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 108.986 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.56 -40.64 79.06 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 335' ' ' ILE . . . . . 0.736 HG21 ' HB1' ' B' ' 230' ' ' ALA . 82.0 mt -67.93 -56.29 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.343 -1.093 . . . . 0.0 109.057 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.51 -35.93 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.928 . . . . 0.0 108.766 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 337' ' ' HIS . . . . . 0.881 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -58.41 -59.18 5.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.184 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 338' ' ' LEU . . . . . 0.916 HD21 ' NE2' ' A' ' 137' ' ' HIS . 11.1 mt -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 75.6 mt -54.24 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.38 -58.1 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.494 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -51.37 -50.76 58.9 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 342' ' ' ILE . . . . . 0.614 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.0 tt -61.94 -41.94 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' HG23 ' C' ' 342' ' ' ILE . 4.9 mt -53.95 -36.14 62.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.968 -1.083 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 344' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -76.28 -29.33 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.36 -35.3 79.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.21 -15.28 20.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.0 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.13 39.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.672 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 348' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.1 OUTLIER -47.95 -33.29 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.457 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.75 -39.34 94.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 25.6 m -67.04 -48.7 67.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 351' ' ' ILE . . . . . 0.481 ' N ' HD12 ' C' ' 351' ' ' ILE . 1.7 mp -63.91 -30.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -73.15 -50.38 22.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -67.8 -38.5 83.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.08 -42.3 90.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.15 -11.39 59.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.898 . . . . 0.0 109.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -148.9 116.09 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.519 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -151.2 -24.51 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 178.01 100.93 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.81 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -1.161 . . . . 0.0 109.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.469 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.0 m 57.54 102.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 420' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' D' ' 420' ' ' ASN . 0.1 OUTLIER -83.23 104.52 13.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.22 106.52 16.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.9 t -74.94 109.3 8.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.03 150.57 11.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.88 70.68 5.25 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.23 -27.09 56.37 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.306 1.337 . . . . 0.0 112.406 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.8 -60.66 2.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 427' ' ' VAL . . . . . 0.431 HG23 ' H ' ' D' ' 427' ' ' VAL . 4.9 t -55.48 -39.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.499 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.32 -56.82 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.37 23.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 430' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -69.54 -30.3 68.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.3 -65.09 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 432' ' ' ILE . . . . . 0.426 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.4 tp -49.89 -37.97 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 108.612 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 433' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' D' ' 430' ' ' ALA . 13.3 mt -54.67 -45.86 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 108.572 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.51 -46.22 88.37 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 435' ' ' ILE . . . . . 0.523 ' N ' HD12 ' D' ' 435' ' ' ILE . 1.8 mp -58.05 -53.9 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 108.885 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.37 -38.16 71.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.44 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 437' ' ' HIS . . . . . 0.807 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.54 -47.16 70.25 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.101 -0.999 . . . . 0.0 109.272 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 438' ' ' LEU . . . . . 0.718 HD13 ' ND1' ' C' ' 337' ' ' HIS . 7.7 tp -67.87 -36.44 80.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.713 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.1 mm -50.03 -39.88 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 107.862 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -37.33 68.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.31 -57.69 11.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.738 . . . . 0.0 109.168 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 67.0 mt -54.77 -53.9 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.64 -52.21 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.79 -33.73 56.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -65.36 -52.97 50.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 446' ' ' LEU . . . . . 0.457 ' N ' HD12 ' D' ' 446' ' ' LEU . 10.9 mp -60.11 -33.05 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 447' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' D' ' 446' ' ' LEU . 2.2 t80 70.99 -3.37 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.607 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.2 t80 62.43 154.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -89.66 124.05 34.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.338 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 1.4 m -85.68 -9.6 56.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 69.3 mt 47.99 87.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.18 91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -52.03 161.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 454' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' D' ' 455' ' ' PHE . 38.0 t80 -148.97 167.63 25.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.332 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 455' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' D' ' 454' ' ' PHE . 0.0 OUTLIER -150.24 140.71 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.29 168.3 13.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.43 154.98 39.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.465 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -80.57 -149.05 5.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 167.91 20.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 18.7 tttp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.434 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.575 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -74.88 -41.97 58.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.557 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.7 mt -51.85 -42.93 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.66 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.0 109.002 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.53 96.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.525 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.3 mt -66.6 -57.29 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.242 -1.152 . . . . 0.0 109.091 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.39 -36.89 23.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 108.73 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.938 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.26 -57.28 13.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.914 HD21 ' NE2' ' C' ' 337' ' ' HIS . 18.3 mt -51.75 -50.35 60.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.833 . . . . 0.0 109.745 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mt -53.05 -31.95 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.3 -59.15 2.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -49.81 -42.85 47.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.584 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.2 tt -72.72 -42.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.485 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 tt -59.78 -28.5 67.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.048 . . . . 0.0 109.064 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -45.43 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.51 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 61.5 ttt180 -55.76 -34.95 65.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.38 -51.07 6.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 -179.894 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 CA-C-O 121.178 0.407 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.42 ' N ' HD12 ' B' ' 226' ' ' LEU . 11.0 mp -60.64 -47.64 85.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.586 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.582 ' CG1' HD21 ' C' ' 331' ' ' ASN . 11.4 t -62.63 -33.58 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.31 -59.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.68 -39.53 17.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.933 . . . . 0.0 108.957 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -71.26 -32.0 68.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.387 -0.821 . . . . 0.0 109.247 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -63.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.442 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -50.94 -38.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.031 -1.043 . . . . 0.0 108.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.442 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.8 mt -54.92 -44.18 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -55.5 -48.41 70.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.553 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -55.91 -38.29 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -1.148 . . . . 0.0 108.705 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.15 -35.91 76.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.247 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.866 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.2 OUTLIER -55.68 -47.98 75.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.046 -1.034 . . . . 0.0 109.025 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.709 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.6 tp -67.79 -36.96 81.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.629 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.827 -1.171 . . . . 0.0 108.145 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.7 -35.13 65.12 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . 0.526 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -60.7 -56.12 25.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 109.419 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . 0.492 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.1 tt -65.32 -41.11 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.375 -0.828 . . . . 0.0 109.575 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.492 ' N ' HG23 ' B' ' 242' ' ' ILE . 0.6 OUTLIER -60.69 -36.86 79.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.441 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.4 -50.58 58.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.62 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.73 -28.69 68.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.553 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.582 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -74.9 -42.1 58.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.9 mt -51.81 -43.01 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.5 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -59.23 -44.5 96.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.561 HG21 ' HB1' ' B' ' 230' ' ' ALA . 83.4 mt -66.63 -57.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -1.111 . . . . 0.0 109.082 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.4 mt -49.31 -36.83 22.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 108.802 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.914 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.36 -57.26 13.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.043 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.938 HD21 ' NE2' ' A' ' 137' ' ' HIS . 18.5 mt -51.7 -50.34 60.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -0.784 . . . . 0.0 109.772 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 19.2 mt -53.09 -32.07 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.626 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.21 -58.81 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.16 -0.962 . . . . 0.0 109.682 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -50.22 -42.59 51.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.869 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.588 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.2 tt -73.03 -41.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 109.6 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.2 tt -59.8 -28.54 67.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 -45.36 30.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 109.421 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . 0.526 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 61.6 ttt180 -55.73 -34.99 65.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.35 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.4 -51.23 6.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.391 -0.818 . . . . 0.0 109.554 -179.817 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-O 121.216 0.423 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . 0.412 ' N ' HD12 ' D' ' 426' ' ' LEU . 11.0 mp -60.61 -47.56 85.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.575 ' CG1' HD21 ' A' ' 131' ' ' ASN . 11.5 t -62.69 -33.48 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.553 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.41 -59.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.72 -39.52 17.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 108.972 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.525 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -71.32 -31.84 67.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.522 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.421 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.7 tp -50.92 -38.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.112 -0.993 . . . . 0.0 108.394 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.421 ' N ' HG23 ' D' ' 432' ' ' ILE . 10.8 mt -54.92 -44.25 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -55.33 -48.53 68.79 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.548 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -55.88 -38.33 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -1.128 . . . . 0.0 108.644 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.06 -36.05 77.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.883 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.58 -48.04 75.46 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.923 -1.11 . . . . 0.0 108.976 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.69 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.7 tp -67.77 -36.96 81.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.821 -1.151 . . . . 0.0 109.665 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.13 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.873 -1.142 . . . . 0.0 108.089 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.74 -35.12 65.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . 0.51 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.2 t90 -60.5 -56.09 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.517 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . 0.491 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.2 tt -65.56 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.624 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . 0.491 ' N ' HG23 ' D' ' 442' ' ' ILE . 0.6 OUTLIER -60.57 -36.89 79.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.437 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.46 -50.52 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.82 -28.72 69.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 121.508 0.671 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -37.5 71.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 109.525 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.85 -46.11 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.518 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.5 tt -75.57 -31.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 108.864 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.03 85.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.632 HG21 ' HB1' ' D' ' 430' ' ' ALA . 63.0 mt -68.32 -52.97 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -1.048 . . . . 0.0 108.936 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -50.02 -35.01 23.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 108.904 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.94 -58.07 7.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.7 mt -55.35 -46.8 76.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.602 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.2 mt -55.27 -34.89 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.53 -57.4 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -50.38 -54.51 21.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.317 -0.864 . . . . 0.0 109.576 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.659 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.8 tt -58.93 -42.7 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.49 ' N ' HG23 ' A' ' 142' ' ' ILE . 6.3 mt -54.41 -31.06 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 0.0 109.043 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.2 -34.92 56.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 109.486 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -29.87 67.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.576 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.04 -15.73 20.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.645 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.686 -179.728 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.489 1.209 0 CA-C-O 121.235 0.431 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.0 mp -50.42 -41.45 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.445 ' H ' HG23 ' B' ' 227' ' ' VAL . 2.7 t -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.23 -58.87 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.07 -39.61 13.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.101 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.65 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.69 -33.68 66.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.865 . . . . 0.0 109.163 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.44 -62.02 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.977 . . . . 0.0 109.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.447 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.2 tp -51.28 -38.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.718 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.447 ' N ' HG23 ' B' ' 232' ' ' ILE . 7.3 mt -54.03 -46.45 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 108.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.67 88.73 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.476 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -57.64 -52.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -1.148 . . . . 0.0 108.715 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.7 -38.32 72.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 109.551 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.825 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.49 -47.44 69.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.036 -1.04 . . . . 0.0 109.352 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.744 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.8 tp -67.16 -36.74 82.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.13 -40.11 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.99 -34.43 66.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.72 -55.19 36.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.6 tt -63.51 -35.5 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.778 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.465 HD23 ' C ' ' B' ' 243' ' ' LEU . 2.0 tt -67.5 -62.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -46.76 -50.85 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.605 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.1 OUTLIER -57.12 -35.41 69.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -37.58 71.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.526 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.81 -46.28 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 tt -75.35 -31.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.115 -0.991 . . . . 0.0 108.978 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.11 -45.92 86.39 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.65 HG21 ' HB1' ' B' ' 230' ' ' ALA . 63.0 mt -68.32 -53.11 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.374 -1.074 . . . . 0.0 108.911 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.4 tp -49.78 -35.22 21.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.7 -58.2 7.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.7 mt -55.33 -46.68 76.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -0.819 . . . . 0.0 109.704 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.28 -35.06 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.56 -56.83 4.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -50.79 -54.3 24.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.68 HD12 ' ND1' ' B' ' 237' ' ' HIS . 3.9 tt -59.18 -42.53 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.09 -1.006 . . . . 0.0 109.436 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.483 ' N ' HG23 ' C' ' 342' ' ' ILE . 6.3 mt -54.49 -31.04 55.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -77.39 -34.75 54.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -29.87 67.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.58 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.05 -15.69 20.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.702 -179.754 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.489 1.241 0 CA-C-O 121.19 0.412 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mp -50.4 -41.39 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.07 -35.98 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.629 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.22 -58.91 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.23 -39.55 14.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.632 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.61 -33.72 66.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.184 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.49 -61.98 1.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.417 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.442 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.2 tp -51.32 -38.57 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 108.688 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.442 ' N ' HG23 ' D' ' 432' ' ' ILE . 7.4 mt -53.95 -46.43 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.67 -46.73 88.71 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.471 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.7 mp -57.58 -52.97 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -1.136 . . . . 0.0 108.744 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.65 -38.45 72.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.827 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.35 -47.54 69.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.054 -1.029 . . . . 0.0 109.334 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.733 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.0 tp -67.05 -36.91 83.09 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.11 -39.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.855 -1.153 . . . . 0.0 107.925 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.13 -34.35 66.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -60.46 -55.32 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.638 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.62 -35.38 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . 0.459 HD23 ' C ' ' D' ' 443' ' ' LEU . 2.0 tt -67.5 -62.48 1.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.533 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -46.77 -50.86 17.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.1 OUTLIER -57.13 -35.29 69.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.469 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.497 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.391 0.615 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.63 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.4 OUTLIER -74.91 -38.03 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.623 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 132' ' ' ILE . 4.1 mt -50.42 -44.95 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.414 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.0 tt -77.91 -35.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 109.025 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.86 -46.65 90.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' D' ' 430' ' ' ALA . 79.2 mt -67.23 -56.4 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -1.072 . . . . 0.0 109.177 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mt -49.93 -33.58 17.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.007 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.777 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.12 -52.71 61.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 109.122 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.784 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.9 mt -55.37 -38.06 68.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.736 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.5 mt -68.77 -29.7 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.65 -55.25 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 109.826 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.12 -43.39 61.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.77 HD13 ' NE2' ' D' ' 437' ' ' HIS . 4.0 tp -72.79 -44.39 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.033 -1.042 . . . . 0.0 109.697 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.561 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 mt -48.52 -35.5 13.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 109.218 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -47.22 23.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -28.16 6.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -16.39 15.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.029 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.872 -179.525 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.49 1.316 0 CA-C-O 121.159 0.4 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.84 -37.81 32.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.634 ' CG1' HD21 ' C' ' 331' ' ' ASN . 6.6 t -64.64 -35.89 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.57 -58.11 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 109.339 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.33 -37.27 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.946 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -73.11 -35.28 66.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.021 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.497 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -64.99 -62.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.481 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.0 tp -51.02 -40.22 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.05 -1.031 . . . . 0.0 108.585 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.481 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.1 mt -53.73 -42.31 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.12 -46.7 92.37 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.543 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -57.28 -39.12 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 0.0 108.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.31 -35.27 73.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.422 -0.799 . . . . 0.0 109.371 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.787 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.3 OUTLIER -55.07 -49.81 70.72 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.934 -1.104 . . . . 0.0 109.014 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 137' ' ' HIS . 12.0 tp -67.68 -36.6 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.66 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.74 -37.56 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.859 -1.151 . . . . 0.0 108.293 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.29 -40.62 62.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -53.74 -53.19 55.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.502 -0.749 . . . . 0.0 109.415 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 14.9 tt -67.39 -33.57 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.18 -59.51 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -52.54 -43.14 64.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -62.85 -30.96 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . 0.486 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.634 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.4 OUTLIER -75.09 -38.07 61.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.529 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.405 HG21 HD13 ' C' ' 332' ' ' ILE . 4.4 mt -50.43 -45.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 tt -77.7 -35.49 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.104 -0.998 . . . . 0.0 108.932 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.79 88.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.549 HG21 ' HB1' ' B' ' 230' ' ' ALA . 79.9 mt -67.06 -56.54 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.276 -1.132 . . . . 0.0 109.198 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 mt -49.84 -33.67 17.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 108.981 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.784 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.15 -52.6 61.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.135 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.777 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.9 mt -55.43 -37.98 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.773 . . . . 0.0 109.753 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 7.7 mt -68.88 -29.63 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.83 -54.66 5.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.819 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -51.55 -43.45 62.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.055 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.787 HD13 ' NE2' ' B' ' 237' ' ' HIS . 4.1 tp -72.62 -44.39 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.555 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.46 -35.65 13.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.014 -1.054 . . . . 0.0 109.21 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -47.16 23.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -28.23 6.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.99 . . . . 0.0 109.565 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.94 -16.34 15.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.528 -0.733 . . . . 0.0 110.017 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 109.853 -179.607 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.489 1.242 0 CA-C-O 121.298 0.458 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.87 -37.79 32.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.63 ' CG1' HD21 ' A' ' 131' ' ' ASN . 7.0 t -64.69 -35.87 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.69 -58.08 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.274 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.37 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.136 -0.978 . . . . 0.0 108.933 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -73.09 -35.21 66.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.058 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.486 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.8 OUTLIER -64.99 -62.74 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.468 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.0 tp -51.01 -40.26 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.21 -0.932 . . . . 0.0 108.573 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.468 ' N ' HG23 ' D' ' 432' ' ' ILE . 10.3 mt -53.6 -42.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.171 -0.955 . . . . 0.0 108.475 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.09 -46.82 92.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.533 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -57.13 -39.23 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.34 -35.19 73.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.459 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.77 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -55.06 -49.8 70.7 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.014 -1.054 . . . . 0.0 109.082 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.717 HD13 ' CE1' ' C' ' 337' ' ' HIS . 12.4 tp -67.62 -36.72 81.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.78 -1.168 . . . . 0.0 109.663 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.7 -37.62 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 108.211 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.2 -40.59 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -53.77 -53.03 57.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 109.481 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.6 -33.4 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.14 -59.65 4.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -52.47 -43.16 64.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -62.91 -30.86 71.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.53 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -40.11 28.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 109.585 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.52 -45.21 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.347 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.486 HG21 HD11 ' B' ' 235' ' ' ILE . 11.0 tt -76.73 -44.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.173 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -48.11 -45.19 26.86 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.506 HG21 ' HB1' ' D' ' 430' ' ' ALA . 95.6 mt -67.1 -55.66 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.01 -33.16 17.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.94 . . . . 0.0 108.929 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.925 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -62.33 -55.12 31.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.91 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.1 mt -55.06 -45.85 75.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.24 -35.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.39 -57.06 3.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.4 t-105 -48.9 -51.76 28.19 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.205 -0.935 . . . . 0.0 109.682 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.508 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.6 tt -65.26 -41.85 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 0.0 110.077 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -59.42 -30.69 68.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.04 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -37.77 59.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.18 73.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.32 -47.38 8.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.662 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 121.203 0.418 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -59.0 5.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.595 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.38 -35.08 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.62 -59.59 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.371 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.27 -37.48 10.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.526 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.45 -32.43 66.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.861 . . . . 0.0 109.233 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -58.51 4.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.71 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.82 -35.41 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.037 -1.039 . . . . 0.0 108.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.12 -44.17 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.75 -45.14 95.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.486 HD11 HG21 ' A' ' 133' ' ' ILE . 75.3 mt -60.56 -53.81 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.224 -1.163 . . . . 0.0 108.961 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.53 -35.41 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.299 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.821 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -56.06 -48.74 75.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.766 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.8 tp -64.48 -37.71 88.5 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.638 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.36 -38.98 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' B' ' 240' ' ' LEU . 52.3 tp -72.85 -32.7 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.31 -57.77 8.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.501 -0.75 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . 0.456 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.5 tt -62.11 -38.12 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.63 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.456 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.2 tp -69.3 -26.84 64.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.66 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.53 -43.15 23.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -64.42 -55.75 18.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.596 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 -40.24 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 mt -51.47 -45.29 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.327 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . 0.481 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -76.54 -44.6 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.249 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . 0.481 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -48.32 -44.98 28.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.526 HG21 ' HB1' ' B' ' 230' ' ' ALA . 95.6 mt -67.25 -55.58 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -1.115 . . . . 0.0 109.211 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.07 -33.07 17.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.91 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.4 -55.07 31.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 108.893 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.925 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.0 mt -55.14 -45.84 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.394 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.28 -35.5 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.41 -56.36 4.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.4 t-105 -49.44 -51.6 34.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -0.863 . . . . 0.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.509 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.5 tt -65.49 -41.85 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.847 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.4 tt -59.22 -30.9 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.036 -1.04 . . . . 0.0 109.2 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -37.66 59.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -32.14 73.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.35 -47.38 8.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.643 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.571 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 121.235 0.431 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -58.95 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.602 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.32 -35.15 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.7 -59.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.417 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -37.35 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.214 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.53 -32.4 66.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -58.38 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.732 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.7 tp -56.97 -35.34 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 108.89 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.3 mt -57.04 -44.24 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 108.568 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.63 -45.26 94.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.469 HD11 HG21 ' C' ' 333' ' ' ILE . 75.2 mt -60.48 -53.75 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -1.146 . . . . 0.0 108.978 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.83 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -55.98 -48.85 75.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.742 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.0 tp -64.41 -37.8 88.8 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.637 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.3 -39.01 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.91 -32.6 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.26 -57.77 8.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.418 -0.801 . . . . 0.0 109.59 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . 0.449 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.6 tt -62.22 -38.0 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . 0.449 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.2 tp -69.23 -26.96 65.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -79.43 -43.26 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -64.41 -55.72 19.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.535 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.578 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.49 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER -80.22 -44.7 19.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 109.989 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.49 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mm -51.77 -42.55 32.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.533 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 134' ' ' GLY . 13.2 tt -76.12 -42.08 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.226 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -51.31 -45.92 52.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.699 HG21 ' HB1' ' D' ' 430' ' ' ALA . 76.0 mt -66.31 -57.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -1.11 . . . . 0.0 109.277 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.52 -34.33 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.154 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.927 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.2 -60.62 3.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.225 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.944 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.3 mt -50.9 -44.55 59.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -57.66 -32.9 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.59 -56.74 3.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.602 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.3 t-105 -48.44 -48.35 37.54 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.333 -0.854 . . . . 0.0 109.619 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.558 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.9 tt -68.69 -42.07 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.518 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -57.85 -31.88 67.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.107 . . . . 0.0 109.183 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -46.07 50.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.12 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.09 -23.26 65.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.109 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.04 -16.54 20.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.568 -179.804 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.223 0.426 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -47.5 73.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.82 -42.67 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.9 t -58.26 -56.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.316 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.23 21.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 108.947 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.743 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -69.39 -28.81 66.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.01 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.5 t-20 -68.48 -63.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.54 -36.49 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.116 -0.99 . . . . 0.0 108.425 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' B' ' 230' ' ' ALA . 22.5 mt -58.4 -42.55 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.58 84.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.577 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.1 -52.11 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.105 -1.232 . . . . 0.0 108.672 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.35 74.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.449 -0.782 . . . . 0.0 109.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.824 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -52.73 -46.78 67.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.075 -1.016 . . . . 0.0 109.449 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.732 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.7 tp -67.5 -37.63 83.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.764 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.8 mm -49.37 -39.86 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.817 -1.177 . . . . 0.0 108.028 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.97 -35.67 66.96 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.92 -57.28 13.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.573 -0.704 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . 0.402 HG23 ' N ' ' B' ' 243' ' ' LEU . 11.3 tt -60.05 -37.86 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.583 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.402 ' N ' HG23 ' B' ' 242' ' ' ILE . 1.0 OUTLIER -56.19 -58.96 5.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.488 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' B' ' 244' ' ' ASP . 4.5 m-20 -55.55 -51.06 68.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -49.73 -28.1 5.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.334 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.18 0.514 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.484 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -80.18 -44.84 19.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 0.0 110.033 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.6 mm -51.72 -42.62 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.504 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . 0.493 HG23 ' N ' ' C' ' 334' ' ' GLY . 13.2 tt -75.99 -42.14 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . 0.493 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -51.32 -45.8 52.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.743 HG21 ' HB1' ' B' ' 230' ' ' ALA . 74.8 mt -66.33 -57.34 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -1.111 . . . . 0.0 109.227 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.42 -34.3 16.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.165 -0.96 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.944 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.18 -60.71 3.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.329 -0.857 . . . . 0.0 109.143 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.927 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.2 mt -50.84 -44.58 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.484 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.72 -32.85 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.66 -56.24 4.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.574 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.3 t-105 -49.02 -47.98 44.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.606 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.567 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.8 tt -69.05 -41.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.499 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tt -57.73 -32.04 67.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.57 -45.92 50.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.183 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.06 -23.26 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.889 . . . . 0.0 109.15 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.01 -16.48 20.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.648 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 109.56 -179.763 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 CA-C-O 121.257 0.44 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.77 -47.41 73.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.78 -42.7 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.611 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.9 t -58.25 -56.61 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.87 -40.4 21.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 108.936 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -69.38 -28.7 66.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 109.029 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.5 t-20 -68.52 -63.81 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.5 -36.54 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' D' ' 430' ' ' ALA . 22.7 mt -58.4 -42.48 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.72 -47.54 84.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.571 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -56.18 -52.06 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.138 -1.213 . . . . 0.0 108.629 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.36 74.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.547 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.83 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -52.69 -46.81 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.095 -1.003 . . . . 0.0 109.402 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.725 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.8 tp -67.55 -37.53 82.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.78 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.2 mm -49.38 -39.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.857 -1.152 . . . . 0.0 108.045 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.99 -35.66 66.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.69 -57.39 13.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.679 . . . . 0.0 109.629 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.25 -37.73 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.12 -58.95 5.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 0.0 109.414 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' D' ' 444' ' ' ASP . 4.5 m-20 -55.71 -50.94 68.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -49.86 -27.98 5.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.296 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.503 179.857 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -80.76 -42.68 21.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 109.641 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 131' ' ' ASN . 4.4 mt -50.12 -44.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.42 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 134' ' ' GLY . 11.1 tt -76.16 -47.24 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.227 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.525 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -47.75 -43.27 22.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.561 HG21 ' HB1' ' D' ' 430' ' ' ALA . 98.1 mt -68.18 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -1.186 . . . . 0.0 109.254 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.7 -31.96 5.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.924 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.17 -58.81 5.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.364 -0.835 . . . . 0.0 109.0 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.929 HD21 ' NE2' ' C' ' 337' ' ' HIS . 13.0 mt -48.98 -50.99 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 139' ' ' ILE . 1.7 mp -55.18 -33.47 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.59 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.63 -58.42 3.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.975 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -53.09 -46.03 68.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.29 -0.882 . . . . 0.0 109.996 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.487 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.0 OUTLIER -67.59 -42.44 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.816 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.483 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -55.63 -34.64 65.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.082 -1.012 . . . . 0.0 108.811 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -74.3 -35.12 63.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.512 -0.743 . . . . 0.0 109.222 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -32.61 72.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.2 -14.72 23.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.65 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.496 1.825 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.798 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.244 0 CA-C-O 121.234 0.431 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.02 -61.25 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.968 . . . . 0.0 109.575 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.437 ' H ' HG23 ' B' ' 227' ' ' VAL . 11.0 t -51.39 -40.52 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 109.432 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.25 -58.0 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.217 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.19 -36.26 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 108.977 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.5 -30.93 64.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.379 -0.826 . . . . 0.0 109.187 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -59.61 3.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.415 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.0 tp -55.44 -36.94 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 0.0 108.689 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.415 ' N ' HG23 ' B' ' 232' ' ' ILE . 12.7 mt -56.64 -42.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.255 -0.903 . . . . 0.0 108.679 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.35 95.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 133' ' ' ILE . 81.3 mt -59.71 -53.27 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 0.0 108.76 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.63 -37.0 70.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.373 -0.829 . . . . 0.0 109.22 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.838 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -54.2 -47.43 72.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.295 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.737 HD13 ' ND1' ' A' ' 137' ' ' HIS . 8.0 tp -67.11 -37.56 84.11 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.683 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 41.0 mm -49.36 -39.4 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.848 -1.157 . . . . 0.0 107.994 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -35.32 65.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -60.12 -57.93 10.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.514 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 9.5 tt -61.27 -35.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.2 -32.72 73.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.3 -36.76 69.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -72.55 -47.1 50.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' C' ' 332' ' ' ILE . 0.2 OUTLIER -80.61 -42.85 21.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.578 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' C' ' 331' ' ' ASN . 4.4 mt -50.02 -44.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.437 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . 0.531 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -76.04 -47.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 109.286 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . 0.531 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -47.95 -43.36 23.91 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.568 HG21 ' HB1' ' B' ' 230' ' ' ALA . 98.2 mt -68.19 -59.1 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -1.129 . . . . 0.0 109.27 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.84 -31.89 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 108.867 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.929 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.21 -58.62 6.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.924 HD21 ' NE2' ' A' ' 137' ' ' HIS . 13.1 mt -49.02 -51.06 33.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -0.877 . . . . 0.0 109.73 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . 0.457 ' N ' HD12 ' C' ' 339' ' ' ILE . 1.7 mp -55.11 -33.64 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -57.87 3.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 109.916 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -53.71 -45.82 70.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 110.01 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.481 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.0 OUTLIER -67.71 -42.25 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 109.665 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tt -55.8 -34.55 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.999 -1.063 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -74.54 -34.95 63.09 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.402 -0.811 . . . . 0.0 109.139 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -32.59 71.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.118 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.31 -14.57 23.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.877 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.413 -0.804 . . . . 0.0 109.647 -179.817 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.49 1.286 0 CA-C-O 121.188 0.412 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.04 -61.09 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.638 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.42 HG23 ' H ' ' D' ' 427' ' ' VAL . 11.3 t -51.55 -40.42 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.6 t -57.31 -57.99 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.26 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.1 -36.35 13.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 108.958 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.46 -30.96 65.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.1 OUTLIER -68.13 -59.6 3.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.656 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.409 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.0 tp -55.43 -36.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.973 -1.08 . . . . 0.0 108.667 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.409 ' N ' HG23 ' D' ' 432' ' ' ILE . 12.7 mt -56.68 -42.6 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.579 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.07 -45.35 95.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.455 HD11 HG21 ' C' ' 333' ' ' ILE . 81.8 mt -59.68 -53.19 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -1.116 . . . . 0.0 108.823 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.73 -36.93 70.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.228 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.845 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -54.21 -47.41 72.18 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.229 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.723 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.0 tp -67.1 -37.69 84.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.62 -1.232 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.8 mm -49.23 -39.59 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -35.19 65.69 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -59.97 -58.0 10.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.512 -0.743 . . . . 0.0 109.493 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 9.7 tt -61.41 -35.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 0.0 109.615 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.24 -32.65 73.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.31 -36.76 68.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -72.55 -47.14 50.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.468 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.336 0.589 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -39.48 61.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.6 mt -52.86 -45.17 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.273 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.46 -26.87 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 0.0 109.018 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.85 -55.75 29.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 136' ' ' LEU . 4.1 tp -65.32 -48.17 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -1.085 . . . . 0.0 108.702 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 135' ' ' ILE . 2.2 tp -50.03 -40.04 43.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 108.59 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.913 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -60.11 -52.89 63.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.409 -0.807 . . . . 0.0 108.882 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.902 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.4 mt -56.84 -49.76 74.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.401 -0.812 . . . . 0.0 109.568 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.62 -33.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.336 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.64 -59.7 2.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -48.57 -53.3 18.86 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.65 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.4 tt -60.15 -43.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.506 ' N ' HG23 ' A' ' 142' ' ' ILE . 7.0 mt -54.8 -31.68 59.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.134 . . . . 0.0 108.952 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.19 -33.49 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mp -93.48 -16.51 24.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.888 . . . . 0.0 109.707 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.63 -179.87 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 121.303 0.46 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 226' ' ' LEU . 10.8 mp -63.44 -57.58 9.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -36.34 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.2 -0.937 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -57.38 -59.31 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.218 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.28 16.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.51 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -69.92 -29.75 66.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -0.823 . . . . 0.0 109.098 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' B' ' 228' ' ' VAL . 33.8 m-20 -67.74 -63.62 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 7.2 tp -50.34 -36.46 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 108.534 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' B' ' 230' ' ' ALA . 17.9 mt -57.85 -43.44 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.212 -0.93 . . . . 0.0 108.579 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.81 88.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.545 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.94 -50.85 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 108.707 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.35 -38.44 77.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.821 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.2 -46.69 69.14 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.957 -1.089 . . . . 0.0 109.278 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.764 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.8 tp -67.82 -36.87 81.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.746 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -49.62 -39.83 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.29 -38.08 68.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -57.21 -56.09 26.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.507 -0.746 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.47 -47.23 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.18 -15.4 63.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.955 . . . . 0.0 109.495 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -58.18 3.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.524 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -61.17 -31.78 71.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.631 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 109.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -39.4 61.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.89 -45.2 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.225 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 12.6 tt -78.3 -27.16 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.79 -55.73 29.2 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.543 HG23 ' N ' ' C' ' 336' ' ' LEU . 4.1 tp -65.32 -48.02 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -1.106 . . . . 0.0 108.78 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . 0.543 ' N ' HG23 ' C' ' 335' ' ' ILE . 2.1 tp -50.11 -39.99 44.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.902 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -60.11 -52.83 63.69 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.913 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.3 mt -56.88 -49.92 74.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.795 . . . . 0.0 109.488 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 36.0 mt -52.49 -33.16 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -79.7 -59.01 2.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -49.13 -52.93 23.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.697 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.662 HD12 ' ND1' ' B' ' 237' ' ' HIS . 3.4 tt -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.5 ' N ' HG23 ' C' ' 342' ' ' ILE . 7.1 mt -54.81 -31.64 59.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.953 -1.092 . . . . 0.0 109.101 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -77.36 -32.63 55.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -72.24 -33.59 67.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.542 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.35 -16.68 24.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.659 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.581 -179.791 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.243 0 CA-C-O 121.238 0.432 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . 0.504 ' N ' HD12 ' D' ' 426' ' ' LEU . 10.8 mp -63.42 -57.59 9.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.93 -36.36 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.429 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -57.44 -59.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.942 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.35 16.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 108.59 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -69.85 -29.82 67.15 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.451 -0.78 . . . . 0.0 109.123 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' D' ' 428' ' ' VAL . 33.5 m-20 -67.65 -63.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 7.3 tp -50.47 -36.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.125 -0.985 . . . . 0.0 108.569 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' D' ' 430' ' ' ALA . 17.7 mt -57.8 -43.52 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.523 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.77 87.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.539 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -56.98 -50.77 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -1.175 . . . . 0.0 108.741 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.42 -38.43 77.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.392 -0.817 . . . . 0.0 109.499 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.815 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.2 -46.64 69.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.747 HD13 ' ND1' ' C' ' 337' ' ' HIS . 7.9 tp -67.78 -36.97 81.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.759 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' D' ' 439' ' ' ILE . 37.0 mm -49.61 -39.74 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.81 -1.181 . . . . 0.0 107.836 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.38 -37.9 68.62 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.4 t90 -57.31 -55.89 28.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.507 -0.746 . . . . 0.0 109.091 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.71 -47.25 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.93 -15.6 63.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -58.09 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -61.23 -31.78 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.3 OUTLIER -74.67 -43.07 57.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -50.74 -45.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 tt -73.0 -34.97 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.223 -0.923 . . . . 0.0 108.894 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -41.86 81.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' D' ' 430' ' ' ALA . 69.0 mt -69.59 -58.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.342 -1.093 . . . . 0.0 108.999 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.91 -33.62 11.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.925 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.842 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -64.12 -51.02 65.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.031 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.761 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.6 mt -59.45 -40.77 87.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.85 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.6 tt -82.81 -54.1 5.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 109.541 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -50.77 -43.7 58.49 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.281 -0.887 . . . . 0.0 109.737 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.0 tp -72.21 -46.68 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.604 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 mt -48.88 -32.51 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 109.062 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.04 -54.27 7.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -50.56 -23.27 2.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.34 -17.57 16.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.812 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 121.324 0.468 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.63 -47.99 28.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.416 ' H ' HG23 ' B' ' 227' ' ' VAL . 2.3 t -62.89 -38.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.96 -58.83 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.49 15.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.635 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -71.72 -32.45 67.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.297 -0.877 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.438 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.431 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -50.12 -37.69 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.123 -0.986 . . . . 0.0 108.519 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.431 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.0 mt -55.92 -43.81 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.182 -0.949 . . . . 0.0 108.497 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.11 -44.29 93.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.532 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -59.9 -41.39 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -1.204 . . . . 0.0 108.561 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' B' ' 239' ' ' ILE . 3.7 tt -68.04 -33.79 75.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.275 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.578 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -57.37 -48.06 80.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.019 -1.051 . . . . 0.0 109.163 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.842 HD13 ' CE1' ' A' ' 137' ' ' HIS . 9.4 tp -68.23 -35.55 78.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.65 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' B' ' 236' ' ' LEU . 16.9 mt -50.42 -41.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.643 -1.286 . . . . 0.0 108.227 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.36 -38.66 71.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -55.45 -54.51 42.87 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.27 -52.45 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.0 109.225 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.03 -41.62 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -62.66 -47.19 84.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.494 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.54 -37.97 82.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.3 OUTLIER -74.75 -43.07 56.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.3 mt -50.65 -46.02 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.9 tt -72.74 -35.09 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.196 -0.94 . . . . 0.0 108.951 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.88 81.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.635 HG21 ' HB1' ' B' ' 230' ' ' ALA . 68.4 mt -69.59 -58.37 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 109.062 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.89 -33.63 11.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.94 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.835 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -64.12 -50.97 66.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.433 -0.792 . . . . 0.0 109.034 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.783 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.5 mt -59.58 -40.69 88.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.523 -0.736 . . . . 0.0 109.609 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.582 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.79 -53.44 5.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 109.581 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -51.34 -43.43 61.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.917 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.61 HG23 ' N ' ' C' ' 343' ' ' LEU . 9.9 tp -72.43 -46.52 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.61 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.74 -32.7 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.139 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -76.19 -54.17 7.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.378 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -50.48 -23.18 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.398 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.48 -17.53 16.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 109.719 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.294 0.456 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.57 -48.04 28.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.405 ' H ' HG23 ' D' ' 427' ' ' VAL . 2.3 t -62.85 -38.65 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.9 -58.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -39.44 15.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.09 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -71.77 -32.38 67.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.229 -0.919 . . . . 0.0 109.175 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -63.45 1.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.421 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.7 tp -50.13 -37.63 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.132 -0.98 . . . . 0.0 108.525 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.421 ' N ' HG23 ' D' ' 432' ' ' ILE . 9.9 mt -56.1 -43.66 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.14 -0.975 . . . . 0.0 108.467 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.33 93.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.532 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -59.87 -41.49 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.111 -1.229 . . . . 0.0 108.54 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . 0.554 ' HA ' HD12 ' D' ' 439' ' ' ILE . 3.7 tt -67.95 -33.81 75.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.426 -0.796 . . . . 0.0 109.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.585 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -57.4 -48.15 79.85 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.027 -1.045 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.835 HD13 ' CE1' ' C' ' 337' ' ' HIS . 9.7 tp -68.05 -35.8 78.82 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.618 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' D' ' 436' ' ' LEU . 17.0 mt -50.45 -41.69 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.725 -1.234 . . . . 0.0 108.21 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.41 -38.55 71.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -55.35 -54.59 41.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.43 -0.794 . . . . 0.0 109.073 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.32 -52.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.328 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -41.73 17.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -62.68 -47.2 84.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.55 -37.98 83.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.628 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.0 OUTLIER -76.03 -39.79 54.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.457 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.626 ' N ' ' ND2' ' A' ' 131' ' ' ASN . 7.2 mt -53.55 -44.3 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 109.378 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.424 HD13 HG13 ' B' ' 235' ' ' ILE . 8.1 tt -74.64 -36.41 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.59 91.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.427 HD11 ' OD1' ' A' ' 131' ' ' ASN . 17.5 mt -70.05 -60.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.344 -1.092 . . . . 0.0 109.136 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.98 -24.96 7.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.267 -0.896 . . . . 0.0 108.899 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.646 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -67.86 -55.51 12.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.159 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.559 HD22 ' ND1' ' D' ' 437' ' ' HIS . 2.4 mt -55.33 -48.27 74.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mt -58.41 -30.96 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 HD21 ' B' ' 238' ' ' LEU . 3.7 tt -75.96 -46.28 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.377 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CZ3' ' C' ' 341' ' ' TRP . 1.0 OUTLIER -50.65 -47.09 58.66 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 110.032 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 143' ' ' LEU . 9.5 tt -71.16 -42.91 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.04 -1.037 . . . . 0.0 109.908 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' N ' HG23 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -48.83 -36.74 17.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -75.63 -53.05 9.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.83 . . . . 0.0 109.592 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 66.9 ttt180 -50.48 -23.14 2.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.57 -17.42 15.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.724 . . . . 0.0 109.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 109.996 -179.63 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.207 0 CA-C-O 121.336 0.473 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.38 -41.62 39.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.595 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.642 ' CG1' HD21 ' C' ' 331' ' ' ASN . 13.8 t -61.05 -42.97 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.564 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.6 t -57.91 -58.63 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.431 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.74 -37.43 13.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.22 -31.2 67.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.137 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.0 t-20 -67.71 -64.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.405 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.1 tp -50.41 -36.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.127 -0.983 . . . . 0.0 108.565 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.405 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.8 mt -55.78 -45.12 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.28 -46.53 86.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.543 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.44 -40.43 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.313 . . . . 0.0 108.533 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -35.44 75.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.461 -0.774 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.608 ' C ' ' HD1' ' B' ' 237' ' ' HIS . 3.1 t-80 -54.07 -52.07 62.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.064 -1.022 . . . . 0.0 109.164 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.646 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.0 tp -69.85 -32.37 70.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.888 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.09 -38.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.516 -1.365 . . . . 0.0 107.864 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.85 62.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -50.5 -52.63 36.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.425 -0.797 . . . . 0.0 109.433 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.8 tt -68.0 -33.7 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.43 ' O ' HD23 ' B' ' 243' ' ' LEU . 1.6 tt -58.4 -58.3 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -58.9 -42.08 88.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -20.77 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.947 . . . . 0.0 109.607 -179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.642 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.0 OUTLIER -76.16 -39.83 54.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.612 ' N ' ' ND2' ' C' ' 331' ' ' ASN . 7.3 mt -53.56 -44.37 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . 0.43 HD13 HG13 ' D' ' 435' ' ' ILE . 8.3 tt -74.61 -36.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.42 91.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.427 HD11 ' OD1' ' C' ' 331' ' ' ASN . 17.5 mt -70.07 -60.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.119 . . . . 0.0 109.103 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.0 -24.84 7.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 108.844 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -68.07 -55.33 12.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.358 -0.839 . . . . 0.0 109.149 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.569 HD22 ' ND1' ' B' ' 237' ' ' HIS . 2.4 mt -55.35 -48.37 74.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.38 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 24.2 mt -58.44 -31.0 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -76.16 -45.45 33.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CZ3' ' CH2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -51.42 -46.72 63.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.436 -0.79 . . . . 0.0 110.063 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.46 HG23 ' N ' ' C' ' 343' ' ' LEU . 9.8 tt -71.42 -42.77 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 0.0 109.946 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.46 ' N ' HG23 ' C' ' 342' ' ' ILE . 0.5 OUTLIER -48.81 -36.7 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.192 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' C' ' 345' ' ' ARG . 0.0 OUTLIER -75.92 -52.89 9.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' C' ' 344' ' ' ASP . 67.0 ttt180 -50.4 -23.13 2.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 109.494 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.66 -17.36 15.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 109.858 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.625 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 121.245 0.436 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -41.6 39.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.628 ' CG1' HD21 ' A' ' 131' ' ' ASN . 14.3 t -61.16 -42.82 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.569 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.6 t -58.09 -58.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.89 -37.32 13.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.21 67.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 109.059 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.0 t-20 -67.71 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.411 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.1 tp -50.42 -36.79 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 108.552 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.411 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.6 mt -55.85 -44.99 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 108.325 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.48 86.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.544 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -56.41 -40.41 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.058 -1.26 . . . . 0.0 108.577 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -35.49 75.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.353 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.613 ' C ' ' HD1' ' D' ' 437' ' ' HIS . 3.0 t-80 -53.96 -52.07 61.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.099 -1.0 . . . . 0.0 109.185 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.633 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.3 tp -69.77 -32.43 70.92 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.976 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.14 -38.21 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.514 -1.366 . . . . 0.0 107.858 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.83 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.5 t90 -50.4 -52.57 36.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 109.487 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.9 tt -68.3 -33.43 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . 0.44 HD23 ' O ' ' D' ' 443' ' ' LEU . 1.6 tt -58.46 -58.28 9.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -58.84 -42.19 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.558 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -63.19 -20.75 65.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.528 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.521 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -72.92 -42.19 63.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.597 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.463 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -51.06 -46.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.504 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 tt -72.17 -34.15 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 108.768 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.69 -41.93 83.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.647 HG21 ' HB1' ' D' ' 430' ' ' ALA . 68.0 mt -68.37 -57.1 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.45 -1.029 . . . . 0.0 109.054 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -39.52 43.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 108.694 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.847 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -55.65 -55.37 32.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.816 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.3 mt -58.24 -53.54 57.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 81.8 mt -52.92 -29.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.47 -57.6 3.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.589 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.4 OUTLIER -50.01 -54.69 18.45 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -58.39 -44.93 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.557 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 mt -48.64 -36.27 15.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.0 -1.062 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -37.04 60.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -0.872 . . . . 0.0 109.604 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -64.37 -28.67 69.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.22 -14.18 18.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.799 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 0.0 109.779 -179.749 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.244 0.435 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.81 -53.91 28.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.539 ' CG1' HD21 ' C' ' 331' ' ' ASN . 21.3 t -56.9 -43.64 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' B' ' 231' ' ' ASN . 9.0 t -57.3 -55.36 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.82 23.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.228 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -67.69 -26.26 66.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.208 -0.932 . . . . 0.0 109.16 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' B' ' 228' ' ' VAL . 0.2 OUTLIER -69.97 -65.73 0.68 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.0 tp -50.31 -36.17 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.736 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' B' ' 230' ' ' ALA . 28.6 mt -57.95 -44.04 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.95 -43.17 95.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.484 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.8 -44.03 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -1.221 . . . . 0.0 108.739 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' B' ' 239' ' ' ILE . 6.0 mp -66.06 -36.03 82.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.812 ' ND1' HD22 ' C' ' 338' ' ' LEU . 1.8 t-80 -55.87 -48.27 75.85 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.847 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.5 tp -67.93 -36.06 79.49 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.767 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' B' ' 236' ' ' LEU . 10.6 mt -50.11 -40.48 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.183 . . . . 0.0 108.006 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.06 -39.21 69.19 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -55.51 -55.75 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.469 -0.77 . . . . 0.0 109.047 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.9 mt -55.49 -48.7 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.75 -50.42 66.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.452 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -48.99 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -53.55 -44.15 69.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 0.0 109.438 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.539 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.09 -42.37 63.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.1 mt -50.77 -46.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.8 tt -71.97 -34.24 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.092 -1.005 . . . . 0.0 108.815 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.9 83.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.691 HG21 ' HB1' ' B' ' 230' ' ' ALA . 67.5 mt -68.41 -57.13 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.343 -1.092 . . . . 0.0 109.071 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.02 -39.72 42.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 108.691 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.825 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -55.41 -55.5 30.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 109.044 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.822 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.3 mt -58.24 -53.57 56.74 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.537 -0.727 . . . . 0.0 109.735 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 82.3 mt -52.92 -29.93 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.57 -56.92 4.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -50.66 -54.67 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 109.738 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.572 HG23 ' N ' ' C' ' 343' ' ' LEU . 0.8 OUTLIER -58.33 -44.87 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.245 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.572 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.49 -36.5 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 0.0 109.197 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -36.85 60.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -64.39 -28.62 69.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.26 -14.24 18.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.786 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.73 -179.779 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.263 0.443 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.67 -54.01 26.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 131' ' ' ASN . 21.4 t -56.89 -43.75 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.616 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' D' ' 431' ' ' ASN . 9.5 t -57.27 -55.34 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.78 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -67.92 -25.97 65.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.238 -0.914 . . . . 0.0 109.157 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.2 OUTLIER -70.06 -65.79 0.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' D' ' 432' ' ' ILE . 8.0 tp -50.22 -36.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' D' ' 430' ' ' ALA . 28.4 mt -58.04 -43.91 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 108.468 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.06 -43.08 95.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.482 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -58.82 -44.1 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -1.234 . . . . 0.0 108.626 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' D' ' 439' ' ' ILE . 6.0 mp -66.14 -35.88 81.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.217 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.798 ' ND1' HD22 ' A' ' 138' ' ' LEU . 1.8 t-80 -56.06 -48.18 76.53 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.98 -1.075 . . . . 0.0 109.439 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.825 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.7 tp -67.83 -36.25 80.03 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.81 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' D' ' 436' ' ' LEU . 10.5 mt -50.02 -40.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 108.059 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.01 -39.14 69.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -55.52 -55.66 29.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.086 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.8 mt -55.79 -48.52 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.43 -0.794 . . . . 0.0 109.146 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.69 -50.54 65.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -48.91 69.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -53.62 -44.15 69.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.603 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.3 OUTLIER -69.07 -38.81 79.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.481 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.46 -47.89 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.8 tt -77.75 -27.08 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -0.922 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.09 -55.12 32.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 mm -65.24 -48.67 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.023 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.5 -38.69 60.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.982 . . . . 0.0 108.735 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.795 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -59.59 -52.35 65.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.025 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.803 HD21 ' CE1' ' C' ' 337' ' ' HIS . 3.5 mt -57.34 -49.43 76.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.78 . . . . 0.0 109.674 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.34 -34.69 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 109.86 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -77.93 -45.14 24.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.06 -1.025 . . . . 0.0 109.918 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 2.1 t-105 -48.7 -51.45 28.56 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 109.948 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -71.33 -39.9 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.53 -40.27 18.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.094 -1.004 . . . . 0.0 109.252 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.31 -43.64 32.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.428 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.25 -34.41 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.74 -49.37 5.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.753 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.715 -179.814 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.294 0.456 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -59.89 3.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.617 ' CG1' HD21 ' C' ' 331' ' ' ASN . 12.7 t -53.5 -39.5 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.32 -54.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.7 -42.37 24.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.15 -32.62 70.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -65.13 -65.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.706 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.474 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.3 tp -50.01 -39.22 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.143 -0.973 . . . . 0.0 108.777 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.474 ' N ' HG23 ' B' ' 232' ' ' ILE . 12.9 mt -53.77 -43.3 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.83 -43.33 98.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.499 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -60.83 -43.55 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -1.143 . . . . 0.0 108.979 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -33.08 73.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.565 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.5 OUTLIER -57.12 -51.42 69.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.018 -1.051 . . . . 0.0 109.281 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.784 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.7 tp -68.19 -33.62 74.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.73 -39.94 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.741 -1.224 . . . . 0.0 108.06 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.5 tt -73.28 -39.52 65.29 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -52.97 -52.17 59.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.48 -33.78 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.571 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.11 -62.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.94 . . . . 0.0 109.406 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -53.06 -47.84 68.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -48.23 -50.43 29.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.598 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 109.475 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.617 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.3 OUTLIER -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.841 . . . . 0.0 109.516 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.28 -48.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.404 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.9 tt -77.63 -27.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 108.782 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.12 -55.09 32.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.7 mm -65.38 -48.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 108.995 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.45 -38.75 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 108.757 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.803 ' CE1' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.56 -52.24 66.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 109.093 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.795 HD21 ' NE2' ' A' ' 137' ' ' HIS . 3.5 mt -57.33 -49.56 75.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 14.4 mt -52.35 -34.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 0.0 109.912 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.21 -44.22 26.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.81 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 2.1 t-105 -49.56 -51.07 39.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 110.06 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.529 HG22 ' O ' ' C' ' 338' ' ' LEU . 0.8 OUTLIER -71.65 -39.79 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.0 109.543 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.49 -40.23 17.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 0.0 109.299 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.48 -43.56 31.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.27 -34.37 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.76 -49.61 5.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.64 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.855 . . . . 0.0 109.733 -179.755 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.267 0.445 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -59.9 3.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.603 ' CG1' HD21 ' A' ' 131' ' ' ASN . 12.3 t -53.52 -39.4 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.373 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 9.3 t -60.34 -54.65 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 109.427 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.81 -42.26 25.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.139 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -70.35 -32.44 70.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.252 -0.905 . . . . 0.0 109.188 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -65.23 -65.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.726 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.458 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.3 tp -49.88 -39.36 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 0.0 108.774 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.458 ' N ' HG23 ' D' ' 432' ' ' ILE . 12.9 mt -53.77 -43.18 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.251 -0.906 . . . . 0.0 108.691 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.3 98.19 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -60.98 -43.4 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -1.188 . . . . 0.0 108.914 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -33.08 73.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.339 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.582 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -57.12 -51.36 69.61 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.049 -1.032 . . . . 0.0 109.314 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.783 HD13 ' CE1' ' C' ' 337' ' ' HIS . 12.0 tp -68.15 -33.65 74.88 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.643 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.71 -39.95 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.658 -1.277 . . . . 0.0 108.125 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.36 -39.43 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -52.86 -52.29 57.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.58 -33.64 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.01 -62.83 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.08 -47.95 68.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -48.09 -50.45 28.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.618 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.386 -179.89 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.442 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -73.53 -40.99 63.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.3 mt -50.85 -42.86 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.45 -29.1 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.977 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.46 -53.53 44.71 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 136' ' ' LEU . 3.8 tp -65.26 -50.21 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -1.154 . . . . 0.0 108.892 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 135' ' ' ILE . 4.3 tp -50.24 -40.12 46.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 108.585 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.935 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.93 -58.95 6.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.427 -0.795 . . . . 0.0 108.939 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.919 HD21 ' NE2' ' C' ' 337' ' ' HIS . 17.1 mt -49.23 -48.74 45.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.693 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.81 -32.37 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.52 -58.44 3.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.042 . . . . 0.0 109.705 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -50.45 -44.04 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.763 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.504 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.6 tt -71.41 -41.46 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.989 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -58.29 -29.32 65.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 0.0 109.02 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -77.77 -44.03 28.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.882 . . . . 0.0 109.367 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.516 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 22.3 ttt180 -54.62 -36.3 64.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 -50.53 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.697 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.462 -0.774 . . . . 0.0 109.524 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.489 1.236 0 CA-C-O 121.182 0.409 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.45 -59.26 5.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.469 ' CG1' HD21 ' C' ' 331' ' ' ASN . 25.5 t -50.66 -47.58 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -48.79 -58.63 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.123 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.73 -36.44 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.535 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -71.28 -32.53 68.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 109.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.3 m120 -66.63 -62.64 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.406 HG23 ' N ' ' B' ' 233' ' ' ILE . 7.9 tp -50.94 -37.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.074 -1.016 . . . . 0.0 108.494 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.406 ' N ' HG23 ' B' ' 232' ' ' ILE . 11.9 mt -57.05 -42.22 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.16 -47.72 85.42 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -55.28 -39.15 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.237 -1.155 . . . . 0.0 108.6 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.5 mp -68.46 -36.83 79.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.421 -0.799 . . . . 0.0 109.276 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.862 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -54.28 -46.93 72.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.019 -1.05 . . . . 0.0 108.982 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.716 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.6 tp -68.74 -37.74 79.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.31 -37.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.973 -1.079 . . . . 0.0 108.095 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.54 -37.37 63.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . 0.56 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -58.52 -57.0 14.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.688 . . . . 0.0 109.436 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . 0.48 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.4 tt -63.72 -40.17 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.544 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.48 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.5 tt -58.29 -48.03 81.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.593 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -41.1 90.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -68.67 -25.36 64.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.469 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.57 -41.09 63.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.419 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.4 mt -50.84 -42.93 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.313 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.33 -29.17 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.034 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.52 -53.39 45.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.565 HG23 ' N ' ' C' ' 336' ' ' LEU . 3.7 tp -65.3 -50.21 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -1.136 . . . . 0.0 108.89 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . 0.565 ' N ' HG23 ' C' ' 335' ' ' ILE . 4.3 tp -50.3 -40.17 47.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 108.57 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.919 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.92 -58.81 6.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.935 HD21 ' NE2' ' A' ' 137' ' ' HIS . 17.1 mt -49.26 -48.86 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.76 -32.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.514 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.68 -58.13 3.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.607 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -50.74 -43.63 58.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 109.905 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.512 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.6 tt -71.88 -41.11 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.077 -1.014 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -58.36 -29.34 65.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.85 -44.0 28.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 22.5 ttt180 -54.58 -36.2 64.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -50.67 6.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.408 -0.807 . . . . 0.0 109.554 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.488 1.156 0 CA-C-O 121.247 0.436 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.42 -59.22 5.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.442 ' CG1' HD21 ' A' ' 131' ' ' ASN . 26.9 t -50.63 -47.53 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -48.8 -58.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.148 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.5 11.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.505 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -71.31 -32.4 68.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 109.085 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.4 m120 -66.7 -62.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.415 HG23 ' N ' ' D' ' 433' ' ' ILE . 7.8 tp -50.89 -37.37 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.415 ' N ' HG23 ' D' ' 432' ' ' ILE . 11.9 mt -57.0 -42.29 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.88 83.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.531 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -55.18 -39.12 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -1.155 . . . . 0.0 108.548 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.59 -36.79 79.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.356 -0.84 . . . . 0.0 109.184 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.88 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -54.3 -46.91 72.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.975 -1.078 . . . . 0.0 108.878 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.696 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.8 tp -68.77 -37.76 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.574 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.36 -37.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.66 -37.3 62.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . 0.516 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.1 t90 -58.37 -56.96 15.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.594 -0.691 . . . . 0.0 109.528 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . 0.477 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.5 tt -63.92 -39.98 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . 0.477 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.5 tt -58.33 -48.0 81.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.86 -41.01 90.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -68.77 -25.34 64.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.377 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.466 179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.39 0.614 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -37.32 65.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.97 -44.77 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 tt -78.12 -32.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.255 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.85 97.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' D' ' 430' ' ' ALA . 82.3 mt -68.22 -57.0 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.314 -1.11 . . . . 0.0 109.058 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.21 -33.67 13.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.142 -0.974 . . . . 0.0 108.7 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.939 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.4 -55.76 27.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.85 . . . . 0.0 108.99 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' C' ' 337' ' ' HIS . 18.0 mt -54.16 -48.07 71.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.675 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.23 -33.67 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -82.31 -57.6 3.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.7 OUTLIER -50.58 -43.69 56.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.849 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.609 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.0 tt -68.94 -44.73 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.861 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.522 ' N ' HG23 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -52.88 -34.68 55.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.74 -1.225 . . . . 0.0 108.741 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -78.21 -31.2 49.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.446 -0.784 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.1 -42.98 95.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.641 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -50.11 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 143' ' ' LEU . 37.8 m-85 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.522 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 CA-C-O 121.2 0.417 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.12 -45.36 52.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 0.0 109.74 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.87 -35.85 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 109.557 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.57 -56.91 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.09 -39.08 19.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.009 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.09 -33.85 68.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.212 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.443 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -66.28 -63.41 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.443 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.457 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.5 tp -49.93 -39.5 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.054 -1.028 . . . . 0.0 108.613 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.457 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.6 mt -53.98 -45.02 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.169 -0.957 . . . . 0.0 108.444 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.1 -49.34 68.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.544 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -53.38 -38.02 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.069 -1.254 . . . . 0.0 108.487 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . 0.606 HD23 ' O ' ' B' ' 236' ' ' LEU . 1.3 tt -68.31 -37.36 80.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.279 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.867 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.2 OUTLIER -55.32 -48.28 74.39 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.094 -1.004 . . . . 0.0 109.314 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.3 tp -67.16 -39.49 86.48 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.697 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' B' ' 236' ' ' LEU . 11.4 mt -47.46 -40.01 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.321 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.73 -34.42 64.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . 0.42 ' N ' ' O ' ' B' ' 238' ' ' LEU . 84.9 t90 -60.1 -54.88 40.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.403 -0.81 . . . . 0.0 109.636 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -51.79 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.257 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.89 -53.57 31.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.609 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -54.85 18.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.598 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -58.02 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.489 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . 0.433 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.83 -37.44 64.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.403 HG13 ' H ' ' C' ' 332' ' ' ILE . 2.8 mt -51.82 -44.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.492 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.8 tt -78.03 -33.04 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.7 97.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' B' ' 230' ' ' ALA . 82.2 mt -68.39 -56.96 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.316 -1.108 . . . . 0.0 109.006 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mt -49.26 -33.49 12.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.59 -55.67 28.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.87 . . . . 0.0 108.976 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.939 HD21 ' NE2' ' A' ' 137' ' ' HIS . 18.0 mt -54.14 -48.11 71.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 55.3 mt -54.38 -33.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -82.35 -57.33 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.044 -1.035 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -50.75 -43.63 58.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.867 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.6 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.9 tt -69.13 -44.56 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.513 ' N ' HG23 ' C' ' 342' ' ' ILE . 0.8 OUTLIER -52.88 -34.77 56.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.7 -1.25 . . . . 0.0 108.835 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.37 -30.97 48.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.11 -43.04 95.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.06 -50.09 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' C' ' 343' ' ' LEU . 37.4 m-85 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.842 . . . . 0.0 109.426 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.2 0.417 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -45.32 54.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.91 -35.86 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.52 -56.89 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.16 -39.11 19.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.019 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.08 -33.79 68.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.205 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.433 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.8 OUTLIER -66.29 -63.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.46 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.5 tp -49.97 -39.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.087 -1.008 . . . . 0.0 108.577 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.46 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.6 mt -54.06 -44.99 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.478 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.07 -49.34 67.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.535 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -53.47 -37.94 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -1.228 . . . . 0.0 108.476 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . 0.605 ' O ' HD23 ' D' ' 436' ' ' LEU . 1.3 tt -68.41 -37.24 80.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.547 -0.72 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.887 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.42 -48.09 74.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.039 -1.038 . . . . 0.0 109.346 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.709 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.4 tp -67.14 -39.62 86.58 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.716 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' D' ' 436' ' ' LEU . 11.4 mt -47.47 -39.97 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 0.0 108.353 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.7 -34.41 64.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' D' ' 438' ' ' LEU . 85.4 t90 -60.03 -54.87 40.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.518 -0.739 . . . . 0.0 109.62 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -51.66 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.121 -0.987 . . . . 0.0 109.368 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.92 -53.57 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -54.79 19.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.553 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.09 -20.09 37.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.321 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.461 0.648 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.478 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -72.7 -43.75 62.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 5.0 mt -48.49 -47.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.1 tt -71.35 -33.44 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 108.776 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.2 64.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.3 mm -70.2 -55.28 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.8 mt -48.89 -34.49 12.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 108.66 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.944 ' CE1' HD21 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -62.18 -57.61 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.964 HD21 ' CE1' ' C' ' 337' ' ' HIS . 3.5 mt -56.35 -51.48 68.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.707 -0.62 . . . . 0.0 110.031 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.07 -28.72 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.4 HD22 HD21 ' B' ' 238' ' ' LEU . 4.5 tt -78.92 -58.72 3.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.73 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -50.19 -52.49 35.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.542 HG23 ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.054 . . . . 0.0 109.249 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.542 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.6 mt -49.46 -35.83 20.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.927 -1.108 . . . . 0.0 109.174 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.72 -36.11 60.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.494 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -67.1 -28.15 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.97 -16.33 19.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 109.699 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.583 -179.686 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 121.273 0.447 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.73 -60.34 2.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 t -52.35 -34.56 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.99 -58.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.01 -41.16 15.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.259 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.13 68.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 109.147 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -59.5 4.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.811 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 232' ' ' ILE . 8.8 tp -58.16 -33.93 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.066 -1.022 . . . . 0.0 109.14 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.99 -49.11 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.126 -0.984 . . . . 0.0 108.815 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.12 -45.13 96.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -49.13 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -1.203 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.6 -36.55 84.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.828 ' ND1' HD22 ' C' ' 338' ' ' LEU . 0.8 OUTLIER -53.68 -49.04 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 109.236 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.761 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.0 tp -67.65 -35.53 79.06 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.821 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' B' ' 238' ' ' LEU . 3.1 mm -50.05 -37.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.35 -38.3 60.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -54.52 -50.53 67.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.81 -38.74 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.719 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -44.0 97.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.524 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.59 35.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.2 OUTLIER -53.99 -42.51 69.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.477 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.1 OUTLIER -72.63 -43.93 62.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.477 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 5.1 mt -48.39 -48.11 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 6.3 tt -71.17 -33.5 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.866 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -53.34 -46.04 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.29 -55.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.81 -34.49 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.668 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.964 ' CE1' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.15 -57.58 10.98 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.944 HD21 ' CE1' ' A' ' 137' ' ' HIS . 3.4 mt -56.5 -51.35 68.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.638 -0.664 . . . . 0.0 110.041 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.02 -28.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.06 -58.23 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -50.55 -52.61 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.579 HD12 ' CD2' ' B' ' 237' ' ' HIS . 0.9 OUTLIER -59.88 -43.85 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.126 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.548 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.6 mt -49.48 -35.75 20.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 109.211 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -36.03 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.887 . . . . 0.0 109.491 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -67.18 -28.15 67.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.93 -16.4 19.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.634 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 109.531 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.49 1.284 0 CA-C-O 121.276 0.448 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.83 -60.34 2.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.424 HG23 ' H ' ' D' ' 427' ' ' VAL . 9.1 t -52.24 -34.63 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.94 -58.09 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.11 15.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.99 68.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.122 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -59.35 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.843 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' D' ' 432' ' ' ILE . 8.8 tp -58.12 -34.07 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.146 -0.971 . . . . 0.0 109.104 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.9 -49.11 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.03 96.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.68 -49.06 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.273 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.65 -36.52 84.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.219 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.841 ' ND1' HD22 ' A' ' 138' ' ' LEU . 0.8 OUTLIER -53.69 -49.1 68.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 109.244 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.748 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.1 tp -67.69 -35.47 78.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.633 -1.227 . . . . 0.0 109.832 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' D' ' 438' ' ' LEU . 3.1 mm -50.03 -37.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.793 -1.192 . . . . 0.0 107.877 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.32 -38.33 60.28 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -54.41 -50.59 67.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.483 -0.76 . . . . 0.0 109.605 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.92 -38.57 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.73 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -43.94 97.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.045 -1.034 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.69 34.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.2 OUTLIER -54.0 -42.46 69.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.508 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.467 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.734 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.471 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.2 OUTLIER -70.4 -36.22 73.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.368 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 132' ' ' ILE . 2.6 mt -53.91 -48.12 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.402 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 tt -72.24 -30.77 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 108.76 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.38 -44.64 84.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.419 HG21 ' HB1' ' D' ' 430' ' ' ALA . 6.6 mt -69.68 -55.04 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -1.102 . . . . 0.0 109.126 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.83 -36.7 27.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 108.963 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.85 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -64.83 -43.5 92.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.833 HD21 ' NE2' ' C' ' 337' ' ' HIS . 3.6 mt -69.42 -47.27 64.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.775 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.5 mt -54.88 -34.41 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.626 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.69 -47.55 18.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.728 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.6 t-105 -46.42 -48.88 18.69 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 143' ' ' LEU . 11.5 tt -72.48 -41.92 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.948 . . . . 0.0 109.96 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tp -47.83 -40.46 21.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 109.345 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.95 -43.83 33.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.92 -33.52 17.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.54 -49.52 5.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.483 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 121.247 0.436 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.09 -49.7 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' C' ' 331' ' ' ASN . 61.3 t -59.82 -37.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.37 -57.25 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -33.77 8.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.47 -33.59 67.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.897 . . . . 0.0 109.241 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.734 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -66.56 -61.05 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.486 ' N ' ' CG ' ' B' ' 231' ' ' ASN . 8.6 tp -52.43 -38.39 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 0.0 108.687 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.437 ' N ' HG23 ' B' ' 232' ' ' ILE . 9.4 mt -54.14 -44.22 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.9 -43.79 96.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.482 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -61.02 -41.75 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -1.221 . . . . 0.0 108.679 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' B' ' 239' ' ' ILE . 0.5 OUTLIER -67.54 -35.16 78.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.83 . . . . 0.0 109.106 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.559 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.4 OUTLIER -56.5 -50.78 70.77 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.088 -1.007 . . . . 0.0 109.416 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.814 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.1 tp -68.16 -33.83 75.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.521 -1.272 . . . . 0.0 109.79 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' B' ' 236' ' ' LEU . 16.9 mt -50.58 -40.1 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.68 -1.263 . . . . 0.0 107.831 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.15 -42.15 66.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -50.25 -48.04 54.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 108.927 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.12 -52.11 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.279 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.33 -31.94 46.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.88 -33.48 64.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.388 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -77.57 -25.95 50.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.439 179.849 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . 0.742 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.47 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.2 OUTLIER -70.45 -36.26 73.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.8 mt -53.79 -48.33 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.2 tt -72.05 -30.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 108.742 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.66 84.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.418 HG21 ' HB1' ' B' ' 230' ' ' ALA . 6.6 mt -69.66 -55.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -1.122 . . . . 0.0 109.054 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.79 -36.56 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.989 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.833 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -64.86 -43.63 92.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.85 HD21 ' NE2' ' A' ' 137' ' ' HIS . 3.6 mt -69.3 -47.4 64.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.766 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.7 mt -54.83 -34.53 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.74 -46.97 20.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.6 t-105 -46.95 -48.71 21.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.47 HG23 ' N ' ' C' ' 343' ' ' LEU . 11.0 tt -72.71 -41.76 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.47 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tp -47.75 -40.59 20.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.357 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -76.97 -43.9 33.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.88 -33.49 17.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.626 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.5 -49.63 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 121.256 0.44 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.19 -49.64 51.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.471 ' CG1' HD21 ' A' ' 131' ' ' ASN . 60.9 t -59.82 -37.77 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 0.0 109.545 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.7 t -64.25 -57.36 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.098 -1.001 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.96 -33.93 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.888 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.54 -33.54 66.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.742 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -66.51 -61.11 2.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' D' ' 431' ' ' ASN . 8.6 tp -52.36 -38.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 108.654 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.434 ' N ' HG23 ' D' ' 432' ' ' ILE . 9.4 mt -54.13 -44.2 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.213 -0.929 . . . . 0.0 108.525 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.99 -43.67 96.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.484 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.7 mp -61.14 -41.61 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.11 -1.229 . . . . 0.0 108.761 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' D' ' 439' ' ' ILE . 0.5 OUTLIER -67.56 -35.24 78.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.099 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.567 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.4 OUTLIER -56.44 -50.71 70.9 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.192 -0.942 . . . . 0.0 109.501 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.803 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.6 tp -68.22 -33.85 75.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.738 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' D' ' 436' ' ' LEU . 16.9 mt -50.64 -40.12 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.637 -1.29 . . . . 0.0 107.81 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.06 -42.12 66.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -50.13 -48.04 53.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.004 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.29 -52.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.18 -32.07 45.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.91 -33.38 63.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -77.56 -26.03 50.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.821 HD21 HG11 ' D' ' 427' ' ' VAL . 0.5 OUTLIER -72.01 -38.34 69.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 0.0 109.54 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.55 -44.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.308 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tt -78.43 -28.71 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 108.763 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.1 27.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.616 HG23 ' N ' ' A' ' 136' ' ' LEU . 6.2 tp -63.34 -50.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -1.227 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.616 ' N ' HG23 ' A' ' 135' ' ' ILE . 3.7 mt -52.1 -37.75 55.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.085 -1.009 . . . . 0.0 108.74 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.754 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -60.03 -56.03 26.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 108.981 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.724 HD21 ' NE2' ' C' ' 337' ' ' HIS . 6.3 mt -50.16 -38.62 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.768 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.39 -30.06 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.604 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.63 -53.27 6.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -52.77 -41.46 64.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.1 tp -74.36 -47.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.039 -1.038 . . . . 0.0 110.007 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.609 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.3 tp -50.2 -30.49 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.006 -1.059 . . . . 0.0 109.032 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.505 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 6.0 t0 -78.35 -46.6 19.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 109.539 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.37 -33.8 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.42 -51.54 4.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.784 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 147' ' ' PHE . 34.7 m-85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 109.616 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.256 0.44 . . . . 0.0 112.394 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.448 ' N ' HD12 ' B' ' 226' ' ' LEU . 11.0 mp -64.79 -62.29 1.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.83 HG11 HD21 ' C' ' 331' ' ' ASN . 39.3 t -50.22 -45.97 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.0 t -48.89 -56.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.042 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.65 18.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.628 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -69.85 -34.64 73.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.431 -0.793 . . . . 0.0 109.145 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -60.8 3.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.067 -1.021 . . . . 0.0 109.254 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.21 -42.0 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.114 -0.991 . . . . 0.0 109.054 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' B' ' 230' ' ' ALA . 18.3 mt -50.49 -37.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -63.63 -44.67 96.12 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.5 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -58.65 -39.69 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -1.208 . . . . 0.0 108.533 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.04 -36.23 77.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.381 -0.824 . . . . 0.0 109.138 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.589 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -54.59 -48.79 71.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.972 -1.08 . . . . 0.0 108.954 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.754 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.3 tp -66.7 -38.53 86.93 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.695 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.91 -38.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.916 -1.115 . . . . 0.0 108.205 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -36.46 64.34 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -59.77 -56.53 20.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.0 109.566 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . 0.433 HG23 ' N ' ' B' ' 243' ' ' LEU . 12.6 tt -61.12 -39.05 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.666 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.433 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.5 mt -59.3 -54.87 41.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.003 . . . . 0.0 109.524 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.83 -50.81 55.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.13 -41.19 87.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.445 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.83 HD21 HG11 ' B' ' 227' ' ' VAL . 0.5 OUTLIER -71.95 -38.61 69.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.48 -44.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.963 . . . . 0.0 109.286 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.42 -28.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 108.743 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -63.59 -54.97 27.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.628 HG12 ' HB1' ' B' ' 230' ' ' ALA . 6.3 tp -63.28 -50.2 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -1.227 . . . . 0.0 108.823 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . 0.608 ' N ' HG23 ' C' ' 335' ' ' ILE . 3.7 mt -52.07 -37.85 55.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.103 -0.998 . . . . 0.0 108.756 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.736 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -60.0 -55.89 28.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.027 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.727 HD21 ' NE2' ' A' ' 137' ' ' HIS . 6.3 mt -50.27 -38.7 42.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.415 -0.803 . . . . 0.0 109.676 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.37 -30.05 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -81.91 -52.64 6.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -53.14 -41.44 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.148 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.612 HG23 ' N ' ' C' ' 343' ' ' LEU . 10.1 tp -74.39 -47.87 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.97 -1.081 . . . . 0.0 109.872 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.612 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.3 tp -50.12 -30.5 11.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.046 -1.034 . . . . 0.0 109.141 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' D' ' 445' ' ' ARG . 6.0 t0 -78.6 -46.41 19.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.36 -33.88 22.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.461 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.3 -51.73 4.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' C' ' 347' ' ' PHE . 34.5 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 121.242 0.434 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . 0.44 ' N ' HD12 ' D' ' 426' ' ' LEU . 11.0 mp -64.88 -62.19 1.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.821 HG11 HD21 ' A' ' 131' ' ' ASN . 39.4 t -50.26 -45.94 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.912 . . . . 0.0 109.208 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.84 -56.88 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.005 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.7 -37.56 18.96 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.603 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -69.87 -34.64 73.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.112 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -60.8 3.25 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.079 -1.013 . . . . 0.0 109.27 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.12 -41.96 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.177 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' D' ' 430' ' ' ALA . 18.7 mt -50.58 -37.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -63.62 -44.7 96.09 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.496 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.7 mp -58.59 -39.71 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -1.206 . . . . 0.0 108.483 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.02 -36.33 77.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.387 -0.82 . . . . 0.0 109.175 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.591 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -54.49 -48.76 71.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.041 -1.037 . . . . 0.0 108.998 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.4 tp -66.69 -38.55 87.0 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.687 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.93 -38.1 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 108.163 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -36.5 64.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.7 -56.39 22.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.684 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . 0.431 HG23 ' N ' ' D' ' 443' ' ' LEU . 12.8 tt -61.33 -38.99 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . 0.431 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.5 mt -59.22 -54.89 41.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.81 -50.87 55.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -59.06 -41.31 87.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.492 ' HB1' ' ND2' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.427 0.632 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 -38.01 45.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.608 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.14 -44.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 134' ' ' GLY . 12.4 tt -79.53 -38.98 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 0.0 109.179 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -54.24 -44.46 75.09 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.554 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.8 mt -69.82 -54.98 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -1.07 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.3 -33.48 13.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.09 -1.006 . . . . 0.0 108.67 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.721 ' ND1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -63.77 -59.01 5.1 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.645 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.6 mt -49.73 -37.72 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.483 -0.76 . . . . 0.0 109.697 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.9 mt -68.99 -30.71 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.08 -54.95 4.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.697 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.2 OUTLIER -50.25 -44.06 53.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.256 -0.903 . . . . 0.0 109.89 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.76 HD13 ' NE2' ' D' ' 437' ' ' HIS . 4.2 tp -72.17 -45.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.617 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.578 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.7 mt -49.46 -31.77 10.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.95 -1.094 . . . . 0.0 108.961 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.62 -45.62 24.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -50.33 -34.46 23.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.86 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 146' ' ' LEU . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.637 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 121.24 0.433 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.03 -41.37 25.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -39.75 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.43 -57.82 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.942 . . . . 0.0 109.481 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -46.92 -40.21 13.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.202 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.38 -35.47 68.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.492 ' ND2' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -65.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -49.55 -38.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.166 -0.959 . . . . 0.0 108.681 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.437 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.1 mt -56.44 -41.38 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 108.486 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.96 95.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.572 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.97 -51.53 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.293 . . . . 0.0 108.503 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.8 -37.95 77.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.757 . . . . 0.0 109.545 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.766 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.2 OUTLIER -52.61 -48.58 66.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.991 -1.068 . . . . 0.0 109.094 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.721 HD13 ' ND1' ' A' ' 137' ' ' HIS . 8.1 tp -65.84 -38.26 88.41 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.713 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 38.5 mm -49.44 -38.34 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.764 -1.21 . . . . 0.0 108.094 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.98 -34.87 64.39 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -60.99 -56.56 19.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.485 -0.76 . . . . 0.0 109.346 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . 0.449 HG23 ' N ' ' B' ' 243' ' ' LEU . 12.5 tt -62.94 -38.57 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.5 -0.75 . . . . 0.0 109.619 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.449 ' N ' HG23 ' B' ' 242' ' ' ILE . 4.7 tp -62.18 -38.37 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.42 -48.13 71.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.349 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.43 -40.74 83.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.413 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . 0.492 ' HB1' ' ND2' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -38.08 44.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.415 HG13 ' H ' ' C' ' 332' ' ' ILE . 3.2 mt -51.08 -44.41 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . 0.433 HG23 ' N ' ' C' ' 334' ' ' GLY . 12.5 tt -79.46 -39.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.168 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . 0.433 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -54.18 -44.45 74.43 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' B' ' 230' ' ' ALA . 86.5 mt -69.8 -55.02 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.333 -1.098 . . . . 0.0 109.115 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.31 -33.52 13.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.665 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.706 ' ND1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -63.67 -58.98 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.428 -0.795 . . . . 0.0 108.92 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.662 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.6 mt -49.78 -37.68 30.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 50.7 mt -69.13 -30.68 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.07 -54.64 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 109.666 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -50.38 -44.18 54.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.97 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.766 HD13 ' NE2' ' B' ' 237' ' ' HIS . 4.2 tp -72.18 -45.42 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 109.6 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.564 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.7 mt -49.48 -31.82 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 108.891 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.78 -45.47 24.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.785 . . . . 0.0 109.457 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -50.23 -34.55 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . 0.47 HD23 ' O ' ' C' ' 346' ' ' LEU . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.572 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.277 0.449 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.02 -41.25 25.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 427' ' ' VAL . 4.5 t -64.55 -39.65 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.138 -0.976 . . . . 0.0 109.597 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.56 -57.77 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -46.89 -40.22 13.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 109.219 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.554 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.31 -35.57 68.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.492 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -65.7 -63.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.417 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.6 tp -49.55 -38.24 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.166 -0.959 . . . . 0.0 108.632 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.417 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.1 mt -56.42 -41.41 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.151 -0.968 . . . . 0.0 108.469 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.94 95.92 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.565 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -58.92 -51.49 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.062 -1.258 . . . . 0.0 108.523 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.84 -37.85 77.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.594 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.76 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -52.67 -48.58 66.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 109.046 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.706 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.3 tp -65.76 -38.38 88.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.751 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 38.1 mm -49.38 -38.41 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.762 -1.211 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.0 -34.74 64.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -61.05 -56.38 21.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . 0.447 HG23 ' N ' ' D' ' 443' ' ' LEU . 12.7 tt -63.26 -38.4 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . 0.447 ' N ' HG23 ' D' ' 442' ' ' ILE . 4.7 tp -62.03 -38.62 89.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -66.32 -48.12 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -40.76 83.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.299 179.9 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.549 ' HB1' ' CG ' ' B' ' 231' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' D' ' 431' ' ' ASN . 0.1 OUTLIER -74.72 -42.88 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.933 . . . . 0.0 109.39 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.424 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mt -51.16 -43.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.604 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.535 ' CD1' HD12 ' B' ' 235' ' ' ILE . 6.3 tt -74.06 -36.26 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.005 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -50.89 -42.79 47.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.2 mt -71.46 -53.06 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.4 -1.059 . . . . 0.0 109.17 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.17 -37.9 23.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.188 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.856 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -67.54 -44.17 78.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.27 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.675 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.5 mt -60.61 -49.69 76.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.485 -0.759 . . . . 0.0 109.983 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.91 -24.05 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.55 HD22 HD21 ' B' ' 238' ' ' LEU . 2.6 tt -80.96 -59.95 2.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -0.94 . . . . 0.0 109.894 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.0 OUTLIER -50.59 -42.49 55.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.261 -0.9 . . . . 0.0 109.962 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.75 HD13 ' NE2' ' D' ' 437' ' ' HIS . 3.7 tp -72.77 -42.38 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.85 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.529 ' N ' HG23 ' A' ' 142' ' ' ILE . 4.9 mt -48.69 -40.69 29.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 0.0 109.096 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -39.1 61.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 145' ' ' ARG . 0.2 OUTLIER -51.03 -37.6 46.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.473 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.9 -48.49 6.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.461 -179.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.276 0 CA-C-O 121.185 0.41 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.15 -51.5 53.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.444 ' CG1' HD21 ' C' ' 331' ' ' ASN . 23.6 t -57.31 -41.55 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.4 -56.29 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.25 -38.43 12.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.248 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.28 66.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 109.375 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.549 ' CG ' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -67.3 -58.46 4.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.444 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.41 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.3 tp -54.01 -36.48 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.067 . . . . 0.0 108.565 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.41 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.4 mt -58.54 -44.44 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 108.728 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.84 -41.56 91.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.535 HD12 ' CD1' ' A' ' 133' ' ' ILE . 23.2 mm -61.18 -36.31 71.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.113 -1.227 . . . . 0.0 108.702 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' B' ' 239' ' ' ILE . 2.7 tt -67.72 -35.47 78.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.868 . . . . 0.0 108.858 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.753 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.3 OUTLIER -58.53 -51.85 68.15 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.856 HD13 ' CE1' ' A' ' 137' ' ' HIS . 14.0 tp -63.27 -38.99 93.33 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.619 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' B' ' 236' ' ' LEU . 13.9 mt -48.68 -43.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.901 -1.125 . . . . 0.0 108.464 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.88 -42.5 90.22 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -57.9 -43.89 86.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.32 -56.08 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 108.969 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.76 -21.17 62.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 109.532 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.33 -60.67 2.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.375 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.03 -34.5 71.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.951 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . 0.548 ' HB1' ' ND2' ' D' ' 431' ' ' ASN . . . . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.444 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -74.65 -43.01 57.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.7 mt -51.02 -43.84 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -0.831 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' D' ' 435' ' ' ILE . 6.6 tt -73.9 -36.3 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -50.93 -42.73 47.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 6.1 mt -71.46 -53.17 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.374 -1.074 . . . . 0.0 109.181 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.09 -37.91 22.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.173 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.844 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -67.54 -44.2 78.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.675 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.4 mt -60.6 -49.84 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.71 -24.25 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.965 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . 0.528 HD22 HD21 ' D' ' 438' ' ' LEU . 2.7 tt -81.06 -59.47 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -50.97 -42.59 60.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 110.006 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.753 HD13 ' NE2' ' B' ' 237' ' ' HIS . 3.8 tp -72.57 -42.57 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 109.611 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.536 ' N ' HG23 ' C' ' 342' ' ' ILE . 4.9 mt -48.62 -40.64 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 109.192 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.96 60.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 109.369 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' C' ' 345' ' ' ARG . 0.3 OUTLIER -51.11 -37.47 46.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.429 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.03 -48.48 6.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.489 1.221 0 CA-C-O 121.187 0.411 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -51.56 52.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.402 ' CG1' HD21 ' A' ' 131' ' ' ASN . 24.3 t -57.3 -41.52 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.41 -56.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.49 13.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.176 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.97 -35.31 66.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 109.383 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.548 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -67.22 -58.46 4.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.403 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.3 tp -53.95 -36.54 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 108.602 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.403 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.4 mt -58.45 -44.45 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.152 -0.968 . . . . 0.0 108.762 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.77 -41.65 90.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' C' ' 333' ' ' ILE . 23.1 mm -61.24 -36.26 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -1.187 . . . . 0.0 108.645 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' D' ' 439' ' ' ILE . 2.7 tt -67.7 -35.44 78.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.341 -0.849 . . . . 0.0 108.913 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.75 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -58.56 -51.89 67.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.107 -0.995 . . . . 0.0 108.977 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.844 HD13 ' CE1' ' C' ' 337' ' ' HIS . 14.4 tp -63.09 -39.23 94.1 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.562 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' D' ' 436' ' ' LEU . 14.0 mt -48.62 -43.35 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.814 -1.179 . . . . 0.0 108.453 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -42.55 89.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.94 -43.67 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.758 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.57 -55.88 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 108.994 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.81 -21.13 62.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.39 -60.66 2.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.98 -34.53 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 0.0 109.343 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.412 0.625 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.757 HD21 HG11 ' D' ' 427' ' ' VAL . 0.0 OUTLIER -77.84 -50.4 12.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.8 mm -47.61 -44.54 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.469 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 134' ' ' GLY . 11.1 tt -72.41 -37.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.012 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -52.17 -49.8 48.59 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.924 HG21 ' HB1' ' D' ' 430' ' ' ALA . 11.0 mm -65.23 -55.05 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -1.217 . . . . 0.0 109.289 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.4 -33.83 14.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.811 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -63.97 -60.25 3.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 109.401 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.7 mt -49.05 -39.68 28.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.712 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.7 mt -69.18 -27.72 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.413 HD22 HD21 ' B' ' 238' ' ' LEU . 4.2 tt -82.78 -54.11 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.12 -0.988 . . . . 0.0 109.627 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.89 -42.49 62.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.3 tp -72.82 -45.26 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.596 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.0 mt -49.12 -33.73 12.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.276 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.78 -43.57 25.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.855 . . . . 0.0 109.655 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.565 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 25.5 ttt180 -50.1 -39.51 42.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.877 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.13 -53.52 3.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 109.854 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.446 179.997 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.49 1.288 0 CA-C-O 121.208 0.42 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . 0.777 HG11 HD21 ' C' ' 331' ' ' ASN . 16.7 t -52.48 -44.63 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.361 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' B' ' 231' ' ' ASN . 4.8 t -53.86 -56.67 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -38.42 17.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 108.806 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -70.52 -28.83 65.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.327 -0.858 . . . . 0.0 109.076 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.2 m-20 -69.04 -63.79 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.215 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.7 tp -49.05 -36.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' B' ' 230' ' ' ALA . 20.2 mt -58.96 -41.07 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 231' ' ' ASN . . . -56.87 -42.86 92.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.597 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -61.22 -41.03 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -1.23 . . . . 0.0 108.662 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . 0.521 ' HA ' HD12 ' B' ' 239' ' ' ILE . 0.5 OUTLIER -67.45 -35.28 78.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 0.0 109.089 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.522 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -56.87 -48.96 76.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.167 -0.958 . . . . 0.0 109.414 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.811 HD13 ' CE1' ' A' ' 137' ' ' HIS . 9.5 tp -68.1 -35.13 77.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.701 -1.2 . . . . 0.0 109.761 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' B' ' 236' ' ' LEU . 13.5 mt -50.56 -41.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.726 -1.233 . . . . 0.0 108.104 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tt -69.96 -40.59 75.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . 0.553 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 88.3 t90 -54.45 -55.93 23.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.05 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.1 mt -53.12 -54.48 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.04 -53.98 23.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.564 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -52.88 -28.13 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -74.64 -48.37 26.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.888 . . . . 0.0 109.516 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 246' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.311 0.577 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.777 HD21 HG11 ' B' ' 227' ' ' VAL . 0.0 OUTLIER -77.92 -50.57 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.998 -179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.479 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.9 mm -47.31 -44.84 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . 0.411 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -72.19 -38.01 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . 0.411 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -52.19 -49.75 48.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.94 HG21 ' HB1' ' B' ' 230' ' ' ALA . 11.5 mm -65.36 -55.01 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -1.22 . . . . 0.0 109.279 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.36 -33.91 14.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.805 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -63.89 -60.4 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.84 . . . . 0.0 109.297 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.78 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.8 mt -48.91 -39.64 26.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 11.0 mt -69.33 -27.73 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . 0.401 HD22 HD21 ' D' ' 438' ' ' LEU . 4.0 tt -82.98 -53.53 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.637 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -52.28 -42.51 63.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.595 HG23 ' N ' ' C' ' 343' ' ' LEU . 10.3 tp -72.72 -45.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.595 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.0 mt -49.14 -33.69 12.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 109.313 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.94 -43.41 24.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . 0.553 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 25.4 ttt180 -50.2 -39.51 44.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.04 -53.75 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.227 0.428 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 131' ' ' ASN . 16.9 t -52.46 -44.59 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.352 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' D' ' 431' ' ' ASN . 4.8 t -53.9 -56.72 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.345 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.0 -38.57 17.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 108.859 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.924 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -70.5 -28.81 65.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.2 m-20 -68.98 -63.88 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.194 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.7 tp -48.93 -36.39 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' D' ' 430' ' ' ALA . 20.2 mt -59.01 -41.03 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' D' ' 431' ' ' ASN . . . -56.99 -42.8 93.06 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.594 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.7 mp -61.22 -40.97 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.14 -1.212 . . . . 0.0 108.631 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . 0.516 ' HA ' HD12 ' D' ' 439' ' ' ILE . 0.5 OUTLIER -67.59 -35.16 78.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.062 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.515 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -56.77 -49.21 75.99 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.362 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.805 HD13 ' CE1' ' C' ' 337' ' ' HIS . 9.9 tp -67.92 -35.27 78.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.712 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' D' ' 436' ' ' LEU . 13.5 mt -50.52 -41.9 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.708 -1.245 . . . . 0.0 108.104 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.0 tt -70.0 -40.56 75.2 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . 0.565 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 89.0 t90 -54.31 -55.98 22.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.102 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 65.8 mt -53.18 -54.46 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.01 -53.99 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -52.82 -28.27 21.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.341 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -74.56 -48.31 27.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.598 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . 0.423 ' N ' HD12 ' D' ' 446' ' ' LEU . 10.8 mp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.311 0.577 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.464 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -74.75 -43.66 53.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.482 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 8.7 mt -51.06 -45.8 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.489 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.74 -36.36 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 108.891 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -40.66 78.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.655 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.0 mt -67.96 -56.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.419 -1.048 . . . . 0.0 109.071 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.56 -35.87 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 108.792 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.916 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -58.5 -59.25 5.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.12 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.881 HD21 ' NE2' ' C' ' 337' ' ' HIS . 11.2 mt -53.25 -51.42 62.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 75.4 mt -54.01 -31.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.15 -58.63 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.552 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.5 OUTLIER -50.95 -50.94 56.96 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.553 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.0 tt -61.72 -41.99 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.488 ' N ' HG23 ' A' ' 142' ' ' ILE . 4.8 mt -54.2 -35.9 62.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.075 . . . . 0.0 108.978 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -29.36 57.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.416 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.32 -35.28 79.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.27 -15.33 20.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.714 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 109.649 -179.708 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.489 1.254 0 CA-C-O 121.323 0.468 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.92 -60.59 2.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.957 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 t -55.51 -39.02 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.481 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.39 -56.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.45 -43.28 23.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.239 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.736 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -69.53 -30.35 68.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.337 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.31 -65.16 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.427 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.4 tp -49.92 -37.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.177 -0.952 . . . . 0.0 108.675 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' B' ' 230' ' ' ALA . 13.2 mt -54.75 -45.89 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.47 -46.2 88.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.526 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.0 -53.93 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -1.167 . . . . 0.0 108.93 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.35 -38.18 71.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 0.0 109.424 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' HIS . . . . . 0.809 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.51 -47.21 70.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.088 -1.008 . . . . 0.0 109.375 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . 0.743 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.4 tp -67.81 -36.36 80.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.04 -39.89 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.764 -1.21 . . . . 0.0 107.894 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -37.47 69.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.4 -57.61 12.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.63 -54.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.258 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.65 -52.17 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.77 -33.8 57.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -65.29 -52.98 50.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.461 ' N ' HD12 ' B' ' 246' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 331' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -74.8 -43.66 53.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 8.8 mt -50.96 -46.0 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.52 -36.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 108.986 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.56 -40.64 79.06 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 335' ' ' ILE . . . . . 0.736 HG21 ' HB1' ' B' ' 230' ' ' ALA . 82.0 mt -67.93 -56.29 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.343 -1.093 . . . . 0.0 109.057 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.51 -35.93 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.928 . . . . 0.0 108.766 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 337' ' ' HIS . . . . . 0.881 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -58.41 -59.18 5.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.184 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 338' ' ' LEU . . . . . 0.916 HD21 ' NE2' ' A' ' 137' ' ' HIS . 11.1 mt -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 75.6 mt -54.24 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.38 -58.1 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.494 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -51.37 -50.76 58.9 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 342' ' ' ILE . . . . . 0.614 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.0 tt -61.94 -41.94 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' HG23 ' C' ' 342' ' ' ILE . 4.9 mt -53.95 -36.14 62.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.968 -1.083 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -29.33 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.36 -35.3 79.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.21 -15.28 20.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.0 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.672 -179.765 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 CA-C-O 121.308 0.462 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.8 -60.66 2.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 427' ' ' VAL . . . . . 0.431 HG23 ' H ' ' D' ' 427' ' ' VAL . 4.9 t -55.48 -39.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.499 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.32 -56.82 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.37 23.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 430' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -69.54 -30.3 68.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.3 -65.09 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 432' ' ' ILE . . . . . 0.426 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.4 tp -49.89 -37.97 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 108.612 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 433' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' D' ' 430' ' ' ALA . 13.3 mt -54.67 -45.86 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 108.572 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.51 -46.22 88.37 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 435' ' ' ILE . . . . . 0.523 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -58.05 -53.9 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 108.885 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.37 -38.16 71.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.44 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 437' ' ' HIS . . . . . 0.807 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.54 -47.16 70.25 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.101 -0.999 . . . . 0.0 109.272 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 438' ' ' LEU . . . . . 0.718 HD13 ' ND1' ' C' ' 337' ' ' HIS . 7.7 tp -67.87 -36.44 80.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.713 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.1 mm -50.03 -39.88 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 107.862 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -37.33 68.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.31 -57.69 11.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.738 . . . . 0.0 109.168 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 67.0 mt -54.77 -53.9 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.64 -52.21 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.79 -33.73 56.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -65.36 -52.97 50.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 446' ' ' LEU . . . . . 0.457 ' N ' HD12 ' D' ' 446' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -86.69 111.91 21.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 120' ' ' ASN . 1.4 m120 -73.22 -16.68 61.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.06 168.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.9 p -81.09 150.74 28.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -87.64 -7.43 57.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.31 70.67 5.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.08 -27.29 57.43 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.409 1.406 . . . . 0.0 112.521 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 126' ' ' LEU . 10.5 mp -73.04 -44.6 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.737 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.31 -56.01 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 109.616 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.674 HG23 ' N ' ' A' ' 129' ' ' ALA . 35.0 m -59.86 -54.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.681 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.674 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.01 -24.31 16.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.195 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.05 -20.73 24.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.575 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -74.88 -41.97 58.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.557 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.7 mt -51.85 -42.93 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.441 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.66 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.0 109.002 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.53 96.27 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.525 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.3 mt -66.6 -57.29 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.242 -1.152 . . . . 0.0 109.091 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.39 -36.89 23.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 108.73 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.938 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.26 -57.28 13.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.914 HD21 ' NE2' ' C' ' 337' ' ' HIS . 18.3 mt -51.75 -50.35 60.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.833 . . . . 0.0 109.745 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.5 mt -53.05 -31.95 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -82.3 -59.15 2.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.038 -1.039 . . . . 0.0 109.71 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -49.81 -42.85 47.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 109.794 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.584 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.2 tt -72.72 -42.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.816 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.485 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 tt -59.78 -28.5 67.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.048 . . . . 0.0 109.064 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.2 OUTLIER -76.55 -45.43 30.66 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.291 -0.881 . . . . 0.0 109.463 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.51 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 61.5 ttt180 -55.76 -34.95 65.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.38 -51.07 6.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.677 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -96.2 35.36 1.45 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' ASP . 30.1 t80 -47.35 -30.15 3.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -67.76 -48.83 65.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 m -55.75 -48.76 74.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.9 mm -53.86 -49.05 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -54.43 -39.97 67.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.05 -41.89 77.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.574 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -49.19 -54.78 14.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -43.98 96.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.36 100.87 4.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 157' ' ' HIS . 2.1 m-70 54.77 -135.07 1.46 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.13 -28.04 2.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 157' ' ' HIS . 11.5 mt -89.34 120.34 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -1.182 . . . . 0.0 109.359 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.8 tttm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.465 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 3.3 p -63.52 -27.87 69.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.445 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.0 129.46 35.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -162.37 63.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 21.7 p -164.04 129.35 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 70.5 m -86.0 -122.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -146.69 71.06 12.63 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.42 -36.42 27.03 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.447 1.431 . . . . 0.0 112.513 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.42 ' N ' HD12 ' B' ' 226' ' ' LEU . 11.0 mp -60.64 -47.64 85.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.586 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.582 ' CG1' HD21 ' C' ' 331' ' ' ASN . 11.4 t -62.63 -33.58 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.31 -59.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.68 -39.53 17.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.206 -0.933 . . . . 0.0 108.957 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -71.26 -32.0 68.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.387 -0.821 . . . . 0.0 109.247 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.25 -63.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.442 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -50.94 -38.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.031 -1.043 . . . . 0.0 108.366 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.442 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.8 mt -54.92 -44.18 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -55.5 -48.41 70.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.553 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -55.91 -38.29 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -1.148 . . . . 0.0 108.705 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.15 -35.91 76.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.247 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.866 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.2 OUTLIER -55.68 -47.98 75.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.046 -1.034 . . . . 0.0 109.025 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.709 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.6 tp -67.79 -36.96 81.38 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.629 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.827 -1.171 . . . . 0.0 108.145 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.7 -35.13 65.12 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . 0.526 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -60.7 -56.12 25.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 109.419 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . 0.492 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.1 tt -65.32 -41.11 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.375 -0.828 . . . . 0.0 109.575 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.492 ' N ' HG23 ' B' ' 242' ' ' ILE . 0.6 OUTLIER -60.69 -36.86 79.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.441 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -67.4 -50.58 58.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.62 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.73 -28.69 68.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -57.22 7.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.553 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -82.45 108.41 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.47 -86.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -144.55 -82.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 7.7 m -87.7 -142.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.378 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 62.1 mt 48.73 89.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.363 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -158.55 94.56 1.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.546 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -82.89 146.99 28.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.317 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -152.67 136.36 16.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.2 OUTLIER -91.64 116.3 28.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.421 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -62.2 108.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -168.75 96.93 0.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.36 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -164.3 -136.48 2.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 42.7 mt -83.34 -11.13 58.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.487 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.278 0.561 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 86.2 p -86.76 111.95 21.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.354 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . 0.517 ' N ' HD22 ' C' ' 320' ' ' ASN . 1.4 m120 -73.21 -16.71 61.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.14 168.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.418 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 86.7 p -81.16 150.83 28.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.922 . . . . 0.0 109.356 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 44.3 t -87.68 -7.48 57.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.877 . . . . 0.0 109.538 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.26 70.77 5.61 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.16 -27.35 56.77 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.426 1.418 . . . . 0.0 112.479 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . 0.561 ' N ' HD12 ' C' ' 326' ' ' LEU . 10.5 mp -72.96 -44.6 60.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.3 -56.02 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.682 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.67 HG23 ' N ' ' C' ' 329' ' ' ALA . 35.0 m -59.88 -54.4 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.669 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.67 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -53.85 -24.49 15.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.264 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.04 -20.53 24.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.293 -0.88 . . . . 0.0 109.337 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.582 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -74.9 -42.1 58.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.456 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.9 mt -51.81 -43.01 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.6 tt -75.85 -34.5 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -59.23 -44.5 96.42 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.561 HG21 ' HB1' ' B' ' 230' ' ' ALA . 83.4 mt -66.63 -57.36 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.312 -1.111 . . . . 0.0 109.082 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.4 mt -49.31 -36.83 22.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 108.802 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.914 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.36 -57.26 13.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.043 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.938 HD21 ' NE2' ' A' ' 137' ' ' HIS . 18.5 mt -51.7 -50.34 60.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -0.784 . . . . 0.0 109.772 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 19.2 mt -53.09 -32.07 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.626 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.21 -58.81 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.16 -0.962 . . . . 0.0 109.682 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -50.22 -42.59 51.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.869 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.588 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.2 tt -73.03 -41.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 109.6 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.2 tt -59.8 -28.54 67.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.071 -1.018 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.2 OUTLIER -76.64 -45.36 30.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.825 . . . . 0.0 109.421 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . 0.526 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 61.6 ttt180 -55.73 -34.99 65.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.35 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.4 -51.23 6.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -96.03 35.27 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.391 -0.818 . . . . 0.0 109.554 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' C' ' 344' ' ' ASP . 30.2 t80 -47.37 -30.03 2.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.388 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -67.8 -48.84 65.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.522 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 5.2 m -55.65 -48.72 74.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.8 -49.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -54.41 -40.04 67.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -69.06 -41.79 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.575 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -49.38 -54.55 16.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.51 -43.98 96.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.503 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.41 100.99 4.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' C' ' 357' ' ' HIS . 2.1 m-70 54.65 -135.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.509 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.2 -28.09 2.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' C' ' 357' ' ' HIS . 11.7 mt -89.27 120.28 30.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -1.127 . . . . 0.0 109.416 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 38.9 tttm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.506 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.289 0.566 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.3 p -63.44 -27.84 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -82.98 129.46 35.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.432 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -162.38 63.28 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 21.1 p -164.01 129.31 2.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 70.3 m -85.95 -122.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -146.71 71.09 12.61 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.41 -36.47 26.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.429 1.419 . . . . 0.0 112.526 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . 0.412 ' N ' HD12 ' D' ' 426' ' ' LEU . 11.0 mp -60.61 -47.56 85.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.575 ' CG1' HD21 ' A' ' 131' ' ' ASN . 11.5 t -62.69 -33.48 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.553 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -66.41 -59.87 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.72 -39.52 17.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 108.972 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.525 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -71.32 -31.84 67.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -63.14 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.875 . . . . 0.0 109.522 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.421 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.7 tp -50.92 -38.53 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.112 -0.993 . . . . 0.0 108.394 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.421 ' N ' HG23 ' D' ' 432' ' ' ILE . 10.8 mt -54.92 -44.25 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -55.33 -48.53 68.79 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.548 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -55.88 -38.33 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -1.128 . . . . 0.0 108.644 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.06 -36.05 77.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.883 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.58 -48.04 75.46 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.923 -1.11 . . . . 0.0 108.976 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.69 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.7 tp -67.77 -36.96 81.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.821 -1.151 . . . . 0.0 109.665 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -49.81 -39.13 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.873 -1.142 . . . . 0.0 108.089 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.74 -35.12 65.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . 0.51 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.2 t90 -60.5 -56.09 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.517 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . 0.491 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.2 tt -65.56 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.624 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . 0.491 ' N ' HG23 ' D' ' 442' ' ' ILE . 0.6 OUTLIER -60.57 -36.89 79.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.437 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.46 -50.52 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.82 -28.72 69.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.28 -57.21 7.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -82.49 108.32 15.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.46 -86.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -144.47 -82.39 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.818 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 7.9 m -87.58 -142.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 61.2 mt 48.69 89.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -158.49 94.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -82.86 147.04 28.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.327 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -152.67 136.32 16.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' D' ' 455' ' ' PHE . 0.2 OUTLIER -91.54 116.26 28.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -62.21 108.99 1.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -168.78 96.96 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.342 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -164.34 -136.48 2.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 42.9 mt -83.41 -11.05 58.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -1.145 . . . . 0.0 109.427 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 73.3 mttt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.477 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.4 33.36 6.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 m120 49.05 53.7 12.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.343 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.53 153.11 20.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.1 t -173.73 10.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.5 p -56.14 -17.21 6.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.901 . . . . 0.0 109.426 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 51.32 70.03 2.2 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.57 -26.53 54.14 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.273 1.315 . . . . 0.0 112.292 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.47 -54.64 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 109.642 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.01 -35.52 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.489 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 131' ' ' ASN . 5.8 t -70.35 -66.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.585 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.87 -17.78 0.22 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.461 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -89.88 -28.45 19.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.578 -0.701 . . . . 0.0 109.31 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -71.46 -37.5 71.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.841 . . . . 0.0 109.525 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.85 -46.11 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.518 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.5 tt -75.57 -31.3 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 108.864 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.03 85.81 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.632 HG21 ' HB1' ' D' ' 430' ' ' ALA . 63.0 mt -68.32 -52.97 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -1.048 . . . . 0.0 108.936 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -50.02 -35.01 23.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 108.904 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.94 -58.07 7.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.7 mt -55.35 -46.8 76.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.602 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.2 mt -55.27 -34.89 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -78.53 -57.4 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -50.38 -54.51 21.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.317 -0.864 . . . . 0.0 109.576 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.659 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.8 tt -58.93 -42.7 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.076 -1.015 . . . . 0.0 109.519 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.49 ' N ' HG23 ' A' ' 142' ' ' ILE . 6.3 mt -54.41 -31.06 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.142 -0.974 . . . . 0.0 109.043 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 148' ' ' PHE . 11.8 t70 -77.2 -34.92 56.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -29.87 67.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.576 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.04 -15.73 20.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.645 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.37 39.06 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.686 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.93 -24.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.38 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.44 -38.64 68.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.902 . . . . 0.0 109.368 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 p -69.46 -45.77 68.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 151' ' ' ILE . 1.7 mp -58.81 -47.66 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.457 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -61.29 -40.83 95.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.46 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -75.0 -30.18 61.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -57.65 -39.9 78.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.502 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -31.32 46.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.544 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -59.27 111.72 1.46 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.491 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -65.91 -63.67 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.35 136.1 1.93 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.92 115.68 28.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.2 mttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.438 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 37.1 m -74.57 2.59 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.412 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -155.78 68.33 0.64 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.392 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -55.57 161.75 1.91 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.849 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.21 -16.75 58.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.63 -21.16 48.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.403 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' B' ' 224' ' ' ASP . 1.3 m-20 56.47 70.74 1.35 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 109.569 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -64.96 -28.27 58.03 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 121.453 1.435 . . . . 0.0 112.359 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.0 mp -50.42 -41.45 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.394 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.445 ' H ' HG23 ' B' ' 227' ' ' VAL . 2.7 t -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.23 -58.87 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.07 -39.61 13.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.101 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.65 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.69 -33.68 66.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.865 . . . . 0.0 109.163 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.44 -62.02 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.136 -0.977 . . . . 0.0 109.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.447 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.2 tp -51.28 -38.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 108.718 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.447 ' N ' HG23 ' B' ' 232' ' ' ILE . 7.3 mt -54.03 -46.45 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 108.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.66 -46.67 88.73 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.476 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -57.64 -52.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.248 -1.148 . . . . 0.0 108.715 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.7 -38.32 72.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.479 -0.763 . . . . 0.0 109.551 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.825 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.49 -47.44 69.83 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.036 -1.04 . . . . 0.0 109.352 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.744 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.8 tp -67.16 -36.74 82.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.13 -40.11 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.99 -34.43 66.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.72 -55.19 36.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.498 -0.751 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.6 tt -63.51 -35.5 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.778 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.465 HD23 ' C ' ' B' ' 243' ' ' LEU . 2.0 tt -67.5 -62.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -46.76 -50.85 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.605 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.1 OUTLIER -57.12 -35.41 69.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -48.41 66.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.502 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.64 127.99 3.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -84.72 -39.17 18.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -64.49 152.57 41.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.877 . . . . 0.0 109.481 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 41.5 m -161.23 -53.63 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.85 116.07 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.619 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' B' ' 253' ' ' ARG . 31.3 m-85 -84.94 -33.95 22.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' B' ' 252' ' ' TYR . 99.2 mtt180 -56.5 -166.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.93 164.69 33.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.415 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.407 ' O ' ' O ' ' B' ' 256' ' ' GLU . 88.2 m-85 -86.92 54.64 3.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.456 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' B' ' 255' ' ' PHE . 34.9 mt-10 48.56 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.418 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 151.71 30.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -172.58 126.37 1.26 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.29 119.67 22.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -1.173 . . . . 0.0 109.433 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 15.7 pttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.506 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.46 33.36 6.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.359 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 5.7 m120 49.0 53.68 12.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.32 153.19 19.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 5.0 t -173.86 10.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 2.5 p -56.24 -17.13 6.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 26.5 t0 51.36 70.03 2.2 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.736 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.64 -26.48 53.71 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.307 1.338 . . . . 0.0 112.246 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.58 -54.55 39.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 88.9 t -52.11 -35.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.389 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' C' ' 331' ' ' ASN . 6.3 t -70.08 -66.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.457 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.87 -17.84 0.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.45 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.18 -27.85 19.29 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.63 -0.669 . . . . 0.0 109.214 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.0 OUTLIER -71.45 -37.58 71.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.526 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.81 -46.28 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 tt -75.35 -31.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.115 -0.991 . . . . 0.0 108.978 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.11 -45.92 86.39 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.65 HG21 ' HB1' ' B' ' 230' ' ' ALA . 63.0 mt -68.32 -53.11 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.374 -1.074 . . . . 0.0 108.911 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.4 tp -49.78 -35.22 21.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.7 -58.2 7.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.7 mt -55.33 -46.68 76.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.389 -0.819 . . . . 0.0 109.704 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.28 -35.06 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.56 -56.83 4.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -50.79 -54.3 24.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.72 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.68 HD12 ' ND1' ' B' ' 237' ' ' HIS . 3.9 tt -59.18 -42.53 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.09 -1.006 . . . . 0.0 109.436 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.483 ' N ' HG23 ' C' ' 342' ' ' ILE . 6.3 mt -54.49 -31.04 55.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' C' ' 348' ' ' PHE . 11.9 t70 -77.39 -34.75 54.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -29.87 67.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.58 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.05 -15.69 20.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -147.38 39.03 0.97 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.702 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.89 -24.75 1.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.91 . . . . 0.0 109.393 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -72.4 -38.55 68.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.424 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 57.9 p -69.47 -45.79 68.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 109.539 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . 0.501 HD12 ' N ' ' C' ' 351' ' ' ILE . 1.7 mp -58.81 -47.76 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.2 -40.87 95.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -74.98 -30.14 61.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.71 -39.89 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -31.31 46.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -59.24 111.79 1.48 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -66.05 -63.6 1.05 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.501 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.98 1.91 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 115.73 28.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -1.169 . . . . 0.0 109.504 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 18.3 mttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.422 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 37.2 m -74.59 2.65 9.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -155.85 68.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.54 161.88 1.84 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -16.62 58.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.6 -21.16 48.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' D' ' 424' ' ' ASP . 1.4 m-20 56.36 70.78 1.35 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.595 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -65.07 -28.13 57.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.402 1.401 . . . . 0.0 112.352 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mp -50.4 -41.39 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.07 -35.98 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.629 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.22 -58.91 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.23 -39.55 14.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.632 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.61 -33.72 66.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.184 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -66.49 -61.98 1.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.417 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.442 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.2 tp -51.32 -38.57 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 108.688 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.442 ' N ' HG23 ' D' ' 432' ' ' ILE . 7.4 mt -53.95 -46.43 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.67 -46.73 88.71 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.471 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.7 mp -57.58 -52.97 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -1.136 . . . . 0.0 108.744 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.65 -38.45 72.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.827 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.35 -47.54 69.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.054 -1.029 . . . . 0.0 109.334 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.733 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.0 tp -67.05 -36.91 83.09 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.603 -1.239 . . . . 0.0 109.735 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.6 mm -50.11 -39.98 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.855 -1.153 . . . . 0.0 107.925 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.13 -34.35 66.06 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -60.46 -55.32 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.555 -0.716 . . . . 0.0 109.638 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.62 -35.38 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.356 -0.84 . . . . 0.0 109.923 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . 0.459 HD23 ' C ' ' D' ' 443' ' ' LEU . 2.0 tt -67.5 -62.48 1.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.533 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -46.77 -50.86 17.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.1 OUTLIER -57.13 -35.29 69.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.469 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -48.48 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.49 128.03 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.65 -39.24 18.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.504 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -64.41 152.62 40.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 40.9 m -161.33 -53.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 60.5 mt -49.76 116.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . 0.412 ' O ' ' O ' ' D' ' 453' ' ' ARG . 31.3 m-85 -84.92 -34.02 22.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' D' ' 452' ' ' TYR . 99.2 mtt180 -56.45 -166.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.84 164.7 33.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.409 ' O ' ' O ' ' D' ' 456' ' ' GLU . 88.3 m-85 -86.88 54.69 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' D' ' 455' ' ' PHE . 35.0 mt-10 48.48 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.884 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 151.66 30.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -172.48 126.34 1.26 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.26 119.66 22.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -1.204 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 15.8 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.479 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.06 160.89 0.67 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.499 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.59 21.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.883 . . . . 0.0 109.522 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.46 164.14 38.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.137 -0.977 . . . . 0.0 109.578 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -74.67 81.69 2.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.4 p -150.24 163.62 37.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.0 70.21 8.5 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.568 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.43 -27.67 54.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.322 1.348 . . . . 0.0 112.321 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.25 -51.99 67.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.0 t -52.52 -35.2 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.366 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' A' ' 130' ' ' ALA . 10.8 t -65.23 -65.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.37 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.49 -17.99 0.36 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.249 -0.907 . . . . 0.0 108.611 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.497 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . -88.22 -27.4 21.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.525 -0.734 . . . . 0.0 109.361 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.63 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.4 OUTLIER -74.91 -38.03 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.623 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 132' ' ' ILE . 4.1 mt -50.42 -44.95 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.414 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.0 tt -77.91 -35.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 109.025 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.86 -46.65 90.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' D' ' 430' ' ' ALA . 79.2 mt -67.23 -56.4 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -1.072 . . . . 0.0 109.177 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mt -49.93 -33.58 17.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.007 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.777 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.12 -52.71 61.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.85 . . . . 0.0 109.122 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.784 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.9 mt -55.37 -38.06 68.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.736 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 7.5 mt -68.77 -29.7 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.65 -55.25 4.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 109.826 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.12 -43.39 61.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.77 HD13 ' NE2' ' D' ' 437' ' ' HIS . 4.0 tp -72.79 -44.39 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.033 -1.042 . . . . 0.0 109.697 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.561 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 mt -48.52 -35.5 13.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.995 -1.066 . . . . 0.0 109.218 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -76.56 -47.22 23.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.92 -28.16 6.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 109.541 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -16.39 15.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.029 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -146.4 42.92 1.19 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.872 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' ASP . 20.2 p90 -50.46 -37.31 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -59.94 -30.37 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.561 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.1 m -77.28 -51.97 9.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.898 . . . . 0.0 109.42 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 151' ' ' ILE . 1.7 mp -59.55 -39.53 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.419 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -64.12 -52.47 59.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -57.89 -39.87 78.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.448 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.82 -55.63 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.65 -22.48 65.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.329 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.445 ' C ' ' CD2' ' A' ' 157' ' ' HIS . 2.4 tt0 59.49 -163.81 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.346 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.445 ' CD2' ' C ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -152.86 -22.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 0.0 109.547 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.07 167.27 36.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 159' ' ' LEU . 10.9 mp -69.32 128.8 37.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -1.114 . . . . 0.0 109.503 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 pttm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.501 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.76 -177.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.563 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.16 144.18 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.448 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.59 107.68 10.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 109.415 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 77.8 p -75.01 -46.38 35.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.47 21.94 1.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.52 161.56 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.237 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -54.34 -27.48 48.59 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.091 1.194 . . . . 0.0 112.369 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.84 -37.81 32.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 0.0 109.616 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.634 ' CG1' HD21 ' C' ' 331' ' ' ASN . 6.6 t -64.64 -35.89 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.57 -58.11 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 109.339 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.33 -37.27 16.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 108.946 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -73.11 -35.28 66.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.021 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.497 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -64.99 -62.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.481 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.0 tp -51.02 -40.22 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.05 -1.031 . . . . 0.0 108.585 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.481 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.1 mt -53.73 -42.31 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.12 -46.7 92.37 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.543 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -57.28 -39.12 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -1.212 . . . . 0.0 108.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.31 -35.27 73.55 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.422 -0.799 . . . . 0.0 109.371 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.787 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.3 OUTLIER -55.07 -49.81 70.72 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.934 -1.104 . . . . 0.0 109.014 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 137' ' ' HIS . 12.0 tp -67.68 -36.6 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.66 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.74 -37.56 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.859 -1.151 . . . . 0.0 108.293 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.29 -40.62 62.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.9 t90 -53.74 -53.19 55.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.502 -0.749 . . . . 0.0 109.415 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 14.9 tt -67.39 -33.57 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.18 -59.51 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -52.54 -43.14 64.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -62.85 -30.96 71.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.9 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -61.0 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 3.3 t80 54.01 -174.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' B' ' 248' ' ' PHE . 0.1 OUTLIER -88.07 179.61 6.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.452 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -56.55 149.23 17.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.197 -0.94 . . . . 0.0 109.438 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 48.2 t -56.61 -34.57 67.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.406 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 9.1 mm -81.33 114.93 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' B' ' 252' ' ' TYR . 0.3 OUTLIER -63.43 141.17 58.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.543 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.02 114.66 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -82.91 -102.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.468 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' B' ' 255' ' ' PHE . 48.1 t80 -148.94 -14.82 0.31 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.362 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.14 153.12 21.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.512 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.23 -43.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.406 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 157.84 98.46 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 7.9 mt -63.42 -37.76 88.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -1.142 . . . . 0.0 109.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 79.0 mttt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.482 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.23 160.9 0.71 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.363 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.57 21.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -153.43 164.12 38.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 2.5 p -74.61 81.68 2.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.401 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 58.2 p -150.19 163.71 37.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -151.11 70.17 8.41 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.42 -27.51 54.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.345 1.363 . . . . 0.0 112.302 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.41 -51.99 67.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.51 -35.4 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.3 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' C' ' 331' ' ' ASN . 11.5 t -65.02 -65.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.302 -0.873 . . . . 0.0 109.308 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.42 -18.11 0.36 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 108.718 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.486 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . -88.48 -26.8 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.532 -0.73 . . . . 0.0 109.275 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.634 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.4 OUTLIER -75.09 -38.07 61.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.529 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.405 HG21 HD13 ' C' ' 332' ' ' ILE . 4.4 mt -50.43 -45.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 tt -77.7 -35.49 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.104 -0.998 . . . . 0.0 108.932 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.79 88.41 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.549 HG21 ' HB1' ' B' ' 230' ' ' ALA . 79.9 mt -67.06 -56.54 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.276 -1.132 . . . . 0.0 109.198 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 mt -49.84 -33.67 17.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 108.981 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.784 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.15 -52.6 61.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.822 . . . . 0.0 109.135 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.777 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.9 mt -55.43 -37.98 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.773 . . . . 0.0 109.753 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 7.7 mt -68.88 -29.63 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.83 -54.66 5.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.819 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -51.55 -43.45 62.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 110.055 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.787 HD13 ' NE2' ' B' ' 237' ' ' HIS . 4.1 tp -72.62 -44.39 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.555 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.46 -35.65 13.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.014 -1.054 . . . . 0.0 109.21 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -76.57 -47.16 23.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.4 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -28.23 6.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.99 . . . . 0.0 109.565 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.94 -16.34 15.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.528 -0.733 . . . . 0.0 110.017 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -146.43 43.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 109.853 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' C' ' 344' ' ' ASP . 20.3 p90 -50.64 -37.24 39.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.431 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 36.0 pttt -60.0 -30.35 69.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.498 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 18.9 m -77.25 -52.0 9.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . 0.45 HD12 ' N ' ' C' ' 351' ' ' ILE . 1.7 mp -59.55 -39.5 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.92 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -64.17 -52.5 58.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.379 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -57.85 -39.85 78.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.492 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -55.52 11.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.61 -22.57 65.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.373 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . 0.447 ' C ' ' CD2' ' C' ' 357' ' ' HIS . 2.4 tt0 59.58 -163.82 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . 0.447 ' CD2' ' C ' ' C' ' 356' ' ' GLU . 0.0 OUTLIER -152.9 -22.16 0.16 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 179.03 167.34 36.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . 0.44 ' N ' HD12 ' C' ' 359' ' ' LEU . 10.9 mp -69.43 128.83 37.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.459 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 3.0 pttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.492 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 54.72 -177.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.27 144.09 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.49 107.73 10.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.485 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 77.8 p -75.06 -46.29 35.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.47 21.87 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.614 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.49 161.56 1.07 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.29 -27.47 48.09 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.042 1.161 . . . . 0.0 112.49 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.87 -37.79 32.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.514 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.63 ' CG1' HD21 ' A' ' 131' ' ' ASN . 7.0 t -64.69 -35.87 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.69 -58.08 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.274 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.37 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.136 -0.978 . . . . 0.0 108.933 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -73.09 -35.21 66.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.058 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.486 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.8 OUTLIER -64.99 -62.74 1.37 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.468 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.0 tp -51.01 -40.26 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.21 -0.932 . . . . 0.0 108.573 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.468 ' N ' HG23 ' D' ' 432' ' ' ILE . 10.3 mt -53.6 -42.32 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.171 -0.955 . . . . 0.0 108.475 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.09 -46.82 92.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.533 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -57.13 -39.23 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.34 -35.19 73.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.459 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.77 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -55.06 -49.8 70.7 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.014 -1.054 . . . . 0.0 109.082 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.717 HD13 ' CE1' ' C' ' 337' ' ' HIS . 12.4 tp -67.62 -36.72 81.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.78 -1.168 . . . . 0.0 109.663 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.9 mm -49.7 -37.62 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 108.211 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.2 -40.59 62.38 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -53.77 -53.03 57.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.579 -0.701 . . . . 0.0 109.481 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.6 -33.4 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.5 tp -63.14 -59.65 4.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -52.47 -43.16 64.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -62.91 -30.86 71.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.53 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -60.95 2.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.525 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 3.3 t80 53.91 -174.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' D' ' 448' ' ' PHE . 0.1 OUTLIER -88.07 179.52 6.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -56.46 149.18 17.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 109.39 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 48.1 t -56.59 -34.46 67.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 8.9 mm -81.38 114.9 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' D' ' 452' ' ' TYR . 0.3 OUTLIER -63.48 141.26 58.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.451 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -162.05 114.77 1.76 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -83.09 -102.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.469 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' D' ' 455' ' ' PHE . 47.9 t80 -148.95 -14.78 0.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.317 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.32 153.08 21.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.482 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.15 -43.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.361 -0.837 . . . . 0.0 109.458 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 157.81 98.42 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 7.9 mt -63.43 -37.81 88.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -1.196 . . . . 0.0 109.436 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 78.8 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.542 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.35 12.86 2.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -56.67 -38.28 72.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -148.12 140.39 24.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.11 157.35 26.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.3 t -148.92 -98.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 1.8 p30 -157.24 69.52 4.37 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.58 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.54 -27.23 53.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.396 1.397 . . . . 0.0 112.435 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.8 mt -72.74 -43.45 62.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.695 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.3 -56.04 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.148 -0.97 . . . . 0.0 109.547 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.5 m -58.91 -53.29 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.121 -0.987 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.669 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -55.63 -26.32 43.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.15 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.15 -17.45 34.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.356 -0.84 . . . . 0.0 109.376 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -40.11 28.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 109.585 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.52 -45.21 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.347 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.486 HG21 HD11 ' B' ' 235' ' ' ILE . 11.0 tt -76.73 -44.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 109.173 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.48 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -48.11 -45.19 26.86 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.506 HG21 ' HB1' ' D' ' 430' ' ' ALA . 95.6 mt -67.1 -55.66 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.01 -33.16 17.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.94 . . . . 0.0 108.929 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.925 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -62.33 -55.12 31.19 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.365 -0.834 . . . . 0.0 108.912 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.91 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.1 mt -55.06 -45.85 75.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.438 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.24 -35.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.39 -57.06 3.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.588 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.4 t-105 -48.9 -51.76 28.19 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.205 -0.935 . . . . 0.0 109.682 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.508 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.6 tt -65.26 -41.85 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 0.0 110.077 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -59.42 -30.69 68.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.037 -1.04 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -37.77 59.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.346 -0.846 . . . . 0.0 109.469 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.18 73.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.32 -47.38 8.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.135 -0.978 . . . . 0.0 109.662 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -93.03 35.47 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.42 ' CE2' ' NH2' ' B' ' 245' ' ' ARG . 32.8 t80 -47.21 -26.73 1.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -69.19 -46.55 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.325 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.7 t -60.37 -44.77 95.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.0 -47.74 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 0.9 OUTLIER -55.23 -43.71 74.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -64.86 -45.02 87.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.01 -46.68 78.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.483 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -30.86 70.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -69.14 135.64 51.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.608 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -160.84 93.07 0.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.16 101.41 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 159' ' ' LEU . 10.4 mp -67.12 -50.44 61.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -1.178 . . . . 0.0 109.367 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.353 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.7 t -160.65 -63.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.43 133.29 7.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -62.46 -52.63 62.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.562 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 59.5 p -84.17 152.27 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.438 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 22.4 t -60.6 -94.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -149.66 70.25 9.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.24 -33.61 38.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.402 1.401 . . . . 0.0 112.534 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.54 -59.0 5.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.595 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.38 -35.08 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.62 -59.59 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 109.371 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.27 -37.48 10.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.526 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.45 -32.43 66.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -0.861 . . . . 0.0 109.233 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -58.51 4.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.71 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.82 -35.41 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.037 -1.039 . . . . 0.0 108.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 10.2 mt -57.12 -44.17 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.75 -45.14 95.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.486 HD11 HG21 ' A' ' 133' ' ' ILE . 75.3 mt -60.56 -53.81 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.224 -1.163 . . . . 0.0 108.961 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.53 -35.41 68.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.299 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.821 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -56.06 -48.74 75.49 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.766 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.8 tp -64.48 -37.71 88.5 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.638 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.36 -38.98 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' B' ' 240' ' ' LEU . 52.3 tp -72.85 -32.7 65.63 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.31 -57.77 8.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.501 -0.75 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . 0.456 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.5 tt -62.11 -38.12 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.63 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.456 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.2 tp -69.3 -26.84 64.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 109.66 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -79.53 -43.15 23.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -64.42 -55.75 18.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.11 -43.43 98.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.596 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 3.2 t80 64.86 173.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -172.4 152.35 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.868 . . . . 0.0 109.469 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -173.55 8.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 46.3 p 49.32 92.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 4.3 tt -62.02 -24.18 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 109.573 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -51.41 130.95 28.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -74.8 -29.51 61.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.468 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' B' ' 255' ' ' PHE . 0.3 OUTLIER -67.45 163.54 20.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' B' ' 254' ' ' PHE . 2.1 t80 71.46 30.1 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.424 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -163.53 163.56 24.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' B' ' 257' ' ' HIS . 0.0 OUTLIER -85.29 -59.86 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.482 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.18 167.8 14.25 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 13.9 mt -78.59 161.49 26.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -1.104 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 43.3 tttt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.432 -179.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.328 0.585 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.31 12.88 2.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -56.72 -38.29 72.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.06 140.25 24.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.91 157.29 26.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 -98.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' C' ' 324' ' ' ASP . 1.8 p30 -157.21 69.39 4.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.684 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.47 -27.17 54.53 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.363 1.375 . . . . 0.0 112.495 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 35.8 mt -72.83 -43.38 62.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.31 -56.1 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.641 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.3 m -58.8 -53.3 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.394 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.641 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -55.6 -26.39 43.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -86.28 -17.16 35.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.284 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 -40.24 28.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 mt -51.47 -45.29 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 109.327 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . 0.481 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -76.54 -44.6 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.249 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . 0.481 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -48.32 -44.98 28.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.526 HG21 ' HB1' ' B' ' 230' ' ' ALA . 95.6 mt -67.25 -55.58 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -1.115 . . . . 0.0 109.211 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.8 mp -50.07 -33.07 17.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.91 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.4 -55.07 31.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.358 -0.839 . . . . 0.0 108.893 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.925 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.0 mt -55.14 -45.84 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.394 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.28 -35.5 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.41 -56.36 4.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.623 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.4 t-105 -49.44 -51.6 34.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -0.863 . . . . 0.0 109.698 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.509 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.5 tt -65.49 -41.85 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.847 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.4 tt -59.22 -30.9 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.036 -1.04 . . . . 0.0 109.2 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -37.66 59.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -32.14 73.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 109.546 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.35 -47.38 8.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.643 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -93.03 35.44 1.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.571 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.418 ' CE2' ' NH2' ' D' ' 445' ' ' ARG . 32.7 t80 -47.11 -26.71 1.17 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -69.4 -46.37 67.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 7.7 t -60.4 -44.72 95.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.37 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.01 -47.62 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 0.9 OUTLIER -55.39 -43.65 75.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.419 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -64.92 -44.99 87.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -56.0 -46.79 78.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -30.77 70.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -69.17 135.75 51.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.584 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -160.93 92.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -177.13 101.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . 0.484 ' N ' HD12 ' C' ' 359' ' ' LEU . 10.4 mp -67.07 -50.49 61.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -1.106 . . . . 0.0 109.433 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.401 179.872 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 31.1 t -160.61 -63.63 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.516 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.5 133.32 7.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -62.64 -52.4 63.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 59.3 p -84.26 152.14 24.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.498 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 21.7 t -60.54 -93.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.366 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -149.7 70.07 9.49 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.22 -33.5 39.43 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.319 1.346 . . . . 0.0 112.608 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -58.95 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.602 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 19.0 t -54.32 -35.15 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.7 -59.43 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.417 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -37.35 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.214 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.53 -32.4 66.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -58.38 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.732 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 9.7 tp -56.97 -35.34 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 108.89 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 10.3 mt -57.04 -44.24 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 108.568 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.63 -45.26 94.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.469 HD11 HG21 ' C' ' 333' ' ' ILE . 75.2 mt -60.48 -53.75 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.252 -1.146 . . . . 0.0 108.978 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.6 -35.48 68.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 109.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.83 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -55.98 -48.85 75.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.742 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.0 tp -64.41 -37.8 88.8 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.637 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 1.3 mp -50.3 -39.01 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.91 -32.6 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -64.26 -57.77 8.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.418 -0.801 . . . . 0.0 109.59 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . 0.449 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.6 tt -62.22 -38.0 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . 0.449 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.2 tp -69.23 -26.96 65.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.574 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -79.43 -43.26 23.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -64.41 -55.72 19.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 8.0 mp -62.13 -43.52 98.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 3.3 t80 64.95 173.69 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.376 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -172.44 152.3 2.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.952 . . . . 0.0 109.483 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -173.46 8.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' D' ' 450' ' ' SER . 45.7 p 49.35 92.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.92 -24.17 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.674 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -51.36 130.95 28.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -74.72 -29.65 61.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . 0.422 ' O ' ' CB ' ' D' ' 455' ' ' PHE . 0.3 OUTLIER -67.44 163.6 20.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' D' ' 454' ' ' PHE . 2.0 t80 71.5 29.93 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -163.34 163.64 25.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.28 -59.96 2.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 149.15 167.77 14.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 14.0 mt -78.58 161.47 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.14 . . . . 0.0 109.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 43.4 tttt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.452 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -167.96 95.76 0.42 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.561 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.532 ' ND2' ' H ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -58.37 -55.8 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -157.94 -9.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t 48.37 31.49 2.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.3 t -74.96 -173.03 1.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 128' ' ' VAL . 5.3 m-20 -148.58 69.76 10.38 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.21 -29.61 55.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.289 1.326 . . . . 0.0 112.376 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.57 -44.96 48.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.42 -56.95 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.088 -1.008 . . . . 0.0 109.739 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 129' ' ' ALA . 33.2 m -57.83 -50.94 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.669 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -63.83 -14.05 49.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.806 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.93 -48.75 6.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.49 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER -80.22 -44.7 19.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 109.989 -179.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.49 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mm -51.77 -42.55 32.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.533 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 134' ' ' GLY . 13.2 tt -76.12 -42.08 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.226 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -51.31 -45.92 52.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.699 HG21 ' HB1' ' D' ' 430' ' ' ALA . 76.0 mt -66.31 -57.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -1.11 . . . . 0.0 109.277 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.52 -34.33 16.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.154 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.927 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.2 -60.62 3.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.225 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.944 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.3 mt -50.9 -44.55 59.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 57.3 mt -57.66 -32.9 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.59 -56.74 3.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.602 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.3 t-105 -48.44 -48.35 37.54 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.333 -0.854 . . . . 0.0 109.619 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.558 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.9 tt -68.69 -42.07 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.518 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -57.85 -31.88 67.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.107 . . . . 0.0 109.183 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.7 OUTLIER -73.5 -46.07 50.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.12 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -61.09 -23.26 65.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.857 . . . . 0.0 109.109 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.04 -16.54 20.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.797 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -140.98 38.12 1.78 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.568 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 144' ' ' ASP . 7.2 t80 -52.29 -39.75 60.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -59.03 -29.38 67.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -76.62 -46.51 25.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 mm -56.4 -50.22 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 152' ' ' TYR . 9.3 t80 -62.57 -42.49 99.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -61.7 -17.23 54.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -83.22 -68.96 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.535 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.73 -55.47 14.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.401 -0.812 . . . . 0.0 109.624 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 57.4 177.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -81.07 -15.3 56.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -91.75 90.78 1.55 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 159' ' ' LEU . 10.9 mp -80.05 -67.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.182 -1.187 . . . . 0.0 109.43 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.8 mttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.467 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.438 ' O ' ' N ' ' B' ' 221' ' ' ASP . 3.9 m 50.18 81.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.391 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -48.61 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' B' ' 219' ' ' SER . 1.8 m-20 -78.49 133.4 37.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 3.6 t 50.45 87.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.907 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 42.0 p -83.2 40.35 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -152.17 69.59 7.54 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.597 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.75 -41.64 17.93 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.302 1.335 . . . . 0.0 112.48 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -47.5 73.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.82 -42.67 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.9 t -58.26 -56.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.316 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.23 21.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 108.947 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.743 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -69.39 -28.81 66.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.01 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 228' ' ' VAL . 2.5 t-20 -68.48 -63.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.54 -36.49 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.116 -0.99 . . . . 0.0 108.425 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' B' ' 230' ' ' ALA . 22.5 mt -58.4 -42.55 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.79 -47.58 84.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.577 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.1 -52.11 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.105 -1.232 . . . . 0.0 108.672 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.35 74.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.449 -0.782 . . . . 0.0 109.56 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.824 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -52.73 -46.78 67.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.075 -1.016 . . . . 0.0 109.449 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.732 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.7 tp -67.5 -37.63 83.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.764 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.8 mm -49.37 -39.86 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.817 -1.177 . . . . 0.0 108.028 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.97 -35.67 66.96 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.92 -57.28 13.57 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.573 -0.704 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . 0.402 HG23 ' N ' ' B' ' 243' ' ' LEU . 11.3 tt -60.05 -37.86 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.281 -0.887 . . . . 0.0 109.583 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.402 ' N ' HG23 ' B' ' 242' ' ' ILE . 1.0 OUTLIER -56.19 -58.96 5.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.488 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' B' ' 244' ' ' ASP . 4.5 m-20 -55.55 -51.06 68.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -49.73 -28.1 5.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.334 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.73 -59.37 2.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -92.11 125.13 36.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.2 131.29 45.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -51.78 -83.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.13 143.58 26.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.0 mm -83.62 118.18 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -65.34 156.93 30.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 49.81 86.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 254' ' ' PHE . 0.1 OUTLIER -76.56 -55.51 5.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.957 . . . . 0.0 109.434 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 1.4 t80 67.23 126.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.15 -62.24 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.386 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 171.5 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 154.25 45.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.47 110.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -1.129 . . . . 0.0 109.395 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 20.4 mttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.534 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 88.8 p -167.93 95.74 0.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . 0.518 ' H ' ' ND2' ' C' ' 320' ' ' ASN . 0.2 OUTLIER -58.35 -55.81 30.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -157.97 -9.58 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 22.8 t 48.42 31.44 2.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 32.1 t -74.89 -173.06 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.426 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . 0.409 ' O ' HG22 ' C' ' 328' ' ' VAL . 5.3 m-20 -148.54 69.69 10.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.709 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.25 -29.4 55.14 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.293 1.329 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.84 -44.85 46.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.598 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.62 -56.74 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 109.631 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.656 HG23 ' N ' ' C' ' 329' ' ' ALA . 33.1 m -57.99 -50.79 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.657 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.656 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -64.0 -13.86 49.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 109.809 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -93.18 -48.6 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.965 . . . . 0.0 110.198 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.484 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.4 OUTLIER -80.18 -44.84 19.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.135 -0.978 . . . . 0.0 110.033 -179.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.6 mm -51.72 -42.62 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.504 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . 0.493 HG23 ' N ' ' C' ' 334' ' ' GLY . 13.2 tt -75.99 -42.14 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . 0.493 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -51.32 -45.8 52.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.743 HG21 ' HB1' ' B' ' 230' ' ' ALA . 74.8 mt -66.33 -57.34 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -1.111 . . . . 0.0 109.227 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.9 mp -49.42 -34.3 16.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.165 -0.96 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.944 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.18 -60.71 3.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.329 -0.857 . . . . 0.0 109.143 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.927 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.2 mt -50.84 -44.58 59.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.484 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.72 -32.85 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.586 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.66 -56.24 4.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.574 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.3 t-105 -49.02 -47.98 44.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.606 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.567 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.8 tt -69.05 -41.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.499 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tt -57.73 -32.04 67.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.258 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.7 OUTLIER -73.57 -45.92 50.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.183 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.06 -23.26 65.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.889 . . . . 0.0 109.15 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.01 -16.48 20.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.648 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.97 38.03 1.78 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 109.56 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 344' ' ' ASP . 7.1 t80 -52.26 -39.83 60.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.455 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -58.94 -29.41 67.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 6.3 t -76.63 -46.57 25.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 109.407 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 10.2 mm -56.3 -50.25 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 9.3 t80 -62.58 -42.55 99.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -61.65 -17.37 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -83.11 -69.08 0.66 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.67 -55.41 15.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.641 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 57.42 177.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -81.13 -15.41 55.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.515 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -91.68 90.75 1.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . 0.421 ' N ' HD12 ' C' ' 359' ' ' LEU . 10.9 mp -79.96 -67.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -1.14 . . . . 0.0 109.507 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 20.9 mttt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.442 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . 0.448 ' O ' ' N ' ' D' ' 421' ' ' ASP . 3.9 m 50.08 81.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -0.852 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -48.63 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' D' ' 419' ' ' SER . 1.8 m-20 -78.39 133.31 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 3.7 t 50.53 87.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.532 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 41.9 p -83.08 40.36 0.69 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.449 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -152.31 69.59 7.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.887 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.81 -41.57 17.84 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.308 1.339 . . . . 0.0 112.492 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.77 -47.41 73.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.606 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 15.0 t -61.78 -42.7 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.611 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.9 t -58.25 -56.61 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.87 -40.4 21.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 108.936 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -69.38 -28.7 66.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.287 -0.883 . . . . 0.0 109.029 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' D' ' 428' ' ' VAL . 2.5 t-20 -68.52 -63.81 0.99 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.2 tp -49.5 -36.54 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' D' ' 430' ' ' ALA . 22.7 mt -58.4 -42.48 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.72 -47.54 84.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.571 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -56.18 -52.06 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.138 -1.213 . . . . 0.0 108.629 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.83 -39.36 74.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.547 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.83 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -52.69 -46.81 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.095 -1.003 . . . . 0.0 109.402 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.725 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.8 tp -67.55 -37.53 82.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.78 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.2 mm -49.38 -39.87 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.857 -1.152 . . . . 0.0 108.045 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.99 -35.66 66.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -59.69 -57.39 13.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.679 . . . . 0.0 109.629 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.5 tt -60.25 -37.73 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 109.658 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.12 -58.95 5.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 0.0 109.414 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' D' ' 444' ' ' ASP . 4.5 m-20 -55.71 -50.94 68.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -49.86 -27.98 5.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.296 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.68 -59.51 2.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.503 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -91.97 125.07 36.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -66.22 131.31 45.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.46 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -51.77 -83.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.322 -0.861 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.02 143.58 26.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.476 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 9.9 mm -83.67 118.32 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -65.38 156.91 30.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 49.81 86.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' D' ' 454' ' ' PHE . 0.1 OUTLIER -76.57 -55.51 5.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 1.4 t80 67.31 127.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.57 171.42 0.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 154.32 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.51 110.52 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -1.106 . . . . 0.0 109.408 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 20.3 mttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.481 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.288 0.566 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -62.66 1.42 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.518 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -167.1 -172.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -162.88 -53.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.331 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 m 54.23 179.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.554 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.9 p -79.86 156.04 27.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.92 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -153.18 70.16 6.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.74 -28.51 51.74 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.328 1.352 . . . . 0.0 112.447 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.5 mt -72.64 -45.7 57.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.57 -57.39 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.72 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.678 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.7 m -57.78 -54.84 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.553 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.678 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.2 -23.18 13.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.126 -0.984 . . . . 0.0 109.226 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.05 -17.34 27.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.444 -0.785 . . . . 0.0 109.386 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 0.2 OUTLIER -80.76 -42.68 21.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.383 -0.823 . . . . 0.0 109.641 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 131' ' ' ASN . 4.4 mt -50.12 -44.29 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.42 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 134' ' ' GLY . 11.1 tt -76.16 -47.24 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.227 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.525 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -47.75 -43.27 22.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.561 HG21 ' HB1' ' D' ' 430' ' ' ALA . 98.1 mt -68.18 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -1.186 . . . . 0.0 109.254 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.7 -31.96 5.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.924 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -63.17 -58.81 5.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.364 -0.835 . . . . 0.0 109.0 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.929 HD21 ' NE2' ' C' ' 337' ' ' HIS . 13.0 mt -48.98 -50.99 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 139' ' ' ILE . 1.7 mp -55.18 -33.47 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 0.0 109.59 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.63 -58.42 3.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.975 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -53.09 -46.03 68.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.29 -0.882 . . . . 0.0 109.996 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.487 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.0 OUTLIER -67.59 -42.44 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.816 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.483 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -55.63 -34.64 65.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.082 -1.012 . . . . 0.0 108.811 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 13.9 t70 -74.3 -35.12 63.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.512 -0.743 . . . . 0.0 109.222 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -32.61 72.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.084 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.2 -14.72 23.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.65 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -137.81 40.62 2.35 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 32.7 p90 -61.79 -37.91 86.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.984 . . . . 0.0 109.498 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.2 tttm -64.82 -20.98 66.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.925 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.1 m -82.8 -57.55 3.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.3 mt -64.0 -28.83 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -78.22 -51.8 9.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.489 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -64.19 -27.25 68.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -76.41 -63.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.44 -8.86 1.32 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.08 -37.32 64.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.405 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -65.6 -78.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 157.99 168.9 20.96 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.07 116.87 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -1.154 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 35.5 mttm . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.504 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.282 0.563 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 1.4 p -70.29 -18.61 63.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.35 88.64 1.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -59.43 -27.32 65.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . 0.401 ' O ' ' O ' ' B' ' 223' ' ' SER . 0.6 OUTLIER -166.92 179.88 5.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 0.0 109.601 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . 0.401 ' O ' ' O ' ' B' ' 222' ' ' SER . 4.3 p 60.92 153.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.14 70.2 6.92 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.669 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.78 -26.8 59.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.352 1.368 . . . . 0.0 112.519 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.02 -61.25 2.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.152 -0.968 . . . . 0.0 109.575 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.437 ' H ' HG23 ' B' ' 227' ' ' VAL . 11.0 t -51.39 -40.52 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 109.432 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.25 -58.0 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.217 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.19 -36.26 13.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 108.977 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.5 -30.93 64.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.379 -0.826 . . . . 0.0 109.187 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -59.61 3.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.415 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.0 tp -55.44 -36.94 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 0.0 108.689 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.415 ' N ' HG23 ' B' ' 232' ' ' ILE . 12.7 mt -56.64 -42.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.255 -0.903 . . . . 0.0 108.679 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.09 -45.35 95.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 133' ' ' ILE . 81.3 mt -59.71 -53.27 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 0.0 108.76 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.63 -37.0 70.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.373 -0.829 . . . . 0.0 109.22 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.838 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -54.2 -47.43 72.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.295 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.737 HD13 ' ND1' ' A' ' 137' ' ' HIS . 8.0 tp -67.11 -37.56 84.11 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.514 -1.274 . . . . 0.0 109.683 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 41.0 mm -49.36 -39.4 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.848 -1.157 . . . . 0.0 107.994 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -35.32 65.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -60.12 -57.93 10.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 109.514 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 9.5 tt -61.27 -35.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.533 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.2 -32.72 73.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.3 -36.76 69.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -72.55 -47.1 50.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' B' ' 248' ' ' PHE . 0.8 OUTLIER -62.19 -41.52 98.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.492 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . 0.465 ' CD2' ' N ' ' B' ' 248' ' ' PHE . 73.8 t80 49.55 -93.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' B' ' 246' ' ' LEU . 0.2 OUTLIER 60.61 -175.94 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.499 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -151.38 150.68 30.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 109.49 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 8.9 p -161.92 11.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.93 3.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.895 . . . . 0.0 109.533 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.85 113.53 5.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.538 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -170.45 81.92 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.481 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.0 OUTLIER -154.99 -37.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' B' ' 254' ' ' PHE . 38.9 t80 -91.13 -64.47 1.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.33 147.96 42.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 0.0 109.416 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 47.95 -150.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -164.16 -117.6 0.41 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.08 -52.6 62.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.135 . . . . 0.0 109.483 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 27.0 mttm . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.424 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -167.14 -172.3 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -162.83 -53.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 8.6 m 54.28 179.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.531 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 13.1 p -79.89 156.05 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -153.25 70.19 6.85 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 109.608 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.68 -28.66 52.13 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.319 1.346 . . . . 0.0 112.48 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.59 -45.57 58.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.641 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 69.3 t -59.63 -57.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 109.606 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.671 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.7 m -57.7 -54.7 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.671 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.24 -23.31 14.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.263 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -90.06 -17.28 28.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' C' ' 332' ' ' ILE . 0.2 OUTLIER -80.61 -42.85 21.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.578 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' C' ' 331' ' ' ASN . 4.4 mt -50.02 -44.36 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 0.0 109.437 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . 0.531 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -76.04 -47.04 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 109.286 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . 0.531 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -47.95 -43.36 23.91 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.568 HG21 ' HB1' ' B' ' 230' ' ' ALA . 98.2 mt -68.19 -59.1 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -1.129 . . . . 0.0 109.27 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 5.2 mp -47.84 -31.89 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 108.867 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.929 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -63.21 -58.62 6.58 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.924 HD21 ' NE2' ' A' ' 137' ' ' HIS . 13.1 mt -49.02 -51.06 33.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.296 -0.877 . . . . 0.0 109.73 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . 0.457 ' N ' HD12 ' C' ' 339' ' ' ILE . 1.7 mp -55.11 -33.64 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.957 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 2.8 tt -78.69 -57.87 3.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 109.916 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.617 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -53.71 -45.82 70.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 110.01 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.481 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.0 OUTLIER -67.71 -42.25 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 109.665 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.473 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tt -55.8 -34.55 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.999 -1.063 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' C' ' 348' ' ' PHE . 13.7 t70 -74.54 -34.95 63.09 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.402 -0.811 . . . . 0.0 109.139 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -32.59 71.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -0.945 . . . . 0.0 109.118 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.31 -14.57 23.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.877 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -138.0 40.76 2.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.413 -0.804 . . . . 0.0 109.647 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' C' ' 344' ' ' ASP . 32.3 p90 -61.93 -37.81 86.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -64.91 -20.86 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 1.1 m -82.83 -57.63 3.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 15.5 mt -63.98 -28.82 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.439 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -78.14 -51.99 9.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.883 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -63.95 -27.34 69.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.629 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -76.44 -63.91 1.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -58.5 -8.67 1.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -54.18 -37.25 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -65.64 -78.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.489 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 157.94 168.89 20.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.11 116.92 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.402 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 35.4 mttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.484 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 -18.71 63.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.31 88.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.55 -27.18 65.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . 0.402 ' O ' ' O ' ' D' ' 423' ' ' SER . 0.6 OUTLIER -166.99 179.92 4.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . 0.402 ' O ' ' O ' ' D' ' 422' ' ' SER . 4.3 p 60.91 153.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.397 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.12 70.17 6.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.721 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.87 -26.8 59.3 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.252 1.301 . . . . 0.0 112.46 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.04 -61.09 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.638 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.42 HG23 ' H ' ' D' ' 427' ' ' VAL . 11.3 t -51.55 -40.42 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.6 t -57.31 -57.99 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.26 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.1 -36.35 13.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 108.958 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.46 -30.96 65.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.209 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.1 OUTLIER -68.13 -59.6 3.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.656 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.409 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.0 tp -55.43 -36.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.973 -1.08 . . . . 0.0 108.667 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.409 ' N ' HG23 ' D' ' 432' ' ' ILE . 12.7 mt -56.68 -42.6 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.579 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.07 -45.35 95.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.455 HD11 HG21 ' C' ' 333' ' ' ILE . 81.8 mt -59.68 -53.19 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -1.116 . . . . 0.0 108.823 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.73 -36.93 70.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.228 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.845 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -54.21 -47.41 72.18 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.027 -1.046 . . . . 0.0 109.229 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.723 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.0 tp -67.1 -37.69 84.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.62 -1.232 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 40.8 mm -49.23 -39.59 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.46 -35.19 65.69 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -59.97 -58.0 10.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.512 -0.743 . . . . 0.0 109.493 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 9.7 tt -61.41 -35.42 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 0.0 109.615 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.24 -32.65 73.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.464 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.31 -36.76 68.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -72.55 -47.14 50.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.468 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' D' ' 448' ' ' PHE . 0.8 OUTLIER -62.15 -41.65 98.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . 0.467 ' CD2' ' N ' ' D' ' 448' ' ' PHE . 74.0 t80 49.67 -93.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.363 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' D' ' 446' ' ' LEU . 0.2 OUTLIER 60.64 -175.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -151.46 150.72 30.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.439 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 8.7 p -161.95 11.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.544 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.98 3.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.89 113.57 5.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -170.43 82.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.947 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' D' ' 455' ' ' PHE . 0.0 OUTLIER -155.08 -37.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 109.439 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' D' ' 454' ' ' PHE . 39.1 t80 -91.1 -64.53 1.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -61.31 147.95 42.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 47.94 -150.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.521 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -164.13 -117.65 0.42 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.0 -52.7 61.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -1.142 . . . . 0.0 109.499 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 27.0 mttm . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.506 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.7 t -71.41 163.52 27.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.41 ' C ' ' N ' ' A' ' 122' ' ' SER . 54.0 m-20 -69.23 -26.43 64.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER 56.16 9.21 0.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 120' ' ' ASN . 34.2 t -70.35 5.62 1.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 121' ' ' ASP . 5.9 t -61.19 -172.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.4 70.93 0.97 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.75 -28.27 51.77 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.393 1.395 . . . . 0.0 112.501 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.0 mp -72.48 -46.17 56.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.78 -56.33 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.672 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.682 HG23 ' N ' ' A' ' 129' ' ' ALA . 35.5 m -58.92 -54.47 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.701 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.682 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.43 -23.44 15.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.33 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.61 -20.97 23.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -39.48 61.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.6 mt -52.86 -45.17 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.273 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.46 -26.87 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 0.0 109.018 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.85 -55.75 29.11 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 136' ' ' LEU . 4.1 tp -65.32 -48.17 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.355 -1.085 . . . . 0.0 108.702 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 135' ' ' ILE . 2.2 tp -50.03 -40.04 43.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 108.59 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.913 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -60.11 -52.89 63.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.409 -0.807 . . . . 0.0 108.882 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.902 HD21 ' NE2' ' C' ' 337' ' ' HIS . 12.4 mt -56.84 -49.76 74.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.401 -0.812 . . . . 0.0 109.568 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 36.2 mt -52.62 -33.07 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.336 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.64 -59.7 2.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.2 t-105 -48.57 -53.3 18.86 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.65 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.4 tt -60.15 -43.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.692 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.506 ' N ' HG23 ' A' ' 142' ' ' ILE . 7.0 mt -54.8 -31.68 59.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.885 -1.134 . . . . 0.0 108.952 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 17.8 t70 -77.15 -32.85 56.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.19 -33.49 67.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mp -93.48 -16.51 24.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.888 . . . . 0.0 109.707 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -147.4 39.72 1.0 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.63 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.52 -27.76 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -68.59 -44.04 75.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.138 -0.976 . . . . 0.0 109.404 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.9 m -62.81 -44.04 97.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.343 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.521 ' CG2' ' HE ' ' B' ' 245' ' ' ARG . 1.7 mp -59.25 -50.06 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.91 -40.96 95.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.475 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -69.54 -29.16 66.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -63.83 -61.24 2.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.78 -42.27 75.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.04 116.79 19.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.864 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.94 137.91 39.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.34 32.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.29 134.73 10.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -1.136 . . . . 0.0 109.343 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 12.2 mttt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.486 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.81 127.5 6.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . 0.43 ' N ' HD22 ' B' ' 220' ' ' ASN . 1.6 m-80 -86.73 -62.54 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.426 ' CG ' ' N ' ' B' ' 222' ' ' SER . 18.9 t0 -79.19 -113.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . 0.426 ' N ' ' CG ' ' B' ' 221' ' ' ASP . 0.7 OUTLIER 58.52 22.57 9.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 1.9 m -61.15 -89.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -151.38 70.92 8.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.2 -28.17 48.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.337 1.358 . . . . 0.0 112.374 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 226' ' ' LEU . 10.8 mp -63.44 -57.58 9.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -36.34 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.2 -0.937 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -57.38 -59.31 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.218 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.28 16.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.51 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -69.92 -29.75 66.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -0.823 . . . . 0.0 109.098 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' B' ' 228' ' ' VAL . 33.8 m-20 -67.74 -63.62 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 7.2 tp -50.34 -36.46 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 108.534 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' B' ' 230' ' ' ALA . 17.9 mt -57.85 -43.44 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.212 -0.93 . . . . 0.0 108.579 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.61 -46.81 88.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.545 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.94 -50.85 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 108.707 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.35 -38.44 77.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.821 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.2 -46.69 69.14 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.957 -1.089 . . . . 0.0 109.278 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.764 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.8 tp -67.82 -36.87 81.16 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.674 -1.21 . . . . 0.0 109.746 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 37.2 mm -49.62 -39.83 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.29 -38.08 68.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -57.21 -56.09 26.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.507 -0.746 . . . . 0.0 109.118 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 73.0 mt -55.47 -47.23 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 109.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.18 -15.4 63.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.955 . . . . 0.0 109.495 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -58.18 3.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.524 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -61.17 -31.78 71.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.631 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.47 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 8.4 t80 55.87 16.73 2.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 52.47 -174.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -149.16 132.82 16.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.597 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . 0.435 ' OG ' ' CG ' ' B' ' 255' ' ' PHE . 0.3 OUTLIER 55.91 177.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.474 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.2 tt -168.64 -31.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -70.28 160.37 32.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -88.54 12.8 13.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -151.06 26.77 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' B' ' 256' ' ' GLU . 58.8 t80 -59.14 156.63 11.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' B' ' 255' ' ' PHE . 11.0 tt0 -168.94 131.81 1.32 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . 0.4 ' H ' ' CD2' ' B' ' 257' ' ' HIS . 9.7 p80 -69.82 155.42 40.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 164.07 96.99 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.0 110.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -1.097 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 86.4 mttt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.489 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.279 0.562 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 6.6 t -71.34 163.62 27.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.245 -0.909 . . . . 0.0 109.479 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' C' ' 322' ' ' SER . 54.5 m-20 -69.36 -26.49 64.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' C' ' 323' ' ' SER . 1.0 OUTLIER 56.29 9.09 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.433 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . 0.404 ' H ' ' C ' ' C' ' 320' ' ' ASN . 33.8 t -70.23 5.57 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . 0.4 ' H ' ' C ' ' C' ' 321' ' ' ASP . 5.9 t -61.22 -172.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.554 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -167.37 71.01 0.97 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.82 -28.28 51.19 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.386 1.391 . . . . 0.0 112.553 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 10.0 mp -72.38 -46.18 56.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.738 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.8 -56.41 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 109.574 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.671 HG23 ' N ' ' C' ' 329' ' ' ALA . 35.6 m -58.81 -54.53 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.671 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.55 -23.42 16.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.892 . . . . 0.0 109.321 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.68 -20.78 23.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.326 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -39.4 61.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -52.89 -45.2 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.225 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 12.6 tt -78.3 -27.16 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.79 -55.73 29.2 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.543 HG23 ' N ' ' C' ' 336' ' ' LEU . 4.1 tp -65.32 -48.02 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.32 -1.106 . . . . 0.0 108.78 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . 0.543 ' N ' HG23 ' C' ' 335' ' ' ILE . 2.1 tp -50.11 -39.99 44.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.611 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.902 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -60.11 -52.83 63.69 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.913 HD21 ' NE2' ' A' ' 137' ' ' HIS . 12.3 mt -56.88 -49.92 74.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.429 -0.795 . . . . 0.0 109.488 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 36.0 mt -52.49 -33.16 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -79.7 -59.01 2.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.618 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.2 t-105 -49.13 -52.93 23.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.697 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.662 HD12 ' ND1' ' B' ' 237' ' ' HIS . 3.4 tt -60.39 -43.5 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.5 ' N ' HG23 ' C' ' 342' ' ' ILE . 7.1 mt -54.81 -31.64 59.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.953 -1.092 . . . . 0.0 109.101 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' C' ' 348' ' ' PHE . 17.9 t70 -77.36 -32.63 55.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.514 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -72.24 -33.59 67.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.542 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.35 -16.68 24.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.659 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -147.39 39.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.581 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.64 -27.8 2.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -68.57 -43.9 75.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 12.2 m -62.86 -43.99 97.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . 0.539 ' CG2' ' HE ' ' D' ' 445' ' ' ARG . 1.7 mp -59.25 -50.14 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.338 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.81 -41.0 94.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -69.61 -29.05 66.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.204 -0.935 . . . . 0.0 109.5 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.96 -61.08 2.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.403 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.04 -42.14 76.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.404 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.0 116.78 19.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 109.401 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.91 137.81 39.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -74.65 144.28 32.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.26 134.77 10.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.334 -1.098 . . . . 0.0 109.291 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 12.1 mttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.93 127.42 6.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . 0.428 HD22 ' N ' ' D' ' 420' ' ' ASN . 1.6 m-80 -86.65 -62.61 1.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -0.915 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . 0.43 ' CG ' ' N ' ' D' ' 422' ' ' SER . 18.9 t0 -79.11 -113.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' D' ' 421' ' ' ASP . 0.7 OUTLIER 58.52 22.63 9.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -61.18 -89.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -151.38 70.83 8.32 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.674 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.13 -28.19 48.83 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.308 1.339 . . . . 0.0 112.442 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . 0.504 ' N ' HD12 ' D' ' 426' ' ' LEU . 10.8 mp -63.42 -57.59 9.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 59.9 t -54.93 -36.36 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 109.429 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -57.44 -59.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.942 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.41 -37.35 16.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 108.59 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -69.85 -29.82 67.15 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.451 -0.78 . . . . 0.0 109.123 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' D' ' 428' ' ' VAL . 33.5 m-20 -67.65 -63.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.333 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 7.3 tp -50.47 -36.36 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.125 -0.985 . . . . 0.0 108.569 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' D' ' 430' ' ' ALA . 17.7 mt -57.8 -43.52 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.213 -0.93 . . . . 0.0 108.523 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.77 87.92 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.539 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -56.98 -50.77 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -1.175 . . . . 0.0 108.741 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.7 mp -58.42 -38.43 77.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.392 -0.817 . . . . 0.0 109.499 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.815 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.2 -46.64 69.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.287 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.747 HD13 ' ND1' ' C' ' 337' ' ' HIS . 7.9 tp -67.78 -36.97 81.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.759 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' D' ' 439' ' ' ILE . 37.0 mm -49.61 -39.74 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.81 -1.181 . . . . 0.0 107.836 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.38 -37.9 68.62 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.4 t90 -57.31 -55.89 28.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.507 -0.746 . . . . 0.0 109.091 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 72.3 mt -55.71 -47.25 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.487 -0.758 . . . . 0.0 109.502 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.93 -15.6 63.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -58.09 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -61.23 -31.78 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.58 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.47 -64.43 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 8.3 t80 55.8 16.67 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 52.46 -174.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -149.11 132.86 16.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' D' ' 455' ' ' PHE . 0.3 OUTLIER 55.81 177.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 16.2 tt -168.75 -31.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -70.18 160.4 32.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.539 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -88.71 12.9 13.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.452 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -151.05 26.82 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.441 ' CG ' ' N ' ' D' ' 456' ' ' GLU . 58.7 t80 -59.18 156.62 11.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' D' ' 455' ' ' PHE . 11.0 tt0 -168.86 131.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -69.82 155.41 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 164.04 96.97 0.11 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.07 110.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.493 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.5 t -62.92 144.75 56.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 120' ' ' ASN . 4.1 p30 -152.27 58.67 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.11 -172.29 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.48 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -63.04 -75.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.52 126.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -159.53 70.31 3.28 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.96 -27.73 50.39 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.421 1.414 . . . . 0.0 112.559 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.82 -40.94 62.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.136 -0.977 . . . . 0.0 109.67 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.21 -55.06 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.658 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.0 m -60.73 -52.7 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.658 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -55.5 -25.09 35.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.261 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.23 -20.98 24.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -74.67 -43.07 57.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -50.74 -45.71 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.39 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.8 tt -73.0 -34.97 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.223 -0.923 . . . . 0.0 108.894 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -41.86 81.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' D' ' 430' ' ' ALA . 69.0 mt -69.59 -58.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.342 -1.093 . . . . 0.0 108.999 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.91 -33.62 11.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 108.925 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.842 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -64.12 -51.02 65.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.031 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.761 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.6 mt -59.45 -40.77 87.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.85 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.6 tt -82.81 -54.1 5.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 109.541 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.3 OUTLIER -50.77 -43.7 58.49 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.281 -0.887 . . . . 0.0 109.737 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.0 tp -72.21 -46.68 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 0.0 109.719 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.604 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.2 mt -48.88 -32.51 9.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 109.062 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 148' ' ' PHE . 11.4 t70 -76.04 -54.27 7.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 109.414 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -50.56 -23.27 2.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.361 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.34 -17.57 16.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.812 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.01 42.36 1.21 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 144' ' ' ASP . 24.8 p90 -47.67 -28.73 2.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.564 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -69.15 -42.28 76.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -64.58 -49.56 70.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 151' ' ' ILE . 1.7 mp -55.97 -44.08 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.423 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -59.58 -45.6 91.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.251 -0.905 . . . . 0.0 109.536 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -65.18 -42.58 93.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -59.6 5.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -30.9 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -82.21 28.73 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.61 113.9 3.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.547 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 176.52 98.89 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.38 125.71 33.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.5 mttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.467 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 4.3 t -161.21 -0.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -70.96 96.53 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.551 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.69 127.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 81.0 p -79.06 148.03 32.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.544 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.24 150.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -170.23 69.97 0.59 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.09 -25.87 58.23 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.333 1.355 . . . . 0.0 112.494 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.63 -47.99 28.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.416 ' H ' HG23 ' B' ' 227' ' ' VAL . 2.3 t -62.89 -38.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.96 -58.83 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.49 15.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.635 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -71.72 -32.45 67.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.297 -0.877 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.438 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.431 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -50.12 -37.69 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.123 -0.986 . . . . 0.0 108.519 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.431 ' N ' HG23 ' B' ' 232' ' ' ILE . 10.0 mt -55.92 -43.81 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.182 -0.949 . . . . 0.0 108.497 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.11 -44.29 93.12 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.532 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -59.9 -41.39 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -1.204 . . . . 0.0 108.561 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' B' ' 239' ' ' ILE . 3.7 tt -68.04 -33.79 75.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.275 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.578 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -57.37 -48.06 80.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.019 -1.051 . . . . 0.0 109.163 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.842 HD13 ' CE1' ' A' ' 137' ' ' HIS . 9.4 tp -68.23 -35.55 78.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.65 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' B' ' 236' ' ' LEU . 16.9 mt -50.42 -41.77 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.643 -1.286 . . . . 0.0 108.227 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.36 -38.66 71.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -55.45 -54.51 42.87 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.27 -52.45 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.0 109.225 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.03 -41.62 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -62.66 -47.19 84.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.494 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.54 -37.97 82.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.28 -62.53 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 5.6 t80 60.07 107.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -65.44 161.54 19.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.412 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -167.23 -179.48 4.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 48.3 t -170.79 92.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.5 pt -80.84 150.05 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.413 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . 0.443 ' O ' ' CB ' ' B' ' 253' ' ' ARG . 0.2 OUTLIER -154.51 -46.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.52 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' B' ' 252' ' ' TYR . 9.9 ttt180 71.13 111.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.81 129.4 35.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.537 ' CD2' ' N ' ' B' ' 256' ' ' GLU . 73.3 t80 -159.84 178.61 9.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.537 ' N ' ' CD2' ' B' ' 255' ' ' PHE . 15.5 tt0 -74.01 103.59 4.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -156.2 101.63 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 160.74 -175.13 37.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.29 127.9 36.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -1.18 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.489 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 4.3 t -62.96 144.7 56.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.173 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' C' ' 320' ' ' ASN . 4.1 p30 -152.17 58.61 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.19 -172.35 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' C' ' 323' ' ' SER . 6.9 m -63.05 -75.89 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.396 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' C' ' 322' ' ' SER . 1.0 OUTLIER 68.57 126.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -159.5 70.34 3.29 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.666 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.96 -27.59 50.5 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.36 1.373 . . . . 0.0 112.529 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.91 -40.96 62.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.23 -55.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.937 . . . . 0.0 109.549 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.642 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.0 m -60.72 -52.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.558 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.642 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -55.6 -25.24 37.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.12 -0.987 . . . . 0.0 109.216 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -88.33 -20.59 25.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 0.3 OUTLIER -74.75 -43.07 56.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.693 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.446 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.3 mt -50.65 -46.02 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.9 tt -72.74 -35.09 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.196 -0.94 . . . . 0.0 108.951 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.88 81.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.635 HG21 ' HB1' ' B' ' 230' ' ' ALA . 68.4 mt -69.59 -58.37 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 109.062 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 mp -48.89 -33.63 11.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.94 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.835 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -64.12 -50.97 66.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.433 -0.792 . . . . 0.0 109.034 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.783 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.5 mt -59.58 -40.69 88.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.523 -0.736 . . . . 0.0 109.609 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 12.2 mt -65.52 -27.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.582 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.79 -53.44 5.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 109.581 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.63 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -51.34 -43.43 61.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.917 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.61 HG23 ' N ' ' C' ' 343' ' ' LEU . 9.9 tp -72.43 -46.52 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.61 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.74 -32.7 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.0 -1.063 . . . . 0.0 109.139 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' C' ' 348' ' ' PHE . 11.5 t70 -76.19 -54.17 7.19 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.378 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -50.48 -23.18 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.398 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.48 -17.53 16.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.469 -0.769 . . . . 0.0 109.769 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.0 42.43 1.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 0.0 109.719 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' C' ' 344' ' ' ASP . 24.4 p90 -47.8 -28.68 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -69.18 -42.3 76.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.493 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 16.8 t -64.41 -49.83 70.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . 0.491 HD12 ' N ' ' C' ' 351' ' ' ILE . 1.7 mp -55.81 -44.06 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -59.66 -45.6 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -65.13 -42.6 93.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -59.58 5.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.59 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -52.18 -30.93 29.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 109.583 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -82.26 28.84 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.65 113.92 3.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.521 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 176.48 98.9 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 18.6 mt -85.43 125.81 33.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.137 . . . . 0.0 109.429 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 17.5 mttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.438 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 4.2 t -161.2 -0.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.596 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -71.04 96.55 1.33 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.76 127.14 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 81.1 p -79.21 147.96 32.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.399 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.32 150.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -170.28 70.02 0.58 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.22 -25.81 57.29 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.338 1.359 . . . . 0.0 112.414 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.8 mt -47.57 -48.04 28.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.405 ' H ' HG23 ' D' ' 427' ' ' VAL . 2.3 t -62.85 -38.65 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.555 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.7 t -63.9 -58.91 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.41 -39.44 15.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.09 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -71.77 -32.38 67.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.229 -0.919 . . . . 0.0 109.175 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -63.45 1.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.421 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.7 tp -50.13 -37.63 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.132 -0.98 . . . . 0.0 108.525 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.421 ' N ' HG23 ' D' ' 432' ' ' ILE . 9.9 mt -56.1 -43.66 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.14 -0.975 . . . . 0.0 108.467 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -44.33 93.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.532 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -59.87 -41.49 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.111 -1.229 . . . . 0.0 108.54 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . 0.554 ' HA ' HD12 ' D' ' 439' ' ' ILE . 3.7 tt -67.95 -33.81 75.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.426 -0.796 . . . . 0.0 109.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.585 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -57.4 -48.15 79.85 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.027 -1.045 . . . . 0.0 109.077 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.835 HD13 ' CE1' ' C' ' 337' ' ' HIS . 9.7 tp -68.05 -35.8 78.82 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.618 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' D' ' 436' ' ' LEU . 17.0 mt -50.45 -41.69 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.725 -1.234 . . . . 0.0 108.21 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.2 tt -71.41 -38.55 71.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -55.35 -54.59 41.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.43 -0.794 . . . . 0.0 109.073 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.32 -52.3 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.328 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -41.73 17.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -62.68 -47.2 84.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -60.55 -37.98 83.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.23 -62.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 5.6 t80 60.17 107.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.838 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -65.46 161.55 19.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -167.22 -179.49 4.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 48.3 t -170.79 92.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.601 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.5 pt -80.7 150.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' D' ' 453' ' ' ARG . 0.2 OUTLIER -154.54 -46.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.49 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' D' ' 452' ' ' TYR . 9.9 ttt180 71.08 111.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.537 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.86 129.42 35.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 109.402 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' D' ' 456' ' ' GLU . 73.4 t80 -159.85 178.69 9.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . 0.533 ' N ' ' CG ' ' D' ' 455' ' ' PHE . 15.6 tt0 -74.05 103.65 4.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -156.28 101.63 2.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 160.77 -175.09 37.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 127.9 36.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -1.142 . . . . 0.0 109.526 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.46 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.8 t -157.86 169.78 23.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 50.83 -147.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -156.5 -41.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.411 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.8 t -158.29 -50.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.9 p -166.49 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -148.72 70.74 10.46 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.49 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.26 -27.87 55.8 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.355 1.37 . . . . 0.0 112.361 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.13 -55.13 30.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' C' ' 328' ' ' VAL . 90.5 t -52.68 -35.77 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.464 ' HA ' HG11 ' C' ' 327' ' ' VAL . 8.9 t -66.05 -67.59 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.67 -17.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.44 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -87.53 -27.03 22.86 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.585 -0.697 . . . . 0.0 109.271 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.628 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.0 OUTLIER -76.03 -39.79 54.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.457 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.626 ' N ' ' ND2' ' A' ' 131' ' ' ASN . 7.2 mt -53.55 -44.3 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 109.378 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.424 HD13 HG13 ' B' ' 235' ' ' ILE . 8.1 tt -74.64 -36.41 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.127 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.59 91.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.427 HD11 ' OD1' ' A' ' 131' ' ' ASN . 17.5 mt -70.05 -60.1 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.344 -1.092 . . . . 0.0 109.136 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.98 -24.96 7.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.267 -0.896 . . . . 0.0 108.899 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.646 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -67.86 -55.51 12.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.159 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.559 HD22 ' ND1' ' D' ' 437' ' ' HIS . 2.4 mt -55.33 -48.27 74.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 24.5 mt -58.41 -30.96 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.386 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 HD21 ' B' ' 238' ' ' LEU . 3.7 tt -75.96 -46.28 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.377 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CZ3' ' C' ' 341' ' ' TRP . 1.0 OUTLIER -50.65 -47.09 58.66 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 110.032 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 143' ' ' LEU . 9.5 tt -71.16 -42.91 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.04 -1.037 . . . . 0.0 109.908 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' N ' HG23 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -48.83 -36.74 17.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.058 -1.026 . . . . 0.0 109.223 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.63 -53.05 9.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.83 . . . . 0.0 109.592 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 66.9 ttt180 -50.48 -23.14 2.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.57 -17.42 15.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.541 -0.724 . . . . 0.0 109.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -148.91 41.85 0.94 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.126 -0.984 . . . . 0.0 109.996 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 144' ' ' ASP . 50.9 p90 -47.29 -25.57 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -71.36 -38.69 71.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.428 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.6 t -70.18 -49.38 50.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 109.368 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 151' ' ' ILE . 1.7 mp -59.75 -32.0 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -74.3 -54.69 7.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.41 ' O ' ' O ' ' A' ' 156' ' ' GLU . 65.1 mtm180 -61.43 -32.3 72.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -56.53 -53.61 55.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -63.2 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.481 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.41 ' O ' ' O ' ' A' ' 153' ' ' ARG . 88.2 tt0 -65.04 123.67 20.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.454 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.49 -50.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.549 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -151.36 -146.15 4.28 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.13 -36.98 66.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 109.467 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.443 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' B' ' 218' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.13 -178.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' B' ' 220' ' ' ASN . 3.1 p30 -60.89 -21.91 63.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.55 161.94 7.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.616 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 5.8 m -88.08 66.06 8.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 0.0 109.369 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 23.2 p -152.89 152.89 32.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -163.52 70.82 1.84 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.69 -25.59 61.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.31 1.34 . . . . 0.0 112.52 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.38 -41.62 39.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.595 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.642 ' CG1' HD21 ' C' ' 331' ' ' ASN . 13.8 t -61.05 -42.97 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.564 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' B' ' 231' ' ' ASN . 3.6 t -57.91 -58.63 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.431 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.74 -37.43 13.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.22 -31.2 67.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.137 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.444 ' ND2' HG13 ' A' ' 127' ' ' VAL . 2.0 t-20 -67.71 -64.06 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.405 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.1 tp -50.41 -36.79 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.127 -0.983 . . . . 0.0 108.565 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.405 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.8 mt -55.78 -45.12 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.28 -46.53 86.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.543 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -56.44 -40.43 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.313 . . . . 0.0 108.533 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -35.44 75.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.461 -0.774 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.608 ' C ' ' HD1' ' B' ' 237' ' ' HIS . 3.1 t-80 -54.07 -52.07 62.09 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.064 -1.022 . . . . 0.0 109.164 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.646 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.0 tp -69.85 -32.37 70.72 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.607 -1.237 . . . . 0.0 109.888 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.09 -38.23 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.516 -1.365 . . . . 0.0 107.864 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.85 62.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -50.5 -52.63 36.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.425 -0.797 . . . . 0.0 109.433 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 12.8 tt -68.0 -33.7 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.462 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.43 ' O ' HD23 ' B' ' 243' ' ' LEU . 1.6 tt -58.4 -58.3 9.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -58.9 -42.08 88.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -20.77 65.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.32 -52.59 7.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.947 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . 0.477 ' C ' ' H ' ' B' ' 249' ' ' LYS . 2.3 m-85 -58.3 -55.07 39.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.52 -4.12 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' B' ' 247' ' ' PHE . 40.3 mttp -81.32 133.07 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . 0.4 ' C ' ' H ' ' B' ' 252' ' ' TYR . 11.5 t -167.96 71.67 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 109.549 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.8 pt -78.9 21.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' B' ' 250' ' ' SER . 61.1 t80 -74.09 -0.85 17.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -82.87 32.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -148.29 -117.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 0.1 OUTLIER -66.43 120.52 13.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.01 -57.76 7.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.519 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 11.9 t60 48.75 -145.53 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.426 ' C ' ' N ' ' B' ' 260' ' ' LYS . . . 79.74 1.17 86.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.2 mt 51.08 14.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.413 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . 0.426 ' N ' ' C ' ' B' ' 258' ' ' GLY . 25.2 ttpt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.491 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 2.9 t -157.89 169.84 23.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 50.81 -147.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -156.44 -41.26 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.471 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 42.9 t -158.26 -50.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.419 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 57.9 p -166.49 -89.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -148.76 70.73 10.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.21 -27.89 56.23 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.373 1.382 . . . . 0.0 112.39 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.12 -55.21 29.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 128' ' ' VAL . 93.1 t -52.62 -35.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.478 ' HA ' HG11 ' A' ' 127' ' ' VAL . 9.9 t -65.9 -67.79 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.954 . . . . 0.0 109.481 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -50.65 -17.3 0.5 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 108.764 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -87.8 -26.41 22.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.279 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.642 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.0 OUTLIER -76.16 -39.83 54.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.612 ' N ' ' ND2' ' C' ' 331' ' ' ASN . 7.3 mt -53.56 -44.37 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 109.324 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . 0.43 HD13 HG13 ' D' ' 435' ' ' ILE . 8.3 tt -74.61 -36.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.42 91.57 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.427 HD11 ' OD1' ' C' ' 331' ' ' ASN . 17.5 mt -70.07 -60.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.299 -1.119 . . . . 0.0 109.103 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 6.1 mt -52.0 -24.84 7.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.347 -0.845 . . . . 0.0 108.844 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -68.07 -55.33 12.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.358 -0.839 . . . . 0.0 109.149 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.569 HD22 ' ND1' ' B' ' 237' ' ' HIS . 2.4 mt -55.35 -48.37 74.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.38 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 24.2 mt -58.44 -31.0 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -76.16 -45.45 33.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CZ3' ' CH2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -51.42 -46.72 63.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.436 -0.79 . . . . 0.0 110.063 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.46 HG23 ' N ' ' C' ' 343' ' ' LEU . 9.8 tt -71.42 -42.77 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 0.0 109.946 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.46 ' N ' HG23 ' C' ' 342' ' ' ILE . 0.5 OUTLIER -48.81 -36.7 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.192 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.92 -52.89 9.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . 0.511 ' N ' ' OD1' ' C' ' 344' ' ' ASP . 67.0 ttt180 -50.4 -23.13 2.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 109.494 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.66 -17.36 15.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 109.858 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -148.9 41.93 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 344' ' ' ASP . 51.2 p90 -47.42 -25.55 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.324 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -71.39 -38.64 71.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 10.7 t -70.15 -49.44 50.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . 0.501 HD12 ' N ' ' C' ' 351' ' ' ILE . 1.7 mp -59.83 -31.86 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.354 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -74.26 -54.69 7.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.455 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' C' ' 356' ' ' GLU . 64.9 mtm180 -61.42 -32.27 72.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.419 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -56.56 -53.61 55.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -63.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' C' ' 353' ' ' ARG . 88.1 tt0 -64.96 123.64 19.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -156.47 -50.13 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.945 . . . . 0.0 109.55 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -151.38 -146.09 4.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.17 -37.09 66.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' D' ' 418' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.04 -178.08 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.551 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . 0.44 ' N ' ' OD1' ' D' ' 420' ' ' ASN . 3.1 p30 -60.91 -21.88 63.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.51 162.0 7.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 5.6 m -88.04 66.09 8.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.317 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 23.5 p -152.89 152.9 32.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.94 . . . . 0.0 109.553 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -163.48 70.74 1.84 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -64.68 -25.61 61.45 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.417 1.411 . . . . 0.0 112.453 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.39 -41.6 39.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.598 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.628 ' CG1' HD21 ' A' ' 131' ' ' ASN . 14.3 t -61.16 -42.82 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.569 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 431' ' ' ASN . 3.6 t -58.09 -58.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.89 -37.32 13.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.21 67.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.362 -0.836 . . . . 0.0 109.059 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.437 ' ND2' HG13 ' C' ' 327' ' ' VAL . 2.0 t-20 -67.71 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.411 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.1 tp -50.42 -36.79 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 108.552 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.411 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.6 mt -55.85 -44.99 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 108.325 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.31 -46.48 86.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.544 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -56.41 -40.41 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.058 -1.26 . . . . 0.0 108.577 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -35.49 75.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.767 . . . . 0.0 109.353 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.613 ' C ' ' HD1' ' D' ' 437' ' ' HIS . 3.0 t-80 -53.96 -52.07 61.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.099 -1.0 . . . . 0.0 109.185 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.633 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.3 tp -69.77 -32.43 70.92 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.976 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.14 -38.21 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.514 -1.366 . . . . 0.0 107.858 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mp -73.35 -41.83 62.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 84.5 t90 -50.4 -52.57 36.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.592 -0.692 . . . . 0.0 109.487 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 12.9 tt -68.3 -33.43 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 109.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . 0.44 HD23 ' O ' ' D' ' 443' ' ' LEU . 1.6 tt -58.46 -58.28 9.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -58.84 -42.19 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.558 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -63.19 -20.75 65.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.528 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.28 -52.67 7.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.561 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . 0.467 ' C ' ' H ' ' D' ' 449' ' ' LYS . 2.3 m-85 -58.31 -55.07 39.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.548 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.57 -4.22 0.6 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.472 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' D' ' 447' ' ' PHE . 40.3 mttp -81.24 133.07 35.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.598 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 11.5 t -168.04 71.77 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.8 pt -78.92 21.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.386 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -74.09 -0.79 17.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.885 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -82.76 32.11 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.439 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -148.26 -117.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' D' ' 455' ' ' PHE . 0.1 OUTLIER -66.43 120.46 13.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.96 -57.82 7.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 11.8 t60 48.76 -145.66 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' D' ' 460' ' ' LYS . . . 79.76 1.15 86.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.1 mt 51.1 14.06 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -1.153 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' D' ' 458' ' ' GLY . 25.3 ttpt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.46 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' ASN . 62.9 ttt180 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.256 0.551 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -62.32 82.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 p30 -66.01 -173.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.1 128.32 2.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.42 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 123' ' ' SER . 1.6 t -164.38 118.86 1.43 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 122' ' ' SER . 1.1 p 70.22 27.61 4.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.86 . . . . 0.0 109.544 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 128' ' ' VAL . 28.6 m-20 48.54 71.06 1.72 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.6 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -68.17 -23.52 39.31 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.363 1.375 . . . . 0.0 112.52 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 126' ' ' LEU . 11.1 mp -77.38 -56.15 4.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -0.923 . . . . 0.0 110.478 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 128' ' ' VAL . 4.2 p -55.9 -42.75 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.67 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.5 m -71.59 -54.36 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.055 . . . . 0.0 109.636 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.67 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.3 -23.8 16.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.954 . . . . 0.0 109.18 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.56 -21.0 21.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.404 -0.81 . . . . 0.0 109.427 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.521 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -72.92 -42.19 63.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.94 . . . . 0.0 109.597 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.463 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 7.3 mt -51.06 -46.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.504 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.7 tt -72.17 -34.15 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 108.768 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.69 -41.93 83.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.647 HG21 ' HB1' ' D' ' 430' ' ' ALA . 68.0 mt -68.37 -57.1 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.45 -1.029 . . . . 0.0 109.054 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -39.52 43.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 108.694 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.847 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -55.65 -55.37 32.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.063 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.816 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.3 mt -58.24 -53.54 57.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 81.8 mt -52.92 -29.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.438 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.47 -57.6 3.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.589 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.4 OUTLIER -50.01 -54.69 18.45 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.639 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -58.39 -44.93 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.557 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 mt -48.64 -36.27 15.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.0 -1.062 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.5 -37.04 60.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -0.872 . . . . 0.0 109.604 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -64.37 -28.67 69.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.615 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.22 -14.18 18.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.799 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -146.84 40.17 1.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 0.0 109.779 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 144' ' ' ASP . 19.7 p90 -47.42 -22.15 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.19 -0.944 . . . . 0.0 109.403 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -75.88 -46.96 27.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.486 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -60.49 -48.11 83.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.1 mm -64.82 -35.68 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.927 . . . . 0.0 109.386 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -49.4 74.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -72.62 -22.7 60.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.354 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.76 -46.39 85.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 0.0 109.334 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.45 -43.05 91.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.314 -0.866 . . . . 0.0 109.422 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -80.6 117.41 21.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.484 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -65.33 -96.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -0.927 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -151.93 158.96 28.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.31 146.79 50.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -1.143 . . . . 0.0 109.517 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.4 mttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.498 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.63 -24.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.908 . . . . 0.0 109.397 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 21.2 t30 59.83 159.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.567 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -38.62 70.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.449 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.67 30.1 6.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.85 165.38 35.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' B' ' 224' ' ' ASP . 12.2 p-10 -161.64 69.83 2.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.32 -28.35 63.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.292 1.328 . . . . 0.0 112.36 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.81 -53.91 28.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.539 ' CG1' HD21 ' C' ' 331' ' ' ASN . 21.3 t -56.9 -43.64 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' B' ' 231' ' ' ASN . 9.0 t -57.3 -55.36 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.82 23.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.228 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -67.69 -26.26 66.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.208 -0.932 . . . . 0.0 109.16 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' B' ' 228' ' ' VAL . 0.2 OUTLIER -69.97 -65.73 0.68 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.658 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.0 tp -50.31 -36.17 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.736 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' B' ' 230' ' ' ALA . 28.6 mt -57.95 -44.04 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.95 -43.17 95.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.484 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.8 -44.03 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -1.221 . . . . 0.0 108.739 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' B' ' 239' ' ' ILE . 6.0 mp -66.06 -36.03 82.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.444 -0.785 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.812 ' ND1' HD22 ' C' ' 338' ' ' LEU . 1.8 t-80 -55.87 -48.27 75.85 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.847 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.5 tp -67.93 -36.06 79.49 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.816 -1.154 . . . . 0.0 109.767 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' B' ' 236' ' ' LEU . 10.6 mt -50.11 -40.48 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.183 . . . . 0.0 108.006 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.06 -39.21 69.19 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -55.51 -55.75 28.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.469 -0.77 . . . . 0.0 109.047 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.9 mt -55.49 -48.7 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.75 -50.42 66.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.452 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -48.99 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -53.55 -44.15 69.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.356 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -62.9 1.45 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 0.0 109.438 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -67.04 -167.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.582 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.15 -23.3 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -168.32 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.07 -178.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 2.8 tt -163.71 150.41 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -72.0 -143.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.338 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -164.03 -19.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.92 -4.12 8.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.76 80.12 7.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -86.03 128.78 34.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -159.46 20.49 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -83.7 101.79 2.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.64 -25.08 18.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 45.1 tttt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.445 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' C' ' 320' ' ' ASN . 63.3 ttt180 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 89.4 p -62.31 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' C' ' 318' ' ' ARG . 6.0 p30 -66.1 -172.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.9 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.14 128.36 2.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.465 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' C' ' 323' ' ' SER . 1.7 t -164.39 118.83 1.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' C' ' 322' ' ' SER . 1.1 p 70.24 27.58 4.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.522 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . 0.547 ' O ' HG22 ' C' ' 328' ' ' VAL . 28.7 m-20 48.5 71.04 1.72 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.315 -0.866 . . . . 0.0 109.657 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -68.2 -23.33 39.36 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.406 1.404 . . . . 0.0 112.499 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . 0.498 ' N ' HD12 ' C' ' 326' ' ' LEU . 11.1 mp -77.55 -56.15 4.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 110.423 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' C' ' 328' ' ' VAL . 4.2 p -55.88 -42.83 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 0.0 110.261 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.664 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.6 m -71.59 -54.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.594 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.664 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.33 -23.94 17.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -91.54 -20.71 21.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.428 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.539 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.09 -42.37 63.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 7.1 mt -50.77 -46.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.8 tt -71.97 -34.24 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.092 -1.005 . . . . 0.0 108.815 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.9 83.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.691 HG21 ' HB1' ' B' ' 230' ' ' ALA . 67.5 mt -68.41 -57.13 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.343 -1.092 . . . . 0.0 109.071 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.02 -39.72 42.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 108.691 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.825 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -55.41 -55.5 30.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 109.044 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.822 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.3 mt -58.24 -53.57 56.74 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.537 -0.727 . . . . 0.0 109.735 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 82.3 mt -52.92 -29.93 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.57 -56.92 4.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.626 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -50.66 -54.67 21.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 109.738 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.572 HG23 ' N ' ' C' ' 343' ' ' LEU . 0.8 OUTLIER -58.33 -44.87 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 109.245 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.572 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 mt -48.49 -36.5 15.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 0.0 109.197 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.6 -36.85 60.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.527 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -64.39 -28.62 69.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 1.3 mt -100.26 -14.24 18.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.786 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -146.86 40.36 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.73 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' C' ' 344' ' ' ASP . 19.5 p90 -47.54 -22.1 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -75.78 -47.05 27.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.534 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -48.06 83.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 11.0 mm -64.83 -35.65 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.372 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' C' ' 352' ' ' TYR . 1.0 OUTLIER -63.02 -49.26 75.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.441 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -72.7 -22.73 60.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.68 -46.47 85.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 109.289 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -65.42 -43.18 91.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -80.51 117.38 21.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -0.879 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -65.29 -96.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -152.07 158.99 28.11 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 6.8 mt -70.36 146.84 50.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -1.131 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 39.3 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.39 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 -24.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.475 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 21.1 t30 59.93 159.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -38.6 70.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.63 30.1 6.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.9 165.42 35.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' D' ' 424' ' ' ASP . 12.2 p-10 -161.68 69.8 2.39 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.32 -28.3 63.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.294 1.329 . . . . 0.0 112.4 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.67 -54.01 26.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 131' ' ' ASN . 21.4 t -56.89 -43.75 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.616 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' D' ' 431' ' ' ASN . 9.5 t -57.27 -55.34 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.31 -44.78 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.211 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -67.92 -25.97 65.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.238 -0.914 . . . . 0.0 109.157 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' D' ' 428' ' ' VAL . 0.2 OUTLIER -70.06 -65.79 0.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' D' ' 432' ' ' ILE . 8.0 tp -50.22 -36.22 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' D' ' 430' ' ' ALA . 28.4 mt -58.04 -43.91 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.956 . . . . 0.0 108.468 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.06 -43.08 95.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.482 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -58.82 -44.1 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -1.234 . . . . 0.0 108.626 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' D' ' 439' ' ' ILE . 6.0 mp -66.14 -35.88 81.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.217 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.798 ' ND1' HD22 ' A' ' 138' ' ' LEU . 1.8 t-80 -56.06 -48.18 76.53 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.98 -1.075 . . . . 0.0 109.439 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.825 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.7 tp -67.83 -36.25 80.03 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.81 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' D' ' 436' ' ' LEU . 10.5 mt -50.02 -40.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 108.059 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.1 tt -72.01 -39.14 69.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -55.52 -55.66 29.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.086 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.8 mt -55.79 -48.52 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.43 -0.794 . . . . 0.0 109.146 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 3.8 mp -53.69 -50.54 65.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -48.91 69.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -53.62 -44.15 69.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.52 -62.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.464 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.14 -167.08 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.56 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -147.12 -23.21 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.51 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' D' ' 450' ' ' SER . 74.7 tttt -168.34 -23.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . 0.402 ' O ' ' O ' ' D' ' 449' ' ' LYS . 0.2 OUTLIER 51.04 -178.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.348 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 2.8 tt -163.71 150.46 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.13 -0.981 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -72.08 -143.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -164.02 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.89 -4.01 8.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -88.69 80.03 7.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -86.06 128.82 34.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -159.49 20.37 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -83.63 101.8 2.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.6 -25.06 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.44 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 44.9 tttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.1 m -78.9 17.05 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 120' ' ' ASN . 15.0 p-10 -82.98 34.17 0.45 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.99 170.2 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.45 -8.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -60.43 -98.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -152.72 70.09 7.21 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.87 -28.16 58.8 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.273 1.315 . . . . 0.0 112.382 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 126' ' ' LEU . 10.8 mp -54.89 -50.17 69.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.3 t -55.36 -36.97 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 131' ' ' ASN . 61.1 t -69.53 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.91 -19.74 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.932 . . . . 0.0 108.674 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.21 -27.08 19.76 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.603 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.3 OUTLIER -69.07 -38.81 79.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.481 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.46 -47.89 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.8 tt -77.75 -27.08 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -0.922 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.09 -55.12 32.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.4 mm -65.24 -48.67 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -1.162 . . . . 0.0 109.023 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.5 -38.69 60.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.982 . . . . 0.0 108.735 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.795 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -59.59 -52.35 65.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.025 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.803 HD21 ' CE1' ' C' ' 337' ' ' HIS . 3.5 mt -57.34 -49.43 76.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.78 . . . . 0.0 109.674 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.34 -34.69 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 109.86 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -77.93 -45.14 24.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.06 -1.025 . . . . 0.0 109.918 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 2.1 t-105 -48.7 -51.45 28.56 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.21 -0.931 . . . . 0.0 109.948 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -71.33 -39.9 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.53 -40.27 18.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.094 -1.004 . . . . 0.0 109.252 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 148' ' ' PHE . 12.0 t0 -77.31 -43.64 32.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.428 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.25 -34.41 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.74 -49.37 5.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.753 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -96.01 36.58 1.3 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 109.715 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 144' ' ' ASP . 17.9 t80 -53.2 -34.33 56.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.443 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -63.68 -34.7 78.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 154' ' ' PHE . 4.4 m -71.57 -54.35 10.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.5 mm -52.26 -32.14 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.404 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.92 -48.69 13.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -73.11 -14.93 61.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 150' ' ' SER . 67.3 t80 -81.83 -54.8 5.06 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -71.4 -42.2 68.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -88.97 167.55 13.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.462 ' CG ' ' H ' ' A' ' 158' ' ' GLY . 4.8 t-80 57.74 -143.85 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.452 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 157' ' ' HIS . . . 64.92 82.47 0.1 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.93 115.64 6.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.656 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.481 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.15 -179.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -166.97 -175.63 3.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -60.58 132.09 52.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 72.5 m -160.78 146.8 14.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 26.0 m -151.8 108.35 3.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 50.23 69.64 2.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.656 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.6 -28.58 52.78 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.295 1.33 . . . . 0.0 112.305 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -59.89 3.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.518 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.617 ' CG1' HD21 ' C' ' 331' ' ' ASN . 12.7 t -53.5 -39.5 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.32 -54.72 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.7 -42.37 24.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.15 -32.62 70.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -65.13 -65.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.706 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.474 HG23 ' N ' ' B' ' 233' ' ' ILE . 9.3 tp -50.01 -39.22 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.143 -0.973 . . . . 0.0 108.777 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.474 ' N ' HG23 ' B' ' 232' ' ' ILE . 12.9 mt -53.77 -43.3 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -59.83 -43.33 98.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.499 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -60.83 -43.55 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -1.143 . . . . 0.0 108.979 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -33.08 73.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.325 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.565 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.5 OUTLIER -57.12 -51.42 69.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.018 -1.051 . . . . 0.0 109.281 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.784 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.7 tp -68.19 -33.62 74.78 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.73 -39.94 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.741 -1.224 . . . . 0.0 108.06 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.5 tt -73.28 -39.52 65.29 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -52.97 -52.17 59.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 109.449 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.48 -33.78 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.571 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.11 -62.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.94 . . . . 0.0 109.406 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -53.06 -47.84 68.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -48.23 -50.43 29.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.598 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.4 mp -56.57 -45.95 81.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.978 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.86 109.9 18.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.244 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.3 142.64 30.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -79.58 85.01 5.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 10.9 t -149.71 -54.19 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 76.1 mt -88.72 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.955 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -164.82 25.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 253' ' ' ARG . 0.0 OUTLIER -89.27 89.65 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 56.1 -174.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.88 -44.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -86.17 123.08 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . 0.491 ' N ' ' ND1' ' B' ' 257' ' ' HIS . 1.6 m-70 -60.03 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.96 . . . . 0.0 109.403 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -89.92 -174.35 45.4 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.65 -53.91 52.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -1.174 . . . . 0.0 109.352 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 17.3 tttp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.491 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 13.5 m -79.11 17.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' C' ' 320' ' ' ASN . 15.0 p-10 -83.0 34.16 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.491 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.06 170.14 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.39 -8.27 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.424 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 71.5 m -60.52 -98.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -152.85 70.01 7.11 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.608 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.76 -28.17 59.79 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.236 1.29 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . 0.48 ' N ' HD12 ' C' ' 326' ' ' LEU . 10.8 mp -54.88 -50.11 69.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.49 -37.02 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' C' ' 331' ' ' ASN . 60.3 t -69.48 -63.01 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.95 -19.82 0.44 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.435 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.38 -26.54 19.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.617 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.3 OUTLIER -69.24 -38.92 78.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.841 . . . . 0.0 109.516 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.28 -48.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.404 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.9 tt -77.63 -27.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 108.782 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.12 -55.09 32.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.7 mm -65.38 -48.6 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -1.158 . . . . 0.0 108.995 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.2 tp -52.45 -38.75 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 108.757 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.803 ' CE1' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -59.56 -52.24 66.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.404 -0.81 . . . . 0.0 109.093 179.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.795 HD21 ' NE2' ' A' ' 137' ' ' HIS . 3.5 mt -57.33 -49.56 75.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 14.4 mt -52.35 -34.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 0.0 109.912 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 tt -78.21 -44.22 26.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.81 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.624 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 2.1 t-105 -49.56 -51.07 39.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 110.06 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.529 HG22 ' O ' ' C' ' 338' ' ' LEU . 0.8 OUTLIER -71.65 -39.79 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.939 -1.101 . . . . 0.0 109.543 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.49 -40.23 17.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 0.0 109.299 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' C' ' 348' ' ' PHE . 12.0 t0 -77.48 -43.56 31.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -49.27 -34.37 15.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.76 -49.61 5.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.64 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.88 36.66 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.331 -0.855 . . . . 0.0 109.733 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' C' ' 344' ' ' ASP . 17.7 t80 -53.32 -34.28 56.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.94 . . . . 0.0 109.438 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -63.56 -34.82 78.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . 0.445 ' O ' ' N ' ' C' ' 354' ' ' PHE . 4.4 m -71.53 -54.44 10.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 12.4 mm -52.11 -32.18 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.424 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -79.99 -48.77 12.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -73.03 -14.95 61.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' C' ' 350' ' ' SER . 67.4 t80 -81.91 -54.72 5.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -71.42 -42.12 68.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -89.05 167.52 13.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.85 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . 0.45 ' CG ' ' H ' ' C' ' 358' ' ' GLY . 4.9 t-80 57.69 -143.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' C' ' 357' ' ' HIS . . . 64.9 82.52 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.05 115.82 7.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 109.501 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 2.2 tttp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.412 179.97 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.07 -179.72 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.537 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -166.96 -175.63 3.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -60.61 132.09 52.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.435 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 72.6 m -160.71 146.82 15.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 26.5 m -151.82 108.33 3.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 50.28 69.63 2.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.63 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.65 -28.59 52.37 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.236 1.291 . . . . 0.0 112.244 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -59.9 3.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.603 ' CG1' HD21 ' A' ' 131' ' ' ASN . 12.3 t -53.52 -39.4 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.873 . . . . 0.0 109.373 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 9.3 t -60.34 -54.65 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 109.427 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.81 -42.26 25.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.139 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -70.35 -32.44 70.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.252 -0.905 . . . . 0.0 109.188 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -65.23 -65.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.726 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.458 HG23 ' N ' ' D' ' 433' ' ' ILE . 9.3 tp -49.88 -39.36 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.075 -1.016 . . . . 0.0 108.774 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.458 ' N ' HG23 ' D' ' 432' ' ' ILE . 12.9 mt -53.77 -43.18 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.251 -0.906 . . . . 0.0 108.691 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.3 98.19 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -60.98 -43.4 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -1.188 . . . . 0.0 108.914 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -33.08 73.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.339 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.582 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -57.12 -51.36 69.61 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.049 -1.032 . . . . 0.0 109.314 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.783 HD13 ' CE1' ' C' ' 337' ' ' HIS . 12.0 tp -68.15 -33.65 74.88 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.643 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 2.8 mm -50.71 -39.95 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.658 -1.277 . . . . 0.0 108.125 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.36 -39.43 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -52.86 -52.29 57.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 13.9 tt -68.58 -33.64 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.01 -62.83 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.08 -47.95 68.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.476 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -48.09 -50.45 28.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.618 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.3 mp -56.64 -46.05 81.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.386 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.76 109.9 18.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.35 142.57 30.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -79.52 84.93 5.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 10.9 t -149.71 -54.11 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 75.7 mt -88.73 138.03 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -164.71 25.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' D' ' 453' ' ' ARG . 0.0 OUTLIER -89.25 89.57 7.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 56.22 -174.36 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.375 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -167.95 -44.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -86.26 123.16 31.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . 0.508 ' N ' ' ND1' ' D' ' 457' ' ' HIS . 1.6 m-70 -60.08 -175.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -89.91 -174.4 45.42 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -56.55 -54.05 50.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -1.143 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 17.3 tttp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.53 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.73 -164.0 0.25 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.406 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -61.72 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.76 97.06 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 123' ' ' SER . 98.6 p -95.29 55.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 122' ' ' SER . 23.2 t -63.55 -134.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.942 . . . . 0.0 109.472 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -148.99 71.02 10.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.8 -29.82 50.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.389 1.392 . . . . 0.0 112.468 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.77 -42.67 60.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.929 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.82 -52.52 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.705 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.676 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.5 m -63.81 -54.28 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.885 . . . . 0.0 109.66 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.676 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.56 -27.99 42.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.132 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -85.17 -21.06 29.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.422 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.442 HD21 ' CG1' ' D' ' 427' ' ' VAL . 0.1 OUTLIER -73.53 -40.99 63.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.3 mt -50.85 -42.86 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.45 -29.1 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 108.977 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.46 -53.53 44.71 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 136' ' ' LEU . 3.8 tp -65.26 -50.21 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -1.154 . . . . 0.0 108.892 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 135' ' ' ILE . 4.3 tp -50.24 -40.12 46.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 108.585 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.935 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -57.93 -58.95 6.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.427 -0.795 . . . . 0.0 108.939 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.919 HD21 ' NE2' ' C' ' 337' ' ' HIS . 17.1 mt -49.23 -48.74 45.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.693 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.81 -32.37 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.52 -58.44 3.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.032 -1.042 . . . . 0.0 109.705 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.8 OUTLIER -50.45 -44.04 55.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.763 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.504 HD12 ' ND1' ' D' ' 437' ' ' HIS . 1.6 tt -71.41 -41.46 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.117 -0.989 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tt -58.29 -29.32 65.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 0.0 109.02 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 148' ' ' PHE . 4.7 t70 -77.77 -44.03 28.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -0.882 . . . . 0.0 109.367 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.516 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 22.3 ttt180 -54.62 -36.3 64.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 -50.53 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.697 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -98.72 36.86 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.462 -0.774 . . . . 0.0 109.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 144' ' ' ASP . 1.8 t80 -52.52 -36.88 56.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.305 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -60.03 -36.1 76.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.298 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 149' ' ' LYS . 15.7 m -69.15 -53.03 22.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 mm -57.11 -23.59 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -84.65 -41.51 16.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -73.81 -21.26 60.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 109.574 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -83.21 -61.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.37 -27.77 63.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.293 -0.879 . . . . 0.0 109.506 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 49.99 -106.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.389 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.6 172.69 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.425 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 160' ' ' LYS . . . -87.28 -134.89 4.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 mt 47.45 18.77 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -1.124 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' GLY . 33.7 mtpt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 77.4 p -65.81 -173.14 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.349 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' B' ' 221' ' ' ASP . 2.2 t-20 -59.23 -72.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.495 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' B' ' 220' ' ' ASN . 12.6 t0 -168.7 145.97 3.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.586 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -4.73 56.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.56 153.54 40.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.837 . . . . 0.0 109.363 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.41 163.5 23.2 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -54.28 -28.03 50.62 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.066 1.177 . . . . 0.0 112.371 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.45 -59.26 5.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.875 . . . . 0.0 109.515 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.469 ' CG1' HD21 ' C' ' 331' ' ' ASN . 25.5 t -50.66 -47.58 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' B' ' 231' ' ' ASN . 2.8 t -48.79 -58.63 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.157 -0.964 . . . . 0.0 109.123 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.73 -36.44 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.535 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -71.28 -32.53 68.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 109.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.3 m120 -66.63 -62.64 1.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.406 HG23 ' N ' ' B' ' 233' ' ' ILE . 7.9 tp -50.94 -37.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.074 -1.016 . . . . 0.0 108.494 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.406 ' N ' HG23 ' B' ' 232' ' ' ILE . 11.9 mt -57.05 -42.22 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -57.16 -47.72 85.42 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -55.28 -39.15 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.237 -1.155 . . . . 0.0 108.6 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.5 mp -68.46 -36.83 79.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.421 -0.799 . . . . 0.0 109.276 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.862 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -54.28 -46.93 72.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.019 -1.05 . . . . 0.0 108.982 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.716 HD13 ' CE1' ' A' ' 137' ' ' HIS . 7.6 tp -68.74 -37.74 79.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.616 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.31 -37.63 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.973 -1.079 . . . . 0.0 108.095 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.54 -37.37 63.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . 0.56 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 85.1 t90 -58.52 -57.0 14.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.688 . . . . 0.0 109.436 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . 0.48 HG23 ' N ' ' B' ' 243' ' ' LEU . 16.4 tt -63.72 -40.17 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.544 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.48 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.5 tt -58.29 -48.03 81.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 109.593 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -41.1 90.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -68.67 -25.36 64.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.367 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.22 -69.49 0.62 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 109.473 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -72.14 150.92 43.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -75.93 129.86 37.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -10.56 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.47 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 3.3 m -157.1 132.72 9.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.7 pt -54.68 162.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -53.39 147.39 10.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -63.23 148.8 47.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' B' ' 255' ' ' PHE . 97.3 m-85 -57.37 -14.3 4.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.361 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' B' ' 254' ' ' PHE . 2.1 t80 59.5 110.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.573 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -55.41 131.41 45.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -62.57 -46.31 88.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.905 . . . . 0.0 109.456 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 67.56 61.44 5.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -38.42 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -1.16 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.568 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.64 -163.94 0.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -61.74 133.62 55.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -151.74 97.12 2.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . 0.405 ' O ' ' O ' ' C' ' 323' ' ' SER . 97.7 p -95.32 55.61 1.77 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.439 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . 0.405 ' O ' ' O ' ' C' ' 322' ' ' SER . 23.0 t -63.55 -134.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -149.0 70.96 10.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.528 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.67 -29.91 51.27 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.392 1.394 . . . . 0.0 112.536 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.58 -42.81 61.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.669 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.77 -52.6 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.691 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.668 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.5 m -63.82 -54.32 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.668 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.45 -28.18 42.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.169 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.91 29.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.431 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.469 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -73.57 -41.09 63.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.419 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.4 mt -50.84 -42.93 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.313 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.33 -29.17 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 109.034 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.52 -53.39 45.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.565 HG23 ' N ' ' C' ' 336' ' ' LEU . 3.7 tp -65.3 -50.21 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -1.136 . . . . 0.0 108.89 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . 0.565 ' N ' HG23 ' C' ' 335' ' ' ILE . 4.3 tp -50.3 -40.17 47.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 108.57 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.919 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -57.92 -58.81 6.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.935 HD21 ' NE2' ' A' ' 137' ' ' HIS . 17.1 mt -49.26 -48.86 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.8 mt -54.76 -32.34 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.514 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.68 -58.13 3.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.607 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.614 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -50.74 -43.63 58.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 109.905 -179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.512 HD12 ' ND1' ' B' ' 237' ' ' HIS . 1.6 tt -71.88 -41.11 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.077 -1.014 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' C' ' 342' ' ' ILE . 3.3 tt -58.36 -29.34 65.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.079 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' C' ' 348' ' ' PHE . 4.6 t70 -77.85 -44.0 28.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 22.5 ttt180 -54.58 -36.2 64.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.62 -50.67 6.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -98.57 36.91 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.408 -0.807 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' C' ' 344' ' ' ASP . 1.8 t80 -52.52 -36.84 56.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -0.973 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . 0.403 ' CG ' ' N ' ' C' ' 350' ' ' SER . 0.4 OUTLIER -59.92 -36.23 76.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.309 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . 0.403 ' N ' ' CG ' ' C' ' 349' ' ' LYS . 15.8 m -69.14 -52.98 22.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 15.4 mm -57.01 -23.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.445 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -84.68 -41.51 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' C' ' 353' ' ' ARG . 0.1 OUTLIER -73.81 -21.34 60.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.499 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -83.14 -61.65 1.8 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -71.28 -27.86 63.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 50.07 -106.64 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.32 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.57 172.77 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' C' ' 360' ' ' LYS . . . -87.34 -134.91 4.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 6.6 mt 47.42 18.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -1.129 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' C' ' 358' ' ' GLY . 33.6 mtpt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 77.6 p -65.89 -173.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' D' ' 421' ' ' ASP . 2.1 t-20 -59.18 -72.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' D' ' 420' ' ' ASN . 12.7 t0 -168.69 146.0 3.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -4.7 56.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.57 153.57 40.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.46 163.47 23.22 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.3 -28.06 50.99 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.07 1.18 . . . . 0.0 112.387 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.0 mt -57.42 -59.22 5.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.442 ' CG1' HD21 ' A' ' 131' ' ' ASN . 26.9 t -50.63 -47.53 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.8 t -48.8 -58.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.148 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.67 -36.5 11.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.505 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -71.31 -32.4 68.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.367 -0.833 . . . . 0.0 109.085 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.4 m120 -66.7 -62.66 1.34 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.415 HG23 ' N ' ' D' ' 433' ' ' ILE . 7.8 tp -50.89 -37.37 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.415 ' N ' HG23 ' D' ' 432' ' ' ILE . 11.9 mt -57.0 -42.29 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -57.06 -47.88 83.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.531 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -55.18 -39.12 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -1.155 . . . . 0.0 108.548 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.59 -36.79 79.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.356 -0.84 . . . . 0.0 109.184 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.88 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -54.3 -46.91 72.89 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.975 -1.078 . . . . 0.0 108.878 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.696 HD13 ' CE1' ' C' ' 337' ' ' HIS . 7.8 tp -68.77 -37.76 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.574 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.0 mm -49.36 -37.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.3 tp -74.66 -37.3 62.75 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . 0.516 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 85.1 t90 -58.37 -56.96 15.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.594 -0.691 . . . . 0.0 109.528 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . 0.477 HG23 ' N ' ' D' ' 443' ' ' LEU . 16.5 tt -63.92 -39.98 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 109.651 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . 0.477 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.5 tt -58.33 -48.0 81.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.86 -41.01 90.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -68.77 -25.34 64.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.377 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.22 -69.39 0.62 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -72.32 150.95 43.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -75.86 129.81 37.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -10.5 2.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.533 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 3.3 m -157.18 132.81 9.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.41 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 7.6 pt -54.77 162.5 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -53.19 147.31 10.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.885 . . . . 0.0 109.44 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -63.21 148.8 47.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.38 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -57.5 -14.16 4.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.386 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 2.1 t80 59.36 110.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.9 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -55.55 131.41 46.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -62.53 -46.39 88.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 109.427 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 67.51 61.53 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.74 -38.56 73.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -1.142 . . . . 0.0 109.409 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.495 -179.931 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.3 m -72.08 -53.44 12.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -80.57 49.96 1.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.456 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -89.98 -5.08 57.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.36 166.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.1 t -177.4 -46.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 54.67 70.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.0 -31.47 46.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.405 1.403 . . . . 0.0 112.31 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.9 -48.59 75.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 109.495 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.4 t -51.04 -38.05 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.918 . . . . 0.0 109.4 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 131' ' ' ASN . 49.0 t -66.99 -64.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.277 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.95 -17.42 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.544 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.42 -27.5 19.25 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.573 -0.704 . . . . 0.0 109.406 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.4 OUTLIER -73.64 -37.32 65.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.97 -44.77 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 tt -78.12 -32.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.255 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.85 97.07 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' D' ' 430' ' ' ALA . 82.3 mt -68.22 -57.0 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.314 -1.11 . . . . 0.0 109.058 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.21 -33.67 13.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.142 -0.974 . . . . 0.0 108.7 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.939 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -61.4 -55.76 27.84 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.85 . . . . 0.0 108.99 179.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.921 HD21 ' NE2' ' C' ' 337' ' ' HIS . 18.0 mt -54.16 -48.07 71.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.675 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.23 -33.67 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 109.671 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 tt -82.31 -57.6 3.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.768 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.7 OUTLIER -50.58 -43.69 56.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.849 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.609 HD12 ' ND1' ' D' ' 437' ' ' HIS . 3.0 tt -68.94 -44.73 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.861 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.522 ' N ' HG23 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -52.88 -34.68 55.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.74 -1.225 . . . . 0.0 108.741 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.439 ' O ' ' CA ' ' A' ' 148' ' ' PHE . 12.6 t70 -78.21 -31.2 49.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.446 -0.784 . . . . 0.0 109.523 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.1 -42.98 95.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.641 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -50.11 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 143' ' ' LEU . 37.8 m-85 -96.39 38.05 1.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.522 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.439 ' CA ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -49.48 -24.69 2.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -74.19 -43.64 56.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.1 m -60.2 -49.14 78.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 151' ' ' ILE . 1.7 mp -64.39 -38.3 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.192 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.93 -40.9 97.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -76.3 -35.26 58.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.455 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.07 -36.64 68.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -28.23 40.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.95 . . . . 0.0 109.432 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.0 -41.52 98.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.408 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -171.21 110.9 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -87.12 -167.26 43.53 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.92 -32.36 71.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -1.147 . . . . 0.0 109.412 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.36 2.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -151.84 -166.98 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' B' ' 221' ' ' ASP . 0.6 OUTLIER -157.15 75.42 0.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.8 m -161.31 81.2 0.61 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.535 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 2.4 p -161.51 -173.98 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -148.08 70.58 11.06 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.83 -27.18 51.76 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.36 1.373 . . . . 0.0 112.477 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.12 -45.36 52.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.875 . . . . 0.0 109.74 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 8.9 t -63.87 -35.85 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 109.557 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 5.2 t -67.57 -56.91 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.09 -39.08 19.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.009 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.09 -33.85 68.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.212 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.443 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -66.28 -63.41 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.443 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.457 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.5 tp -49.93 -39.5 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.054 -1.028 . . . . 0.0 108.613 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.457 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.6 mt -53.98 -45.02 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.169 -0.957 . . . . 0.0 108.444 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.1 -49.34 68.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.544 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -53.38 -38.02 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.069 -1.254 . . . . 0.0 108.487 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . 0.606 HD23 ' O ' ' B' ' 236' ' ' LEU . 1.3 tt -68.31 -37.36 80.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.279 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.867 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.2 OUTLIER -55.32 -48.28 74.39 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.094 -1.004 . . . . 0.0 109.314 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.3 tp -67.16 -39.49 86.48 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 118.638 -1.225 . . . . 0.0 109.697 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' B' ' 236' ' ' LEU . 11.4 mt -47.46 -40.01 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.321 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.73 -34.42 64.78 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . 0.42 ' N ' ' O ' ' B' ' 238' ' ' LEU . 84.9 t90 -60.1 -54.88 40.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.403 -0.81 . . . . 0.0 109.636 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -51.79 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.257 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.89 -53.57 31.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.609 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -54.85 18.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.598 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -58.02 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.489 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -40.47 18.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.37 103.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.572 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -85.19 -58.65 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -49.81 129.53 20.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 40.7 t -153.28 3.85 0.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 mt 54.31 71.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.171 -0.956 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -90.12 -22.91 21.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 50.52 -159.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 0.0 109.396 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.41 -30.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.39 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.36 147.93 50.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 109.358 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.78 -175.4 5.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . 0.546 ' N ' ' ND1' ' B' ' 257' ' ' HIS . 0.0 OUTLIER -73.8 126.25 29.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 153.51 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.79 179.97 8.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -1.123 . . . . 0.0 109.431 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 49.7 mttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.524 -179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 7.6 m -72.03 -53.56 12.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.482 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -80.54 49.91 1.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -89.93 -5.1 57.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.49 166.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 7.1 t -177.42 -46.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 54.55 70.37 1.7 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.1 -31.39 45.69 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.318 1.345 . . . . 0.0 112.297 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 9.7 mt -55.84 -48.69 75.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.02 -38.35 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.39 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' C' ' 331' ' ' ASN . 48.9 t -66.44 -64.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.84 -17.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 108.624 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.453 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.65 -26.85 19.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.731 . . . . 0.0 109.327 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.5 OUTLIER -73.83 -37.44 64.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.403 HG13 ' H ' ' C' ' 332' ' ' ILE . 2.8 mt -51.82 -44.97 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.492 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.8 tt -78.03 -33.04 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.7 97.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.551 HG21 ' HB1' ' B' ' 230' ' ' ALA . 82.2 mt -68.39 -56.96 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.316 -1.108 . . . . 0.0 109.006 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 4.0 mt -49.26 -33.49 12.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 108.731 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.921 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -61.59 -55.67 28.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.87 . . . . 0.0 108.976 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.939 HD21 ' NE2' ' A' ' 137' ' ' HIS . 18.0 mt -54.14 -48.11 71.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.613 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 55.3 mt -54.38 -33.58 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.6 tt -82.35 -57.33 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.044 -1.035 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.625 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -50.75 -43.63 58.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.867 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.6 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.9 tt -69.13 -44.56 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.513 ' N ' HG23 ' C' ' 342' ' ' ILE . 0.8 OUTLIER -52.88 -34.77 56.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.7 -1.25 . . . . 0.0 108.835 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.445 ' O ' ' CA ' ' C' ' 348' ' ' PHE . 12.5 t70 -78.37 -30.97 48.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -60.11 -43.04 95.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.06 -50.09 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' C' ' 343' ' ' LEU . 37.4 m-85 -96.4 38.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.842 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.445 ' CA ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -49.54 -24.71 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 109.458 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -74.15 -43.72 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 21.4 m -60.15 -49.2 78.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . 0.45 HD12 ' N ' ' C' ' 351' ' ' ILE . 1.7 mp -64.39 -38.16 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.962 . . . . 0.0 109.195 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -64.02 -40.91 97.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 29.2 mtp180 -76.34 -35.23 58.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.487 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -56.07 -36.62 68.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -28.08 39.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.13 -41.51 98.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.353 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -171.2 110.9 0.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -87.14 -167.21 43.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.93 -32.44 71.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.443 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.393 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.38 2.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -151.87 -166.98 2.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.469 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' D' ' 421' ' ' ASP . 0.6 OUTLIER -157.12 75.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.8 m -161.32 81.11 0.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 2.4 p -161.41 -173.98 4.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.938 . . . . 0.0 109.436 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -148.12 70.65 11.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.82 -27.18 51.82 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.309 1.339 . . . . 0.0 112.448 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -45.32 54.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 t -63.91 -35.86 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 5.1 t -67.52 -56.89 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.16 -39.11 19.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.019 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.08 -33.79 68.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 109.205 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.433 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.8 OUTLIER -66.29 -63.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.46 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.5 tp -49.97 -39.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.087 -1.008 . . . . 0.0 108.577 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.46 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.6 mt -54.06 -44.99 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.478 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.07 -49.34 67.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.535 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -53.47 -37.94 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -1.228 . . . . 0.0 108.476 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . 0.605 ' O ' HD23 ' D' ' 436' ' ' LEU . 1.3 tt -68.41 -37.24 80.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.547 -0.72 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.887 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.42 -48.09 74.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.039 -1.038 . . . . 0.0 109.346 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.709 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.4 tp -67.14 -39.62 86.58 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.716 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' D' ' 436' ' ' LEU . 11.4 mt -47.47 -39.97 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 0.0 108.353 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.7 -34.41 64.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . 0.429 ' N ' ' O ' ' D' ' 438' ' ' LEU . 85.4 t90 -60.03 -54.87 40.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.518 -0.739 . . . . 0.0 109.62 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -51.66 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.121 -0.987 . . . . 0.0 109.368 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.9 mp -50.92 -53.57 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.52 -54.79 19.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.553 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.09 -20.09 37.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.89 -40.61 18.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.51 102.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -85.12 -58.78 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.401 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -49.81 129.5 20.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 40.7 t -153.22 3.78 0.31 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.881 . . . . 0.0 109.451 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . 0.411 HG21 HD13 ' D' ' 451' ' ' ILE . 13.4 mt 54.33 71.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.443 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -90.2 -22.77 21.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 50.51 -159.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.46 -30.16 0.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.3 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.42 147.88 50.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.855 . . . . 0.0 109.369 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.75 -175.27 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . 0.536 ' N ' ' ND1' ' D' ' 457' ' ' HIS . 0.0 OUTLIER -73.94 126.23 29.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 153.6 -96.75 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.81 179.95 8.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -1.115 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 50.1 mttt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.439 -179.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -153.5 165.95 34.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.367 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -146.45 36.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.547 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -49.05 -36.56 18.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.18 30.02 5.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.492 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -53.55 161.64 0.99 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -173.54 70.84 0.36 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.691 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.27 -25.77 49.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.418 1.412 . . . . 0.0 112.3 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.44 -42.74 58.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.52 -53.49 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 109.636 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.655 HG23 ' N ' ' A' ' 129' ' ' ALA . 34.0 m -61.57 -52.5 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.655 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.82 -24.8 24.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 109.133 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.92 -21.82 23.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.392 -0.817 . . . . 0.0 109.351 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.478 ' CG ' ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER -72.7 -43.75 62.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 5.0 mt -48.49 -47.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.1 tt -71.35 -33.44 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 0.0 108.776 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.2 64.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.3 mm -70.2 -55.28 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.8 mt -48.89 -34.49 12.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 108.66 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.944 ' CE1' HD21 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -62.18 -57.61 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.964 HD21 ' CE1' ' C' ' 337' ' ' HIS . 3.5 mt -56.35 -51.48 68.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.707 -0.62 . . . . 0.0 110.031 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.07 -28.72 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 109.556 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.4 HD22 HD21 ' B' ' 238' ' ' LEU . 4.5 tt -78.92 -58.72 3.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 109.73 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -50.19 -52.49 35.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.542 HG23 ' N ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -60.02 -43.87 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.054 . . . . 0.0 109.249 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.542 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.6 mt -49.46 -35.83 20.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.927 -1.108 . . . . 0.0 109.174 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -75.72 -36.11 60.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.494 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -67.1 -28.15 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.97 -16.33 19.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.391 -0.818 . . . . 0.0 109.699 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -146.17 41.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.583 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 144' ' ' ASP . 2.8 p90 -47.62 -23.42 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -73.24 -45.87 53.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 m -61.44 -50.73 71.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.7 mm -64.12 -37.53 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.877 . . . . 0.0 109.397 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -65.14 -37.29 86.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.19 -0.943 . . . . 0.0 109.421 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -63.38 -39.22 93.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.328 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.09 -48.63 80.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.79 -42.29 46.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.44 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -67.01 165.56 15.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 109.465 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -77.15 -110.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.78 -179.93 44.75 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 130.59 36.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.0 tttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.499 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 8.3 t -152.11 150.74 30.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.51 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.73 -35.3 55.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 0.0 109.393 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.48 168.74 25.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.7 t -85.94 -140.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 21.8 t 50.73 -175.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.617 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -148.59 70.53 10.54 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.627 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.24 -30.0 46.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.322 1.348 . . . . 0.0 112.41 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.73 -60.34 2.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 9.0 t -52.35 -34.56 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.99 -58.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.01 -41.16 15.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.259 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.13 68.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 109.147 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -59.5 4.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.811 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 232' ' ' ILE . 8.8 tp -58.16 -33.93 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.066 -1.022 . . . . 0.0 109.14 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.99 -49.11 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.126 -0.984 . . . . 0.0 108.815 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.12 -45.13 96.54 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.6 -49.13 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -1.203 . . . . 0.0 109.302 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.6 -36.55 84.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.828 ' ND1' HD22 ' C' ' 338' ' ' LEU . 0.8 OUTLIER -53.68 -49.04 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.93 -1.106 . . . . 0.0 109.236 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.761 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.0 tp -67.65 -35.53 79.06 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.592 -1.243 . . . . 0.0 109.821 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' B' ' 238' ' ' LEU . 3.1 mm -50.05 -37.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.35 -38.3 60.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -54.52 -50.53 67.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.81 -38.74 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.719 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -44.0 97.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.025 -1.047 . . . . 0.0 109.524 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.59 35.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.2 OUTLIER -53.99 -42.51 69.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.472 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.45 -78.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.441 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -67.31 -175.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.52 175.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -148.18 41.48 0.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.562 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.14 -159.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.22 163.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 109.516 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.81 160.97 31.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -82.74 108.79 16.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 109.415 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -70.49 -38.31 74.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -58.86 -62.46 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -68.94 149.25 49.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -61.96 173.42 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.555 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -75.22 171.5 54.0 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.67 156.82 23.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -1.126 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 37.9 tttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.456 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.31 0.576 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 50.1 m -153.49 165.98 34.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -146.48 36.19 0.98 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.546 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -48.93 -36.72 17.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 51.32 30.01 5.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.397 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 8.2 m -53.6 161.63 1.01 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -173.48 70.84 0.37 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.28 -25.71 49.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.427 1.418 . . . . 0.0 112.303 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.43 -42.7 58.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.855 . . . . 0.0 109.72 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.67 -53.42 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.599 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.647 HG23 ' N ' ' C' ' 329' ' ' ALA . 33.9 m -61.56 -52.55 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.545 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.647 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.81 -24.79 24.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.973 . . . . 0.0 109.195 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -89.02 -21.69 23.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.276 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.477 ' CG ' ' N ' ' C' ' 332' ' ' ILE . 0.1 OUTLIER -72.63 -43.93 62.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.477 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 5.1 mt -48.39 -48.11 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 6.3 tt -71.17 -33.5 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.866 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -53.34 -46.04 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.29 -55.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.81 -34.49 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 108.668 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.964 ' CE1' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.15 -57.58 10.98 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.944 HD21 ' CE1' ' A' ' 137' ' ' HIS . 3.4 mt -56.5 -51.35 68.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.638 -0.664 . . . . 0.0 110.041 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.02 -28.85 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.06 -58.23 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.622 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -50.55 -52.61 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.579 HD12 ' CD2' ' B' ' 237' ' ' HIS . 0.9 OUTLIER -59.88 -43.85 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.126 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.548 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.6 mt -49.48 -35.75 20.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.919 -1.113 . . . . 0.0 109.211 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -75.79 -36.03 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.887 . . . . 0.0 109.491 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -67.18 -28.15 67.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.93 -16.4 19.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.634 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.08 41.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -0.91 . . . . 0.0 109.531 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' C' ' 344' ' ' ASP . 2.9 p90 -47.75 -23.28 0.68 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.849 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -73.26 -45.86 53.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 14.8 m -61.56 -50.68 71.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 11.7 mm -64.04 -37.59 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.935 . . . . 0.0 109.394 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -65.23 -37.28 86.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.374 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -63.28 -39.31 94.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -0.931 . . . . 0.0 109.358 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -59.06 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.8 -42.32 46.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.0 165.6 15.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -77.17 -110.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.508 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -173.77 -179.98 44.77 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.52 130.67 36.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.484 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.509 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 8.4 t -152.1 150.77 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -52.75 -35.31 56.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.349 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.48 168.65 25.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.6 t -85.85 -140.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 22.0 t 50.71 -175.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.584 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -148.54 70.55 10.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.18 -30.05 46.76 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.345 1.363 . . . . 0.0 112.381 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.83 -60.34 2.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.424 HG23 ' H ' ' D' ' 427' ' ' VAL . 9.1 t -52.24 -34.63 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.94 -58.09 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.11 15.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.265 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.99 68.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.122 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -59.35 4.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.843 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' D' ' 432' ' ' ILE . 8.8 tp -58.12 -34.07 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.146 -0.971 . . . . 0.0 109.104 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . . . . . . . . . 1.4 mm -55.9 -49.11 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -60.24 -45.03 96.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.68 -49.06 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -1.195 . . . . 0.0 109.273 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.65 -36.52 84.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.219 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.841 ' ND1' HD22 ' A' ' 138' ' ' LEU . 0.8 OUTLIER -53.69 -49.1 68.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 109.244 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.748 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.1 tp -67.69 -35.47 78.89 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.633 -1.227 . . . . 0.0 109.832 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' D' ' 438' ' ' LEU . 3.1 mm -50.03 -37.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.793 -1.192 . . . . 0.0 107.877 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 2.6 tt -75.32 -38.33 60.28 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -54.41 -50.59 67.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.483 -0.76 . . . . 0.0 109.605 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.92 -38.57 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.73 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -43.94 97.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.045 -1.034 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.02 -54.69 34.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.2 OUTLIER -54.0 -42.46 69.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.508 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.41 -78.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -67.3 -175.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.517 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.61 175.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.371 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -148.28 41.52 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.08 -159.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.59 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 1.9 pt -68.31 163.5 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.485 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.01 31.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -82.74 108.84 16.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.48 -38.33 74.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -58.88 -62.48 1.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -68.93 149.29 49.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -61.93 173.32 1.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -75.14 171.52 53.94 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.67 156.9 23.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -1.163 . . . . 0.0 109.386 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 37.9 tttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.475 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m -79.61 -66.92 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.51 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 0.9 OUTLIER -50.98 -52.6 41.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 120' ' ' ASN . 0.5 OUTLIER 73.3 -13.77 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.614 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 120' ' ' ASN . 34.3 t -59.62 -38.89 82.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.442 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.0 m -50.09 -27.04 5.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 47.9 69.86 2.43 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.2 -25.78 57.47 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.24 1.294 . . . . 0.0 112.357 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.9 mp -51.23 -45.79 62.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 54.5 t -51.47 -44.12 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 131' ' ' ASN . 78.0 t -62.5 -62.02 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.406 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.73 -18.34 0.26 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.734 ' HB1' ' OD1' ' B' ' 231' ' ' ASN . . . -89.88 -27.75 19.68 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER -70.4 -36.22 73.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.368 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 132' ' ' ILE . 2.6 mt -53.91 -48.12 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.402 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.1 tt -72.24 -30.77 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 108.76 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.38 -44.64 84.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.419 HG21 ' HB1' ' D' ' 430' ' ' ALA . 6.6 mt -69.68 -55.04 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -1.102 . . . . 0.0 109.126 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.83 -36.7 27.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 108.963 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.85 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -64.83 -43.5 92.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.265 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.833 HD21 ' NE2' ' C' ' 337' ' ' HIS . 3.6 mt -69.42 -47.27 64.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.775 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 26.5 mt -54.88 -34.41 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.626 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.69 -47.55 18.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.122 -0.986 . . . . 0.0 109.728 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 1.6 t-105 -46.42 -48.88 18.69 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 143' ' ' LEU . 11.5 tt -72.48 -41.92 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.948 . . . . 0.0 109.96 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.3 tp -47.83 -40.46 21.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.96 . . . . 0.0 109.345 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 148' ' ' PHE . 7.8 t0 -76.95 -43.83 33.71 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.92 -33.52 17.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.643 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.54 -49.52 5.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.867 . . . . 0.0 109.627 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.1 35.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 144' ' ' ASP . 33.5 p90 -48.67 -25.94 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.32 -47.07 45.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -57.4 -49.16 77.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.378 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.9 mm -59.61 -50.53 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.268 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -52.53 -53.89 40.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -61.64 -33.09 73.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.229 -0.919 . . . . 0.0 109.452 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -51.8 -39.5 58.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -73.53 -41.25 63.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.07 -52.64 64.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -93.1 172.39 8.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.416 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 160' ' ' LYS . . . 89.24 64.4 1.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.81 79.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.143 . . . . 0.0 109.407 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 158' ' ' GLY . 17.8 tttp . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.502 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.319 0.581 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.98 168.4 27.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.857 . . . . 0.0 109.415 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -54.36 -30.07 50.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -147.55 160.77 42.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.73 92.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 67.7 p -83.54 175.31 9.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.597 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -153.94 69.99 6.37 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 109.596 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.32 -27.3 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.34 1.36 . . . . 0.0 112.502 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.09 -49.7 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' C' ' 331' ' ' ASN . 61.3 t -59.82 -37.67 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.37 -57.25 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -33.77 8.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.47 -33.59 67.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.266 -0.897 . . . . 0.0 109.241 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.734 ' OD1' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -66.56 -61.05 2.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.486 ' N ' ' CG ' ' B' ' 231' ' ' ASN . 8.6 tp -52.43 -38.39 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 0.0 108.687 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.437 ' N ' HG23 ' B' ' 232' ' ' ILE . 9.4 mt -54.14 -44.22 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.9 -43.79 96.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.482 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -61.02 -41.75 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -1.221 . . . . 0.0 108.679 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' B' ' 239' ' ' ILE . 0.5 OUTLIER -67.54 -35.16 78.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.83 . . . . 0.0 109.106 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.559 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.4 OUTLIER -56.5 -50.78 70.77 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.088 -1.007 . . . . 0.0 109.416 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.814 HD13 ' CE1' ' A' ' 137' ' ' HIS . 11.1 tp -68.16 -33.83 75.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.521 -1.272 . . . . 0.0 109.79 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' B' ' 236' ' ' LEU . 16.9 mt -50.58 -40.1 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.68 -1.263 . . . . 0.0 107.831 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.15 -42.15 66.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -50.25 -48.04 54.84 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 108.927 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.12 -52.11 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.279 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.33 -31.94 46.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.88 -33.48 64.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.388 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -77.57 -25.95 50.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.04 -59.7 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -47.95 74.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 8.1 t80 48.23 24.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.699 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -149.56 133.81 17.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.57 143.51 24.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.2 pt -74.88 172.7 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.352 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.09 126.71 30.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.436 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -90.33 -77.09 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -59.56 109.35 0.88 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.504 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -64.81 112.14 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.418 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 49.0 -120.32 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -154.78 -11.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 63.95 67.94 1.86 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 14.7 mt -70.36 106.65 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -1.179 . . . . 0.0 109.436 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 45.3 tttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.456 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.577 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 1.9 m -79.59 -67.02 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.524 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' C' ' 321' ' ' ASP . 0.9 OUTLIER -50.88 -52.68 39.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.579 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' C' ' 320' ' ' ASN . 0.5 OUTLIER 73.31 -13.75 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . 0.424 ' H ' ' C ' ' C' ' 320' ' ' ASN . 33.8 t -59.54 -39.04 82.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 50.1 m -50.03 -26.96 4.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 47.84 69.9 2.41 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.34 -25.71 56.51 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.345 1.363 . . . . 0.0 112.278 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 8.9 mp -51.19 -45.82 61.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' C' ' 330' ' ' ALA . 54.7 t -51.58 -44.12 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' C' ' 331' ' ' ASN . 79.5 t -62.38 -62.04 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -48.81 -18.34 0.26 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.214 -0.929 . . . . 0.0 108.641 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.742 ' HB1' ' OD1' ' D' ' 431' ' ' ASN . . . -90.12 -27.29 19.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.491 -0.756 . . . . 0.0 109.076 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.2 OUTLIER -70.45 -36.26 73.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.358 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 2.8 mt -53.79 -48.33 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 7.2 tt -72.05 -30.92 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 108.742 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.66 84.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.418 HG21 ' HB1' ' B' ' 230' ' ' ALA . 6.6 mt -69.66 -55.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.293 -1.122 . . . . 0.0 109.054 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.79 -36.56 26.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 108.989 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.833 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -64.86 -43.63 92.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.85 HD21 ' NE2' ' A' ' 137' ' ' HIS . 3.6 mt -69.3 -47.4 64.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.41 -0.806 . . . . 0.0 109.766 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 27.7 mt -54.83 -34.53 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.6 tt -77.74 -46.97 20.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.629 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 1.6 t-105 -46.95 -48.71 21.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.47 HG23 ' N ' ' C' ' 343' ' ' LEU . 11.0 tt -72.71 -41.76 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.47 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.3 tp -47.75 -40.59 20.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.357 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' C' ' 348' ' ' PHE . 7.8 t0 -76.97 -43.9 33.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -49.88 -33.49 17.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.626 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.5 -49.63 5.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.585 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.05 35.52 1.42 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' C' ' 344' ' ' ASP . 33.8 p90 -48.63 -26.02 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -73.31 -47.04 45.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 23.3 p -57.39 -49.1 77.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.4 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.68 -50.49 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.332 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -52.48 -53.9 39.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.499 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -61.68 -33.0 73.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.86 -39.45 58.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.197 -0.939 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -73.57 -41.17 63.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.07 -52.61 64.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.863 . . . . 0.0 109.396 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -93.14 172.39 8.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.424 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' C' ' 360' ' ' LYS . . . 89.34 64.19 1.29 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.7 79.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.448 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' C' ' 358' ' ' GLY . 17.9 tttp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.417 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.06 168.38 27.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.308 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -54.36 -30.11 50.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -147.53 160.69 42.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.63 92.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 68.8 p -83.54 175.35 9.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -153.89 69.83 6.39 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.19 -27.3 48.92 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.381 1.387 . . . . 0.0 112.496 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 9.1 mt -50.19 -49.64 51.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.471 ' CG1' HD21 ' A' ' 131' ' ' ASN . 60.9 t -59.82 -37.77 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 0.0 109.545 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' D' ' 431' ' ' ASN . 2.7 t -64.25 -57.36 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.098 -1.001 . . . . 0.0 109.229 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.96 -33.93 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.888 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.54 -33.54 66.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.742 ' OD1' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -66.51 -61.11 2.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.428 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.487 ' N ' ' CG ' ' D' ' 431' ' ' ASN . 8.6 tp -52.36 -38.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 108.654 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.434 ' N ' HG23 ' D' ' 432' ' ' ILE . 9.4 mt -54.13 -44.2 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.213 -0.929 . . . . 0.0 108.525 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -58.99 -43.67 96.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.484 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.7 mp -61.14 -41.61 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.11 -1.229 . . . . 0.0 108.761 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' D' ' 439' ' ' ILE . 0.5 OUTLIER -67.56 -35.24 78.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.099 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.567 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.4 OUTLIER -56.44 -50.71 70.9 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.192 -0.942 . . . . 0.0 109.501 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.803 HD13 ' CE1' ' C' ' 337' ' ' HIS . 11.6 tp -68.22 -33.85 75.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.69 -1.204 . . . . 0.0 109.738 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' D' ' 436' ' ' LEU . 16.9 mt -50.64 -40.12 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.637 -1.29 . . . . 0.0 107.81 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.06 -42.12 66.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -50.13 -48.04 53.84 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.782 . . . . 0.0 109.004 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.29 -52.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -53.18 -32.07 45.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -73.91 -33.38 63.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -77.56 -26.03 50.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.523 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.05 -59.68 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.3 -47.85 74.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 8.1 t80 48.2 24.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.697 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -149.54 133.78 17.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.63 143.51 24.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.433 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 11.3 pt -74.76 172.65 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.05 126.63 30.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.928 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -90.29 -77.13 0.41 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -59.51 109.36 0.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -64.79 112.13 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.915 . . . . 0.0 109.448 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 49.12 -120.37 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -154.78 -12.01 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 64.04 67.84 1.89 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.34 106.7 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.438 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 45.3 tttp . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.453 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -53.29 -28.49 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.492 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.8 t30 54.84 73.84 0.39 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -62.46 -33.06 74.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.97 -178.68 0.21 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.561 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.9 m -150.94 -76.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.383 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -151.36 69.77 8.16 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 -27.38 55.2 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.318 1.346 . . . . 0.0 112.36 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.1 mt -53.69 -55.13 28.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.645 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.0 t -53.02 -34.03 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.965 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 131' ' ' ASN . 10.5 t -72.23 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.486 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.16 -19.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' ' C ' ' A' ' 128' ' ' VAL . . . -90.65 -25.52 20.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.609 -0.682 . . . . 0.0 109.181 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.821 HD21 HG11 ' D' ' 427' ' ' VAL . 0.5 OUTLIER -72.01 -38.34 69.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 0.0 109.54 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.55 -44.83 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.308 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.1 tt -78.43 -28.71 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 108.763 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.44 -55.1 27.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.616 HG23 ' N ' ' A' ' 136' ' ' LEU . 6.2 tp -63.34 -50.12 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -1.227 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.616 ' N ' HG23 ' A' ' 135' ' ' ILE . 3.7 mt -52.1 -37.75 55.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.085 -1.009 . . . . 0.0 108.74 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.754 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -60.03 -56.03 26.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.41 -0.806 . . . . 0.0 108.981 179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.724 HD21 ' NE2' ' C' ' 337' ' ' HIS . 6.3 mt -50.16 -38.62 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.768 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.39 -30.06 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.604 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.63 -53.27 6.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -52.77 -41.46 64.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.338 -0.851 . . . . 0.0 110.158 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.1 tp -74.36 -47.93 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.039 -1.038 . . . . 0.0 110.007 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.609 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.3 tp -50.2 -30.49 11.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.006 -1.059 . . . . 0.0 109.032 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 148' ' ' PHE . 6.0 t0 -78.35 -46.6 19.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 109.539 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.37 -33.8 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.42 -51.54 4.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.784 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 147' ' ' PHE . 34.7 m-85 -97.08 35.57 1.56 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 109.616 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.8 OUTLIER -47.82 -35.53 10.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.596 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -63.85 -45.81 87.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.619 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -57.62 -47.5 82.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.9 mm -55.1 -50.03 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.31 -49.85 68.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.552 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -65.07 -43.2 92.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -53.74 -36.08 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.442 ' CE1' HD21 ' B' ' 246' ' ' LEU . 0.2 OUTLIER -75.58 -51.43 12.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.532 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -146.44 131.36 18.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -76.11 -54.53 6.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.82 128.07 0.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 mp -84.58 164.79 18.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.318 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.41 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 3.9 t 56.79 171.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -163.68 175.2 10.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.5 t0 57.24 166.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 7.2 m -72.49 171.21 12.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.895 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 54.8 m -77.76 -10.34 59.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.913 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -156.78 69.53 4.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.624 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.43 -31.17 52.26 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.31 1.34 . . . . 0.0 112.394 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.448 ' N ' HD12 ' B' ' 226' ' ' LEU . 11.0 mp -64.79 -62.29 1.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.42 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.83 HG11 HD21 ' C' ' 331' ' ' ASN . 39.3 t -50.22 -45.97 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.0 t -48.89 -56.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.042 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.65 18.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.628 ' HB1' HG12 ' C' ' 335' ' ' ILE . . . -69.85 -34.64 73.89 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.431 -0.793 . . . . 0.0 109.145 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -60.8 3.25 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.067 -1.021 . . . . 0.0 109.254 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.21 -42.0 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.114 -0.991 . . . . 0.0 109.054 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' B' ' 230' ' ' ALA . 18.3 mt -50.49 -37.86 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -63.63 -44.67 96.12 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.5 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -58.65 -39.69 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -1.208 . . . . 0.0 108.533 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.04 -36.23 77.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.381 -0.824 . . . . 0.0 109.138 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.589 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -54.59 -48.79 71.72 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.972 -1.08 . . . . 0.0 108.954 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.754 HD13 ' CE1' ' A' ' 137' ' ' HIS . 8.3 tp -66.7 -38.53 86.93 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.824 -1.15 . . . . 0.0 109.695 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.91 -38.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.916 -1.115 . . . . 0.0 108.205 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.06 -36.46 64.34 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -59.77 -56.53 20.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.0 109.566 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . 0.433 HG23 ' N ' ' B' ' 243' ' ' LEU . 12.6 tt -61.12 -39.05 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.666 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.433 ' N ' HG23 ' B' ' 242' ' ' ILE . 2.5 mt -59.3 -54.87 41.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.003 . . . . 0.0 109.524 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.83 -50.81 55.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.13 -41.19 87.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.445 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' A' ' 155' ' ' PHE . 0.5 OUTLIER -53.0 -48.7 67.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.61 151.69 29.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -91.1 66.64 5.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.612 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -67.59 171.99 5.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.337 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 11.8 t -153.18 69.1 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.528 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -73.03 -20.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.425 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -55.6 -59.52 4.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -82.28 134.4 35.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.69 -170.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.558 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -149.09 -42.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.97 149.36 34.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -84.29 58.84 5.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 79.76 -154.93 38.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.454 ' N ' HD12 ' B' ' 259' ' ' LEU . 9.9 mp 51.49 -172.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.372 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 90.5 mttt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.012 -0.995 . . . . 0.0 109.46 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 88.1 p -53.26 -28.42 27.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 51.6 t30 54.82 73.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.548 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -62.51 -32.95 73.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.92 -178.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.53 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 58.1 m -151.04 -76.83 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -151.32 69.83 8.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.605 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.46 -27.33 54.52 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.286 1.324 . . . . 0.0 112.371 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.81 -55.21 28.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.519 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 66.6 t -52.81 -34.25 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' C' ' 331' ' ' ASN . 11.3 t -72.05 -66.07 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.03 -19.1 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.156 -0.965 . . . . 0.0 108.623 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.431 ' N ' ' C ' ' C' ' 328' ' ' VAL . . . -90.91 -25.17 19.93 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.474 -0.766 . . . . 0.0 109.116 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.83 HD21 HG11 ' B' ' 227' ' ' VAL . 0.5 OUTLIER -71.95 -38.61 69.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.48 -44.84 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.963 . . . . 0.0 109.286 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 9.0 tt -78.42 -28.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 108.743 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -63.59 -54.97 27.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.628 HG12 ' HB1' ' B' ' 230' ' ' ALA . 6.3 tp -63.28 -50.2 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -1.227 . . . . 0.0 108.823 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . 0.608 ' N ' HG23 ' C' ' 335' ' ' ILE . 3.7 mt -52.07 -37.85 55.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.103 -0.998 . . . . 0.0 108.756 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.736 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -60.0 -55.89 28.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.027 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.727 HD21 ' NE2' ' A' ' 137' ' ' HIS . 6.3 mt -50.27 -38.7 42.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.415 -0.803 . . . . 0.0 109.676 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 46.9 mt -68.37 -30.05 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -0.925 . . . . 0.0 109.7 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 tt -81.91 -52.64 6.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.822 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.628 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -53.14 -41.44 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.148 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.612 HG23 ' N ' ' C' ' 343' ' ' LEU . 10.1 tp -74.39 -47.87 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.97 -1.081 . . . . 0.0 109.872 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.612 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.3 tp -50.12 -30.5 11.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.046 -1.034 . . . . 0.0 109.141 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 348' ' ' PHE . 6.0 t0 -78.6 -46.41 19.39 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.901 . . . . 0.0 109.527 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -50.36 -33.88 22.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.461 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 10.7 mp -93.3 -51.73 4.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' C' ' 347' ' ' PHE . 34.5 m-85 -96.95 35.66 1.52 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.602 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.8 OUTLIER -47.87 -35.62 10.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.823 . . . . 0.0 109.536 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -63.7 -45.99 87.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.634 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 6.5 t -57.51 -47.57 81.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 13.6 mm -55.06 -50.09 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 109.542 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -54.22 -49.91 68.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.972 . . . . 0.0 109.529 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -65.02 -43.26 93.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 109.509 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -53.73 -36.05 61.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.614 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . 0.445 ' CE1' HD21 ' D' ' 446' ' ' LEU . 0.2 OUTLIER -75.62 -51.46 12.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.487 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -146.41 131.34 18.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.456 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . 0.402 ' ND1' ' N ' ' C' ' 357' ' ' HIS . 10.4 m80 -76.07 -54.61 6.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.396 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.96 128.07 0.32 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 3.4 mp -84.52 164.74 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -1.133 . . . . 0.0 109.37 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 89.4 mttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.423 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.293 0.568 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.9 t 56.74 171.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.52 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -163.66 175.21 10.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 2.5 t0 57.17 166.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 7.1 m -72.59 171.24 12.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 56.2 m -77.8 -10.33 59.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -156.77 69.59 4.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.653 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.54 -31.09 51.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.257 1.304 . . . . 0.0 112.359 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . 0.44 ' N ' HD12 ' D' ' 426' ' ' LEU . 11.0 mp -64.88 -62.19 1.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.821 HG11 HD21 ' A' ' 131' ' ' ASN . 39.4 t -50.26 -45.94 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.912 . . . . 0.0 109.208 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.84 -56.88 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.005 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.7 -37.56 18.96 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.603 ' HB1' HG12 ' A' ' 135' ' ' ILE . . . -69.87 -34.64 73.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.112 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -60.8 3.25 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.079 -1.013 . . . . 0.0 109.27 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.12 -41.96 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.177 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' D' ' 430' ' ' ALA . 18.7 mt -50.58 -37.84 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -63.62 -44.7 96.09 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.496 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.7 mp -58.59 -39.71 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -1.206 . . . . 0.0 108.483 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.02 -36.33 77.64 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.387 -0.82 . . . . 0.0 109.175 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.591 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -54.49 -48.76 71.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.041 -1.037 . . . . 0.0 108.998 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' C' ' 337' ' ' HIS . 8.4 tp -66.69 -38.55 87.0 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.687 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 3.1 mm -48.93 -38.1 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 108.163 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -36.5 64.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.7 -56.39 22.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.684 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . 0.431 HG23 ' N ' ' D' ' 443' ' ' LEU . 12.8 tt -61.33 -38.99 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . 0.431 ' N ' HG23 ' D' ' 442' ' ' ILE . 2.5 mt -59.22 -54.89 41.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.81 -50.87 55.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -59.06 -41.31 87.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . 0.445 HD21 ' CE1' ' C' ' 355' ' ' PHE . 0.5 OUTLIER -52.92 -48.74 67.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.64 151.68 29.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.405 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -91.12 66.62 5.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.161 -0.962 . . . . 0.0 109.593 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -67.61 171.95 5.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.319 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 11.9 t -153.13 69.12 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 13.5 pt -73.02 -20.88 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 109.465 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -55.55 -59.48 4.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -82.38 134.47 35.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.58 -170.62 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.07 -42.65 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.03 149.38 34.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -84.29 58.95 5.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.44 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 79.66 -154.92 38.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . 0.445 HD12 ' N ' ' D' ' 459' ' ' LEU . 9.9 mp 51.47 -172.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.417 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 90.6 mttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.447 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.493 HH22 ' CB ' ' B' ' 219' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -68.16 -15.03 63.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.21 -77.79 0.24 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.474 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 11.1 p30 -167.24 148.13 5.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.568 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.4 134.3 37.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.0 t -170.96 -171.33 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -146.77 70.78 12.48 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.88 -26.87 51.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.315 1.343 . . . . 0.0 112.524 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 126' ' ' LEU . 11.0 mp -59.7 -50.23 74.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.662 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.3 t -54.42 -35.86 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.504 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 131' ' ' ASN . 80.7 t -65.36 -62.89 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.92 -18.67 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.965 . . . . 0.0 108.52 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.492 ' HB1' ' ND2' ' B' ' 231' ' ' ASN . . . -88.95 -23.03 22.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.592 -0.692 . . . . 0.0 109.36 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -78.06 -38.01 45.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.608 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.14 -44.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 134' ' ' GLY . 12.4 tt -79.53 -38.98 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 0.0 109.179 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -54.24 -44.46 75.09 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.554 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.8 mt -69.82 -54.98 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -1.07 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.3 -33.48 13.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.09 -1.006 . . . . 0.0 108.67 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.721 ' ND1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -63.77 -59.01 5.1 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.645 HD21 ' NE2' ' C' ' 337' ' ' HIS . 5.6 mt -49.73 -37.72 30.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.483 -0.76 . . . . 0.0 109.697 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.9 mt -68.99 -30.71 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.08 -54.95 4.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.697 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.2 OUTLIER -50.25 -44.06 53.41 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.256 -0.903 . . . . 0.0 109.89 -179.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.76 HD13 ' NE2' ' D' ' 437' ' ' HIS . 4.2 tp -72.17 -45.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.617 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.578 ' N ' HG23 ' A' ' 142' ' ' ILE . 2.7 mt -49.46 -31.77 10.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.95 -1.094 . . . . 0.0 108.961 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 148' ' ' PHE . 8.2 t70 -77.62 -45.62 24.57 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.4 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -50.33 -34.46 23.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.86 . . . . 0.0 109.603 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 146' ' ' LEU . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.171 -0.955 . . . . 0.0 109.637 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.78 36.49 1.39 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.548 ' CE1' ' NH2' ' B' ' 245' ' ' ARG . 2.9 t80 -51.33 -34.15 32.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -64.45 -38.24 90.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.7 m -67.43 -53.47 28.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.49 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.4 mm -53.02 -35.93 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.436 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -69.91 -53.36 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -62.19 -33.91 75.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -60.48 -60.32 4.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.518 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -79.8 -69.64 0.57 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 65.48 174.96 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 155.99 38.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 86.18 92.44 0.88 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 159' ' ' LEU . 10.0 mp -66.68 -28.13 68.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mttm . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.54 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.493 ' CB ' HH22 ' A' ' 118' ' ' ARG . 29.1 t -167.17 63.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.0 109.415 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -78.87 -6.91 57.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -169.84 67.92 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 7.7 t -72.7 -39.65 66.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -83.92 -32.31 25.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 26.8 t0 53.55 70.51 1.74 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.69 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -65.17 -26.34 57.28 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.412 1.408 . . . . 0.0 112.466 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.03 -41.37 25.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.428 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.46 -39.75 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.43 -57.82 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.942 . . . . 0.0 109.481 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -46.92 -40.21 13.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.202 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -72.38 -35.47 68.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.492 ' ND2' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -65.74 -63.35 1.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 109.323 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.6 tp -49.55 -38.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.166 -0.959 . . . . 0.0 108.681 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.437 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.1 mt -56.44 -41.38 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 108.486 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.96 95.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.572 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.97 -51.53 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.293 . . . . 0.0 108.503 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.8 -37.95 77.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.757 . . . . 0.0 109.545 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.766 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.2 OUTLIER -52.61 -48.58 66.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.991 -1.068 . . . . 0.0 109.094 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.721 HD13 ' ND1' ' A' ' 137' ' ' HIS . 8.1 tp -65.84 -38.26 88.41 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.505 -1.278 . . . . 0.0 109.713 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 38.5 mm -49.44 -38.34 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.764 -1.21 . . . . 0.0 108.094 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 4.5 tt -73.98 -34.87 64.39 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -60.99 -56.56 19.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.485 -0.76 . . . . 0.0 109.346 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . 0.449 HG23 ' N ' ' B' ' 243' ' ' LEU . 12.5 tt -62.94 -38.57 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.5 -0.75 . . . . 0.0 109.619 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.449 ' N ' HG23 ' B' ' 242' ' ' ILE . 4.7 tp -62.18 -38.37 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.539 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.42 -48.13 71.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.349 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.548 ' NH2' ' CE1' ' A' ' 148' ' ' PHE . 0.5 OUTLIER -58.43 -40.74 83.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.413 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.15 -37.46 87.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.345 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.32 176.12 7.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.687 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.96 147.58 26.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.427 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -89.6 29.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 1.3 p -59.31 -16.36 21.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 9.7 mm -66.21 128.43 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.909 . . . . 0.0 109.44 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -63.26 171.74 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -82.94 164.2 20.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.02 168.05 24.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.573 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -147.19 161.47 40.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.51 170.78 14.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.43 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 54.28 66.06 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -166.08 4.3 0.05 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.39 168.89 17.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -1.163 . . . . 0.0 109.463 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.543 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . 0.494 HH22 ' CB ' ' D' ' 419' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 99.2 p -68.17 -15.02 63.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.29 -77.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.381 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' C' ' 321' ' ' ASP . 11.0 p30 -167.36 148.05 5.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.502 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.25 134.31 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 47.0 t -171.06 -171.52 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.409 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -146.65 70.84 12.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.574 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.86 -26.86 51.74 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.431 1.421 . . . . 0.0 112.569 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 326' ' ' LEU . 11.0 mp -59.8 -50.14 74.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.628 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.6 -35.8 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' C' ' 331' ' ' ASN . 89.1 t -65.18 -62.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.313 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -50.92 -18.79 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.143 -0.973 . . . . 0.0 108.529 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.492 ' HB1' ' ND2' ' D' ' 431' ' ' ASN . . . -89.12 -22.62 22.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.474 -0.766 . . . . 0.0 109.302 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' C' ' 328' ' ' VAL . 0.5 OUTLIER -78.15 -38.08 44.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.881 . . . . 0.0 109.584 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.415 HG13 ' H ' ' C' ' 332' ' ' ILE . 3.2 mt -51.08 -44.41 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . 0.433 HG23 ' N ' ' C' ' 334' ' ' GLY . 12.5 tt -79.46 -39.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.065 -1.022 . . . . 0.0 109.168 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . 0.433 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -54.18 -44.45 74.43 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' B' ' 230' ' ' ALA . 86.5 mt -69.8 -55.02 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.333 -1.098 . . . . 0.0 109.115 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.31 -33.52 13.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.665 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.706 ' ND1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -63.67 -58.98 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.428 -0.795 . . . . 0.0 108.92 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.662 HD21 ' NE2' ' A' ' 137' ' ' HIS . 5.6 mt -49.78 -37.68 30.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 50.7 mt -69.13 -30.68 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.07 -54.64 5.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -0.92 . . . . 0.0 109.666 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.2 OUTLIER -50.38 -44.18 54.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.97 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.766 HD13 ' NE2' ' B' ' 237' ' ' HIS . 4.2 tp -72.18 -45.42 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 109.6 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.564 ' N ' HG23 ' C' ' 342' ' ' ILE . 2.7 mt -49.48 -31.82 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 108.891 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' C' ' 348' ' ' PHE . 8.2 t70 -77.78 -45.47 24.48 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.445 -0.785 . . . . 0.0 109.457 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -50.23 -34.55 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.565 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . 0.47 HD23 ' O ' ' C' ' 346' ' ' LEU . 1.1 tt -92.93 -51.66 4.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -96.7 36.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.572 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.543 ' CE1' ' NH2' ' D' ' 445' ' ' ARG . 2.9 t80 -51.26 -34.2 31.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.578 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -64.42 -38.2 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.594 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 4.7 m -67.33 -53.46 29.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.566 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 16.3 mm -53.19 -35.72 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -69.97 -53.47 17.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -62.14 -33.9 75.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -60.46 -60.34 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -79.78 -69.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 65.43 174.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 155.92 39.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 92.49 0.89 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . 0.433 ' N ' HD12 ' C' ' 359' ' ' LEU . 10.0 mp -66.76 -28.07 68.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 38.1 mttm . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.494 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . 0.494 ' CB ' HH22 ' C' ' 318' ' ' ARG . 29.1 t -167.25 63.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.408 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -78.99 -6.9 57.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -169.85 67.88 0.05 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 7.6 t -72.64 -39.69 66.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.487 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -83.94 -32.32 25.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.422 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 26.8 t0 53.58 70.51 1.74 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.602 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.18 -26.39 57.22 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.423 1.416 . . . . 0.0 112.411 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.02 -41.25 25.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 427' ' ' VAL . 4.5 t -64.55 -39.65 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.138 -0.976 . . . . 0.0 109.597 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.56 -57.77 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -46.89 -40.22 13.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 109.219 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.554 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -72.31 -35.57 68.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.257 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.492 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -65.7 -63.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.259 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.417 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.6 tp -49.55 -38.24 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.166 -0.959 . . . . 0.0 108.632 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.417 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.1 mt -56.42 -41.41 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.151 -0.968 . . . . 0.0 108.469 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.94 95.92 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.565 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -58.92 -51.49 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.062 -1.258 . . . . 0.0 108.523 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.84 -37.85 77.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.594 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.76 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -52.67 -48.58 66.4 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 109.046 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.706 HD13 ' ND1' ' C' ' 337' ' ' HIS . 8.3 tp -65.76 -38.38 88.91 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.611 -1.236 . . . . 0.0 109.751 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 38.1 mm -49.38 -38.41 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.762 -1.211 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.0 -34.74 64.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -61.05 -56.38 21.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . 0.447 HG23 ' N ' ' D' ' 443' ' ' LEU . 12.7 tt -63.26 -38.4 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 109.639 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . 0.447 ' N ' HG23 ' D' ' 442' ' ' ILE . 4.7 tp -62.03 -38.62 89.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -66.32 -48.12 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.421 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.543 ' NH2' ' CE1' ' C' ' 348' ' ' PHE . 0.5 OUTLIER -58.4 -40.76 83.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.23 -37.4 87.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.299 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.39 176.12 7.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.69 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.06 147.57 26.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.902 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -89.63 29.96 1.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 1.3 p -59.24 -16.47 21.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 9.7 mm -66.16 128.44 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -63.31 171.58 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -82.83 164.24 20.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.11 168.03 25.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.92 . . . . 0.0 109.492 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -147.19 161.46 40.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.51 170.78 14.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 54.28 66.13 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -166.16 4.26 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 5.3 mt -82.4 169.03 16.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -1.126 . . . . 0.0 109.337 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.504 -179.951 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.8 m -154.56 70.99 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -156.06 -176.46 5.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -167.26 56.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.6 p -58.76 -72.65 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 109.494 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.4 m -152.28 13.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.7 t0 47.49 69.76 2.49 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.326 -0.858 . . . . 0.0 109.607 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.26 -27.15 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.342 1.362 . . . . 0.0 112.363 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 126' ' ' LEU . 10.9 mp -51.59 -55.36 19.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.479 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 59.8 t -51.55 -54.29 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 131' ' ' ASN . 62.3 t -48.5 -64.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.269 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.76 -19.42 0.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.949 . . . . 0.0 108.704 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 127' ' ' VAL . . . -83.46 -29.41 28.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.251 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' D' ' 431' ' ' ASN . 0.1 OUTLIER -74.72 -42.88 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.933 . . . . 0.0 109.39 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.424 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.6 mt -51.16 -43.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.604 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.535 ' CD1' HD12 ' B' ' 235' ' ' ILE . 6.3 tt -74.06 -36.26 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.005 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -50.89 -42.79 47.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.2 mt -71.46 -53.06 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.4 -1.059 . . . . 0.0 109.17 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.17 -37.9 23.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.188 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.856 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -67.54 -44.17 78.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.206 -0.934 . . . . 0.0 109.27 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.675 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.5 mt -60.61 -49.69 76.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.485 -0.759 . . . . 0.0 109.983 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.91 -24.05 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.55 HD22 HD21 ' B' ' 238' ' ' LEU . 2.6 tt -80.96 -59.95 2.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -0.94 . . . . 0.0 109.894 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.0 OUTLIER -50.59 -42.49 55.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.261 -0.9 . . . . 0.0 109.962 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.75 HD13 ' NE2' ' D' ' 437' ' ' HIS . 3.7 tp -72.77 -42.38 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.064 -1.022 . . . . 0.0 109.85 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.529 ' N ' HG23 ' A' ' 142' ' ' ILE . 4.9 mt -48.69 -40.69 29.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 0.0 109.096 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.5 OUTLIER -75.04 -39.1 61.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.486 -0.759 . . . . 0.0 109.341 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 145' ' ' ARG . 0.2 OUTLIER -51.03 -37.6 46.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.473 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.9 -48.49 6.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -94.99 35.27 1.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.461 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' ASP . 2.0 t80 -51.95 -33.7 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -68.73 -37.63 79.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 109.546 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.9 -57.81 3.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mm -52.53 -33.16 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.409 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -75.42 -56.67 4.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.14 -25.24 66.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -69.82 -39.44 76.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -44.34 97.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -52.16 -28.98 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.452 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -71.85 146.39 47.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 133.68 4.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.9 -33.32 68.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -1.152 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.8 mttp . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.463 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.463 ' C ' HD22 ' B' ' 220' ' ' ASN . 80.4 p -158.92 152.71 23.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.391 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . 0.463 HD22 ' C ' ' B' ' 219' ' ' SER . 1.0 OUTLIER 51.8 46.22 26.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.424 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' B' ' 222' ' ' SER . 21.8 t0 -91.6 151.59 20.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.47 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . 0.468 ' N ' ' OD1' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -148.32 -58.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 109.392 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 3.6 m -83.44 -1.66 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.13 70.29 1.89 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.56 -29.25 61.27 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.323 1.348 . . . . 0.0 112.524 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.15 -51.5 53.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.444 ' CG1' HD21 ' C' ' 331' ' ' ASN . 23.6 t -57.31 -41.55 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.4 -56.29 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.25 -38.43 12.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.248 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.28 66.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 109.375 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.549 ' CG ' ' HB1' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -67.3 -58.46 4.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.444 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.41 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.3 tp -54.01 -36.48 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.992 -1.067 . . . . 0.0 108.565 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.41 ' N ' HG23 ' B' ' 232' ' ' ILE . 8.4 mt -58.54 -44.44 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 108.728 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.84 -41.56 91.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.535 HD12 ' CD1' ' A' ' 133' ' ' ILE . 23.2 mm -61.18 -36.31 71.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.113 -1.227 . . . . 0.0 108.702 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' B' ' 239' ' ' ILE . 2.7 tt -67.72 -35.47 78.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.868 . . . . 0.0 108.858 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.753 ' NE2' HD13 ' C' ' 342' ' ' ILE . 0.3 OUTLIER -58.53 -51.85 68.15 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.856 HD13 ' CE1' ' A' ' 137' ' ' HIS . 14.0 tp -63.27 -38.99 93.33 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.619 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' B' ' 236' ' ' LEU . 13.9 mt -48.68 -43.35 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.901 -1.125 . . . . 0.0 108.464 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.88 -42.5 90.22 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -57.9 -43.89 86.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.32 -56.08 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 108.969 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.76 -21.17 62.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.944 . . . . 0.0 109.532 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -78.33 -60.67 2.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.375 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -59.03 -34.5 71.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.33 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.66 -47.98 57.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 17.3 t80 55.31 61.47 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.367 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.75 109.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -93.25 -170.09 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 17.7 t 49.75 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.22 -43.4 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.403 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -67.74 -132.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -155.84 1.69 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.8 -66.56 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.0 157.95 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -81.78 -39.6 23.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -158.38 132.24 7.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 164.31 -52.49 0.29 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 1.3 tt -164.02 108.81 1.01 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -1.128 . . . . 0.0 109.431 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 49.4 mttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.499 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 73.8 m -154.45 70.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -156.02 -176.42 5.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -167.22 56.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 2.5 p -58.76 -72.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 74.9 m -152.43 13.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 40.8 t0 47.53 69.76 2.49 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.29 -27.07 48.35 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.349 1.366 . . . . 0.0 112.394 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . 0.488 ' N ' HD12 ' C' ' 326' ' ' LEU . 10.9 mp -51.66 -55.29 20.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.905 . . . . 0.0 109.515 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . 0.629 ' O ' ' HB3' ' C' ' 330' ' ' ALA . 60.0 t -51.59 -54.38 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 109.197 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.42 ' C ' ' N ' ' C' ' 330' ' ' ALA . 65.9 t -48.44 -64.43 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . . . . . . . . . . . -49.73 -19.54 0.65 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.237 -0.915 . . . . 0.0 108.733 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' C' ' 327' ' ' VAL . . . -83.64 -29.07 27.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.393 -0.817 . . . . 0.0 109.208 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.444 HD21 ' CG1' ' B' ' 227' ' ' VAL . 0.1 OUTLIER -74.65 -43.01 57.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.417 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.7 mt -51.02 -43.84 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.37 -0.831 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' D' ' 435' ' ' ILE . 6.6 tt -73.9 -36.3 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.125 -0.984 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -50.93 -42.73 47.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . . . . . . . . . 6.1 mt -71.46 -53.17 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.374 -1.074 . . . . 0.0 109.181 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 1.5 tp -49.09 -37.91 22.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.173 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.844 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -67.54 -44.2 78.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.675 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.4 mt -60.6 -49.84 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 77.1 mt -66.71 -24.25 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.965 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . 0.528 HD22 HD21 ' D' ' 438' ' ' LEU . 2.7 tt -81.06 -59.47 2.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 109.854 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.621 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.0 OUTLIER -50.97 -42.59 60.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 110.006 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.753 HD13 ' NE2' ' B' ' 237' ' ' HIS . 3.8 tp -72.57 -42.57 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.985 -1.072 . . . . 0.0 109.611 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.536 ' N ' HG23 ' C' ' 342' ' ' ILE . 4.9 mt -48.62 -40.64 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 109.192 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.5 OUTLIER -75.16 -38.96 60.71 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.389 -0.82 . . . . 0.0 109.369 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' C' ' 345' ' ' ARG . 0.3 OUTLIER -51.11 -37.47 46.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.429 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.03 -48.48 6.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -94.9 35.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 344' ' ' ASP . 2.0 t80 -51.95 -33.68 38.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.554 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -68.72 -37.64 79.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.83 -57.93 3.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 1.6 mm -52.43 -33.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.439 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -75.44 -56.76 4.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.404 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -61.11 -25.13 66.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -69.93 -39.23 76.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -44.36 97.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.96 . . . . 0.0 109.432 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -52.18 -28.95 20.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -71.73 146.23 48.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . -147.3 133.68 4.85 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.92 -33.31 68.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 21.6 mttp . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.419 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . 0.451 ' C ' HD22 ' D' ' 420' ' ' ASN . 79.6 p -158.93 152.73 23.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . 0.451 HD22 ' C ' ' D' ' 419' ' ' SER . 1.0 OUTLIER 51.83 46.17 27.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.434 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' D' ' 422' ' ' SER . 21.8 t0 -91.55 151.6 20.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.497 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . 0.461 ' N ' ' OD1' ' D' ' 421' ' ' ASP . 0.0 OUTLIER -148.31 -58.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.373 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 3.6 m -83.47 -1.69 54.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.373 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.15 70.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.517 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.56 -29.2 61.35 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.34 1.36 . . . . 0.0 112.495 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.19 -51.56 52.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.337 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.402 ' CG1' HD21 ' A' ' 131' ' ' ASN . 24.3 t -57.3 -41.52 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.41 -56.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.49 13.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.176 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.97 -35.31 66.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 109.383 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.548 ' ND2' ' HB1' ' C' ' 330' ' ' ALA . 0.1 OUTLIER -67.22 -58.46 4.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.403 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.3 tp -53.95 -36.54 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 108.602 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.403 ' N ' HG23 ' D' ' 432' ' ' ILE . 8.4 mt -58.45 -44.45 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.152 -0.968 . . . . 0.0 108.762 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.77 -41.65 90.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' C' ' 333' ' ' ILE . 23.1 mm -61.24 -36.26 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -1.187 . . . . 0.0 108.645 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' D' ' 439' ' ' ILE . 2.7 tt -67.7 -35.44 78.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.341 -0.849 . . . . 0.0 108.913 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.75 ' NE2' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -58.56 -51.89 67.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.107 -0.995 . . . . 0.0 108.977 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.844 HD13 ' CE1' ' C' ' 337' ' ' HIS . 14.4 tp -63.09 -39.23 94.1 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.562 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' D' ' 436' ' ' LEU . 14.0 mt -48.62 -43.35 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.814 -1.179 . . . . 0.0 108.453 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.96 -42.55 89.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.94 -43.67 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.758 . . . . 0.0 109.344 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.57 -55.88 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 108.994 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.81 -21.13 62.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.39 -60.66 2.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -58.98 -34.53 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.872 . . . . 0.0 109.343 179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.73 -47.94 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 17.0 t80 55.23 61.51 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.493 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.76 109.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.162 -0.961 . . . . 0.0 109.511 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -93.21 -170.09 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 17.8 t 49.75 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.16 -43.44 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.448 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -67.71 -132.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.415 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -155.83 1.71 0.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.452 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.84 -66.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.48 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.02 158.01 3.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -81.83 -39.57 23.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -158.4 132.24 7.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 164.32 -52.55 0.29 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 1.3 tt -163.99 108.8 1.01 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 49.0 mttp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.547 -179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -53.97 111.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -149.47 -67.71 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.47 120.55 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.23 -52.3 64.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.47 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.5 p -161.34 43.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.402 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 128' ' ' VAL . 2.2 m-20 48.71 70.41 2.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.315 -0.865 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.05 -28.7 57.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.32 1.347 . . . . 0.0 112.518 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 126' ' ' LEU . 10.8 mp -76.31 -44.68 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.883 . . . . 0.0 109.766 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.65 -45.99 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 110.079 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 129' ' ' ALA . 32.9 m -69.43 -51.43 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.669 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -64.17 -14.97 58.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.44 -48.65 5.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.757 HD21 HG11 ' D' ' 427' ' ' VAL . 0.0 OUTLIER -77.84 -50.4 12.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.484 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 3.8 mm -47.61 -44.54 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.944 . . . . 0.0 109.469 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 134' ' ' GLY . 11.1 tt -72.41 -37.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.012 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 133' ' ' ILE . . . -52.17 -49.8 48.59 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.924 HG21 ' HB1' ' D' ' 430' ' ' ALA . 11.0 mm -65.23 -55.05 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -1.217 . . . . 0.0 109.289 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.4 -33.83 14.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.811 ' CE1' HD13 ' B' ' 238' ' ' LEU . 0.0 OUTLIER -63.97 -60.25 3.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.837 . . . . 0.0 109.401 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' C' ' 337' ' ' HIS . 4.7 mt -49.05 -39.68 28.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.712 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.7 mt -69.18 -27.72 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.413 HD22 HD21 ' B' ' 238' ' ' LEU . 4.2 tt -82.78 -54.11 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.12 -0.988 . . . . 0.0 109.627 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.1 OUTLIER -51.89 -42.49 62.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 143' ' ' LEU . 10.3 tp -72.82 -45.26 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.596 ' N ' HG23 ' A' ' 142' ' ' ILE . 3.0 mt -49.12 -33.73 12.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.276 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 148' ' ' PHE . 3.9 t70 -78.78 -43.57 25.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.333 -0.855 . . . . 0.0 109.655 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.565 ' NH1' ' CD1' ' D' ' 441' ' ' TRP . 25.5 ttt180 -50.1 -39.51 42.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.877 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.13 -53.52 3.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 109.854 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -96.04 36.47 1.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -47.88 -29.15 3.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -69.03 -33.38 73.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.1 t -75.21 -52.34 11.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 mm -65.59 -21.24 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.546 ' HH ' ' CE1' ' A' ' 157' ' ' HIS . 82.4 t80 -84.57 -47.91 10.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.393 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.307 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -72.98 -57.53 3.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.24 -58.3 8.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.536 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.38 142.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.546 ' CE1' ' HH ' ' A' ' 152' ' ' TYR . 10.2 m80 -58.64 143.9 44.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.446 ' C ' ' N ' ' A' ' 160' ' ' LYS . . . -83.74 -112.3 0.57 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 49.54 15.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -1.108 . . . . 0.0 109.351 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' N ' ' C ' ' A' ' 158' ' ' GLY . 17.7 pttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.95 110.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -167.15 50.64 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -153.23 89.38 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 1.6 t 62.01 104.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -153.37 127.45 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -148.41 69.17 10.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.33 -40.18 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.28 1.32 . . . . 0.0 112.343 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . 0.777 HG11 HD21 ' C' ' 331' ' ' ASN . 16.7 t -52.48 -44.63 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.361 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' B' ' 231' ' ' ASN . 4.8 t -53.86 -56.67 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -48.14 -38.42 17.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 108.806 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -70.52 -28.83 65.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.327 -0.858 . . . . 0.0 109.076 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 228' ' ' VAL . 7.2 m-20 -69.04 -63.79 0.99 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.215 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 6.7 tp -49.05 -36.35 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' B' ' 230' ' ' ALA . 20.2 mt -58.96 -41.07 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 231' ' ' ASN . . . -56.87 -42.86 92.47 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.597 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.7 mp -61.22 -41.03 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -1.23 . . . . 0.0 108.662 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . 0.521 ' HA ' HD12 ' B' ' 239' ' ' ILE . 0.5 OUTLIER -67.45 -35.28 78.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 0.0 109.089 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.522 ' CE1' HD22 ' C' ' 338' ' ' LEU . 0.3 OUTLIER -56.87 -48.96 76.91 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.167 -0.958 . . . . 0.0 109.414 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.811 HD13 ' CE1' ' A' ' 137' ' ' HIS . 9.5 tp -68.1 -35.13 77.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.701 -1.2 . . . . 0.0 109.761 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' B' ' 236' ' ' LEU . 13.5 mt -50.56 -41.9 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.726 -1.233 . . . . 0.0 108.104 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tt -69.96 -40.59 75.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . 0.553 ' CD1' ' NH1' ' C' ' 345' ' ' ARG . 88.3 t90 -54.45 -55.93 23.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.446 -0.784 . . . . 0.0 109.05 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 66.1 mt -53.12 -54.48 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.04 -53.98 23.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 109.564 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -52.88 -28.13 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -74.64 -48.37 26.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.888 . . . . 0.0 109.516 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 246' ' ' LEU . 10.9 mp -63.29 -47.47 82.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -86.73 86.13 7.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 0.0 109.529 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . 0.404 ' C ' ' H ' ' B' ' 250' ' ' SER . 48.0 p90 -69.4 -5.52 24.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.07 18.06 0.54 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . 0.404 ' H ' ' C ' ' B' ' 248' ' ' PHE . 23.3 t -47.88 -32.02 5.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.895 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.76 117.03 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.415 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -87.12 124.26 33.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.477 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -85.42 44.91 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 50.39 -169.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 49.79 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.79 78.6 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 109.557 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 52.33 -175.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.587 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 70.66 -84.79 0.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . 0.441 ' N ' HD12 ' B' ' 259' ' ' LEU . 10.9 mp -76.96 148.84 36.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -1.15 . . . . 0.0 109.368 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 83.5 tttt . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.49 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 3.5 p -54.06 111.28 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.384 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -149.48 -67.75 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -71.48 120.62 17.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.27 -52.25 65.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -0.867 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 80.5 p -161.34 43.73 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.442 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . 0.422 ' O ' HG22 ' C' ' 328' ' ' VAL . 2.2 m-20 48.82 70.39 2.11 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.408 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.08 -28.64 56.92 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.345 1.363 . . . . 0.0 112.484 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . 0.435 ' N ' HD12 ' C' ' 326' ' ' LEU . 10.8 mp -76.43 -44.68 34.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.742 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 96.2 t -62.73 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.973 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.658 HG23 ' N ' ' C' ' 329' ' ' ALA . 32.9 m -69.4 -51.53 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.963 . . . . 0.0 109.8 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.658 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -64.19 -14.82 57.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -95.78 -48.3 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.069 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.777 HD21 HG11 ' B' ' 227' ' ' VAL . 0.0 OUTLIER -77.92 -50.57 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.998 -179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.479 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 3.9 mm -47.31 -44.84 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . 0.411 HG23 ' N ' ' C' ' 334' ' ' GLY . 11.2 tt -72.19 -38.01 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.083 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . 0.411 ' N ' HG23 ' C' ' 333' ' ' ILE . . . -52.19 -49.75 48.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.94 HG21 ' HB1' ' B' ' 230' ' ' ALA . 11.5 mm -65.36 -55.01 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -1.22 . . . . 0.0 109.279 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 3.8 mp -49.36 -33.91 14.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.233 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.805 ' CE1' HD13 ' D' ' 438' ' ' LEU . 0.0 OUTLIER -63.89 -60.4 3.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.84 . . . . 0.0 109.297 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.78 HD21 ' NE2' ' A' ' 137' ' ' HIS . 4.8 mt -48.91 -39.64 26.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.758 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 11.0 mt -69.33 -27.73 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . 0.401 HD22 HD21 ' D' ' 438' ' ' LEU . 4.0 tt -82.98 -53.53 5.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.637 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.619 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -52.28 -42.51 63.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.595 HG23 ' N ' ' C' ' 343' ' ' LEU . 10.3 tp -72.72 -45.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.0 109.519 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.595 ' N ' HG23 ' C' ' 342' ' ' ILE . 3.0 mt -49.14 -33.69 12.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 109.313 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' C' ' 348' ' ' PHE . 3.7 t70 -78.94 -43.41 24.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . 0.553 ' NH1' ' CD1' ' B' ' 241' ' ' TRP . 25.4 ttt180 -50.2 -39.51 44.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.04 -53.75 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -95.92 36.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.0 OUTLIER -47.81 -29.13 2.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -69.21 -33.31 73.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 32.1 t -75.15 -52.25 11.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.63 -21.25 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . 0.532 ' HH ' ' CE1' ' C' ' 357' ' ' HIS . 82.7 t80 -84.58 -47.83 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.893 . . . . 0.0 109.426 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -64.44 -24.64 67.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.315 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -72.99 -57.61 3.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.14 -58.32 8.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.38 142.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . 0.532 ' CE1' ' HH ' ' C' ' 352' ' ' TYR . 10.1 m80 -58.72 143.93 45.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 109.373 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . 0.449 ' C ' ' N ' ' C' ' 360' ' ' LYS . . . -83.89 -112.29 0.59 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 49.62 15.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 109.319 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . 0.449 ' N ' ' C ' ' C' ' 358' ' ' GLY . 17.6 pttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.94 110.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -167.23 50.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -153.28 89.3 1.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.424 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 1.6 t 62.03 104.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 6.3 t -153.45 127.43 8.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -148.45 69.13 10.36 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.704 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.31 -40.17 33.64 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.276 1.318 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -60.35 3.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 131' ' ' ASN . 16.9 t -52.46 -44.59 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.352 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' D' ' 431' ' ' ASN . 4.8 t -53.9 -56.72 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.345 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -48.0 -38.57 17.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 108.859 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.924 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -70.5 -28.81 65.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.343 -0.848 . . . . 0.0 109.099 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' D' ' 428' ' ' VAL . 7.2 m-20 -68.98 -63.88 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.194 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . . . . . . . . . 6.7 tp -48.93 -36.39 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' D' ' 430' ' ' ALA . 20.2 mt -59.01 -41.03 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' D' ' 431' ' ' ASN . . . -56.99 -42.8 93.06 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.594 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.7 mp -61.22 -40.97 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.14 -1.212 . . . . 0.0 108.631 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . 0.516 ' HA ' HD12 ' D' ' 439' ' ' ILE . 0.5 OUTLIER -67.59 -35.16 78.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.062 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.515 ' CE1' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -56.77 -49.21 75.99 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.362 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.805 HD13 ' CE1' ' C' ' 337' ' ' HIS . 9.9 tp -67.92 -35.27 78.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.712 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' D' ' 436' ' ' LEU . 13.5 mt -50.52 -41.9 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.708 -1.245 . . . . 0.0 108.104 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 3.0 tt -70.0 -40.56 75.2 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . 0.565 ' CD1' ' NH1' ' A' ' 145' ' ' ARG . 89.0 t90 -54.31 -55.98 22.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 109.102 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 65.8 mt -53.18 -54.46 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 4.3 mp -50.01 -53.99 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 0.0 109.537 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -52.82 -28.27 21.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.341 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -74.56 -48.31 27.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.598 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . 0.423 ' N ' HD12 ' D' ' 446' ' ' LEU . 10.8 mp -63.37 -47.46 82.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.553 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -86.66 86.18 7.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -69.48 -5.55 24.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -78.02 18.08 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.35 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 23.3 t -47.93 -31.97 5.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 89.8 mt -79.74 117.07 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 109.445 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -87.24 124.29 33.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -85.44 44.97 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.572 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 50.33 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.858 . . . . 0.0 109.561 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 49.88 88.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.409 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.82 78.7 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.535 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 52.31 -175.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.528 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . 70.57 -84.72 0.35 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . 0.443 HD12 ' N ' ' D' ' 459' ' ' LEU . 10.9 mp -76.95 148.82 36.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 83.4 tttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.454 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.1 m -68.65 -81.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -61.76 -31.02 71.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 t70 53.0 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.494 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.6 p -167.4 164.25 15.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.56 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.12 -8.19 59.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -165.07 70.9 1.41 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.07 -27.51 49.75 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.385 1.39 . . . . 0.0 112.53 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -74.06 -45.48 49.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.868 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.91 -51.18 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.701 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.687 HG23 ' N ' ' A' ' 129' ' ' ALA . 35.0 m -64.84 -54.73 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.716 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.687 ' N ' HG23 ' A' ' 128' ' ' VAL . . . -54.92 -23.53 19.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.99 . . . . 0.0 109.185 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.47 -20.34 22.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -0.861 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 128' ' ' VAL . 0.4 OUTLIER -74.75 -43.66 53.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.482 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 131' ' ' ASN . 8.7 mt -51.06 -45.8 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.489 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 8.2 tt -71.74 -36.36 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 108.891 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -55.45 -40.66 78.22 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.655 HG21 ' HB1' ' D' ' 430' ' ' ALA . 85.0 mt -67.96 -56.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.419 -1.048 . . . . 0.0 109.071 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.56 -35.87 42.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 108.792 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.916 ' NE2' HD21 ' C' ' 338' ' ' LEU . 0.0 OUTLIER -58.5 -59.25 5.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.12 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.881 HD21 ' NE2' ' C' ' 337' ' ' HIS . 11.2 mt -53.25 -51.42 62.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 75.4 mt -54.01 -31.68 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.655 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.15 -58.63 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -0.976 . . . . 0.0 109.552 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' C' ' 341' ' ' TRP . 0.5 OUTLIER -50.95 -50.94 56.96 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.553 HD12 ' ND1' ' D' ' 437' ' ' HIS . 2.0 tt -61.72 -41.99 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.488 ' N ' HG23 ' A' ' 142' ' ' ILE . 4.8 mt -54.2 -35.9 62.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.979 -1.075 . . . . 0.0 108.978 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -76.35 -29.36 57.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.823 . . . . 0.0 109.416 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.32 -35.28 79.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.27 -15.33 20.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.714 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -144.11 39.17 1.32 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 109.649 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' ASP . 0.1 OUTLIER -47.86 -33.33 7.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.521 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.75 -39.29 93.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.392 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.0 m -67.13 -48.59 67.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 151' ' ' ILE . 1.7 mp -63.94 -30.24 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -73.07 -50.37 23.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.87 -38.46 83.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 109.41 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -59.21 -42.25 90.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.463 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.04 -11.43 60.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -148.87 116.09 6.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.447 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -151.23 -24.45 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.03 100.81 0.14 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.93 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.252 -1.146 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.422 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 3.0 m 57.46 102.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' B' ' 220' ' ' ASN . 0.1 OUTLIER -83.29 104.5 13.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.405 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -85.12 106.48 16.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.487 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 2.9 t -74.88 109.32 8.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.09 150.49 11.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.79 70.84 5.31 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.31 -27.01 55.8 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.33 1.353 . . . . 0.0 112.417 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.92 -60.59 2.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.17 -0.957 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 t -55.51 -39.02 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.481 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.39 -56.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -47.45 -43.28 23.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.239 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.736 ' HB1' HG21 ' C' ' 335' ' ' ILE . . . -69.53 -30.35 68.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.337 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.31 -65.16 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.427 HG23 ' N ' ' B' ' 233' ' ' ILE . 8.4 tp -49.92 -37.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.177 -0.952 . . . . 0.0 108.675 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' B' ' 230' ' ' ALA . 13.2 mt -54.75 -45.89 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -56.47 -46.2 88.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.526 ' N ' HD12 ' B' ' 235' ' ' ILE . 1.8 mp -58.0 -53.93 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -1.167 . . . . 0.0 108.93 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.35 -38.18 71.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 0.0 109.424 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' HIS . . . . . 0.809 ' CD2' HD22 ' C' ' 338' ' ' LEU . 0.1 OUTLIER -53.51 -47.21 70.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.088 -1.008 . . . . 0.0 109.375 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . 0.743 HD13 ' ND1' ' A' ' 137' ' ' HIS . 7.4 tp -67.81 -36.36 80.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.812 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' ILE . . . . . . . . . . . . . 39.3 mm -50.04 -39.89 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.764 -1.21 . . . . 0.0 107.894 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -37.47 69.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.4 -57.61 12.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.63 -54.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.258 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.65 -52.17 32.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.77 -33.8 57.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' B' ' 245' ' ' ARG . 0.0 OUTLIER -65.29 -52.98 50.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.461 ' N ' HD12 ' B' ' 246' ' ' LEU . 10.9 mp -60.16 -33.13 71.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' PHE . . . . . 0.421 ' CB ' ' O ' ' B' ' 246' ' ' LEU . 2.2 t80 71.21 -3.52 2.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' PHE . . . . . . . . . . . . . 2.2 t80 62.49 154.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -89.68 124.02 34.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' SER . . . . . . . . . . . . . 1.5 m -85.64 -9.58 57.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 69.4 mt 47.91 87.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.25 91.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -52.02 161.67 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' B' ' 255' ' ' PHE . 37.9 t80 -148.96 167.65 25.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' B' ' 254' ' ' PHE . 0.0 OUTLIER -150.24 140.69 22.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.908 . . . . 0.0 109.513 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.26 168.41 13.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.62 154.91 39.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -80.6 -149.08 5.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.16 167.93 20.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -1.071 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' LYS . . . . . . . . . . . . . 18.8 tttp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.427 -179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 318' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.304 0.574 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 319' ' ' SER . . . . . . . . . . . . . 33.0 m -68.65 -81.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.955 . . . . 0.0 109.494 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 320' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.76 -31.03 71.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 321' ' ' ASP . . . . . . . . . . . . . 7.5 t70 52.97 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 322' ' ' SER . . . . . . . . . . . . . 1.6 p -167.35 164.36 15.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 323' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -7.97 59.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 324' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -165.22 70.94 1.38 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.544 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 325' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.03 -27.5 50.04 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.407 1.404 . . . . 0.0 112.55 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 326' ' ' LEU . . . . . . . . . . . . . 7.8 mt -74.13 -45.49 48.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 327' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.88 -51.23 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.716 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . 0.681 HG23 ' N ' ' C' ' 329' ' ' ALA . 34.8 m -64.77 -54.85 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.715 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 329' ' ' ALA . . . . . 0.681 ' N ' HG23 ' C' ' 328' ' ' VAL . . . -54.85 -23.48 18.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.248 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 330' ' ' ALA . . . . . . . . . . . . . . . -90.63 -20.17 22.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 331' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' C' ' 328' ' ' VAL . 0.4 OUTLIER -74.8 -43.66 53.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 332' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' C' ' 331' ' ' ASN . 8.8 mt -50.96 -46.0 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.414 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.52 -36.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.164 -0.96 . . . . 0.0 108.986 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 334' ' ' GLY . . . . . . . . . . . . . . . -55.56 -40.64 79.06 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 335' ' ' ILE . . . . . 0.736 HG21 ' HB1' ' B' ' 230' ' ' ALA . 82.0 mt -67.93 -56.29 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.343 -1.093 . . . . 0.0 109.057 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 336' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.51 -35.93 42.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.928 . . . . 0.0 108.766 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 337' ' ' HIS . . . . . 0.881 ' NE2' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -58.41 -59.18 5.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.184 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 338' ' ' LEU . . . . . 0.916 HD21 ' NE2' ' A' ' 137' ' ' HIS . 11.1 mt -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 339' ' ' ILE . . . . . . . . . . . . . 75.6 mt -54.24 -31.53 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.38 -58.1 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.494 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 341' ' ' TRP . . . . . 0.631 ' CH2' ' CH2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -51.37 -50.76 58.9 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.394 -0.816 . . . . 0.0 109.635 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 342' ' ' ILE . . . . . 0.614 HD12 ' ND1' ' B' ' 237' ' ' HIS . 2.0 tt -61.94 -41.94 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 343' ' ' LEU . . . . . 0.481 ' N ' HG23 ' C' ' 342' ' ' ILE . 4.9 mt -53.95 -36.14 62.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.968 -1.083 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 344' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' C' ' 348' ' ' PHE . 0.0 OUTLIER -76.28 -29.33 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.505 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 345' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -67.36 -35.3 79.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 346' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.21 -15.28 20.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.399 -0.813 . . . . 0.0 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 347' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -144.13 39.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.672 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 348' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 344' ' ' ASP . 0.1 OUTLIER -47.95 -33.29 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.457 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 349' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.75 -39.34 94.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 350' ' ' SER . . . . . . . . . . . . . 25.6 m -67.04 -48.7 67.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.422 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 351' ' ' ILE . . . . . 0.481 HD12 ' N ' ' C' ' 351' ' ' ILE . 1.7 mp -63.91 -30.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 352' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -73.15 -50.38 22.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 353' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -67.8 -38.5 83.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 354' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.08 -42.3 90.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 355' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -79.15 -11.39 59.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.898 . . . . 0.0 109.443 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 356' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -148.9 116.09 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.519 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 357' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -151.2 -24.51 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 358' ' ' GLY . . . . . . . . . . . . . . . 178.01 100.93 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 359' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.81 -174.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -1.161 . . . . 0.0 109.476 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.469 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 418' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 419' ' ' SER . . . . . . . . . . . . . 3.0 m 57.54 102.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 420' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' D' ' 420' ' ' ASN . 0.1 OUTLIER -83.23 104.52 13.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 421' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.22 106.52 16.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 422' ' ' SER . . . . . . . . . . . . . 2.9 t -74.94 109.3 8.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 423' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.03 150.57 11.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.88 70.68 5.25 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 425' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.23 -27.09 56.37 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.306 1.337 . . . . 0.0 112.406 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 426' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.8 -60.66 2.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 427' ' ' VAL . . . . . 0.431 HG23 ' H ' ' D' ' 427' ' ' VAL . 4.9 t -55.48 -39.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 109.499 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 428' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.32 -56.82 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 429' ' ' ALA . . . . . . . . . . . . . . . -47.4 -43.37 23.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 430' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 135' ' ' ILE . . . -69.54 -30.3 68.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 431' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -67.3 -65.09 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 432' ' ' ILE . . . . . 0.426 HG23 ' N ' ' D' ' 433' ' ' ILE . 8.4 tp -49.89 -37.97 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 108.612 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 433' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' D' ' 430' ' ' ALA . 13.3 mt -54.67 -45.86 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 108.572 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 434' ' ' GLY . . . . . . . . . . . . . . . -56.51 -46.22 88.37 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 435' ' ' ILE . . . . . 0.523 HD12 ' N ' ' D' ' 435' ' ' ILE . 1.8 mp -58.05 -53.9 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 108.885 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 436' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.37 -38.16 71.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.44 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 437' ' ' HIS . . . . . 0.807 ' CD2' HD22 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -53.54 -47.16 70.25 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.101 -0.999 . . . . 0.0 109.272 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 438' ' ' LEU . . . . . 0.718 HD13 ' ND1' ' C' ' 337' ' ' HIS . 7.7 tp -67.87 -36.44 80.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.713 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 439' ' ' ILE . . . . . . . . . . . . . 39.1 mm -50.03 -39.88 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 107.862 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 440' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -37.33 68.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 441' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -58.31 -57.69 11.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.518 -0.738 . . . . 0.0 109.168 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 442' ' ' ILE . . . . . . . . . . . . . 67.0 mt -54.77 -53.9 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 443' ' ' LEU . . . . . . . . . . . . . 2.9 mp -49.64 -52.21 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.79 -33.73 56.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 445' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' D' ' 445' ' ' ARG . 0.0 OUTLIER -65.36 -52.97 50.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 446' ' ' LEU . . . . . 0.457 ' N ' HD12 ' D' ' 446' ' ' LEU . 10.9 mp -60.11 -33.05 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 109.39 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 447' ' ' PHE . . . . . 0.434 ' CB ' ' O ' ' D' ' 446' ' ' LEU . 2.2 t80 70.99 -3.37 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.607 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 448' ' ' PHE . . . . . . . . . . . . . 2.2 t80 62.43 154.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 449' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -89.66 124.05 34.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.338 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 450' ' ' SER . . . . . . . . . . . . . 1.4 m -85.68 -9.6 56.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 451' ' ' ILE . . . . . . . . . . . . . 69.3 mt 47.99 87.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 452' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.18 91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 453' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -52.03 161.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.484 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 454' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' D' ' 455' ' ' PHE . 38.0 t80 -148.97 167.63 25.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.332 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 455' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' D' ' 454' ' ' PHE . 0.0 OUTLIER -150.24 140.71 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 456' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.29 168.3 13.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.43 154.98 39.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.465 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 458' ' ' GLY . . . . . . . . . . . . . . . -80.57 -149.05 5.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 459' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.21 167.91 20.2 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 460' ' ' LYS . . . . . . . . . . . . . 18.7 tttp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.434 -180.0 . . . . . . . . 0 0 . 1 stop_ save_